concept_id	concept_synonym_name	language_concept_id
1018862	Other kids wanted to be with my child in past 7D	4180186
1018863	I shared with other kids (food, games, pens, etc.) in past 7D	4180186
1018868	My child was able to talk about everything with his or her friends in past 7D	4180186
1018869	My child has been physically able to do the activities he or she enjoys most in past 7D	4180186
1018870	My child could ride a bike in past 7D	4180186
1018871	My child could do sports and exercise that other kids his or her age could do in past 7D	4180186
1018873	My child could go up one step in past 7D	4180186
1018874	My child could run a mile in past 7D	4180186
1018875	My child could walk up stairs without holding on to anything in past 7D	4180186
1018876	My child could get up from a regular toilet in past 7D	4180186
1018877	My child could stand up on his or her tiptoes in past 7D	4180186
1018878	My child could turn his or her head all the way to the side in past 7D	4180186
1018880	My child could get into bed by himself or herself in past 7D	4180186
1018882	My child used a walker, cane or crutches to get around in past 7D	4180186
1018884	My child could get up from the floor in past 7D	4180186
1018886	My child could get in and out of a car in past 7D	4180186
1018887	My child could walk more than one block in past 7D	4180186
1018888	My child could keep up when he or she played with other kids in past 7D	4180186
1018889	My child could get out of bed by himself or herself in past 7D	4180186
1018900	Heart failure.team	4180186
1018905	Multi-specialty program.social worker	4180186
1018906	Mental health.social worker	4180186
1018908	Addiction medicine.social worker	4180186
1018909	Community health care.social worker	4180186
1018911	Primary care.social worker	4180186
1018924	Anesthesiology.attending	4180186
1018925	Cardiovascular disease.attending	4180186
1018926	Cardiovascular disease.fellow	4180186
1018931	Critical care medicine.attending	4180186
1018936	Endocrinology.attending	4180186
1018938	Endocrinology.resident	4180186
1018940	Gastroenterology.fellow	4180186
1018946	Gynecology.attending	4180186
1018948	Hematology+Medical oncology.attending	4180186
1018950	Hematology+Medical oncology.resident	4180186
1018952	Infectious disease.fellow	4180186
1018959	Mental health.resident	4180186
1018960	Nephrology.attending	4180186
1018962	Nephrology.resident	4180186
1018965	Neurology.attending	4180186
1018967	Nuclear medicine.attending	4180186
1018969	Obstetrics and gynecology.attending	4180186
1018970	Obstetrics and gynecology.resident	4180186
1018971	Obstetrics.attending	4180186
1018972	Obstetrics.resident	4180186
1018973	Ophthalmology.attending	4180186
1018979	Orthopaedic surgery.attending	4180186
1018983	Palliative care.attending	4180186
1018986	Physical medicine and rehab.attending	4180186
1018987	Physical medicine and rehab.resident	4180186
1018989	Plastic surgery.attending	4180186
1018990	Plastic surgery.fellow	4180186
1018991	Plastic surgery.resident	4180186
1018993	Podiatry.resident	4180186
1018995	Primary care.resident	4180186
1018996	Psychiatry.attending	4180186
1018998	Psychology.intern	4180186
1019000	Pulmonary disease.fellow	4180186
1019001	Pulmonary disease.resident	4180186
1019004	Radiology.attending	4180186
1019006	Rheumatology.fellow	4180186
1019008	Spinal cord injury medicine.attending	4180186
1019009	Spinal cord injury medicine.fellow	4180186
1019010	Spinal cord injury medicine.resident	4180186
1019011	Surgery.attending	4180186
1019013	Surgery.resident	4180186
1019015	Thoracic and cardiac surgery.fellow	4180186
1019016	Thoracic and cardiac surgery.resident	4180186
1019020	Urology.resident	4180186
1019021	Vascular surgery.attending	4180186
1019022	Vascular surgery.resident	4180186
1019056	DUKE-AD	4180186
1019061	I have had pain in the shoulder or neck at some time in the last 2W	4180186
1019062	I have only walked short distances because of my back pain in the last 2W	4180186
1019063	I have dressed more slowly than usual because of back pain in the last 2W	4180186
1019064	Thinking about the last 2W, it's not really safe for a person with a condition like mine to be physically active	4180186
1019065	Worrying thoughts have been going through my mind a lot of the time in the last 2W	4180186
1019066	Thinking about the last 2W, I feel that my back pain is terrible and it's never going to get any better	4180186
1019067	Thinking about the last 2W, in general I have not enjoyed all the things I used to enjoy	4180186
1019114	PUSH	4180186
1019130	Thromboelastography.resonance	4180186
1019137	When my child was in pain he or she tried not to move in past 7D	4180186
1019138	When my child was in pain his or her face looked sad in past 7D	4180186
1019139	When my child was in pain he or she asked for help with doing things in past 7D	4180186
1019141	When my child was in pain he or she moved stiffly in past 7D	4180186
1019142	When my child was in pain he or she yelled for someone to help him or her in past 7D	4180186
1019144	When my child was in pain he or she used something for support (cane, crutches, wheelchair) to move from place to place in past 7D	4180186
1019145	When my child was in pain he or she limped in past 7D	4180186
1019151	When my child was in pain he or she screamed in past 7D	4180186
1019153	When my child was in pain he or she tightened his or her jaw in past 7D	4180186
1019154	When my child was in pain he or she talked about his or her pain in past 7D	4180186
1019156	When my child was in pain he or she rubbed his or her body where it hurt in past 7D	4180186
1019157	When my child was in pain he or she moved slower in past 7D	4180186
1019165	When my child was in pain he or she went to sleep in past 7D	4180186
1019167	When my child was in pain he or she avoided lifting or carrying heavy things in past 7D	4180186
1019168	When my child was in pain he or she stayed near to someone who cares about him or her in past 7D	4180186
1019171	When my child was in pain he or she asked to see a doctor in past 7D	4180186
1019172	When my child was in pain he or she pulled away if someone touched him or her where it hurt in past 7D	4180186
1019173	When my child was in pain he or she argued with people in past 7D	4180186
1019174	When my child was in pain he or she avoided using the part of his or her body that hurt in past 7D	4180186
1019177	When my child was in pain he or she had a fixed or dazed expression in past 7D	4180186
1019179	When my child was in pain he or she had circles under his or her eyes in past 7D	4180186
1019180	When my child was in pain he or she sighed in past 7D	4180186
1019181	When my child was in pain he or she took breaks from what he or she was doing in past 7D	4180186
1019182	When my child was in pain he or she told people he or she couldn't do his or her usual chores in past 7D	4180186
1019186	When my child was in pain he or she lay down in past 7D	4180186
1019187	When my child was in pain he or she felt his or her body get tense in past 7D	4180186
1019230	I felt as if I needed to move my legs a lot in past 7D	4180186
1019231	A sudden noise made me jump in past 7D	4180186
1019232	My muscles felt tight in past 7D	4180186
1019233	I could not stay still for long in past 7D	4180186
1019234	My mouth was dry in past 7D	4180186
1019235	My breathing was fast, even when I was not exercising or playing hard in past 7D	4180186
1019236	My palms were sweaty in past 7D	4180186
1019237	I was sweaty, even when I was not exercising or playing hard in past 7D	4180186
1019238	My heart pounded, even when I was not exercising or playing hard in past 7D	4180186
1019239	My heart beat faster than usual, even when I was not exercising or playing hard in past 7D	4180186
1019240	I had trouble breathing, even when I was not exercising or playing hard in past 7D	4180186
1019244	My legs shook in past 7D	4180186
1019247	My neck hurt in past 7D	4180186
1019249	I had a bad stomach ache in past 7D	4180186
1019251	My appetite changed in past 7D	4180186
1019252	I felt some food coming up into my throat in past 7D	4180186
1019254	My neck felt tight in past 7D	4180186
1019257	My child felt like he or she couldn't do anything right in past 7D	4180186
1019258	My child felt everything in his or her life went wrong in past 7D	4180186
1019260	My child felt lonely in past 7D	4180186
1019261	My child felt unhappy in past 7D	4180186
1019262	My child felt too sad to eat in past 7D	4180186
1019263	My child didn't care about anything in past 7D	4180186
1019264	My child felt sad in past 7D	4180186
1019265	It was hard for my child to have fun in past 7D	4180186
1019269	My child got tired easily because of his or her asthma in past 7D	4180186
1019270	My child was bothered by asthma when he or she was with friends in past 7D	4180186
1019272	My child's body felt bad when he or she was out of breath in past 7D	4180186
1019274	It was hard for my child to play sports or exercise because of asthma in past 7D	4180186
1019275	My child had trouble sleeping at night because of asthma in past 7D	4180186
1019276	It was hard for my child to play with pets because of asthma in past 7D	4180186
1019278	My child felt wheezy because of his or her asthma in past 7D	4180186
1019279	My child had asthma attacks in past 7D	4180186
1019281	It was hard for my child to take a deep breath because of asthma in past 7D	4180186
1019282	My child had trouble breathing because of his or her asthma in past 7D	4180186
1019289	How many D were you strong enough to hold a full plate or tray of food in past 7D	4180186
1019290	How many D were you strong enough to get out of bed and stand without help in past 7D	4180186
1019291	How many D were you strong enough to jump up and down in past 7D	4180186
1019295	How many D were you strong enough to get down on the floor in past 7D	4180186
1019296	How many D were you strong enough to lift heavy things over your head in past 7D	4180186
1019298	How many D was your child strong enough to carry heavy things with his or her hands in past 7D	4180186
1019299	How many D was your child strong enough to go up and down stairs in past 7D	4180186
1019301	How many D was your child strong enough to open a heavy door in past 7D	4180186
1019303	How many D was your child strong enough to get out of bed and stand without help in past 7D	4180186
1019305	How many D was your child strong enough to pour a drink from a full pitcher or carton in past 7D	4180186
1019306	How many D was your child strong enough to open a jar by himself or herself in past 7D	4180186
1019312	Everything bothered me in past 7D	4180186
1019315	I felt overwhelmed in past 7D	4180186
1019319	I felt so upset that I could not remember what happened or what I did in past 7D	4180186
1019320	I had trouble concentrating in past 7D	4180186
1019321	I had trouble controlling my thoughts in past 7D	4180186
1019324	I felt unable to react to something that bothered me in past 7D	4180186
1019326	I felt I had too much going on in past 7D	4180186
1019327	My child felt concerned about what was going on in his or her life in past 7D	4180186
1019329	Everything bothered my child in past 7D	4180186
1019330	My child felt under pressure in past 7D	4180186
1019331	My child felt that his or her problems kept piling up in past 7D	4180186
1019334	My child had trouble concentrating in past 7D	4180186
1019335	My child's thoughts went very fast in past 7D	4180186
1019337	My child felt he or she had too much going on in past 7D	4180186
1019339	My child felt peaceful in past 7D	4180186
1019341	My child felt content in past 7D	4180186
1019342	My child felt grateful in past 7D	4180186
1019343	My child felt thankful in past 7D	4180186
1019345	My child felt carefree in past 7D	4180186
1019355	My child felt cheerful in past 7D	4180186
1019356	My child felt happy in past 7D	4180186
1019359	My child felt delighted in past 7D	4180186
1019363	My child felt merry in past 7D	4180186
1019367	My child felt blissful in past 7D	4180186
1019368	My child felt enthusiastic in past 7D	4180186
1019369	My child felt energetic in past 7D	4180186
1019370	My child had a lot of energy in past 7D	4180186
1019374	My child felt full of pep in past 7D	4180186
1019376	My child felt healthy in past 7D	4180186
1019377	I felt calm in past 7D	4180186
1019381	I felt grateful in past 7D	4180186
1019383	I felt positive in past 7D	4180186
1019385	I felt relaxed in past 7D	4180186
1019386	I felt comfortable in past 7D	4180186
1019387	I felt fulfilled in past 7D	4180186
1019388	I felt respected in past 7D	4180186
1019389	I felt appreciated in past 7D	4180186
1019393	I felt great in past 7D	4180186
1019394	I felt cheerful in past 7D	4180186
1019398	I felt delighted in past 7D	4180186
1019400	I smiled a lot in past 7D	4180186
1019402	I was merry in past 7D	4180186
1019403	I was in a good mood in past 7D	4180186
1019404	I was in good spirits in past 7D	4180186
1019409	I had a lot of energy in past 7D	4180186
1019411	I felt refreshed in past 7D	4180186
1019413	I felt full of pep in past 7D	4180186
1019416	How many D did you exercise so much that you breathed hard in past 7D	4180186
1019417	How many D did you play sports for 10M or more in past 7D	4180186
1019418	How many D were you so physically active that you sweated in past 7D	4180186
1019419	How many D did you exercise or play so hard that your body got tired in past 7D	4180186
1019420	How many D did you exercise or play so hard that your muscles burned in past 7D	4180186
1019421	How many D did you exercise or play so hard that you felt tired in past 7D	4180186
1019422	On a usual day, how physically active were you in past 7D	4180186
1019423	How many D did you exercise really hard for 10M or more in past 7D	4180186
1019424	How many D were you physically active for 10M or more in past 7D	4180186
1019426	How many D did your child exercise so much that he or she breathed hard in past 7D	4180186
1019428	How many D was your child so physically active that he or she sweated in past 7D	4180186
1019429	How many D did your child exercise or play so hard that his or her body got tired in past 7D	4180186
1019430	How many D did your child exercise or play so hard that his or her muscles burned in past 7D	4180186
1019432	On a usual day, how physically active was your child in past 7D	4180186
1019440	Twelve or more drinks in a D	4180186
1019441	Four or more drinks in 2H or less	4180186
1019443	Five or more drinks in a period of 2H or less	4180186
1019489	Have you been under or felt you were under any strain, stress, or pressure during the past Mo	4180186
1019490	Have you been anxious, worried, or upset during the past Mo	4180186
1019505	ORT	4180186
1019515	Plasma cells.abnormal	4180186
1019520	Bacterial cephalosporin resistance (bla(CTX-M)) gene	4180186
1019548	Because of my health situation I have problems in my work with fatigue AndOr lack of energy	4180186
1019552	QWLQ-CS	4180186
1019555	Percent intake by artificial route during the last 7D	4180186
1019626	Bld/Bone mar^Donor	4180186
1019627	Bld^Father	4180186
1019660	PPP^Fetus	4180186
1019662	PRP^Donor	4180186
1019670	Ser/Plas/Bld^Donor	4180186
1019671	Ser/Plas^Fetus	4180186
1019679	Amnio fld cells	4180186
1019750	BldCoA	4180186
1019752	BldCoV	4180186
1019869	Lung.FNA	4180186
1019904	J little o super little a	4180186
1019913	PlasA	4180186
1019914	PlasV	4180186
1019915	Lymph node.FNA	4180186
1019918	Salivary gland.FNA	4180186
1019919	Prostate.FNA	4180186
1019920	Liver.FNA	4180186
1019921	Pancreas.FNA	4180186
1019923	Soft tissue.FNA	4180186
1019925	Pelvis.FNA	4180186
1019929	Bld^control	4180186
1019932	Heart.atrium.right.mid	4180186
1019935	Aggl.cord RBC	4180186
1019937	3D 37 deg C incubation	4180186
1019939	Cytology.non-gyn	4180186
1019941	TPN	4180186
1019944	Allergic & immunologic	4180186
1019954	Anterior chamber.left	4180186
1019957	Adrenal artery.bilateral	4180186
1019958	Carotid artery.external.bilateral	4180186
1019961	Biliary duct.common	4180186
1019963	Bld^BPU	4180186
1019964	Bld^Donor	4180186
1019968	Brachiocephalic artery.left	4180186
1019972	Carotid artery.extracranial	4180186
1019973	Carotid artery.intracranial	4180186
1019980	Choroidea.right	4180186
1019981	Ciliary body.left	4180186
1019990	Contact lens.prescription.right	4180186
1019991	Contact lens.right	4180186
1019992	Cornea.left	4180186
1020001	Eye lid.left	4180186
1020002	Eye lid.right	4180186
1020014	Glasses prescription.lens.left	4180186
1020027	Heart.interventricular septum.defect	4180186
1020044	Iris.right	4180186
1020046	Kidney.bilateral+Collecting system+Renal vessels	4180186
1020047	Lacrimal gland.left	4180186
1020050	Liver+Pancreas	4180186
1020053	LM glasses.lens.right	4180186
1020055	Mastoid.left	4180186
1020059	Mouth & throat	4180186
1020069	Pelvis+Fetus	4180186
1020070	Pelvis>Symphysis pubis	4180186
1020075	Plas+CSF	4180186
1020089	Pulmonary vein.left lower	4180186
1020092	Pulmonary vein.right upper	4180186
1020098	Rectum+Colon	4180186
1020099	Rectum+Urinary bladder	4180186
1020104	Retina.right	4180186
1020107	Ser+Saliva	4180186
1020109	Ser/Plas^Donor	4180186
1020116	Spinal artery.bilateral	4180186
1020117	Spinal artery.left	4180186
1020118	Spinal artery.right	4180186
1020122	Thigh.bilateral	4180186
1020129	Lower extremity.left>Tibial artery	4180186
1020144	Vaccine.administered	4180186
1020145	Adrenal vein.bilateral	4180186
1020146	Peripheral veins.bilateral	4180186
1020148	Head>Intracranial vessel & Neck>Neck vessel	4180186
1020159	Head>Zygomatic arch.right	4180186
1021157	Pleural space.left	4180186
1021263	Skin.scar	4180186
1023719	CVS	4180186
1024395	Nph	4180186
1025601	How have you been feeling in general during the past Mo	4180186
1025603	Have you been bothered by nervousness or your nerves during the past Mo	4180186
1025606	Have you been in firm control of your behavior, thoughts, emotions, or feelings during the past Mo	4180186
1025609	Have you had any reason to wonder if you were losing your mind, or losing control over the way you act, talk, think, feel, or of your memory during the past Mo	4180186
1025610	Have you been waking up fresh and rested during the past Mo	4180186
1025611	Has your daily life been full of things that were interesting to you during the past Mo	4180186
1025612	Have you been feeling emotionally stable and sure of yourself during the past Mo	4180186
1025613	Have you felt tired, worn out, used-up, or exhausted during the past Mo	4180186
1025615	How relaxed or tense have you been during the past Mo	4180186
1025616	How much energy, pep, and vitality have you felt during the past Mo	4180186
1025643	Are you able to walk briskly for 20M without stopping to rest	4180186
1025666	Are you able to hit the backboard with a basketball from the free-throw line (13 ft or 4 m)	4180186
1025677	Are you able to dig a 2-foot (.5 m) deep hole in the dirt with a shovel	4180186
1025697	LW super little b Ag	4180186
1025698	J little o super little a Ag	4180186
1025708	Adult self-report short form total score	4180186
1025713	CSF3R gene exons 14 & 17	4180186
1025735	When I was in pain I asked people to let me be by myself in past 7D	4180186
1025737	When I was in pain I criedin past 7D	4180186
1025740	When I was in pain I became quiet in past 7D	4180186
1025741	When I was in pain I asked for help getting around in past 7D	4180186
1025742	When I was in pain I stayed away from other people in past 7D	4180186
1025743	When I was in pain I asked for medicine in past 7D	4180186
1025744	When I was in pain I tightened my jaw in past 7D	4180186
1025750	When I was in pain I didn't want anyone to touch me in past 7D	4180186
1025751	When I was in pain I avoided standing in past 7D	4180186
1025753	When I was in pain I couldn't stay still in past 7D	4180186
1025755	When I was in pain I tried to think of something nice or fun in past 7D	4180186
1025760	When I was in pain I tried to rest or relax in past 7D	4180186
1025761	When I was in pain I complained in past 7D	4180186
1025764	When I was in pain I argued with people in past 7D	4180186
1025765	When I was in pain I avoided using the part of my body that hurt in past 7D	4180186
1025767	When I was in pain I got mad and threw or hit something in past 7D	4180186
1025771	When I was in pain it showed on my face in past 7D	4180186
1025774	When I was in pain I lay down in past 7D	4180186
1025784	My child was too tired to go out with his or her family in past 7D	4180186
1025787	My child felt tired in past 7D	4180186
1025791	My child was too tired to do sports or exercise in past 7D	4180186
1025793	It was hard for my child to get out of bed in the morning because he or she was too tired in past 7D	4180186
1025801	PROMIS parent proxy item bank - fatigue - version 2.0	4180186
1025806	Cholestane-3-beta, 5-alpha, 6-beta triol & Lyso-sphingomyelin panel	4180186
1025815	My child got scared really easy in past 7D	4180186
1025817	My child woke up at night scared in past 7D	4180186
1025818	My child worried when he or she was away from home in past 7D	4180186
1025819	My child felt nervous in past 7D	4180186
1025821	My child felt like something awful might happen in past 7D	4180186
1025822	My child felt scared in past 7D	4180186
1025824	My child worried when he or she went to bed at night in past 7D	4180186
1025825	My child worried when he or she was at home in past 7D	4180186
1025827	My child felt worried in past 7D	4180186
1025841	Electroencephalography study	4180186
1025842	Video electroencephalography study	4180186
1025853	A sudden noise made my child jump in past 7D	4180186
1025855	My child could not stay still for long in past 7D	4180186
1025857	My child's breathing was fast, even when he or she was not exercising or playing hard in past 7D	4180186
1025858	My child's palms were sweaty in past 7D	4180186
1025860	My child's heart pounded, even when he or she was not exercising or playing hard in past 7D	4180186
1025861	My child's heart beat faster than usual, even when he or she was not exercising or playing hard in past 7D	4180186
1025862	My child had trouble breathing, even when he or she was not exercising or playing hard in past 7D	4180186
1025864	My child's breathing was fast in past 7D	4180186
1025865	My child's hands shook in past 7D	4180186
1025871	My child had a bad stomach ache in past 7D	4180186
1025874	My child felt some food coming up into his or her throat in past 7D	4180186
1025876	My child had trouble staying asleep in past 7D	4180186
1025882	Aggl.micro	4180186
1025888	Aggl.slide	4180186
1025892	Saline	4180186
1025893	RIPA	4180186
1025902	BldC^fetus	4180186
1025903	RelCCnc	4180186
1025912	PressDiff	4180186
1025964	{Provider}	4180186
1025974	Cardiology	4180186
1025977	CT.3D	4180186
1025985	Detection limit <= 20 mg/L test strip	4180186
1025989	Enteroscopy.thru stoma	4180186
1025993	Estimated.Bolton analysis	4180186
1026009	MRI.angio	4180186
1026034	Pulmonary	4180186
1026050	US.derived.LWT	4180186
1026056	US+Estimated from AC.Shinozuka 1996	4180186
1026057	US.estimated from Alexander 1996	4180186
1026058	US.estimated from APAD.Lessoway 1998	4180186
1026062	US.estimated from Arbuckle 1993 male twins	4180186
1026063	US.estimated from ASUM 2000	4180186
1026066	US+Estimated from BPD&FTA&FL.Osaka 1990	4180186
1026068	US+Estimated from BPD.ASUM 1989	4180186
1026069	US+Estimated from BPD.Hansmann 1986	4180186
1026070	US+Estimated from BPD.Jeanty 1982	4180186
1026071	US+Estimated from BPD.Lessoway 1998	4180186
1026072	US+Estimated from BPD.Merz 1988	4180186
1026077	US.estimated from Brenner 1976	4180186
1026079	US.estimated from Campbell 1997	4180186
1026081	US.estimated from clavicle length.Yarkoni 1985	4180186
1026082	US+Estimated from CRL.ASUM 1991	4180186
1026084	US+Estimated from CRL.Daya 1993	4180186
1026085	US+Estimated from CRL.Hansmann 1986	4180186
1026087	US+Estimated from CRL.Osaka 1989	4180186
1026088	US+Estimated from CRL.Rempen 1991	4180186
1026092	US.estimated from EFW2.Shinozuka 1996	4180186
1026094	US.estimated from fibula length.Jeanty 1983	4180186
1026095	US+Estimated from FL.Chitty 1997	4180186
1026096	US+Estimated from FL.Hansmann 1986	4180186
1026097	US+Estimated from FL.Jeanty 1982	4180186
1026102	US.estimated from FTA.Osaka 1989	4180186
1026103	US.estimated from Goldstein 1987	4180186
1026105	US+Estimated from GSD.Hansmann 1982	4180186
1026109	US.estimated from Hadlock 1981	4180186
1026110	US.estimated from Hadlock 1984	4180186
1026111	US.estimated from Hadlock 1985	4180186
1026112	US.estimated from Hadlock 1991	4180186
1026118	US+Estimated from HC.Hansmann 1986	4180186
1026119	US+Estimated from HC.Jeanty 1982	4180186
1026120	US+Estimated from HC.Lessoway 1998	4180186
1026123	US+Estimated from HL.Osaka 1989	4180186
1026127	US.estimated from Jeanty 1983	4180186
1026130	US+Estimated from O-I BPD.Chitty 1997	4180186
1026131	US+Estimated from O-O BPD.Chitty 1997	4180186
1026132	US+Estimated from OFD.ASUM 2000	4180186
1026133	US+Estimated from OFD.Hansmann 1985	4180186
1026135	US+Estimated from OFD.Lessoway 1998	4180186
1026137	US+Estimated from OOD.Trout 1994	4180186
1026141	US.estimated from spine length.Tokyo 1989	4180186
1026144	US+Estimated from TAD.Tokyo 1986	4180186
1026145	US+Estimated from TC.Chitkara 1987	4180186
1026147	US+Estimated from TCD.Chitty 1994	4180186
1026148	US+Estimated from TCD.Goldstein 1987	4180186
1026149	US+Estimated from TCD.Hill 1990	4180186
1026150	US+Estimated from Tokyo 1987	4180186
1026156	XR.DXA	4180186
1026157	XR.fluor	4180186
1026158	XR.fluor.angio	4180186
1026159	XR.measured	4180186
1026160	XR.tomo	4180186
1026210	Critical care	4180186
1026213	General medicine.medical student	4180186
1026214	General medicine.nurse	4180186
1026265	MSCnc	4180186
1026267	LnCnc	4180186
1026269	Compli	4180186
1026310	Views AP & lateral	4180186
1026318	Femoral vessel+Popliteal artery	4180186
1026324	Leg.left	4180186
1026343	Guidance for substance removal of foreign body	4180186
1026351	Guidance for removal of embolus	4180186
1026364	Views limited diagnostic	4180186
1026367	Guidance for biopsy.core needle	4180186
1026368	Guidance for biopsy.needle	4180186
1026376	View apical lordotic	4180186
1026385	Views+views uptake	4180186
1026387	Views AP R-lateral decubitus	4180186
1026392	Views PA + lateral + apical lordotic upright	4180186
1026407	Multisection & 3D reconstruction	4180186
1026410	Abdomen+Fetus	4180186
1026425	View lateral^W hyperextension	4180186
1026454	Views AP + axillary	4180186
1026455	Views AP + axillary + outlet	4180186
1026456	Views AP + axillary + outlet + Zanca	4180186
1026457	Views AP + lateral crosstable	4180186
1026458	Views AP + lateral + Mortise	4180186
1026463	Views AP & odontoid & lateral	4180186
1026466	Views AP + lateral + Sunrise + tunnel	4180186
1026468	Views AP + lateral + oblique + tunnel	4180186
1026469	Views AP + lateral + oblique + Sunrise + tunnel	4180186
1026470	Views AP + oblique	4180186
1026471	Views AP + odontoid + lateral crosstable	4180186
1026472	Views AP + Serendipity	4180186
1026473	Views AP + Stryker Notch	4180186
1026474	Views AP + West Point	4180186
1026476	Views AP & axillary & Y	4180186
1026477	Views axillary + Y	4180186
1026478	Views R-lateral + L-lateral	4180186
1026480	Views lateral + Y	4180186
1026482	Views outlet + Y	4180186
1026484	Views PA + lateral + Ball Catcher	4180186
1026486	Views PA + lateral + R-oblique	4180186
1026487	Views PA + lateral + oblique + Towne	4180186
1026492	Views oblique + Sunrise	4180186
1026494	Views Sunrise + tunnel	4180186
1026498	Views lateral + Caldwell + Waters + submentovertex	4180186
1026499	Views lateral + Caldwell + Waters + submentovertex + Towne	4180186
1026501	Aortic arch+Subclavian artery.left	4180186
1026502	Adrenal artery.left	4180186
1026504	Celiac artery+Superior mesenteric artery+Inferior mesenteric artery	4180186
1026505	Upper extremity arteries.left	4180186
1026506	Gastric artery.left	4180186
1026508	Superior mesenteric artery+Inferior mesenteric artery	4180186
1026509	Celiac artery+Gastric artery.left+Superior mesenteric artery	4180186
1026510	Subclavian artery.bilateral	4180186
1026512	Head+Neck>Vertebral artery.bilateral	4180186
1026513	Head+Neck>Vertebral artery.left	4180186
1026525	Views AP + transthoracic	4180186
1026528	Spine.cervical vessels	4180186
1026530	Spine.thoracic vessels	4180186
1026537	Finger.third.left	4180186
1026541	Views Law + Mayer + Stenver + Towne	4180186
1026543	Views open mouth + closed mouth	4180186
1026545	Views magnification+spot	4180186
1026554	Views AP + inlet	4180186
1026555	Views AP + Judet	4180186
1026561	View for scoliosis	4180186
1026570	Views AP + lateral + axillary	4180186
1026575	Views PA + lateral + Caldwell + Waters	4180186
1026578	Views lateral + Caldwell + Waters + Towne	4180186
1026579	Adrenal artery.right	4180186
1026580	Adrenal vein.right	4180186
1026583	Carotid artery.external.right	4180186
1026587	Subclavian artery.right	4180186
1026588	Upper extremity arteries.right	4180186
1026589	Head+Neck>Vertebral artery.right	4180186
1026591	Spine.thoracolumbar junction	4180186
1026603	Views AP + lateral + oblique + odontoid + swimmers	4180186
1026604	Views AP + L-posterior oblique	4180186
1026609	Breast.duct.left	4180186
1026617	How short of breath did you get walking up 20 stairs (2 flights) without stopping over past 7D	4180186
1026623	How short of breath did you get carrying something weighing 10-20 lbs (about 4.5-9 kg, like a large bag of groceries) from one room to another over past 7D	4180186
1026624	How short of breath did you get walking (faster than your usual speed) for .5 mile (almost 1 km) without stopping over past 7D	4180186
1026628	How short of breath did you get standing for at least 5M over past 7D	4180186
1026631	How short of breath did you get walking .5 mile (almost 1 km) on flat ground at a normal speed without stopping over past 7D	4180186
1026632	How short of breath did you get walking up 5 stairs without stopping over past 7D	4180186
1026633	How short of breath did you get walking up 10 stairs (1 flight) without stopping over past 7D	4180186
1026637	How short of breath did you get lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase) over past 7D	4180186
1026639	How short of breath did you get carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another over past 7D	4180186
1026641	How short of breath did you get dining out over past 7D	4180186
1026642	How short of breath did you get low-intensity leisure activity (gardening, etc.) over past 7D	4180186
1026647	How short of breath did you get talking while walking over past 7D	4180186
1026670	Finger.third.right	4180186
1026678	Finger.fourth.right	4180186
1026775	LISS	4180186
1026935	Planned intervention &or services panel	4180186
1026944	Guidance for drainage of abscess+placement of chest tube	4180186
1026948	Guidance for drainage of pseudocyst+placement of drainage catheter	4180186
1026949	Guidance for drainage of cyst+placement of drainage catheter	4180186
1026956	Codon &or region with poor sequence quality	4180186
1026960	Other intervention &or service plan to provide	4180186
1027025	Power of attorney+Living will	4180186
1027043	Pain severity.total	4180186
1027046	Pain severity.legs	4180186
1027048	Pain severity.cry	4180186
1027050	Pain severity.consolability	4180186
1027051	TmMCnc	4180186
1027062	Friction & shear	4180186
1027063	Braden scale score.total	4180186
1027089	Natural & feet together & tandem stance assessment	4180186
1027095	Planned intervention &or services duration	4180186
1027096	Planned intervention &or services visit frequency	4180186
1027098	Hepatitis B virus core Ab & surface and little e Ab & Ag panel	4180186
1027099	Hepatitis A & B & C virus immunity &or previous exposure panel	4180186
1027100	Chronic hepatitis differentiation between B & C virus panel	4180186
1027107	Alpha globin gene cluster & HS-40 region	4180186
1027111	Candida sp & Gardnerella vaginalis & Trichomonas vaginalis DNA panel	4180186
1027118	Views AP + PA	4180186
1027120	Length.crown rump	4180186
1027125	Views for patency of biliary structures+ejection fraction	4180186
1027127	Views AP + PA upright	4180186
1027139	Views AP (KUB & upright)	4180186
1027140	Views R-lateral-decubitus + L-lateral-decubitus	4180186
1027174	Have you or any family members you live with been unable to get any of the following when it was really needed in past 1Y	4180186
1027178	Have you spent more than 2 nights in a row in a jail, prison, detention center, or juvenile correctional facility in past 1Y	4180186
1027182	Chlamydophila pneumoniae & Mycoplasma pneumoniae DNA panel	4180186
1027184	Human coronavirus 229E+HKU1+NL63+OC43 & Parainfluenza virus 1+2+3+4 RNA panel	4180186
1027185	Human metapneumovirus & Respiratory syncytial virus RNA panel	4180186
1027186	Range of motion in the last 7D	4180186
1027188	Measles & Mumps & Rubella virus Ab.IgG panel	4180186
1027211	Allergy+Immunology.nurse	4180186
1027223	Splenic vein+Portal vein	4180186
1027244	Views Grashey + outlet	4180186
1027246	Views Grashey + outlet + Serendipity	4180186
1027248	Aortic arch+Subclavian artery.right	4180186
1027250	Tibia.right	4180186
1027251	Breast.duct.right	4180186
1027252	Carotid artery.cervical.left	4180186
1027253	Carotid artery.internal.left	4180186
1027269	Apt-Downey	4180186
1027270	Beta-N-acetylhexosaminidase A & B	4180186
1027274	RelACnc	4180186
1027276	Multisection limited for pelvimetry	4180186
1027278	Views AP + lateral + apical lordotic	4180186
1027279	Views AP + lateral + Merchants	4180186
1027280	Views AP + lateral + R-oblique + L-oblique	4180186
1027298	Wound irrigation &or cleaning fluid	4180186
1027302	Wound.base	4180186
1027327	Views AP internal rotation + AP external rotation + Y	4180186
1027328	View AP internal rotation + West Point	4180186
1027332	Views 3 + radial deviation	4180186
1027337	Views + oblique	4180186
1027342	Views 2 + tunnel	4180186
1027344	Views 4 + oblique	4180186
1027345	Views 4 + tunnel	4180186
1027346	Views 4 + Sunrise + tunnel	4180186
1027347	Views + tunnel	4180186
1027350	Views 3 + axillary	4180186
1027351	Views 3 + Y	4180186
1027352	Views AP internal rotation + AP external rotation + West Point	4180186
1027354	Views + Carpal tunnel	4180186
1027355	Views AP + Grashey + axillary	4180186
1027358	Views lateral + R-oblique + L-oblique	4180186
1027359	Views lateral + R-anterior oblique	4180186
1027365	Views AP + Danelius Miller	4180186
1027366	Views + Danelius Miller	4180186
1027371	Views PA + R-lateral + L-lateral + Towne	4180186
1027374	Guidance limited for localization of abscess	4180186
1027375	Guidance for localization of abscess	4180186
1027398	Multisection ventilation+perfusion	4180186
1027410	Views first pass+ejection fraction	4180186
1027411	Views for infarct+first pass	4180186
1027422	Views first pass+wall motion+ventricular volume	4180186
1027423	Views first pass+wall motion+ventricular volume+ejection fraction	4180186
1027424	Views first pass+wall motion+ejection fraction	4180186
1027425	View first pass & wall motion & ejection fraction	4180186
1027426	Multisection gated+ejection fraction	4180186
1027430	Multisection gated+wall motion	4180186
1027431	Views gated+first pass	4180186
1027432	Views gated+wall motion+ejection fraction	4180186
1027438	Views ventilation+perfusion+differential	4180186
1027439	Views ventilation+equilibrium	4180186
1027444	Cytokeratin AE1+AE3	4180186
1027450	37 deg C incubation	4180186
1027451	Ser^control	4180186
1027456	RFLP	4180186
1027461	Flexion.active range of motion	4180186
1027462	Flexion.passive range of motion	4180186
1027463	Extension.active range of motion	4180186
1027465	Abduction.active range of motion	4180186
1027468	Adduction.passive range of motion	4180186
1027471	External rotation.active range of motion	4180186
1027477	Probe.amp detection limit = 2.6 log copies/mL	4180186
1027495	Insulin name + ID	4180186
1027520	Salmonella & Shigella sp	4180186
1027521	Views lateral + Mortise + Broden	4180186
1027536	Submandibular gland.left	4180186
1027538	Gastrointestinal tract.upper+Small bowel+Gallbladder	4180186
1027543	Contributing factor.environment	4180186
1027545	Contributing factor.staff-related	4180186
1027547	Contributing factor.other	4180186
1027553	Event description.medication	4180186
1027554	Event description.procedure &or treatment &or surgery	4180186
1027559	Event description.equipment &or device	4180186
1027560	Event description.laboratory	4180186
1027564	Event description.environmental hazard &or safety	4180186
1027565	Event description.crime &or intentional harm	4180186
1027568	Contributing factor.technical	4180186
1027573	Lt 1H	4180186
1027574	Gt 1H	4180186
1027591	Views && view PA	4180186
1027592	Views 4 && view PA	4180186
1027593	Views lateral & PA chest	4180186
1027595	(View Sunrise) + (views^W standing)	4180186
1027633	Older adult behavior alteration.sixty five Y and older	4180186
1027651	Views GE 3	4180186
1027654	Aorta+Lower extremity vessels	4180186
1027655	Ovary.bilateral	4180186
1027658	Views GE 5	4180186
1027659	Mandible.right	4180186
1027660	Mandible.left	4180186
1027663	Study observation.general	4180186
1027666	View AP && View upright	4180186
1027668	Views limited for blood flow	4180186
1027670	Views qualitative+quantitative for infarct	4180186
1027688	Views Grashey + Y	4180186
1027693	Age.at delivery	4180186
1027694	Metanephrine & Normetanephrine	4180186
1027699	Multisection limited cine for function	4180186
1027702	Views GE 4	4180186
1027704	Ribs.unilateral+Chest	4180186
1027725	Hepatitis B virus & Hepatitis D virus	4180186
1027732	Aerobic culture 25 deg C incubation	4180186
1027733	Anaerobic culture 25 deg C incubation	4180186
1027735	Alder Ab	4180186
1027738	Ash Ab	4180186
1027747	Disialylganglioside GD1a Ab.IgM	4180186
1027750	Disialylganglioside GD1b Ab.IgM	4180186
1027752	Helianthus annuus Ab.IgG	4180186
1027753	Helianthus annuus Ab	4180186
1027754	Hepatitis B virus & hepatitis D virus Ab	4180186
1027761	Microfilaria sp identified	4180186
1027763	Monosialoganglioside GM1 Ab.IgG	4180186
1027766	O NOS Ag	4180186
1027768	Pneumocystis carinii Ag	4180186
1027772	Spermatozoa.head Ab.IgA	4180186
1027773	Spermatozoa.head Ab.IgG	4180186
1027774	Spermatozoa.head Ab.IgM	4180186
1027775	Spermatozoa.midpiece Ab.IgA	4180186
1027777	Spermatozoa.midpiece Ab.IgM	4180186
1027780	Spermatozoa.tail Ab.IgM	4180186
1027781	Spermatozoa.tail tip Ab.IgA	4180186
1027783	Spermatozoa.tail tip Ab.IgM	4180186
1027797	Tetrasialylganglioside GQ1b Ab.IgG	4180186
1027799	Wuchereria bancrofti + Brugia malayi Ag	4180186
1027800	Yeast bakers Ab.IgG	4180186
1027801	Yeast bakers Ab	4180186
1027815	Views GE 2 + PA + lateral	4180186
1027823	Rheumatoid factor & cyclic citrullinated peptide Ab.IgG	4180186
1027825	Rheumatoid factor & Cyclic citrullinated peptide Ab.IgG panel	4180186
1027826	Rheumatoid factor & Cyclic citrullinated peptide	4180186
1027834	MLH1 gene deletion+duplication & full mutation analysis	4180186
1027838	CSF3R gene exons 14 & 17 targeted mutation analysis	4180186
1027850	Fetal chromosome X & Y aneuploidy	4180186
1027875	NuMoM2b	4180186
1027876	Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-Be Difficulties in Pregnancy form	4180186
1027897	Monotypic plasma cell identification & risk stratification panel	4180186
1027898	During the past 4W, because of my health situation I feel uncertain about the future	4180186
1027899	During the past 4W, because of my health situation I have little trust in my own body	4180186
1027905	During the past 4W, I have good relations with my immediate superior	4180186
1027906	During the past 4W, my immediate superior understands my health situation and possible health problems	4180186
1027909	During the past 4W, I have good relations with my colleagues	4180186
1027910	During the past 4W, I am content with my work	4180186
1027912	During the past 4W, I feel there is a positive atmosphere in my working environment	4180186
1027917	During the past 4W, I do my work well	4180186
1027918	During the past 4W, I consider my work important	4180186
1027920	During the past 4W, I think it is good to work	4180186
1027921	During the past 4W, working gives me structure in my life	4180186
1027942	Cells.cytogenetic abnormality	4180186
1027952	TPMT gene & NUDT15 gene	4180186
1027955	Blood flow velocity.max.left ventricular outflow tract/blood flow.max.aortic valve	4180186
1027970	Pressure gradient.2.mean	4180186
1027974	Regurgitant pressure gradient.max	4180186
1027977	Coarctation.pressure gradient.max	4180186
1027978	HTR2A gene.c.614-2211T>C	4180186
1027983	Radiology.team	4180186
1028011	Blood flow velocity.mean	4180186
1028020	Regurgitant pressure gradient.mean	4180186
1028023	Regurgitant pressure gradient.diastole.max	4180186
1028025	Upper extremity>Hand.metacarpal.first	4180186
1028026	Upper extremity>Hand.metacarpal.third	4180186
1028028	Upper extremity>Thumb.proximal phalanx	4180186
1028029	Upper extremity>Finger.third.proximal phalanx	4180186
1028033	Upper extremity>Finger.third.distal phalanx	4180186
1028034	Upper extremity>Finger.fifth.distal phalanx	4180186
1028035	Upper extremity>Thumb.distal phalanx	4180186
1028037	Upper extremity>Wrist.hamate	4180186
1028038	Upper extremity>Wrist.triquetrum	4180186
1028042	Upper extremity>Wrist.trapezoid	4180186
1028051	Regurgitant pressure gradient.systole.max	4180186
1028054	Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.0	4180186
1028076	IRF-PAI v4.0, LCDS v5.00 - Swallowing &or nutritional status - discharge	4180186
1028079	IRF-PAI v4.0, LCDS v5.00 - Medications - discharge	4180186
1028111	LCDS v5.00 - Swallowing &or nutritional status - admission	4180186
1028165	Actual lethality or medical damage most lethal suicide attempt	4180186
1028170	Potential lethality initial or first suicide attempt	4180186
1028176	4-Fluorofentanyl	4180186
1028177	Hearing.ability to hear during 3D assessment period	4180186
1028178	Vision.ability to see in adequate light during 3D assessment period	4180186
1028201	Bacterial carbapenem resistance blaOXA-23-like+blaOXA-48-like genes	4180186
1028226	Parainfluenza virus 1+2+3+4 Ab.IgG	4180186
1028227	Glial fibrillary acidic protein.alpha subunit	4180186
1028232	Rickettsia rickettsii & Coxiella burnetii phase 1 & Coxiella burnetii phase 2 Ab.IgG panel	4180186
1028234	Glial fibrillary acidic protein.alpha subunit Ab.IgG	4180186
1028246	SILS	4180186
1028267	Blood flow reversal.diastolic	4180186
1028271	Atrial contraction strain rate.max	4180186
1028285	Orthopaedic surgery.team	4180186
1028286	Hematology.team	4180186
1028293	NTRK1 gene & NTRK2 gene & NTRK3 gene	4180186
1028294	NTRK1 gene & NTRK2 gene & NTRK3 gene rearrangements	4180186
1028296	^Escort	4180186
1028328	Nonalcoholic steatohepatitis & fibrosis panel	4180186
1028332	Francisella tularensis Ab.IgG & IgM	4180186
1028333	Francisella tularensis Ab.IgG & IgM panel	4180186
1028337	Gas & CO & electrolytes panel	4180186
1028338	Velocity-time integral.left ventricular outflow tract	4180186
1028339	Blood flow velocity.max.left ventricular outflow tract	4180186
1028356	Emergency department visits in last 6Mo	4180186
1028358	Number of times hospitalized in last 6Mo	4180186
1028360	Brassica oleracea var capitata f rubra	4180186
1028362	Brassica oleracea var capitata f rubra Ab	4180186
1028363	Brassica oleracea var botrytis cooked Ab.IgE	4180186
1028365	Brassica oleracea var gongylodes	4180186
1028366	Allium schoenoprasum	4180186
1028370	Melissa officinalis	4180186
1028371	HTLV I & II Ab.IgG band	4180186
1028376	Lymphocytes.villous	4180186
1028385	Rh antigens & K Ag panel	4180186
1028390	ABO & Rh group post transfusion reaction panel	4180186
1028418	ABO & Rh group during infancy panel	4180186
1028420	Rh antigens & K Ag during infancy panel	4180186
1028430	NOP56 gene.GGCCTG repeats	4180186
1028450	UGT1A1 gene.TA repeats & c.211G>A	4180186
1028506	Color Me Healthy - children's symptom assessment app panel	4180186
1028507	LRat	4180186
1028508	MR && MR.angio	4180186
1028516	Chikungunya virus Ab.IgM & IgG panel	4180186
1028683	Abuse.status	4180186
1028686	Cognition.status	4180186
1028689	Digestion-hydration.status	4180186
1028690	Family planning.status	4180186
1028691	Grief.status	4180186
1028695	Income.status	4180186
1028697	Medication regimen.status	4180186
1028700	Neuro-musculo-skeletal function.status	4180186
1028701	Nutrition.status	4180186
1028705	Physical activity.status	4180186
1028709	Residence.status	4180186
1028710	Respiration.status	4180186
1028711	Role change.status	4180186
1028712	Sanitation.status	4180186
1028715	Skin.status	4180186
1028719	Spirituality.status	4180186
1028724	Abuse.knowledge	4180186
1028726	Bowel function.knowledge	4180186
1028728	Circulation.knowledge	4180186
1028729	Cognition.behavior	4180186
1028730	Cognition.knowledge	4180186
1028734	Consciousness.knowledge	4180186
1028735	Digestion-hydration.behavior	4180186
1028740	Grief.knowledge	4180186
1028741	Growth and development.behavior	4180186
1028742	Growth and development.knowledge	4180186
1028745	Hearing.behavior	4180186
1028747	Income.behavior	4180186
1028749	Interpersonal relationship.behavior	4180186
1028750	Interpersonal relationship.knowledge	4180186
1028753	Mental health.behavior	4180186
1028755	Neglect.behavior	4180186
1028757	Neuro-musculo-skeletal function.behavior	4180186
1028759	Nutrition.behavior	4180186
1028764	Pain.knowledge	4180186
1028767	Physical activity.behavior	4180186
1028769	Postpartum function.behavior	4180186
1028771	Pregnancy function.behavior	4180186
1028774	Reproductive function.knowledge	4180186
1028775	Residence.behavior	4180186
1028777	Respiration.behavior	4180186
1028779	Role change.behavior	4180186
1028781	Sanitation.behavior	4180186
1028782	Sanitation.knowledge	4180186
1028786	Skin.knowledge	4180186
1028788	Sleep and rest pattern.knowledge	4180186
1028791	Speech and language.behavior	4180186
1028792	Speech and language.knowledge	4180186
1028794	Spirituality.knowledge	4180186
1028795	Substance use.behavior	4180186
1028796	Substance use.knowledge	4180186
1028799	Vision.behavior	4180186
1028803	Cytokeratin 5+6	4180186
1028804	Cytokeratin HMW	4180186
1028805	NKI-C3	4180186
1028830	HIV care & family status section	4180186
1028832	1D cold incubation	4180186
1028833	2D cold incubation	4180186
1028837	3D cold incubation	4180186
1028842	6D cold incubation	4180186
1028849	Acridine orange and Giemsa stain	4180186
1028851	Acute respiratory distress culture	4180186
1028853	Agar diffusion	4180186
1028855	Aggl.card	4180186
1028856	Aggl.plate	4180186
1028857	Aggl.plate.buffered acidified	4180186
1028861	Aggl.serial ring test	4180186
1028871	Anaerobic culture	4180186
1028872	Anaerobic+Aerobic culture	4180186
1028873	Angiogram	4180186
1028874	Angiogram.visual estima	4180186
1028875	Angiography.biplane	4180186
1028893	Multisection sagittal & coronal	4180186
1028894	Multisection sagittal & coronal disarticulation	4180186
1028906	Calcofluor white preparation	4180186
1028908	Calculated.HWL	4180186
1028909	Calculated.PLN	4180186
1028915	Breast.ductal lavage	4180186
1028929	Coag	4180186
1028930	Coag inverse ratio	4180186
1028931	Coag.saline 1:1	4180186
1028937	Concentration.Baermann	4180186
1028981	Dye test	4180186
1028982	EEG	4180186
1028983	EGD	4180186
1028988	Electromyogram	4180186
1028991	Views 2 && View PA	4180186
1028992	Views 3 + Swimmers	4180186
1028994	Electrophoresis.agarose gel	4180186
1028996	Probe.amp.tar detection limit = 1.7 log copies/mL	4180186
1029024	Probe.amp.tar detection limit = 2.6 log copies/mL	4180186
1029025	Fick	4180186
1029044	Guidance for injection of sentinel lymph node	4180186
1029045	GC	4180186
1029057	HAI	4180186
1029073	HPLC	4180186
1029075	ICA	4180186
1029076	Immune diffusion	4180186
1029078	IF rat kidney substrate	4180186
1029079	IF rat liver substrate	4180186
1029080	IFA	4180186
1029091	Incubation.1M	4180186
1029092	India ink preparation	4180186
1029097	Intravascular line culture	4180186
1029100	Ivy	4180186
1029102	Kleihauer-Betke	4180186
1029107	SCB	4180186
1029108	LA	4180186
1029113	Gestational age in W	4180186
1029114	Gestational age in D	4180186
1029117	BldCRRT	4180186
1029118	Antibody score	4180186
1029120	Lee White	4180186
1029121	LHR	4180186
1029127	California encephalitis virus Ab.IgG & IgM	4180186
1029128	Macro/Micro ID	4180186
1029148	Microscopy.electron	4180186
1029150	Microscopy.electron.thin section	4180186
1029172	Nuclear.blood pool	4180186
1029184	Oxygen analyzer	4180186
1029204	Perm mount	4180186
1029207	PET scan	4180186
1029208	Phosphotungstic acid hematoxyl	4180186
1029264	Calcidiol & Calciferol	4180186
1029272	Probe.amp.tar detection limit = 5 IU/mL	4180186
1029274	RBCs diluted	4180186
1029276	Reaction: pyruvate to lactate	4180186
1029289	RFLP probe	4180186
1029292	RIA	4180186
1029293	Ring and weigh	4180186
1029315	Sedimentation	4180186
1029334	LnRto	4180186
1029338	BldA+BldMV	4180186
1029340	Spun Westergren tube	4180186
1029345	Dial fld+Ser/Plas	4180186
1029359	Antibody titered	4180186
1029363	Test strip.automated	4180186
1029368	TLC	4180186
1029372	Trichrome modified	4180186
1029383	US	4180186
1029385	MDS.full	4180186
1029386	Electrophoresis pH 6.0	4180186
1029387	BldCoMV	4180186
1029388	US.2D.aortic root.calculated	4180186
1029393	US.2D.mitral valve.calculated	4180186
1029394	US.2D.mod	4180186
1029396	US.2D.mod.biplane	4180186
1029400	BldA+Inhl gas	4180186
1029405	US.2D.mod.single-plane.calculated	4180186
1029408	US.2D.tricuspid valve	4180186
1029409	US.2D.tricuspid valve.calculated	4180186
1029411	US.composite.estimated	4180186
1029412	US.continuity	4180186
1029414	US.continuity.Vmax+Diameter	4180186
1029415	US.continuity.VTI+Area	4180186
1029422	US.derived from OFD&O-I BPD	4180186
1029424	US.derived.AUT	4180186
1029425	IgM.CSF	4180186
1029427	US.derived.HWL	4180186
1029429	US.derived.PLN	4180186
1029431	US.doppler	4180186
1029435	US.doppler.derived.full Bernoulli	4180186
1029436	US.doppler+Calculated by simplified Bernoulli	4180186
1029437	US.doppler.pressure half time	4180186
1029439	US.doppler.velocity+Diameter.calculated	4180186
1029442	US.doppler.Vmax+Area.calculated	4180186
1029444	US.doppler.VTI+Aorta.calculated	4180186
1029447	US.doppler.VTI+LVOT.calculated	4180186
1029448	US+Estimated	4180186
1029449	US+Estimated from AC	4180186
1029451	US+Estimated from AC&BPD&FL	4180186
1029454	US+Estimated from AC&BPD&FL&HC.Roberts 1985	4180186
1029458	US+Estimated from AC&BPD.Eik-Nes 1982	4180186
1029460	US+Estimated from AC&BPD.Shepard 1982	4180186
1029462	US+Estimated from AC&BPD.Warsof 1977	4180186
1029466	US+Estimated from AC&FL&HC.Hadlock 1984	4180186
1029470	US+Estimated from AC&FL&HC.Weiner 1985	4180186
1029471	US+Estimated from AC&FL.Hadlock 1984	4180186
1029473	US+Estimated from AC&FL.Woo 1985	4180186
1029475	US+Estimated from AC&HC	4180186
1029477	US+Estimated from AC&HC.Jordaan 1983	4180186
1029479	US+Estimated from AC.Hadlock 1982	4180186
1029481	Probe.amp.tar detection limit = 0.5 log copies/mL	4180186
1029482	US+Estimated from AC.Jeanty 1984	4180186
1029486	US+Estimated from AD&BPD	4180186
1029487	US+Estimated from AD&BPD&FL	4180186
1029489	Head & Ears & Eyes & Nose & Throat	4180186
1029494	US+Estimated from AD&BPD.Rose 1987	4180186
1029495	US+Estimated from AD&BPD.Vintzileos 1987	4180186
1029496	US+Estimated from AD&FL	4180186
1029499	US+Estimated from BD	4180186
1029505	US+Estimated from BD.Jeanty 1984	4180186
1029506	US.estimated from BPC	4180186
1029509	US+Estimated from BPD.Doubilet 1993	4180186
1029511	US+Estimated from BPD.Hadlock 1984	4180186
1029512	US+Estimated from BPD.Hansmann 1985	4180186
1029513	US+Estimated from BPD.Hobbins 1983	4180186
1029514	US+Estimated from BPD.Jeanty 1984	4180186
1029519	US+Estimated from BPD.Sabbagha 1978	4180186
1029521	US.estimated from cerebellar diameter	4180186
1029526	US+Estimated from CRL.Hadlock 1992	4180186
1029527	US+Estimated from CRL.Hansmann 1985	4180186
1029528	Diam	4180186
1029529	US+Estimated from CRL.Jeanty 1984	4180186
1029530	US+Estimated from CRL.Nelson 1981	4180186
1029531	US+Estimated from CRL.Robinson 1975	4180186
1029533	US.estimated from fibula length	4180186
1029535	US.estimated from fibula length.Merz 1987	4180186
1029536	US+Estimated from FL	4180186
1029538	US+Estimated from FL.Hansmann 1985	4180186
1029540	US+Estimated from FL.Jeanty 1984	4180186
1029542	US+Estimated from FL.Merz 1987	4180186
1029544	US+Estimated from GSD	4180186
1029546	US+Estimated from GSD.Rempen 1991	4180186
1029547	US+Estimated from HC	4180186
1029556	US.estimated from radius length	4180186
1029557	US.estimated from radius length.Merz 1987	4180186
1029558	US+Estimated from tibia length	4180186
1029559	US+Estimated from tibia length.Jeanty 1984	4180186
1029560	US+Estimated from tibia length.Merz 1987	4180186
1029561	US.estimated from ulna length	4180186
1029563	US.estimated from ulna length.Merz 1987	4180186
1029564	US.M-mode	4180186
1029565	US.M-mode.calculated	4180186
1029569	US.mod.single-plane.calculated	4180186
1029570	US.modified Simpson.calculated	4180186
1029571	US.Teichholz	4180186
1029589	Westergren.2H reading	4180186
1029598	Accel	4180186
1029599	ACnc	4180186
1029601	Addr	4180186
1029602	Anat	4180186
1029605	ARat	4180186
1029608	AreaRto	4180186
1029609	ArEnrg	4180186
1029611	ArVol	4180186
1029617	CFr	4180186
1029619	CircFr	4180186
1029622	CRat	4180186
1029623	Desc	4180186
1029625	Elpot	4180186
1029627	EngRat	4180186
1029628	Enrg	4180186
1029629	EntNum	4180186
1029631	EntLen	4180186
1029632	EntMass	4180186
1029634	Equ	4180186
1029635	Fcn	4180186
1029636	Find	4180186
1029638	FldResist	4180186
1029641	ID	4180186
1029642	Imp	4180186
1029643	Instrct	4180186
1029645	Len	4180186
1029646	LenFr	4180186
1029647	LenRto	4180186
1029648	Loc	4180186
1029654	MFr	4180186
1029655	Morph	4180186
1029667	MRto	4180186
1029670	Naric	4180186
1029699	NRat	4180186
1029705	NRto	4180186
1029706	Num	4180186
1029715	Prctl	4180186
1029718	PresRto	4180186
1029719	Prid	4180186
1029721	RelRto	4180186
1029724	Resis	4180186
1029725	RelMCnc	4180186
1029726	SCnc	4180186
1029727	SCnt	4180186
1029731	SFr	4180186
1029734	Sub	4180186
1029735	Susc	4180186
1029743	TmStp	4180186
1029744	TQ2	4180186
1029751	VelRto	4180186
1029756	VRatCnt	4180186
1029766	1D	4180186
1029767	1H	4180186
1029768	1M	4180186
1029772	1Mo	4180186
1029774	Glucose CSF	4180186
1029778	Protein.CSF	4180186
1029779	Protein.plr fld	4180186
1029780	1W	4180186
1029784	Lactate dehydrogenase.plr fld	4180186
1029785	IgA.CSF	4180186
1029792	2D	4180186
1029793	2H	4180186
1029795	Coagulation surface induced^after addition of protein C activator+factor V depleted plasma/Coagulation surface induced	4180186
1029798	30M	4180186
1029803	45M	4180186
1029805	4H	4180186
1029810	72H	4180186
1029811	8H	4180186
1029812	90M	4180186
1029815	Procedure dur	4180186
1029816	Pt	4180186
1029817	Stdy	4180186
1029823	Dial fld prt+Ser/Plas	4180186
1029827	Coagulation surface induced^after addition of protein C activator	4180186
1029831	Abdomen.mid	4180186
1029834	Semin plas	4180186
1029837	Airway.proximal	4180186
1029842	Views supine + upright	4180186
1029843	View PA && Views supine + upright	4180186
1029847	Amnio fld	4180186
1029852	Am fld space	4180186
1029854	Views+AP	4180186
1029855	View PA && View AP	4180186
1029856	Views L-lateral-decubitus + R-lateral-decubitus	4180186
1029862	Anatomic part.*	4180186
1029863	Views PA + lateral + AP lateral-decubitus	4180186
1029864	Views PA + lateral + AP L-lateral-decubitus	4180186
1029865	Views PA + lateral + AP R-lateral-decubitus	4180186
1029866	Views AP + AP R-lateral-decubitus	4180186
1029871	Aorta.abdominal.proximal	4180186
1029873	Aorta.root	4180186
1029875	Aorta.thoracic.ascending	4180186
1029876	Aorta.thoracic.descending	4180186
1029877	Aorta.thoracic.proximal ascending	4180186
1029878	LsCnc	4180186
1029882	Computer assisted	4180186
1029885	Aortic valve.annulus	4180186
1029886	Aortic valve.regurgitant jet	4180186
1029893	Asp	4180186
1029895	CSF.spun	4180186
1029911	BBL	4180186
1029914	HIV 2 Ab Signal	4180186
1029919	Bld	4180186
1029920	Bld.postductal	4180186
1029921	Bld.preductal	4180186
1029923	Bld/Bone mar	4180186
1029924	Bld/Tiss	4180186
1029928	BldA	4180186
1029929	BldC	4180186
1029931	BldMV	4180186
1029932	BldP	4180186
1029937	Brachial artery.left	4180186
1029938	Brachial artery.right	4180186
1030000	Calf.left	4180186
1030001	Calf.right	4180186
1030016	Cancer.XXX.morphology	4180186
1030030	5M RT incubation	4180186
1030041	Cervical canal.internal os	4180186
1030043	CFTR gene.p.IVS8 polyT 7T	4180186
1030045	Cervix.externally palpable surface	4180186
1030052	Circulatory system.XXX	4180186
1030054	Clavicle.diaphysis	4180186
1030057	Cnl	4180186
1030067	CSF	4180186
1030071	Lactate dehydrogenase.periton fld	4180186
1030072	Periton fld+Ser/Plas	4180186
1030073	MoM	4180186
1030076	Cvx	4180186
1030077	Cvx/Vag	4180186
1030079	Dial fld.spun	4180186
1030085	Deep tendon reflexes	4180186
1030086	Deep tissue.FNA	4180186
1030091	Digital artery.right	4180186
1030094	Dorsal pedal artery.right	4180186
1030100	Duod fld	4180186
1030101	Duod fld/Gast fld	4180186
1030103	Ears & nose & mouth & throat	4180186
1030108	Edit overrides &or Conversion history &or System admin section	4180186
1030112	{HIV ART medication} doses missed 2D ago	4180186
1030115	{HIV ART medication} doses missed 4D ago	4180186
1030146	Accommodation width.measured	4180186
1030165	Alcohol binge episodes per M	4180186
1030169	Endoscopy procedure.XXX	4180186
1030205	Exhl gas	4180186
1030217	Blood flow.diastolic.atrial wave	4180186
1030241	Eye.left	4180186
1030251	Eye.right	4180186
1030262	Carcinogenesis & mutagenesis & impairment of fertility section	4180186
1030268	Census block group 1970&80&90	4180186
1030270	Census tract certainty 1970&80&90	4180186
1030283	Circumference.at nipple line	4180186
1030296	COC site & type override flag	4180186
1030379	Date last menstrual period	4180186
1030391	Date of vaccination temporary contraindication &or precaution expiration	4180186
1030470	Drug &or laboratory test interactions section	4180186
1030473	Dx &or stage	4180186
1030486	ED disposition consult &or referral	4180186
1030488	Small intes fixed	4180186
1030495	ED procedure practitioner ID	4180186
1030497	Tiss fixed	4180186
1030521	Examination level.ultrasound	4180186
1030540	Gastrointestinal tract.lower	4180186
1030576	Gradient.diastole	4180186
1030603	Genital loc	4180186
1030614	Vag	4180186
1030615	Hospitalization	4180186
1030655	GI cnt	4180186
1030661	Hospital sequence & site override flag	4180186
1030719	Head.choroid plexus	4180186
1030720	Intrachamber.systole	4180186
1030721	Intratumoral + Peritumoral lymphocytic response	4180186
1030725	Head.fourth ventricle	4180186
1030728	Invasive carcinoma.uninvolved margin distance.closest	4180186
1030729	Invasive carcinoma.uninvolved margin.closest	4180186
1030730	Invasive component size.additional dimension 1	4180186
1030733	Head.intracranial anatomy	4180186
1030744	Labor & delivery section	4180186
1030752	Lesion size.additional dimension 1	4180186
1030754	Leukemia & lymphoma override flag	4180186
1030756	Head.third ventricle	4180186
1030757	Licensed blood intermediate &or paste label	4180186
1030767	Major axis.diastole	4180186
1030768	Major axis.systole	4180186
1030804	Minor axis.systole	4180186
1030835	Heart.atria	4180186
1030851	Operations (?)	4180186
1030856	Heart.atrium.right	4180186
1030869	Heart.great vessels	4180186
1030878	Heart.interventricular septum	4180186
1030882	Overrides&conversion&system administration battery	4180186
1030911	Heart.valves	4180186
1030916	Heart.ventricle	4180186
1030924	Physical findings.sensation	4180186
1030925	Physical findings.shoulder shrug	4180186
1030929	Heart.ventricle.left	4180186
1030935	Planned &or next follow-up	4180186
1030941	Heart.ventricle.left.basal anterior	4180186
1030943	Position.placenta	4180186
1030953	Pressure half time.velocity	4180186
1030955	Heart.ventricle.left.basal lateral	4180186
1030976	Heart.ventricle.left.inferior apical	4180186
1031008	Heart.ventricle.left.mid inferior	4180186
1031024	Heart.ventricle.left.mid septum	4180186
1031028	Relevant diagnostic tests &or laboratory data	4180186
1031045	RR duration	4180186
1031051	Heart.ventricle.left.posterior wall	4180186
1031061	Heart.ventricle.posterior wall.left	4180186
1031067	Sequence number&diagnosis confirm override flag	4180186
1031069	Short axis.systole	4180186
1031075	Site & behavior override flag	4180186
1031076	Site & extent of disease & diagnosis date override flag	4180186
1031078	Site & laterality & extent of disease override flag	4180186
1031079	Site & laterality & morphology override flag	4180186
1031082	Site&type override flag	4180186
1031086	Size.additional dimension	4180186
1031101	Specimen size.additional dimension 1	4180186
1031111	Stage &or prognostic factors section	4180186
1031117	Stage.summary & regional lymph nodes positive override flag	4180186
1031119	Stage.summary & TNM-N override flag	4180186
1031121	Heart.ventricle.XXX	4180186
1031129	Heart.ventricles	4180186
1031136	Subject participation+Epochs section	4180186
1031155	Surgery&diagnosis confirm override flag	4180186
1031176	Surgical operation note postoperative Dx	4180186
1031187	Telephone	4180186
1031212	Inhl gas	4180186
1031219	Treatment of subjects+Epochs section	4180186
1031225	Iliac artery.right	4180186
1031238	Incubator.pediatric	4180186
1031256	Vaccination contraindication &or precaution	4180186
1031269	Intravascular space.XXX	4180186
1031272	Views AP & lateral & oblique	4180186
1031274	Views multiple sagittal & coronal	4180186
1031308	Forced vital capacity.post bronchodilation	4180186
1031318	Glasgow coma score.total	4180186
1031343	Thickness.septal wall	4180186
1031347	Volume at 25-75% of forced expiration	4180186
1031382	Behavioral &or mental health screen follow-up status	4180186
1031384	Behavioral &or mental health screen results indicator	4180186
1031454	Little finger arteries.right	4180186
1031457	Destination site longitude	4180186
1031462	Diagnosis.addressed by plan	4180186
1031465	Dictating practitioner ID	4180186
1031527	Follow-up (referred to) provider &or specialist, catchment location indicator	4180186
1031529	Follow-up (referred to) provider &or specialist, network location indicator	4180186
1031532	Follow-up (referred to) provider &or specialist, state location indicator	4180186
1031557	Hemoglobin test status &or results	4180186
1031570	Bone mar	4180186
1031575	Include all data of the selected type that represents observations made 3Mo or fewer before the starting date of service	4180186
1031577	Include all data of the selected type that represents observations made nine Mo or fewer before the starting date of service	4180186
1031579	Include all data of the selected type that represents observations made six Mo or fewer before the starting date of service	4180186
1031613	Medication.administered	4180186
1031620	Medications.administered.report request	4180186
1031622	Medications.current.report request	4180186
1031623	Medications.discharge.report request	4180186
1031624	Medications.report request	4180186
1031640	New &or revised	4180186
1031675	Middle finger arteries.left	4180186
1031690	Past medical history+Level of function	4180186
1031710	Prenatal interview w infants primary care provider indicator	4180186
1031723	Mitral valve.annulus	4180186
1031742	Reason for follow-up (referred to) provider &or specialist	4180186
1031756	Rehabilitation.alcohol &or substance abuse service attachment	4180186
1031758	Mitral valve.regurgitant jet	4180186
1031819	Mouth & throat & teeth	4180186
1031869	12 steps-interior during 2D assessment period	4180186
1031878	Absence of contact with family &or friends	4180186
1031924	Nose/Trac	4180186
1031940	CMS certification number	4180186
1031944	Allergies & Adverse Drug Reactions	4180186
1031952	Altered level of consciousness &or alertness during 2D assessment period	4180186
1031958	Occupation & industry Hx	4180186
1031959	Antepartum &or postpartum	4180186
1032000	Average fluid intake per D by IV or tube in last 7D	4180186
1032005	Aware of normal hazards & take appropriate precautions	4180186
1032026	Ovary.largest follicle	4180186
1032053	Ovary.left	4180186
1032056	Bowel elimination pattern regular - at least one movement every three D	4180186
1032068	Can recall staff names &or faces	4180186
1032071	Ovary.right	4180186
1032077	Continuity assessment record and evaluation tool - acute care	4180186
1032078	Continuity assessment record and evaluation tool - expired	4180186
1032079	Continuity assessment record and evaluation tool - interim	4180186
1032101	Change in communication &or hearing	4180186
1032132	Completes normal workday & week WO interruptions from psych symptoms & performs at consistent pace WO unreasonable number & length of rests	4180186
1032144	Continence in last 14D section	4180186
1032149	Covert &or open conflict with or repeated criticism of staff	4180186
1032177	Daily animal companion &or presence	4180186
1032179	Daily contact with relatives &or close friends	4180186
1032197	Dehydration &or fluid maintenance trigger	4180186
1032219	Did not use toilet room &or commode &or urinal	4180186
1032245	Disorganized thinking during 2D assessment period	4180186
1032286	Plas	4180186
1032291	Eating during 2D assessment period	4180186
1032293	Eats between meals all or most D	4180186
1032300	End-Stage disease, 6 or fewer Mo to live	4180186
1032302	Enemas &or irrigation	4180186
1032308	Evaluation by a licensed mental health specialist in last 90D	4180186
1032343	Feeling tired or having little energy in last 2W	4180186
1032344	Fell in past 30D	4180186
1032359	Four steps-exterior during 2D assessment period	4180186
1032378	Gas &or bloating	4180186
1032386	Geriatric depression scale total	4180186
1032388	Popliteal artery.right	4180186
1032391	Goes out 1 or more D a W	4180186
1032394	Grip strength during 2D assessment period	4180186
1032418	Height & weight	4180186
1032422	Hip fracture in last 180D	4180186
1032425	Falls in the past Y	4180186
1032428	History of stay at mental health &or psychiatric setting	4180186
1032441	PPP	4180186
1032460	Inattention during 2D assessment period	4180186
1032483	Inpatient stay within last 14D - ICD code	4180186
1032484	Insomnia &or change in sleeping pattern	4180186
1032522	Laundry during 2D assessment period	4180186
1032531	Light shopping during 2D assesssment	4180186
1032534	Limited activities because of pain during last 2D	4180186
1032535	Little interest or pleasure in doing things in last 2W	4180186
1032540	Prostate.adenoma	4180186
1032559	Maintains socially appropriate behavior & adheres to basic standards of neatness & cleanliness	4180186
1032564	Major treatments admitted &or discharged with	4180186
1032566	Major treatments admitted &or discharged with panel	4180186
1032571	Major treatments used on or 1D prior to day of death	4180186
1032573	Major treatments used within 2D interim period	4180186
1032574	Major treatments used within 2D interim period panel	4180186
1032584	Periton fld	4180186
1032608	Medical procedures &or treatments assistance needed	4180186
1032610	Medical services received in the last 2Mo	4180186
1032616	Medication management-inhalant &or mist medications during 2D assessment period	4180186
1032618	Medication management-injectable medications during 2D assessment period	4180186
1032619	Medication management-oral medications during 2D assessment period	4180186
1032627	Memory &or recall ability during 2D assessment period	4180186
1032640	Mobility endurance - able to walk or wheel 50 feet during 2D assessment period	4180186
1032657	Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2W	4180186
1032658	Pulmonary artery.wedge	4180186
1032664	Nails &or calluses trimmed during last 90D	4180186
1032674	Neighborhood &or workplace safety	4180186
1032712	Number of D injections received	4180186
1032714	Number hospital admissions in last 90D	4180186
1032715	Number of D antianxiety medication received	4180186
1032716	Number of D antidepressant medication received	4180186
1032717	Number of D antipsychotic medication received	4180186
1032722	Number of D of other rehabilitation or restorative techniques or procedures	4180186
1032725	Number of D of training & skill practice in amputation or prosthesis care	4180186
1032726	Number of D of training & skill practice in bed mobility	4180186
1032727	Number of D of training & skill practice in communication	4180186
1032729	Number of D of training & skill practice in eating or swallowing	4180186
1032730	Number of D of training & skill practice in transfer	4180186
1032731	Number of D of training & skill practice in walking	4180186
1032732	Number of D physician orders changed in last 14D	4180186
1032734	Number of D with at least 15M of physical therapy in the last 7D	4180186
1032735	Number of D with at least 15M of psychological therapy by any licensed mental health professional in the last 7D	4180186
1032737	Number of D with at least 15M of speech language pathology and audiology services in the last 7D	4180186
1032742	Number of D physician examined the patient in last 14D	4180186
1032755	Pulmonic valve.annulus	4180186
1032774	Observational Assessment of Cognitive Status at 2D Assessment Period	4180186
1032781	One step (curb) during 2D assessment period	4180186
1032782	Pulmonic valve.regurgitant jet	4180186
1032785	Openly expresses conflict &or anger with family &or friends	4180186
1032787	Oral hygiene during 2D assessment period	4180186
1032794	Oral status &or disease prevention - none of above	4180186
1032805	Other current diagnoses & ICD9 codes (quarterly)	4180186
1032817	Radial artery.left	4180186
1032822	Other fracture in last 180D	4180186
1032843	Overall Plan of Care &or Advance Care Directives - Subheading	4180186
1032849	Pads &or briefs used	4180186
1032853	Pain has made it hard to sleep during last 2D	4180186
1032854	Radius.diaphysis	4180186
1032890	RBC	4180186
1032912	Picking up objects during 2D assessment period	4180186
1032953	Prior functioning.functional cognition	4180186
1032959	Region of interest.XXX	4180186
1032992	Proportion of total calories received through parenteral or tube feeding in last 7D	4180186
1033000	Psychomotor retardation during 2D assessment period	4180186
1033001	Psychosocial well being section	4180186
1033003	Psychosocial well being trigger	4180186
1033008	Push &or pull	4180186
1033025	Reason for one on one 24H supervision	4180186
1033036	Recent loss of close family member &or friend	4180186
1033042	Regimen change in past 14D - ICD code	4180186
1033062	Renal pelvis.right	4180186
1033068	Resident assessment protocol 14--Dehydration &or Fluid maint - proceed with care	4180186
1033088	Resident assessment protocol 5--ADL functional &or Rehab - triggered	4180186
1033101	Resident expresses &or indicates preference to return to the community	4180186
1033107	Resident-specific deliberate changes in the environment to address mood &or behavior patterns	4180186
1033111	Respiratory status with oxygen therapy during 2D assessment period	4180186
1033121	Roll left and right during 2D assessment period	4180186
1033138	Sense of initiative &or involvement	4180186
1033150	Retinal artery.left	4180186
1033177	Ring finger arteries.right	4180186
1033184	Social Security & Medicare numbers	4180186
1033197	Special treatments &or programs - none of above	4180186
1033217	Stay projected to be of a short duration - discharge projected within 90D	4180186
1033219	Ser+Bld	4180186
1033229	Suctioning frequency per H during stay.max	4180186
1033255	Ser+Prostate	4180186
1033257	Telephone-answering during 2D assessment period	4180186
1033258	Telephone-placing call during 2D assessment period	4180186
1033263	Temporal Orientation &or Mental Status	4180186
1033264	Ser+RBC	4180186
1033268	Therapy orders to begin in 1st 14D of stay	4180186
1033281	Toilet transfer during 2D assessment period	4180186
1033289	Total minutes of respiratory therapy in the last 7D	4180186
1033290	Total minutes of speech language pathology and audiology services in the last 7D	4180186
1033292	Total population of age 10-14Y	4180186
1033293	Total population of age 1-4Y	4180186
1033297	Ser/Bld	4180186
1033298	Total population of age 29D to 1Y	4180186
1033300	Total population of age 35-39Y	4180186
1033304	Total population of age 55-59Y	4180186
1033305	Total population of age 5-9Y	4180186
1033307	Total population of age 60-64Y	4180186
1033308	Total population of age 65-69Y	4180186
1033309	Total population of age 70-74Y	4180186
1033310	Total population of age 75-79Y	4180186
1033315	Ser/Plas+Stool	4180186
1033324	Ser/Plas.ultracentrifugate	4180186
1033338	Trouble falling or staying asleep, or sleeping too much in last 2W	4180186
1033340	Tube feeding during 2D assessment period	4180186
1033343	Ser/Plas/Bld	4180186
1033356	Unable to assess memory &or recall ability during 2D assessment period .specified reason	4180186
1033360	Understands & remembers very short & simple instructions	4180186
1033364	Unknown customary routine - resident &or family unable to provide information	4180186
1033371	Upper body dressing during 2D assessment period	4180186
1033377	Urinary tract infection in last 7D	4180186
1033393	Verbal behavioral symptoms directed towards others during 2D assessment period	4180186
1033409	Walk 100 ft (30 m) during 2D assessment period	4180186
1033418	Walking 10 feet on uneven surfaces during 2D assessment period	4180186
1033422	Wash upper body during 2D assessment period	4180186
1033426	Weight gain or loss of 3+ Lbs. within a 7D period	4180186
1033428	Weight-bearing restrictions during 2D assessment period	4180186
1033431	Wheel 100 ft (30 m) during 2D assessment period	4180186
1033432	Wheel 150 ft (45 m) during 2D assessment period	4180186
1033435	Wheel long ramp during 2D assessment period	4180186
1033447	Wipe down surface during 2D assessment period	4180186
1033459	Synv fld	4180186
1033502	Cheek.left	4180186
1033503	Cheek.right	4180186
1033504	Clavicle.diaphysis.right	4180186
1033507	Femur.diaphysis.right	4180186
1033508	Fibula.diaphysis.right	4180186
1033510	Head.lateral cerebral ventricle.right	4180186
1033514	Lung.left	4180186
1033515	Lung.right	4180186
1033531	Tibia.diaphysis.right	4180186
1033532	Ulna.diaphysis.right	4180186
1033535	MDS	4180186
1033543	Subclavian vein.left	4180186
1033546	Fluid intake.urinary bladder irrigation	4180186
1033547	Fluid output.biliary drain	4180186
1033549	Fluid output.cerebral ventricle drain	4180186
1033550	Fluid output.chest tube	4180186
1033556	Fluid output.misc.route	4180186
1033559	Fluid output.subarachnoid drain	4180186
1033560	Fluid output.total	4180186
1033563	Fluid output.urine in and out urethral catheter	4180186
1033564	Fluid output.wound drain identifier	4180186
1033574	Surgical procedure	4180186
1033603	Fluid intake.nasogastric tube	4180186
1033604	Fluid intake.oral	4180186
1033606	Fluid intake.synovial	4180186
1033609	Testis.left	4180186
1033610	Testis.right	4180186
1033619	Velocity slope.XXX	4180186
1033624	Caretaking &or parenting.knowledge	4180186
1033625	Caretaking &or parenting.status	4180186
1033628	Communicable &or infectious condition function.status	4180186
1033634	Thigh.left	4180186
1033635	Neighborhood &or workplace safety.knowledge	4180186
1033636	Neighborhood &or workplace safety.status	4180186
1033640	Thigh.right	4180186
1033642	Thorax+Lungs	4180186
1033647	Volume at 25-75% of forced expiration.post bronchodilation	4180186
1033648	Volume at 25-75% of forced expiration.pre bronchodilation	4180186
1033651	AHIC	4180186
1033655	Thrt	4180186
1033658	Thumb arteries.left	4180186
1033660	USSG-FHT	4180186
1033664	Thumb arteries.right	4180186
1033676	Thyroid.FNA	4180186
1033683	Tiss	4180186
1033684	Tiss.FNA	4180186
1033685	TLGI	4180186
1033689	Trachea.airway	4180186
1033694	Tricuspid valve.annulus	4180186
1033695	Tricuspid valve.orifice	4180186
1033699	Tube/Drain	4180186
1033703	Ulna.diaphysis	4180186
1033704	Ulnar artery.left	4180186
1033705	Ulnar artery.right	4180186
1033709	Umbilical artery.between fetus and placenta	4180186
1033715	Urinary bladder irrigation tube	4180186
1033727	Ventilator.alarm	4180186
1033729	Ventilator.neonatal	4180186
1033730	Ventilator.servo	4180186
1033731	Ventilator.synchronized intermittent mandatory	4180186
1033732	Vitr fld	4180186
1033733	Volume.planimetry	4180186
1033741	Wound.shlw	4180186
1033753	IF Hep2 substrate	4180186
1033754	IF rat liver+stomach+kidney substrate	4180186
1033756	Glucose & Protein	4180186
1033763	Activities of Daily Living (ADL) Assistance in last 7D	4180186
1033768	Additional ICD diagnosis 3 in last 7D	4180186
1033770	Additional ICD diagnosis 5 in last 7D	4180186
1033771	Additional ICD diagnosis 6 in last 7D	4180186
1033773	Additional ICD diagnosis 8 in last 7D	4180186
1033774	Additional ICD diagnosis 9 in last 7D	4180186
1033775	Additional ICD diagnosis 10 in last 7D	4180186
1033800	Heart &or circulation	4180186
1033807	Psychiatric &or mood disorder	4180186
1033819	Oral &or dental status	4180186
1033843	Comatose in last 7D	4180186
1033851	Can recall current season in last 7D	4180186
1033852	Can recall location of own room in last 7D	4180186
1033853	Can recall staff names and faces in last 7D	4180186
1033854	Can recall that he or she is in a nursing home in last 7D	4180186
1033855	None of the above were recalled in last 7D	4180186
1033856	Cognitive skills for daily decision making in last 7D	4180186
1033857	Procedural memory OK in last 7D	4180186
1033860	Inattention in last 7D	4180186
1033862	Altered level of consciousness in last 7D	4180186
1033869	Little interest or pleasure in doing things in last 2W.frequency	4180186
1033871	Feeling down, depressed or hopeless in last 2W.frequency	4180186
1033873	Trouble falling or staying asleep, or sleeping too much in last 2W.frequency	4180186
1033874	Feeling tired or having little energy in last 2W.presence	4180186
1033875	Feeling tired or having little energy in last 2W.frequency	4180186
1033879	Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2W.frequency	4180186
1033889	Feeling or appearing down, depressed, or hopeless in last 2W.frequency	4180186
1033890	Indicating that (s)he feels bad about self, is a failure, or has let self or family down in last 2W.presence	4180186
1033892	States that life isn't worth living, wishes for death, or attempts to harm self in last 2W.presence	4180186
1033894	Being short-tempered, easily annoyed in last 2W.presence	4180186
1033895	Being short-tempered, easily annoyed in last 2W.frequency	4180186
1033911	Rejection of care - presence and frequency in last 7D	4180186
1033913	Wandering places resident at significant risk of getting to a potentially dangerous place in last 7D	4180186
1033914	Wandering significantly intrudes on the privacy or activities of others in last 7D	4180186
1033958	Toilet transfer in last 7D	4180186
1033960	Walk in room in last 7D	4180186
1033961	Walk in facility in last 7D	4180186
1033962	Locomotion in last 7D	4180186
1033963	Dressing upper body in last 7D	4180186
1033964	Dressing lower body in last 7D	4180186
1033965	Eating in last 7D	4180186
1033967	Bathing in last 7D	4180186
1033974	Walker normally used in last 7D	4180186
1033975	Wheelchair (manual or electric) normally used in last 7D	4180186
1033981	Ostomy (including suprapubic catheter, ileostomy, and colostomy) present in last 7D	4180186
1033982	Intermittent catheterization used in last 7D	4180186
1033988	Bowel continence in last 7D	4180186
1033992	Anemia in last 7D	4180186
1033994	Coronary artery disease in last 7D	4180186
1033999	Peripheral vascular disease in last 7D	4180186
1034002	Ulcerative colitis &or Crohn's disease &or inflammatory bowel disease in last 7D	4180186
1034005	HIV infection in last 30D	4180186
1034006	Staphylococcus aureus.methicillin resistant or Enterococcus species.vancomycin resistant or Clostridium difficile infections &or colonization in last 30D	4180186
1034010	Urinary tract infection in last 30D	4180186
1034012	Diabetes mellitus in last 7D	4180186
1034013	Hyponatremia in last 7D	4180186
1034017	Arthritis in last 7D	4180186
1034019	Hip fracture in last 7D	4180186
1034020	Other fracture in last 7D	4180186
1034021	Alzheimer's disease in last 7D	4180186
1034022	Aphasia in last 7D	4180186
1034027	Paraplegia in last 7D	4180186
1034028	Quadriplegia in last 7D	4180186
1034035	Depression other than bipolar in last 7D	4180186
1034036	Manic depression other than schizophrenia in last 7D	4180186
1034037	Schizophrenia in last 7D	4180186
1034038	Post-traumatic stress disorder in last 7D	4180186
1034039	Asthma &or chronic obstructive lung disease or chronic lung disease in last 7D	4180186
1034040	Cataracts &or glaucoma or macular degeneration in last 7D	4180186
1034041	None of the above active diagnoses in last 7D	4180186
1034042	On scheduled pain medication regimen in last 7D	4180186
1034043	Received PRN pain medications in last 7D	4180186
1034044	Received non-medication intervention for pain in last 7D	4180186
1034047	Pain frequency in last 5D	4180186
1034050	Pain severity in last 5D	4180186
1034052	Vocal complaints of pain in last 5D	4180186
1034055	None of these signs of pain observed or documented in last 5D	4180186
1034057	Shortness of breath or trouble breathing with exertion in last 7D	4180186
1034058	Shortness of breath or trouble breathing when sitting at rest in last 7D	4180186
1034059	Shortness of breath or trouble breathing when lying flat in last 7D	4180186
1034060	None of the above shortness of breath symptoms in last 7D	4180186
1034063	Fall one or more times in the last Mo prior to admission	4180186
1034071	Loss of liquids &or solids from mouth when eating or drinking in last 7D	4180186
1034073	Coughing or choking during meals or when swallowing medications in last 7D	4180186
1034077	Parenteral &or IV feeding in last 7D	4180186
1034078	Nasogastric or abdominal feeding tube in last 7D	4180186
1034080	Therapeutic diet in last 7D	4180186
1034081	Nutritional approaches in last 7D - none of the above	4180186
1034085	No natural teeth or tooth fragments in last 7D	4180186
1034086	Abnormal mouth tissue in last 7D	4180186
1034088	Inflamed or bleeding gums or loose natural teeth in last 7D	4180186
1034091	Pressure injury risk by resident has a stage 1 or greater, a scar over bony prominence, or a non-removable dressing, device in last 7D	4180186
1034097	Number of pressure ulcers present upon admission &or reentry - stage 2	4180186
1034107	Proportion of total calories the resident received through parenteral or tube feedings in the last 7D	4180186
1034110	Moving or speaking so slowly that other people have noticed. Or the opposite - being so fidgety or restless that (s)he has been moving around a lot more than usual in last 2W.frequency	4180186
1034115	Date of onset of pressure ulcers onset in this facility - oldest or only unstageable due to coverage of wound bed by slough &or eschar	4180186
1034117	Number of pressure ulcers present upon admission &or reentry - unstageable with suspected deep tissue injury in evolution	4180186
1034121	Venous or arterial ulcers in last 7D	4180186
1034122	Diabetic foot pressure injury(ies) in last 7D	4180186
1034125	Surgical wound(s) in last 7D	4180186
1034127	Second or third degree burns in last 7D	4180186
1034128	Other ulcers, wounds, and skin problems - none of above in last 7D	4180186
1034129	Number of venous and arterial ulcers in last 7D	4180186
1034131	Pressure reducing device for chair provided in last 7D	4180186
1034133	Turning &or repositioning provided in last 7D	4180186
1034134	Nutrition or hydration intervention to manage skin problems provided in last 7D	4180186
1034138	Applications of ointments &or medications other than to feet provided in last 7D	4180186
1034142	Medications received in last 7D or since admission &or reentry if less than 7D	4180186
1034143	Antipsychotic received in last 7D or since admission &or reentry if less than 7D	4180186
1034144	Antianxiety received in last 7D or since admission &or reentry if less than 7D	4180186
1034146	Hypnotic received in last 7D or since admission &or reentry if less than 7D	4180186
1034150	Chemotherapy in last 14D - while not a resident	4180186
1034151	Chemotherapy in last 14D - while a resident	4180186
1034155	Oxygen therapy in last 14D - while a resident	4180186
1034157	Suctioning in last 14D - while a resident	4180186
1034159	Tracheostomy care in last 14D - while a resident	4180186
1034160	Ventilator or respirator in last 14D - while not a resident	4180186
1034161	Ventilator or respirator in last 14D - while a resident	4180186
1034163	BIPAP &or CPAP machine in last 14D - while a resident	4180186
1034165	IV medications in last 14D - while a resident	4180186
1034166	Transfusions in last 14D - while not a resident	4180186
1034169	Dialysis in last 14D - while a resident	4180186
1034171	Hospice care in last 14D - while a resident	4180186
1034174	Isolation or quarantine for active infectious disease in last 14D - while not a resident	4180186
1034188	Total minutes of recreational and music therapy in last 7D	4180186
1034192	Nursing rehabilitation &or restorative care in last 7D	4180186
1034236	Other special treatments and programs in last 14D	4180186
1034258	Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2W.presence	4180186
1034259	Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2W.frequency	4180186
1034291	Number of male sexual partners in 6Mo before symptom onset	4180186
1034330	Views & (view AP	4180186
1034331	(View Sunrise) + (views	4180186
1034333	View oblique & (views	4180186
1034368	Blood pressure systolic & diastolic	4180186
1034386	Reported.PHQ-2	4180186
1034406	Horizontal adduction.passive range of motion	4180186
1034424	PhenX measure - mid upper arm circumference	4180186
1034434	ALSPAC	4180186
1034467	Albumin.serum	4180186
1034469	Phenx - hand dominance - 42Mo and older protocol 020601	4180186
1034486	ED accepting or admitting provider	4180186
1034547	Serology & blood bank studies	4180186
1034566	Neuro & emotional & behavioral status	4180186
1034634	Patient &or caregiver drug education intervention	4180186
1034678	Hemoglobin disorders newborn screening comment-discussion	4180186
1034679	Infectious diseases newborn screening comment-discussion	4180186
1034683	Hearing loss newborn screening comment-discussion	4180186
1034699	Entry &or discharge reporting	4180186
1034700	Multidrug-resistant organism (MDRO) in last 7D	4180186
1034702	Neurogenic bladder in last 7D	4180186
1034703	Obstructive uropathy in the last 7D	4180186
1034705	Tourette's syndrome in last 7D	4180186
1034706	Psychotic disorder (other than schizophrenia) in last 7D	4180186
1034707	Respiratory failure in last 7D	4180186
1034711	Prior Functioning ADL and IADL	4180186
1034714	Other disease diagnoses in last 7D	4180186
1034720	Number of D the physician changed the resident's insulin orders in last 7D or since admission &or reentry if less than 7D	4180186
1034721	Antibiotic received in last 7D or since admission &or reentry if less than 7D	4180186
1034750	Cognitive loss &or dementia - addressed in care plan	4180186
1034754	ADL functional &or rehabilitation potential - addressed in care plan	4180186
1034757	Psychosocial well being - care area triggered	4180186
1034758	Psychosocial well being - addressed in care plan	4180186
1034840	Mention of the participant having either trauma, a surgical procedure, or rhabdomyolysis within 1W prior to the cardiac enzymes measurement	4180186
1034855	Y permanent pacemaker inserted	4180186
1034871	Rheumatic fever in the past 12Mo	4180186
1034951	Velocity-time integral.pulmonary vein A wave	4180186
1035277	Respiratory system.airway opening	4180186
1036708	Acinetobacter Infection	4180186
1036708	Infection, Acinetobacter	4180186
1036708	Infection, Mimae	4180186
1036708	Infections, Acinetobacter	4180186
1036708	Infections, Mimae	4180186
1036708	Mimae Infection	4180186
1036708	Mimae Infections	4180186
1036710	1,2-Propanediol, 3-chloro-	4180186
1036710	3 Chloro 1,2 propanediol	4180186
1036710	3-Chloro-1,2-propanediol	4180186
1036710	3 Chloropropanediol	4180186
1036710	3-Chloropropanediol	4180186
1036710	3-MCPD	4180186
1036710	3 Monochloropropane 1,2 diol	4180186
1036710	3-Monochloropropane-1,2-diol	4180186
1036710	alpha Chlorhydrin	4180186
1036710	alpha-Chlorhydrin	4180186
1036710	alpha Chlorohydrin	4180186
1036710	alpha-Monochlorohydrin, Glycerol	4180186
1036710	Glycerol alpha Monochlorohydrin	4180186
1036710	Glycerol alpha-Monochlorohydrin	4180186
1036710	U5897	4180186
1036710	U 5897	4180186
1036710	U-5897	4180186
1036711	Acid Maltase	4180186
1036711	alpha-D-Glucoside glucohydrolases	4180186
1036711	alpha Glucosidase	4180186
1036711	alpha-Glucosidase	4180186
1036711	alpha-Glucosidase, Lysosomal	4180186
1036711	alpha-Glucosidase, Neutral	4180186
1036711	alpha Glucosidases	4180186
1036711	Lysosomal alpha Glucosidase	4180186
1036711	Lysosomal alpha-Glucosidase	4180186
1036711	Maltase	4180186
1036711	Maltase Glucoamylase	4180186
1036711	Maltase-Glucoamylase	4180186
1036711	Maltases	4180186
1036711	Neutral alpha Glucosidase	4180186
1036711	Neutral alpha-Glucosidase	4180186
1036711	Neutral Maltase	4180186
1036714	Blood Viscosities	4180186
1036714	Viscosities, Blood	4180186
1036714	Viscosity, Blood	4180186
1036716	Body Compositions	4180186
1036716	Composition, Body	4180186
1036716	Compositions, Body	4180186
1036717	Body Heights	4180186
1036717	Height, Body	4180186
1036717	Heights, Body	4180186
1036718	Index, Body Mass	4180186
1036718	Index, Quetelet	4180186
1036718	Quetelet Index	4180186
1036718	Quetelet's Index	4180186
1036718	Quetelets Index	4180186
1036719	Area, Body Surface	4180186
1036719	Areas, Body Surface	4180186
1036719	Body Surface Areas	4180186
1036719	Surface Area, Body	4180186
1036719	Surface Areas, Body	4180186
1036721	Body Weight Change	4180186
1036721	Change, Body Weight	4180186
1036721	Changes, Body Weight	4180186
1036721	Weight Change, Body	4180186
1036721	Weight Changes, Body	4180186
1036723	Atrio Biventricular Pacing	4180186
1036723	Atrio-Biventricular Pacing	4180186
1036723	Biventricular Pacing	4180186
1036723	Cardiac Resynchronization	4180186
1036723	Cardiac Resynchronization Pacing Therapy	4180186
1036723	Pacing, Atrio-Biventricular	4180186
1036723	Pacing, Biventricular	4180186
1036723	Resynchronization, Cardiac	4180186
1036723	Resynchronization Pacing Therapy, Cardiac	4180186
1036723	Resynchronization Therapy, Cardiac	4180186
1036723	Therapy, Cardiac Resynchronization	4180186
1036724	Cardiac Toxicities	4180186
1036724	Cardiac Toxicity	4180186
1036724	Cardiotoxicities	4180186
1036724	Toxicity, Cardiac	4180186
1036726	Sensitivity, Contrast	4180186
1036726	Sensitivity, Visual Contrast	4180186
1036726	Visual Contrast Sensitivity	4180186
1036727	Brain Tumor, DIPG	4180186
1036727	DIPG Brain Tumor	4180186
1036727	DIPG Brain Tumors	4180186
1036727	DIPG, Diffuse Intrinsic Pontine Glioma	4180186
1036728	Erythrocyte Volumes	4180186
1036728	Masses, Red Cell	4180186
1036728	Mass, Red Cell	4180186
1036728	Red Cell Mass	4180186
1036728	Red Cell Masses	4180186
1036728	Volume, Erythrocyte	4180186
1036728	Volumes, Erythrocyte	4180186
1036732	Concentration, Hydrogen-Ion	4180186
1036732	Concentrations, Hydrogen-Ion	4180186
1036732	Hydrogen Ion Concentration	4180186
1036732	Hydrogen-Ion Concentrations	4180186
1036732	pH	4180186
1036734	1H-Indol-3-ol, hydrogen sulfate (ester)	4180186
1036734	1H-Indol-3-ol Hydrogen Sulfate Ester	4180186
1036734	Indican Monopotassium Salt	4180186
1036734	Indican Monosodium Salt	4180186
1036734	Indoxyl Sulfate	4180186
1036734	Monopotassium Salt, Indican	4180186
1036734	Monosodium Salt, Indican	4180186
1036734	Sulfate, Indoxyl	4180186
1036735	Intraocular Pressures	4180186
1036735	Ocular Tension	4180186
1036735	Ocular Tensions	4180186
1036735	Pressure, Intraocular	4180186
1036735	Pressures, Intraocular	4180186
1036735	Tension, Ocular	4180186
1036735	Tensions, Ocular	4180186
1036736	Lactobacillus fermentum	4180186
1036736	Lactobacillus cellobiosus	4180186
1036738	Lactococcus lactis subsp. lactis	4180186
1036738	Streptococcus lactis	4180186
1036739	Dose 50, Lethal	4180186
1036739	LD50	4180186
1036742	Concentration, Osmolar	4180186
1036742	Concentrations, Osmolar	4180186
1036742	Ionic Strength	4180186
1036742	Ionic Strengths	4180186
1036742	Osmolalities	4180186
1036742	Osmolality	4180186
1036742	Osmolar Concentrations	4180186
1036742	Osmolarities	4180186
1036742	Osmolarity	4180186
1036742	Strength, Ionic	4180186
1036742	Strengths, Ionic	4180186
1036745	Blood Plasma Volume	4180186
1036745	Blood Plasma Volumes	4180186
1036745	Plasma Volumes	4180186
1036745	Volume, Blood Plasma	4180186
1036745	Volume, Plasma	4180186
1036745	Volumes, Blood Plasma	4180186
1036745	Volumes, Plasma	4180186
1036754	Circumferences, Waist	4180186
1036754	Circumference, Waist	4180186
1036754	Waist Circumferences	4180186
1036760	oct-1-en-3-yl acetate	4180186
1036762	2-ethyl-1-hexanol	4180186
1036762	2-ethylhexanol, titanium (4+) salt	4180186
1036763	2-isopropyl-5-methyl-phenol	4180186
1036764	Isoeugenol acetate	4180186
1036764	Isoeugenyl acetate	4180186
1036767	4-cresol, aluminum salt	4180186
1036767	4-cresol, potassium salt	4180186
1036767	4-cresol, sodium salt	4180186
1036767	4-methylphenol	4180186
1036767	para-cresol	4180186
1036767	p-cresol	4180186
1036775	death cap mushroom	4180186
1036776	Gaffkya anaerobia	4180186
1036776	Peptostreptococcus tetradius	4180186
1036776	Tetracoccus anaerobius	4180186
1036777	ansuvimab-zykl	4180186
1036777	Ebanga	4180186
1036777	mAb114	4180186
1036777	mAb-114	4180186
1036779	Aspergillus rubrobrunneus	4180186
1036779	Aspergillus rubrum	4180186
1036779	Eurotium rubrum	4180186
1036780	atoltivimab-ebgn	4180186
1036780	REGN3470	4180186
1036780	REGN-3470	4180186
1036781	LY3819253	4180186
1036781	LY-3819253	4180186
1036781	LY-COV555	4180186
1036783	1-(3-(aminomethyl)phenyl)-N-(5-((R)-(3-cyanophenyl)((cyclopropylmethyl)amino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide	4180186
1036783	1H-pyrazole-5-carboxamide, 1-(3-(aminomethyl)phenyl)-N-(5-((R)-(3-cyanophenyl)((cyclopropylmethyl)	4180186
1036783	BCX7353	4180186
1036783	BCX-7353	4180186
1036788	burosumab-TWZA	4180186
1036788	Crysvita	4180186
1036788	KRN23	4180186
1036788	KRN-23	4180186
1036788	KRN23 monoclonal antibody	4180186
1036791	C auris infection	4180186
1036791	C. auris infection	4180186
1036797	3,7-dimethyl-6-octenenitrile	4180186
1036799	(-)-cocaine-3-acylhydrolase	4180186
1036799	cocaine carboxylesterase	4180186
1036799	CocE protein, Rhodococcus	4180186
1036802	semen loss syndrome	4180186
1036802	semen-loss syndrome	4180186
1036805	diethylmalonate	4180186
1036805	malonic acid, diethyl ester	4180186
1036805	propanedioic acid, diethyl ester	4180186
1036807	succinic acid, dimethyl ester	4180186
1036809	N-(2-(3-methoxyphenyl)-2-ethylbutyl-(1))-gamma-hydroxybutyramide	4180186
1036810	chrysosporium infection	4180186
1036810	Emergomyces africanus infection	4180186
1036810	Emergomycosis	4180186
1036810	Emmonsia helica infection	4180186
1036810	Emmonsia pasteurian infection	4180186
1036811	LY-CoV016	4180186
1036811	JS016	4180186
1036813	ethyl caproate	4180186
1036813	hexanoic acid ethyl ester	4180186
1036815	1,4-p-menthadiene	4180186
1036815	alpha-terpinene	4180186
1036815	beta-terpinene	4180186
1036820	grazoprevir anhydrous	4180186
1036820	grazoprevir monohydrate	4180186
1036820	MK5172	4180186
1036820	MK 5172	4180186
1036820	MK-5172	4180186
1036820	cyclopropanecarboxamide, n-((((1r,2r)-2-(5-(3-hydroxy-6-methoxy-2-quinoxalinyl)pentyl)cyclopropyl)oxy)carbonyl)-3-methyl-l-valyl-(4R)-4-hydroxy-l-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenyl-, cyclic (1->2)-ether, (1R,2S)-	4180186
1036820	cyclopropanecarboxamide, N-((((1R,2R)-2-(5-(3-hydroxy-6-methoxy-2-quinoxalinyl)pentyl)cyclopropyl)oxy)carbonyl)-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenyl-, cyclic (1->2)-ether, hydrate (1 :1) (1R,2S)-	4180186
1036820	grazoprevir hydrate	4180186
1036820	MK-5172 monohydrate	4180186
1036822	2-((4-amino-2-nitrophenyl)amino)ethanol	4180186
1036826	REGN-10987	4180186
1036827	Al-imidazole	4180186
1036827	Cu-imidazole	4180186
1036827	imidazole acetate	4180186
1036827	imidazole citrate	4180186
1036827	imidazole conjugate monoacid	4180186
1036827	imidazole monohydrochloride	4180186
1036827	imidazole monophosphonate	4180186
1036827	imidazole sodium	4180186
1036827	imidazolium chloride	4180186
1036828	isatuximab-irfc	4180186
1036828	SAR650984	4180186
1036828	SAR6 50984	4180186
1036828	Sarclisa	4180186
1036829	Candida kefyr	4180186
1036829	Candida pseudotropicalis	4180186
1036829	Dekkeromyces marxianus	4180186
1036829	Guilliermondella marxiana	4180186
1036829	Kluyveromyces cicerisporus	4180186
1036829	Kluyveromyces fragilis	4180186
1036829	Saccharomyces marxianus	4180186
1036829	Zygofabospora marxiana	4180186
1036829	Zygorenospora marxiana	4180186
1036829	Zygosaccharomyces marxianus	4180186
1036831	4-(2-(4-(8-chloro-3,10-dibromo-6,11-dihydro-5H-benzo-(5,6)-cyclohepta(1,2-b)-pyridin-11(R)-yl)-1-piperidinyl)-2-oxo-ethyl)-1-piperidinecarboxamide	4180186
1036831	(+)4-(2-(4-(8-chloro-3,10-dibromo-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-yl)-1-piperidinyl)-2-oxoethyl)-1-piperidinecarboxamide	4180186
1036831	SCH66336	4180186
1036831	SCH 66336	4180186
1036831	1-piperidinecarboxamide, 4(2-(4-(11R-3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridine-11-yl)-1-piperidinyl)-2-oxoethyl)-	4180186
1036831	Sarasar	4180186
1036831	SCH-66336	4180186
1036831	Zokinvy	4180186
1036832	3-Methyl-N-(2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)-5-((5S)-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl)-2-thiophenecarboxamide	4180186
1036832	Credelio	4180186
1036839	2-Propenoic acid, 2-methyl- 3-(trimethoxysilyl)propyl ester	4180186
1036839	3-methacryloyloxypropyl-trimethoxysilane	4180186
1036839	gamma-MAPS	4180186
1036839	gamma-methacryloxypropyltrimethoxysilane	4180186
1036839	gamma-MPTS	4180186
1036839	Kerr Ceramic Primer	4180186
1036839	KH 570	4180186
1036839	KH-570	4180186
1036839	MAOPTMS	4180186
1036839	Silanit	4180186
1036839	Silicoup adhesion primer	4180186
1036839	Silicoup silane coupling agents	4180186
1036839	Siliseal	4180186
1036841	Myopathy, Congenital, Due To Integrin Alpha-7 Deficiency	4180186
1036843	acetyl arginine	4180186
1036843	N-alpha-acetylarginine	4180186
1036844	2-butoxyethanol	4180186
1036844	butylcellosolve	4180186
1036844	ethyleneglycol monobutyl ether	4180186
1036844	n-butoxyethanol sodium salt	4180186
1036846	odesivimab-ebgn	4180186
1036846	REGN3471	4180186
1036846	REGN-3471	4180186
1036848	ABT-450	4180186
1036848	veruprevir	4180186
1036848	veruprevir anhydrous	4180186
1036848	(2R,6S,12Z,13aS,14aR,16aS)-N-(cyclopropylsulfonyl)-6-(5-methylpyrazin-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16atetradecahydrocyclopropa(E)pyrrolo(1,2-a)(1,4)diazacyclopentadecine-14a(5H)-carboxamide	4180186
1036848	ABT 450	4180186
1036848	ABT450	4180186
1036848	paritaprevir dihydrate	4180186
1036848	paritaprevir hydrate	4180186
1036850	Citromyces glaber	4180186
1036850	Penicillium frequentans	4180186
1036852	decalin perfluoride	4180186
1036852	DKLine	4180186
1036852	fluosol-DC	4180186
1036852	perfluorodecalin, (cis)-isomer	4180186
1036852	perfluorodecalin, (trans)-isomer	4180186
1036853	diphenyl ether	4180186
1036854	Pleospora betae	4180186
1036855	isobornyl acetate	4180186
1036856	PG-MG-DS	4180186
1036857	postlaminectomy syndrome	4180186
1036857	post-laminectomy syndrome	4180186
1036858	gavreto	4180186
1036858	BLU-667	4180186
1036858	Cyclohexanecarboxamide, N-((1S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)-, trans-	4180186
1036858	trans-N-((1S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)cyclohexanecarboxamide	4180186
1036860	orgovyx	4180186
1036860	1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno(2,3-d)pyrimidin-6-yl)phenyl)-3-methoxyurea	4180186
1036860	TAK385	4180186
1036860	TAK 385	4180186
1036860	TAK-385	4180186
1036862	S. vasiformis infection	4180186
1036862	S vasiformis infections	4180186
1036862	S. vasiformis infections	4180186
1036862	Saksenaea erythrospora infection	4180186
1036862	Saksenaea erythrospora infections	4180186
1036862	Saksenaea infections	4180186
1036862	Saksenaea vasiformis infection	4180186
1036862	Saksenaea vasiformis infections	4180186
1036862	S erythrospora infection	4180186
1036862	S. erythrospora infection	4180186
1036862	S erythrospora infections	4180186
1036862	S. erythrospora infections	4180186
1036862	S vasiformis infection	4180186
1036864	satralizumab-mwge	4180186
1036864	enspryng	4180186
1036866	2-amino-1,3-propanediol	4180186
1036866	2-aminopropane-1,3-diol	4180186
1036866	serinol, (+-)-isomer	4180186
1036872	taijin-kyofusho	4180186
1036875	TBPi cpd	4180186
1036877	triethylene glycoldimethacrylate	4180186
1036877	triethyleneglycol dimethacrylate	4180186
1036877	2-Propenoic acid, 2-methyl-, 1,2-ethanediylbis(oxy-2,1-ethanediyl) ester	4180186
1036877	TEGDMA	4180186
1036877	TEGMA	4180186
1036877	trioxyethylene dimethacrylate	4180186
1036879	ukoniq	4180186
1036879	TGR-1202	4180186
1036882	viltepso	4180186
1175102	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; ANED; Blood; Closure time; Closure Tme; COAGULATION; FCN; Func; Funct; Medication stress; Pan; PANEL.COAGULATION; Panl; Pl; Platelet function ADP-induced Pnl; Platelets; Platelt; Plt; Pnl; Res TEG; TEG; Thrombelastography; Thrombelastometry; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1175102	Platelet func ADP-ind Pnl Bld Res TEG	4180186
1175102	:-:-::-:.	4182948
1175103	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Porcine kobuvirus; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1175103	Aichivirus C RNA Ct Spec Qn NAA+probe	4180186
1175103	 C  RNA:::XXX::..	4182948
1175105	D/T of risk assessment; Date and time; Date+time; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
1175105	D/T of risk assessment	4180186
1175105	:::^:	4182948
1175107	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1175111	C trach L1 IgA Titr Ser IA	4180186
1175111	 L1  .IgA:::::	4182948
1175111	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach L1; C tracho; C trachom L1 Ab.IgA; C trachomatis; Chlam; Chlam trac; Chlamid; CT; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Trachoma; Ttr	4180186
1175112	Cardio; Cardiology; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; Heart function; notes; Point in time; Random; Visit note	4180186
1175112	Heart failure Phone Note	4180186
1175112	:::::	4182948
1175113	4 weeks; Finding; Findings; FR; Last; Non-protein bound; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175114	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175118	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175120	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; SVC; Tissue; Tissue, unspecified	4180186
1175120	Virus Tiss Shell Vial Cult	4180186
1175120	 :::::	4182948
1175128	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175129	BAFF-R cells/100 CD19 cells NFr Bld	4180186
1175129	100 CD19 cells; B cell activating factor; B cell activating factor receptor; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; Cell; CELL MARKERS; Cellularity; HD-37; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right; WB; Whole blood	4180186
1175129	BAFF-R /100 .CD19::::	4182948
1175132	Cnt; Count; Dental; Dentistry; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Teeth+gum	4180186
1175132	Openbite teeth	4180186
1175132	:():::	4182948
1175133	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175136	Heparan sulfate DBS-sCnc	4180186
1175136	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; HS; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; SO4; SO4-2; Substance concentration; Sulf; WB; Whole blood	4180186
1175136	:::.:	4182948
1175137	MAG/SGPG IgM Titr CSF IA	4180186
1175137	- .IgM:::::	4182948
1175137	ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; IAA; Immune globulin M; Immunoglobulin M; MAG; MAG/SGPG; MAGM; MAG-SGPG; MEIA; Neuro; Neurology; Point in time; Random; Serology; SGPG.IGM; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Titer; Titered; Titre; Ttr	4180186
1175138	Cnt; Count; Lung; Neuro; Neurology; Number; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1175138	Num central apnea	4180186
1175138	:()::^:	4182948
1175141	H+P; H+P.PX; Integument; Nominal; P prime; Point in time; Random; Typ	4180186
1175141	Emoji skin tone mod	4180186
1175141	:::^::Unicode	4182948
1175142	Est; Est from PE; estimation; Fetal; GA; Gest; Gestation; Gyn; Gynecology; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; PEA; Point in time; predicted; Prenatal; QNT; Quan; Quant; Quantitative; Random	4180186
1175142	GA Est from PE	4180186
1175142	:::^::	4182948
1175145	4 weeks; Cogn func; cognition; cognitive status; FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175146	AQP4 H2O channel Ab CSF Ql IF	4180186
1175146	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; AQP4; AQP4 H2O channel; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Devic's disease; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF; Water channel aquaporin-4	4180186
1175146	 4  :::::	4182948
1175149	120 min; 120 minutes; 120min; 17-beta estradiol; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; E2; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175149	Estradiol 2h p chal SerPl-mCnc	4180186
1175149	^XXX2:::/:	4182948
1175150	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175151	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175153	AI; Count/time; Lung; nRate; Number rate; Number Rate = Count/Time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1175153	Apnea index nRate	4180186
1175153	:::^:	4182948
1175154	:::^:	4182948
1175154	D/T of deaths assessment	4180186
1175154	D/T of deaths assessment; Date and time; Date+time; Death; Fatalities; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
1175156	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175157	ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; CASPR2; CASPR2 Ab; Cerebral spinal fluid; Cerebrospinal Fl; II; Indirect Fluorescence Antibody; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1175157	CASPR2 Ab CSF Ql CBA IFA	4180186
1175157	 2 :::::CBA IFA	4182948
1175158	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175159	4 weeks; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175160	Cnt; Count; Lung; Number; O2; O2 desaturation; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies; tO2	4180186
1175160	Num O2 desaturation	4180186
1175160	:()::^:	4182948
1175161	Blood; DNA; Document; Finding; Findings; Fluorescent in situ hybridization; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Point in time; Random; RNA; T prime; t(14;20)(IGH,MAFB); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
1175161	t(14;20)(IGH,MAFB) Bld/T FISH	4180186
1175161	t(14;20)(q32;q12)(IGH,MAFB) :::/::FISH	4182948
1175162	abn; abnorm; Ejaculate; FERTILITY TESTING; Genitourinary; GU; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Abnorm; URO; Urology	4180186
1175162	Abnormal principal pieces NFr Smn	4180186
1175162	./100 ::::	4182948
1175164	Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cardio; Cardiology; Cult; Cultures; Heart Disease; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; PCAR; Pericardial Fluid; Point in time; Random	4180186
1175164	Bacteria Pcar Aerobe Cult	4180186
1175164	 :::::	4182948
1175168	Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175169	ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1175169	Bictegravir Islt Genotyp	4180186
1175169	:::::	4182948
1175175	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175176	bod; Bodies; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; RN; RNC; Scan; W RNC IV; WB	4180186
1175176	SPECT+CT Whole body W RNC IV	4180186
1175176	^:::::NM.SPECT+CT	4182948
1175181	120 min; 120 minutes; 120min; 2 hours; 2h p levo; After; c99; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
1175181	T4 2h p levo SerPl-mCnc	4180186
1175181	^2:::/:	4182948
1175182	Conc increment SerPl Calc-MCDiff	4180186
1175182	After; Calc; Calculation; Conc increment; DRUG/TOXICOLOGY; Drugs; MCDiff; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175182	XXX  - :::/::	4182948
1175185	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175186	Abd; Abdo; Abdomen+; Abdominal; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Kidney-R; Nephric; Nephrology; Perc; Point in time; Pyelogram; R; Rad; RADIOLOGY; Random; Renal; RT	4180186
1175186	CT Guided Kidney-R Cyst asp	4180186
1175186	:::>.::CT	4182948
1175188	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175189	9-Hydroxy risperidone; 9-Hydroxy-risperidone; 9-OH-Risperidone; 9OH-risperidone; DRUG/TOXICOLOGY; Drugs; Invega; Ordinal; Paliperidone; Point in time; PR; QL; Qual; Qualitative; Random; Risperidone metabolite; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1175189	9OH-risperidone Ur Ql Scn	4180186
1175189	9-:::::	4182948
1175190	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chagas disease; Donr; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; T cruzi; Trypanosomiasis; Trypanosomosis	4180186
1175190	T cruzi IgG Ser Donr Ql IA	4180186
1175190	 .IgG:::^::	4182948
1175191	Bili; Bilirubins; Billirubin; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; TBIL; Venous	4180186
1175191	Bilirub BldV-sCnc	4180186
1175191	::::	4182948
1175193	Genetics; Heredity; Heritable; Inherited; ITPA g.9381A&gt;C; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Typ	4180186
1175193	ITPA g.9381A>C SerPl	4180186
1175193	ITPA .g.9381A>C:::/::	4182948
1175194	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175195	Ang; Angio; Angiography; Angm; CAT scan; Computed tomography; Computerized tomography; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; LMTED; LTD; Misc; Miscellaneous; Other; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1175195	CTA Ltd	4180186
1175195	:::XXX::CT.	4182948
1175198	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; ZIKV; ZIKV RNA	4180186
1175198	ZIKV RNA Bld Ql NAA+probe	4180186
1175198	 RNA:::::..	4182948
1175202	Abortus blauw; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue-eared pig disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin A; Immunoglobulin A; Lelystad virus; MEIA; Microbiology; Misc; Miscellaneous; Mystery swine disease; Other; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; Pos; Pos cntrl; PRRS; PRRS virus Ab.IgA; PRRSV; PRRSV Ab; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Seuchenhafter spatabort der schweine; SIRSV; Spec; SUDS; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
1175202	PRRSV IgA/Pos cntrl Spec IA	4180186
1175202	 .IgA/:::XXX::	4182948
1175203	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HRV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Rhino virus; RHV; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175203	Rhinovirus RNA Lower resp Ql NAA+probe	4180186
1175203	 RNA:::.::..	4182948
1175204	ADMIN; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1175204	:::^:	4182948
1175206	Cardio; Cardiology; Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; Heart function; HF+TC; notes; Point in time; Random; TC; Visit note	4180186
1175206	HF+TC Consult note	4180186
1175206	:::{}::+	4182948
1175207	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nuc med; Nuc Medicine; Point in time; Random; Visit note	4180186
1175207	Nuc Medicine Consult note	4180186
1175207	:::{}::	4182948
1175208	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T vaginalis; TMA; Transcription mediated amplification; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis	4180186
1175208	T vaginalis DNA Cvx Ql NAA+probe	4180186
1175208	 DNA:::::..	4182948
1175210	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175211	1 month; 1 month (30 days); 30 days; Count/time; f247; Last; month; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Rf247; Survey; SURVEY.NHANES	4180186
1175212	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175215	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH; Tx	4180186
1175219	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Random; Visit note	4180186
1175219	Sports medicine OP Note	4180186
1175219	:::::	4182948
1175221	4 weeks; Finding; Findings; Last; Must use written lists so will not forget things; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175222	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175224	Blood; Chemistry; Chondroitin sulfate B; DBS; Dried blood spot; Filter paper; FP; keratosulfate; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; SO4; SO4-2; Substance concentration; Sulf; WB; Whole blood	4180186
1175224	Keratan Sulfate DBS-sCnc	4180186
1175224	:::.:	4182948
1175228	CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Drain+cath place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; Removal of fluid	4180186
1175228	CT Guided Perirectal Drain+cath place	4180186
1175228	+:::>::CT	4182948
1175229	ADMIN; Nominal; Point in time; Random; Typ	4180186
1175229	::::	4182948
1175230	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; LMTED; Local; LTD; Misc; Miscellaneous; Other; PET Scan; PET+CT; Point in time; Position Emmision Tomography; Positron Emission Tomography; Rad; RADIOLOGY; Radnuc.PET; Random; Spec; To be specified in another part of the message; Tum loc Ltd; Unspecified; W 18F-FDG+contr IV; W contr IV; WC	4180186
1175230	PET+CT Tum loc Ltd--W 18F-FDG+contr IV	4180186
1175230	^ 18F-FDG+:::XXX::PT+CT	4182948
1175231	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-R; Finding; Findings; Imaging; LE; Leg; LE-R; Low; Mid ft-R; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; R; Rad; Radiology; Random; RLE; RT; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1175231	CT Mid ft-R WO+W contr IV	4180186
1175231	^ & :::.>::CT	4182948
1175232	Cnt; Count; NEG; Number; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
1175232	Confirmed negative lab results Pop	4180186
1175232	:()::^:	4182948
1175233	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175235	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175237	bod; Bodies; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; RN; RNC; Scan; W RNC IV; WB	4180186
1175237	SPECT+CT Skeletal W RNC IV	4180186
1175237	^:::>::NM.SPECT+CT	4182948
1175238	PNH GPI-Linked WBC + RBC Ag Bld-Imp	4180186
1175238	Antigen; Antigens; Blood; CELL MARKERS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; PNH GPI-Linked WBC + RBC; PNH GPI-Lkd WBC + RBC Ag; Point in time; Random; Report; WB; Whole blood	4180186
1175238	 GPI- ::::	4182948
1175243	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Luvox; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1175243	fluvoxaMINE Ur Cfm-mCnc	4180186
1175243	:::::	4182948
1175244	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175248	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175249	Chronic Respiratory Questionnaire Self-Administered, Individualized Format; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
1175250	Chol; Choles; Cholest; Cholesterol total; Cholesterols; HEDIS 2019-20 Chol Tests not LDL; Lipid; Othr; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1175250	HEDIS 2019-20 Chol Tests not LDL	4180186
1175250	HEDIS 2019  - LDL:-::^:-	4182948
1175253	Ang; Angio; Angiography; Angm; Arm; c; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CT venography; CTA; CTV; Document; EXT; Extr-R; Finding; Findings; Heart Disease; Imaging; Point in time; R; Rad; RADIOLOGY; Random; RT; RUE; UE; UE vv; UE vv-R; UE-R; Up; Venogram; Venography; W contr IV; WC	4180186
1175253	CTA UE vv-R W contr IV	4180186
1175253	^:::.>::CT.	4182948
1175254	VMA + HMA panel Ur	4180186
1175254	:-:::-	4182948
1175254	3-methoxy-4-hydroxymandelate; 3-methoxy-4-hydroxy-phenylacetic acid; 3-methyl,4-hydroxy mandelate; 3-methyl,4-oh mandelic acid; Catecholamine metabolite; Chemistry; HMMA; Homovanilic; Homovanillate Pnl; Homovanillic acid; HVA; Hydroxy-methoxy-mandelate; Hydroxy-methoxy-mandelic acid; MHMA; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Tumor marker; UA; UR; Urn; Vanillylmandelic acid; Vanilmandelate; VMA; VMA + HMA panel	4180186
1175256	:::{}::	4182948
1175256	Anesthesia; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1175256	Anesthesiology Prog note	4180186
1175259	:::^:	4182948
1175259	Cause of deaths	4180186
1175259	Fatalities; Finding; Findings; Narrative; Point in time; Public Health; PUBLICHEALTH; Random; Report	4180186
1175260	Addiction; Blood; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Illicit; MDMA; Methamphet; Methamphet+MDMA; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
1175260	Methamphet+MDMA SerPlBld Ql Scn	4180186
1175260	+::://::	4182948
1175261	Addiction; B/F; Barb; Barbiturate; Barbs; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1175261	Barbiturates Fld Ql Scn	4180186
1175261	:::::	4182948
1175262	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1175262	:::::	4182948
1175264	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175266	AIDS; Blood; high-throughput sequencing; HIV type 1; HIV type I; HIV1; HTS; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Next generation sequencing; NGS; Nominal; Pl; PlasBld; Plasma; Plsm; Point in time; Random; Ribonucleic acid; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
1175266	HIV 1 RNA IN SerPlBld-Seq	4180186
1175266	HIV 1  RNA ::://::	4182948
1175269	Email addr of person generating rprt	4180186
1175269	ADMIN; Nominal; Person generating report; Persons; Point in time; Random	4180186
1175269	::::	4182948
1175271	FDA insert Postmarketing exp section	4180186
1175271	DOCUMENT.REF; FDA insert; Narrative; Postmarketing exp section; Report; SPL; Structured Product Labelling	4180186
1175271	:-:-:^FDA :	4182948
1175273	Abd; Abdo; Abdomen+; Abdominal; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Kidney-L; L; LT; Nephric; Nephrology; Point in time; Pyelogram; Rad; Radiology; Random; Renal	4180186
1175273	CT Guided Kidney-L Ablation	4180186
1175273	:::>.::CT	4182948
1175274	Clin Pharm; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Pharmacy; Point in time; Random; Visit note	4180186
1175274	Clin Pharm Procedure note	4180186
1175274	:::{}::	4182948
1175275	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorg prel grow det pnl; Microorganisms; Org; Organism; Organisms; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random	4180186
1175275	Microorg prel grow det pnl Fld Cult	4180186
1175275	:-:::-:	4182948
1175277	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175278	Bind; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; GH; GHBP; Growth hormone; HGH; Human growth hormone; Human growth hormone binding protein; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH; SUDS	4180186
1175278	GHBP SerPl IA-mCnc	4180186
1175278	:::/::	4182948
1175279	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDL5; LDL5c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175279	LDL5c SerPl-mCnc	4180186
1175279	.LDL 5 :::/:	4182948
1175280	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; C burnet; C burnet aroE; C burnetii; Coxiella burnettii; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; PlasBld; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Q fev; Q fever; QBR; Qfever; QL; Qual; Qualitative; Random; Screen; SDA; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1175280	C burnet aroE SerPlBld Ql NAA+non-probe	4180186
1175280	 aroE ::://::..	4182948
1175282	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; Removal of fluid; Transrectal absc drainage	4180186
1175282	CT Guided Pelvis Transrect Absc drainage	4180186
1175282	:::::CT	4182948
1175283	Preliminary positive lab results Pop	4180186
1175283	Cnt; Count; Number; Point in time; Pos; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
1175283	:()::^:	4182948
1175284	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; K kingae; K kingella; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Moraxella kingae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rheum; Rheumatology; Screen; SDA; SF; SNV; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1175284	K kingae DNA Snv Ql NAA+probe	4180186
1175284	 DNA:::::..	4182948
1175285	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1175287	HEDIS 2019-20 Chlamydia	4180186
1175287	Chlam; Chlamid; HEDIS 2019-20 Chlamydia; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1175287	HEDIS 2019  - :-::^:-	4182948
1175290	clinical genomics; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genetic; Genomic; Medical Genetics; medical genomics; notes; Point in time; Random; Visit note	4180186
1175290	:::{}::	4182948
1175293	AF; Amn; Amn fl; Amn/CVS; Amnio; Amniotic flu; Amniotic fluid; Beta globulin gene; Beta thalessemia; beta-globin; CD113t-C; Chorionic villi; Chorionic villus sample; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Gyn; Gynecology; Hemoglobin beta chain; Hemoglobin S gene; hemoglobin, beta; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; OB; ObGyn; Obstetrics; Point in time; Random; sequencing of entire coding region; Sickle cell anemia	4180186
1175293	HBB gene Full Mut Anl Amn/CVS Seq	4180186
1175293	HBB  :::/::	4182948
1175299	Dentist; Dentistry Attend; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175299	Dentistry Attend Note	4180186
1175299	:::{}::.	4182948
1175300	A1; AFP; AFP Pnl; Alfa; Alpha fetoprotein; Alphafetoprotein; EIA; ELFA; ELISA; Enzyme immunoassay; Feto; i; IAA; Liver cancer Ab + AFP; Liver cancer Ab + AFP pnl; Maternal screen; Maternal screen 1; Maternal screen for neural tube defect; MEIA; msAFP; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Single marker screen; SR; SUDS; Tumor marker	4180186
1175300	Liver cancer Ab + AFP pnl SerPl IA	4180186
1175300	 Alpha-1-:-::/:-:	4182948
1175301	BIFL; Bile fluid; Biliary fluid; Gie Stn; GMS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn	4180186
1175301	Gie Stn Bifl	4180186
1175301	:::::	4182948
1175302	EM plan approver name; Ident; Identifier; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
1175303	Anaer cult+Abx neut; Anaero; Anaerobe; Anaerobe Cult; Blood; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
1175303	Microorg prel Bld Ql Anaer cult + neut	4180186
1175303	:::::+	4182948
1175304	ADMIN; Nominal; Person name; Persons; Point in time; Random	4180186
1175304	::::	4182948
1175305	1 week; Finding; Findings; Health Assessment Questionnaire; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1175306	Anaero; Anaerobe; Anaerobe Cult; Blood; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
1175306	Microorg prel grow Bld Ql Anaerobe Cult	4180186
1175306	:::::	4182948
1175308	2; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Human Calcivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Norovirus 2; Norovirus G2; Norovirus GII; Norwalk virus; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Regurgitation; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vom; Vomitus	4180186
1175308	Norovirus GII RNA Vom Ql NAA+probe	4180186
1175308	 II RNA:::::..	4182948
1175310	LGI1 Ab CSF Ql CBA IFA	4180186
1175310	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; i; Indirect Fluorescence Antibody; Leu; LGI1; LGI1 Ab; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1175310	 1 :::::CBA IFA	4182948
1175311	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175313	1 week; Finding; Findings; Health Assessment Questionnaire; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1175315	Event activate or deactivate; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC; Typ	4180186
1175317	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175318	FDA insert Clinical trials exp section	4180186
1175318	Clinical trials exp section; DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
1175318	:-:-:^FDA :	4182948
1175320	Addiction; B/F; BEC; BEG; Benz; Benzoylec; Benzoylmethylecgonine; BF; bod; Bodies; Body fluid; Body fluid, unsp; BZE; Cocaine degradation production; Cocaine metabolite; Cocaine+BZE; Coke; Crack; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; Fl; Fld; FLU; Fluid; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Snow	4180186
1175320	Cocaine+BZE Fld Ql Scn	4180186
1175320	+:::::	4182948
1175322	Finding; Findings; Nominal; Point in time; Public Health; PUBLICHEALTH; Random; Sx; Symptoms incident or outbreak	4180186
1175322	Symptoms incident or outbreak Pop	4180186
1175322	:::^:	4182948
1175325	Calc; Calculation; Dental; Dentistry; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Teeth+gum	4180186
1175325	Malocclusion index Score Teeth+gum Calc	4180186
1175325	:::::	4182948
1175327	Abd; Abdo; Abdomen+; Abdominal; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Ileum-L; Imaging; L; LT; Perc; Point in time; Rad; RADIOLOGY; Random	4180186
1175327	CT Guided Ileum-L Cyst asp	4180186
1175327	:::>.::CT	4182948
1175328	Etiology of a PH emergency	4180186
1175328	Etiology of a PH emergency; Nominal; Point in time; Public Health; PUBLICHEALTH; Random; Typ	4180186
1175328	:::^:	4182948
1175331	Inhalant Allerg Mix 6 IgE Ql	4180186
1175331	3gAllergy IP6; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C herbarum; Common silver birch; g006; g6; Hormodendrum; IFR; Immune globulin E; Immunoglobulin E; Inhalant Allerg Mix 6; IP6; Isoflavone reductase; m002; m2; Mugwort; Ordinal; Phleum pretense; Point in time; PR; QL; Qual; Qualitative; Random; rx6; Screen; Serum; Siemens IP6; Silver Birch; SR; t3; Timothy; Timothy grass; w006; w6	4180186
1175331	(++++) .IgE:::::Multidisk 	4182948
1175335	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; Gentyp; HPV; Human papillomavirus; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
1175335	HPV Gentyp Tiss NAA+probe	4180186
1175335	 :::::..	4182948
1175339	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Podiatry Attend; Point in time; Random; Visit note	4180186
1175339	Podiatry Attend Note	4180186
1175339	:::{}::.	4182948
1175340	Finding; Findings; II; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175344	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1175344	Mycoplasma suis DNA Ct Spec Qn NAA+probe	4180186
1175344	 DNA:::XXX::..	4182948
1175347	Incident commander email	4180186
1175347	ADMIN; Nominal; Point in time; Random	4180186
1175347	::::	4182948
1175349	Cardiac surg Team Conf eval note	4180186
1175349	Cardiac surg Team; Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note	4180186
1175349	:::{}::.	4182948
1175350	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175354	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; MeV; Microbiology; Msls; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Rubeola; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175354	MeV RNA Lower resp Ql NAA+probe	4180186
1175354	 RNA:::.::..	4182948
1175355	Amount beef, pork, tuna, salmon eaten	4180186
1175355	Amount beef, pork, tuna, salmon eaten; Bos spp; f026; f027; f26; f27; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Past; Pig; Point in time; Porcine; QL; Qual; Qualitative; Random; Screen; Sus spp; Swine	4180186
1175355	:::^:	4182948
1175360	Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; II; Level; Mass concentration; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; ST2.soluble; SUDS	4180186
1175360	ST2.soluble Ser IA-mCnc	4180186
1175360	 2.:::::	4182948
1175363	Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; Ejaculate; Genitourinary; GU; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
1175363	Bacteria Smn Aerobe Cult	4180186
1175363	 :::::	4182948
1175365	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Low; Lower resp; Lung; Microbiology; Myco; Mycobact; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec; species; spp; Tuberculosis	4180186
1175365	Mycobacterium Lower resp Cult	4180186
1175365	 :::.::	4182948
1175367	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175369	Average; Avg; Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Report period	4180186
1175369	New cases per D RptPeriod Mean nRate	4180186
1175369	::^:^:	4182948
1175370	Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cath Tip; Catheter tip; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random	4180186
1175370	Bacteria Cath Tip Anaerobe Cult	4180186
1175370	 :::::	4182948
1175372	Cnt; Count; Dental; Dentistry; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Teeth+gum	4180186
1175372	Closed-spaced teeth	4180186
1175372	:():::	4182948
1175377	Nuc Medicine Procedure note	4180186
1175377	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nuc med; Nuc Medicine; Point in time; Random; Visit note	4180186
1175377	:::{}::	4182948
1175380	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175385	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175389	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175390	Bx; CAT scan; Computed tomography; Computerized tomography; CT scan; Deep Bx; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified; XXX.tiss	4180186
1175390	CT Guided Tiss Deep Bx	4180186
1175390	:::XXX>::CT	4182948
1175391	4 weeks; Cnc; Conc; Finding; Findings; Hard to concentrate in school; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175392	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Giardiasis; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175392	Giardia DNA Stl Ql NAA+probe	4180186
1175392	 DNA:::::..	4182948
1175393	Date and time; DOC.MISC; MISC; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
1175393	::::	4182948
1175395	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Dorsal spine; Finding; Findings; Guid; Guide; Guided; Imaging; Local; NDL; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine	4180186
1175395	CT Guided T-spine Needle loc	4180186
1175395	:::>.::CT	4182948
1175400	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175403	4 weeks; Finding; Findings; FR; Last; Non-protein bound; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175404	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175407	Acd; Acid fast Stn; Acids; AFB stain; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Mlk; Nominal; Point in time; Random; St; Stains; Stn	4180186
1175407	Acid fast Stn Mlk	4180186
1175407	:::::	4182948
1175411	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175413	Addiction; Cannabinoid; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Marijuana; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; THC; Tissue; Tissue, unspecified	4180186
1175413	Cannabinoids Tiss Ql Scn	4180186
1175413	:::::	4182948
1175414	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; Othr; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES	4180186
1175416	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Multi-spec prog; Multi-spec prog SW; notes; Point in time; Random; Social work; SW; Visit note	4180186
1175416	Multi-spec prog SW Note	4180186
1175416	:::{}::.	4182948
1175420	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175422	Activ; Actvty; Average; Avg; Point in time; Polyethylene Glycol; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PEG	4180186
1175426	CD3 Cells/lymph NFr Bld	4180186
1175426	Blood; CD3 Cells; Cell; CELL MARKERS; Cellularity; Leu4; Leu-4; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; Whole blood	4180186
1175426	.CD3/100 ::::	4182948
1175428	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175429	4 weeks; Arterial Stenosis; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175430	7OH-chlorpromazine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1175430	7OH-chlorpromazine Ur Cfm-mCnc	4180186
1175430	7-:::::	4182948
1175431	Globotriaosylsphingosine SerPl-mCnc	4180186
1175431	Chemistry; Fabry disease; Globotriaosyl lysosphingolipid; Level; LGb3; Lysogb3; Lyso-Gb3; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175431	:::/:	4182948
1175434	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175435	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175441	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175445	Blood; HEMATOLOGY/CELL COUNTS; i; II; NK; NK cyto IL2 7.5:1 E:T; PBMC; Peripheral blood mononuclear cells; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; RlACnc; WB; Whole blood	4180186
1175445	NK cyto IL2 7.5:1 E:T/Pos cntrl Bld MC	4180186
1175445	.IL-2  / 7.5:1/::::	4182948
1175446	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175449	:()::^:	4182948
1175449	Cnt; Count; Fatalities; Number; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
1175449	Total event-associated deaths #	4180186
1175450	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175451	Dis; Diseases; Dz; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1175452	Monoclonal gammopathy Pnl SerPl	4180186
1175452	Chemistry; Monoclonal gammopathy Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175452	:-::/:-	4182948
1175453	AQP4 H2O channel IgG CSF Ql CBA IFA	4180186
1175453	ABS; Aby; Antby; Anti; Antibodies; Antibody; AQP4; AQP4 H2O channel; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Devic's disease; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Water channel aquaporin-4	4180186
1175453	 4  .IgG:::::CBA IFA	4182948
1175456	Aerobe; Aerobe Cult; Aerobed; Bact; Blood product unit; Blood Product Unit (Pack); C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Platelet; Plt; Plts; Point in time; Random; Thrb; Thrombocyte; Thrombocytes	4180186
1175456	Bacteria Plts BPU Aerobe Cult	4180186
1175456	 :::^::	4182948
1175457	 rRNA :-:::-:..	4182948
1175457	C trach+GC pnl Anorectl NAA+probe	4180186
1175457	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anorectl; C trac; C trach; C trach+GC; C trach+GC pnl; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT/GC; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen-Probe; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Rectum; ribosomal RNA; SDA; Strand Displacement Amplification; TMA; Trachoma; Transcription mediated amplification	4180186
1175458	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175459	Est date next emerg resp plan	4180186
1175459	DOC.MISC; Est date next emerg resp plan; MISC; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1175459	::::	4182948
1175460	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1175464	Absorp; c99; CHEMISTRY.CHALLENGE TESTING; Levothyroxine absorption pnl; L-thyroxine; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175464	Levothyroxine absorption pnl SerPl	4180186
1175464	:-::/:	4182948
1175467	Inter-agency communication doc type; Nominal; Point in time; Public Health; Public Health Documents; PUBLICHEALTH; Random; Typ	4180186
1175467	Inter-agency communication doc type	4180186
1175467	::::	4182948
1175468	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175471	Arm; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-L; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; PC fluid asp; Perc; Point in time; Rad; Radiology; Random; Should-L; UE; UE-L; Up; Upper extremity joint	4180186
1175471	CT Guided Should-L Arthrocentesis	4180186
1175471	:::.>::CT	4182948
1175475	Wound care management Prog note	4180186
1175475	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1175475	:::{}::	4182948
1175477	Abd; Abdo; Abdomen+; Abdominal; Bx; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Pancr; Pancreatc; Pancreatic; Perc; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC	4180186
1175477	CT Guided Pancreas Bx--W contr IV	4180186
1175477	^:::>::CT	4182948
1175478	Vilaz Ur Cfm-mCnc	4180186
1175478	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Viibryd	4180186
1175478	:::::	4182948
1175479	1 week; Dextro; Finding; Findings; Fld; Integument; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
1175481	Bdy surface; bod; Bodies; BSA; Lung; O2; O2 delivery; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Surf; tO2; Volume rate/area; Volume Rate/Ratio	4180186
1175481	O2 delivery/BSA ArVRat	4180186
1175481	/:::^:	4182948
1175482	:::{}::	4182948
1175482	Pharmacogenomics Prog note	4180186
1175482	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1175483	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175485	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; species; spp; To be specified in another part of the message; Unspecified	4180186
1175485	Acinetobacter Spec Cult	4180186
1175485	 :::XXX::	4182948
1175488	:::{}::	4182948
1175488	Heart failure Prog note	4180186
1175488	Cardio; Cardiology; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; Heart function; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1175490	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175493	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175494	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; Pos; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175496	EM plan purpose; Finding; Findings; Narrative; Point in time; Random; Report; Survey; SURVEY.CDC	4180186
1175498	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1175499	Abd; Abdo; Abdomen+; Abdominal; c; CAT scan; Cath; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Drain; Drain+cath place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Removal of fluid; without contrast	4180186
1175499	CT Guided Abd Drain+cath place--WO contr	4180186
1175499	+^:::::CT	4182948
1175500	Ang; Angio; Angiography; Angm; Arm; Arm and hand vessels; Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; EXT; Extr ves; Extr-Bl; Finding; Findings; Imaging; Point in time; Rad; Radiology; Random; UE; UE ves; UE ves-Bl; UE-Bl; Up; Vesl; Vessels.XXX; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1175500	CTA UE ves-Bl WO+W contr IV	4180186
1175500	^ & :::.>::CT.	4182948
1175504	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; Pos; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175505	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175505	Fungal 18s rRNA gene L. Resp Ql NAA+probe	4180186
1175505	 18s rRNA :::.::..	4182948
1175507	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1175508	4 weeks; Arterial Stenosis; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1175510	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175511	Abd; Abdo; Abdomen+; Abdominal; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Kidney-L; L; LT; Nephric; Nephrology; Perc; Point in time; Pyelogram; Rad; RADIOLOGY; Random; Renal	4180186
1175511	CT Guided Kidney-L Cyst asp	4180186
1175511	:::>.::CT	4182948
1175512	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175514	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175515	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
1175516	Dental; Dentistry; Nominal; Point in time; Random; Typ	4180186
1175516	Severe traumatic deviations	4180186
1175516	:::^:	4182948
1175519	Document; Finding; Findings; Point in time; Public Health; Public Health Documents; PUBLICHEALTH; Random	4180186
1175519	Event Inter-agency communication doc	4180186
1175519	:::^:	4182948
1175522	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175526	Chemistry; Cl; Clear; Clearanc; Clearances; Clr; GFR; Iothal clear; Iothal clear Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn	4180186
1175526	Iothal clear Pnl Ur+SerPl	4180186
1175526	:-::+/:-	4182948
1175528	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Derm spec; Dermatologic; DNA NUCLEIC ACID PROBE; DNA probe; Epidermis; Har; ID; Infectious Disease; InfectiousDisease; Integument; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; Nails; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Skn; Strand Displacement Amplification; TMA; Transcription mediated amplification; Ungal nail	4180186
1175528	Fungal ITS region Derm spec Ql NAA+probe	4180186
1175528	::://::..	4182948
1175529	TPMT RBC production 6-MMP riboside-cCnc	4180186
1175529	Catalytic Concentration; Chemistry; Erythrocytes; Methyl transferase; Point in time; production of 6-MMP; production of 6-MMP riboside; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; TPMT	4180186
1175529	:::::6-	4182948
1175530	BON; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; L; LT; Point in time; Rad; RADIOLOGY; Random; Skull; Temporal bone-L; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1175530	CT Temporal bone-L WO+W contr IV	4180186
1175530	^ & :::>.::CT	4182948
1175533	Anaero; Anaerobe; Anaerobe Cult; Bact; Blood product unit; Blood Product Unit (Pack); C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Platelet; Plt; Plts; Point in time; Random; Thrb; Thrombocyte; Thrombocytes	4180186
1175533	Bacteria Plts BPU Anaerobe Cult	4180186
1175533	 :::^::	4182948
1175535	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175536	Encounter certificate	4180186
1175536	Admission certificate; DOC.ONT; Document; Finding; Findings; Point in time; Proof of visit; Random	4180186
1175536	:::{}::{}	4182948
1175538	1 month; 1 month (30 days); 30 days; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES	4180186
1175539	:::{}::	4182948
1175539	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn Onc; notes; Oncology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1175539	Gyn Onc Prog note	4180186
1175540	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175541	D/T of event response status; Date and time; Date+time; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC; Time stamp; Timestamp	4180186
1175545	Ident; Identifier; Nominal; Point in time; Public Health; PUBLICHEALTH; Random	4180186
1175545	:::^:	4182948
1175552	Cogn func; cognition; cognitive status; FCN; Func; Funct; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175553	Vedol + Vedol Ab Pnl SerPl-mCnc	4180186
1175553	DRUG/TOXICOLOGY; Drugs; Entyvio; Level; Mass concentration; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vedol; Vedolizumab + Vedolizumab Ab Pnl; VEMAB	4180186
1175553	:::/:	4182948
1175555	Preg prevention intention Reported	4180186
1175555	Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Ordinal; P prime; Point in time; Preg prevention intention; Pregnancies; QL; Qual; Qualitative; Random; Screen	4180186
1175555	:::^::	4182948
1175556	inFLIXimab Ab Ser IA-aCnc	4180186
1175556	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Remicade; Serology; Serum; SR; SUDS	4180186
1175556	 :::::	4182948
1175557	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175558	Palliative care SW LTC fac Note	4180186
1175558	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; LTC fac; LTCF; notes; Palliative care SW; Point in time; Random; Social work; SW; Visit note	4180186
1175558	:::::.	4182948
1175559	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C diphtheriae; C diphtheriae Tox; Diphtheria; Diptheria; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
1175559	C diphtheriae Tox IgG Ser Ql IA	4180186
1175559	 .IgG:::::	4182948
1175562	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C burnet; C burnet aroE; C burnetii; Coxiella burnettii; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Q fev; Q fever; QBR; Qfever; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
1175562	C burnet aroE Tiss Ql NAA+non-probe	4180186
1175562	 aroE :::::..	4182948
1175563	Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; Level; Mass concentration; MEIA; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tumor marker	4180186
1175563	Parathyrin.1-84 SerPl IA-mCnc	4180186
1175563	.1-84:::/::	4182948
1175564	4h p levo; After; c99; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
1175564	T4 4h p levo SerPl-mCnc	4180186
1175564	^4:::/:	4182948
1175565	100 CD19 cells; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; Cell; CELL MARKERS; Cellularity; HD-37; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; TACI cells; Transmembrane activator and calcium modulator and cyclophilin ligand interactor; WB; Whole blood	4180186
1175565	TACI cells/100 CD19 cells NFr Bld	4180186
1175565	.TACI/100 .CD19::::	4182948
1175567	PESI score interp PESI	4180186
1175567	CLIN; CLIN.RISK; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Ordinal; PESI score interp; Point in time; Pulm; Pulmonary Function Test; QL; Qual; Qualitative; Random; Screen	4180186
1175567	:::^::PESI 	4182948
1175568	Arm; Bil; Bilat; Both; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random; Shoulder-Bl; UE; UE-Bl; Up; Upper extremity joint	4180186
1175568	CT Guided Shoulder-Bl Inj	4180186
1175568	:::.>::CT	4182948
1175570	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Started; Survey; SURVEY.PROMIS	4180186
1175572	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Peds; Point in time; Random; Telemedicine; Visit note	4180186
1175572	Peds Telehealth Note	4180186
1175572	:::::	4182948
1175574	Thromboemb Team Conf eval note	4180186
1175574	Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Thromboemb Team; Visit note	4180186
1175574	:::{}::.	4182948
1175576	Anaplastic lymphoma kinase (Ki-1); Blood; DNA; Document; Finding; Findings; gene fusion; gene translocation; Genetics; Heredity; Heritable; II; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; NPM; Nucleolar phosphoprotein b23; Numatrin; PCR; Point in time; Random; RNA; T prime; t(2,5)(ALK,NPM1) gene translocation; t(2;5)(ALK,NPM1); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
1175576	t(2;5)(ALK,NPM1) Bld/T	4180186
1175576	t(2;5)(p23;q35.1)(ALK,NPM1) :::/::	4182948
1175577	HEDIS 2019-20 PSA Tests; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1175577	HEDIS 2019-20 PSA Tests	4180186
1175577	HEDIS 2019  - PSA :-::^:-	4182948
1175578	Addiction; Amphepramone; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diethylprop; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Tenuate; WB; Whole blood	4180186
1175578	Diethylpropion SerPlBld Cfm-mCnc	4180186
1175578	::://::	4182948
1175580	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175581	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175581	Vortioxetine SerPl-mCnc	4180186
1175581	:::/:	4182948
1175583	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175584	Cnt; Count; Lung; Number; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1175584	Num mixed apnea	4180186
1175584	:()::^:	4182948
1175585	SF IgG+IgM Pnl Titr Ser	4180186
1175585	.IgG  IgM ::::	4182948
1175585	Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Rick SF; Ricket; Rickettsial; Serum; SF IgG+IgM Pnl; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
1175586	Vortioxetine Ur Ql Scn	4180186
1175586	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1175586	:::::	4182948
1175587	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Orthopedic; Orthopedic surgery; Point in time; Random; Surg; Telemedicine; Visit note	4180186
1175587	:::::	4182948
1175588	Finding; Findings; II; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175592	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175594	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175599	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175602	Neo peri med OP Note	4180186
1175602	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neo peri med; notes; OP; Point in time; Random; Visit note	4180186
1175602	:::::	4182948
1175603	Count/time; Lung; nRate; Number rate; Number Rate = Count/Time; O2; O2 desaturation; O2 desaturation index; ODI; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies; tO2	4180186
1175603	O2 desaturation index nRate	4180186
1175603	:::^:	4182948
1175605	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175605	HSV1 DNA Aspirate Ql NAA+probe	4180186
1175605	 1  DNA:::::..	4182948
1175606	HEDIS 2019 Value Set - Ser K; k; K+; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Potass; Random; Ser; SR	4180186
1175606	HEDIS 2019 Value Set - Ser K	4180186
1175606	HEDIS 2019  - :-::^:-	4182948
1175607	4 weeks; Arterial Stenosis; Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175611	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B quintana; Cat Scratch Disease; Cat Scratch Fever; CSD; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Implnt dev; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Prostheses; Prosthesis; Prosthetic; QBR; QL; Qual; Qualitative; R quintana; Random; Rochalimae quintana; Rochalimaea quintana; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Trench fever	4180186
1175611	B quintana DNA Implnt dev Ql NAA+probe	4180186
1175611	 DNA:::::..	4182948
1175612	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175613	TPMT RBC production 6-MTG riboside-cCnc	4180186
1175613	Catalytic Concentration; Chemistry; Erythrocytes; Methyl transferase; Point in time; production of 6-MTG riboside; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; TPMT	4180186
1175613	:::::6-	4182948
1175614	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Nuc med; Nuc Medicine; Point in time; Pre-Op; Pre-op note; Pre-Operative; Random; Visit note	4180186
1175614	Nuc Medicine Pre-op note	4180186
1175614	:::{}::	4182948
1175615	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175619	ADCC; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Social work; SW; Visit note	4180186
1175619	SW ADCC Note	4180186
1175619	:::::	4182948
1175621	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175622	1 month; 1 month (30 days); 30 days; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES	4180186
1175623	Date of confinement; Deliv date; Due date; EDC; EDD; Est; Est from PE; estimation; Gyn; Gynecology; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; PEA; Point in time; predicted; QNT; Quan; Quant; Quantitative; Random	4180186
1175623	Deliv date Est from PE	4180186
1175623	:::^::	4182948
1175625	Breathing; Count/time; Lung; Lungs; nRate; Number rate; Number Rate = Count/Time; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Respiratory rate; RS	4180186
1175625	Breaths.spontaneous	4180186
1175625	.::::	4182948
1175626	Aerobe; Aerobe Cult; Aerobed; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
1175626	Microorg prel grow Fld Ql Aerobe Cult	4180186
1175626	:::::	4182948
1175628	DRUG/TOXICOLOGY; Drugs; Lanzek; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zypadhera; Zyprexa	4180186
1175628	OLANZapine SerPl Ql Scn	4180186
1175628	:::/::	4182948
1175629	Drugs of abuse Pnl Hair	4180186
1175629	DAU; Drug; DRUG/TOXICOLOGY; Drugs; Drugs of abuse Pnl; Har; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random	4180186
1175629	:-:::-	4182948
1175630	Abd; Abd.reper; Abdo; Abdomen+; Abdominal; Bx; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Retroperitoneal; W contr IV; WC	4180186
1175630	CT Guided Retroperitoneum Bx--W contr IV	4180186
1175630	^:::>::CT	4182948
1175631	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175632	Abd; Abdo; Abdomen+; Abdominal; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Ileum-R; Imaging; Perc; Point in time; R; Rad; RADIOLOGY; Random; RT	4180186
1175632	CT Guided Ileum-R Cyst asp	4180186
1175632	:::>.::CT	4182948
1175637	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; ZIKV	4180186
1175637	ZIKV IgG SerPl Ql IA	4180186
1175637	 .IgG:::/::	4182948
1175642	Count/time; Freq DHEA, A4 or hGH in past Y; gamma-4-Androstenedione; H+P; H+P.HX; Horm; Last; Musc; Muscl; nRate; Number rate; Number Rate = Count/Time; Ordinal; P prime; QL; Qual; Qualitative; Screen	4180186
1175642	Freq DHEA, A4 or hGH in past Y	4180186
1175642	::1:^:	4182948
1175645	Adalimumab Ab Ser IA-aCnc	4180186
1175645	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Humira; IAA; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
1175645	 :::::	4182948
1175646	AMCBX2; Blood; CGD; CYBB full + NCF1 c.75_76delGT; CYBB gene full + NCF1 gene; cytochrome b-245, beta polypeptide; Cytochrome b-245, beta polypeptide (chronic granulomatous disease); Document; Finding; Findings; Genetics; GP91-1; GP91PHOX; GP91-PHOX; Heredity; Heritable; IMD34; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NCF-1; NCF1A; NCF-47K; neutrophil cytosolic factor 1; Neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1); NOX2; NOXO2; p47phox; p91-PHOX; PCR; Point in time; Random; SH3PXD1A; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1175646	CYBB full + NCF1 c.75_76delGT Bld/T	4180186
1175646	CYBB  NCF1  c.75_76delGT :::/::	4182948
1175648	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175649	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-R; Finding; Findings; Imaging; LE; Leg; LE-R; Low; Mid ft-R; Mid+Fore ft-R; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; R; Rad; RADIOLOGY; Random; RLE; RT	4180186
1175649	CT Mid+Fore ft-R	4180186
1175649	:::.>+::CT	4182948
1175650	Dental; Dental abnormalities orthodontic care; Dentistry; Finding; Findings; Nominal; Point in time; Random; Teeth+gum	4180186
1175650	Dental abnormalities orthodontic care	4180186
1175650	::::	4182948
1175654	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1175654	CT Guided Tendon or ligament Inj	4180186
1175654	:::XXX>::CT	4182948
1175656	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Kidney; Nephrology; notes; Point in time; Random; Renal; Telemedicine; Visit note	4180186
1175656	:::::	4182948
1175657	3 Self-Sustaining Sequence Replication; 3SR SR; A,B; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV + FLUBV; FLUAV + FLUBV Pnl; FLUAV+FLUBV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
1175657	FLUAV + FLUBV Pnl Tiss NAA+probe	4180186
1175657	 A  B  RNA :-:::-:..	4182948
1175662	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Dorsal spine; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Jnt; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; T-spine facet joint; Zygapophysial Joint	4180186
1175662	CT Guided T-spine facet joint Inj	4180186
1175662	:::>.::CT	4182948
1175663	A1; AFP; Alfa; Alpha fetoprotein; Alphafetoprotein; Feto; i; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Liver cancer Ab + AFP; Oncology; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
1175663	Liver cancer Ab + AFP SerPl-Imp	4180186
1175663	 Alpha-1-:::/:	4182948
1175664	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175664	Clinical Neurophys Phone Note	4180186
1175664	:::::	4182948
1175668	Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; L; LT; Lung; PC fluid asp; Perc; Pl space; Pl space-L; Point in time; Pulmonary; Pulmonology; Rad; Radiology; Random; Respiratory; Thoracentesis; Thorax; Thorocentesis	4180186
1175668	CT Guided Pl space-L PC fluid asp	4180186
1175668	:::>.::CT	4182948
1175670	Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Metab; Metabolites; Metb; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tissue; Tissue, unspecified	4180186
1175670	Methadone+metab Tiss Ql Scn	4180186
1175670	+:::::	4182948
1175671	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175672	Mat fetal med Phone Note	4180186
1175672	:::::	4182948
1175672	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mat fetal med; notes; Point in time; Random; Visit note	4180186
1175675	Cardio; Cardiology; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Point in time; Random; Surg; Visit note	4180186
1175675	:::{}::	4182948
1175676	Ident; Identifier; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
1175679	Cardio; Cardiology; Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Point in time; Random; Surg; Visit note	4180186
1175679	Cardiac surgery Conf eval note	4180186
1175679	:::{}::	4182948
1175680	C auris; C&S; Cand; Candidiasis; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
1175680	C auris Spec Ql Cult	4180186
1175680	:::XXX::	4182948
1175684	D/T lab result reported	4180186
1175684	D/T lab result reported; Date and time; Date+time; Lab orders; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
1175684	:::^:	4182948
1175687	3 Self-Sustaining Sequence Replication; 3SR SR; American plague; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; yellow jack; YFV	4180186
1175687	YFV RNA Bld Ql NAA+probe	4180186
1175687	 RNA:::::..	4182948
1175689	Aerobe; Aerobe Cult; Aerobed; Blood product unit; Blood Product Unit (Pack); C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Platelet; Platelet adequacy; Platelet estimate; Plt; Plts; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrb; Thrombocyte; Thrombocytes	4180186
1175689	Microorg prel Plts BPU Ql Aerob Cult	4180186
1175689	:::^::	4182948
1175691	1 week; Dextro; Finding; Findings; Integument; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
1175692	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; LMTED; LTD; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified; W contr IV; WC	4180186
1175692	CT Ltd W contr IV	4180186
1175692	^:::XXX::CT	4182948
1175693	Abd; Abdo; Abdomen+; Abdominal; Bx; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Perc; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC	4180186
1175693	CT Guided Abd Bx--W contr IV	4180186
1175693	^:::::CT	4182948
1175698	4 weeks; Cnc; Conc; Finding; Findings; Hard to concentrate in school; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175700	Activated partial thromboplastin time; aPTT; aPTT-FS; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; i; Little(A)PTT; Mixing aPTT; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
1175700	Mixing aPTT PPP	4180186
1175700	.  1:1 :::::	4182948
1175701	Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Metab; Metabolites; Metb; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1175701	Methadone+metab Hair Ql Scn	4180186
1175701	+:::::	4182948
1175702	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175706	B-cell TACI + BAFF-R subsets panel Bld	4180186
1175706	B- TACI  BAFF-R :-:::-	4182948
1175706	B Cell; B-ALL; B-cell acute lymphoblastic leukemia; B-cell TACI + BAFF-R subsets panel; BCELLS; Blood; CELL MARKERS; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; R prime; Random; Right; WB; Whole blood	4180186
1175709	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175713	2; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Human Calcivirus; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Norovirus 1; Norovirus G1; Norovirus GI; Norovirus GI + GII; Norovirus GI + GII RNA; Norovirus GI+II; Norwalk virus; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1175713	Norovirus GI + GII RNA Spec NAA+probe	4180186
1175713	 I  II RNA:::XXX::..	4182948
1175717	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175721	FA omega-3 + omega-6 panel Bld	4180186
1175721	Acd; Acids; Blood; Chemistry; DHA; Docosahexaenoate; Docosapentaenic acid; DPA; Eicosapentaenoate; EPA; FA omega-3 + omega-6 panel; III; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
1175721	 omega-3  omega-6 :-:::-	4182948
1175724	MH SW Note	4180186
1175724	DOC.ONT; Document; Emotional stability; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; MH SW; notes; Point in time; Random; Social work; SW; Visit note	4180186
1175724	:::{}::.	4182948
1175727	Knee/hip replacement satisfaction	4180186
1175727	CLIN; Finding; Findings; Knee/hip replacement satisfaction; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1175727	:::^:	4182948
1175728	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175730	Cnt; Count; Lung; Number; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1175730	Num hypopnea	4180186
1175730	:()::^:	4182948
1175731	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175732	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175732	EV RNA Corn/Cnjt Ql NAA+probe	4180186
1175732	 RNA:::/::..	4182948
1175733	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175736	B parapert; B parapertussis; B pert; B pert+parapert DNA Pnl; B pertussis; Deoxyribonucleic acid; ID; Infectious Disease; InfectiousDisease; Microbiology; Nasopharynx; Pan; PANEL.MICROBIOLOGY; Panl; Pertussis; Pnl; Point in time; Random; Whooping cough	4180186
1175736	B pert+parapert DNA Pnl Nph	4180186
1175736	 DNA :-:::-	4182948
1175738	Bx; CAT scan; Chest Pleura; Chest.pleura; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Pleura-R; Point in time; R; Rad; RADIOLOGY; Random; RT; Thorax	4180186
1175738	CT Guided Pleura-R Bx	4180186
1175738	:::>.::CT	4182948
1175740	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175741	Dialy; Finding; Findings; Narrative; Point in time; Random; Report; Survey; SURVEY.CDC	4180186
1175742	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175743	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175745	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175746	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Dextro; DNA NUCLEIC ACID PROBE; DNA probe; FLUDV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1175746	FLUDV RNA Ct Spec Qn NAA+probe	4180186
1175746	 D  RNA:::XXX::..	4182948
1175749	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Derm spec; Dermatologic; DNA NUCLEIC ACID PROBE; DNA probe; Epidermis; Gen-Probe; Har; ID; Infectious Disease; InfectiousDisease; Integument; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; Nails; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Skn; Strand Displacement Amplification; TMA; Transcription mediated amplification; Ungal nail	4180186
1175749	Fungal 18s rRNA gene Derm Ql NAA+probe	4180186
1175749	 18s rRNA ::://::..	4182948
1175750	Finding; Findings; Narrative; Point in time; Random; Report; Survey; SURVEY.CDC	4180186
1175758	Endocrin Team Conf eval note	4180186
1175758	Conf eval note; DOC.ONT; Document; Encounter; Endocrin Team; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175758	:::{}::.	4182948
1175759	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; ADP MA; ANED; Blood; COAGULATION; Hematology; Heme; Length; MA ADP; MA, ADP; Medication stress; Point in time; QNT; Quan; Quant; Quantitative; Random; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood	4180186
1175759	MA ADP Bld Res TEG	4180186
1175759	.:::::.	4182948
1175760	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175761	HEDIS 2019-20 PSA Test Excl	4180186
1175761	HEDIS 2019-20 PSA Test Excl; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1175761	HEDIS 2019  - PSA :-::^:-	4182948
1175763	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175765	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUV; Fowl plague; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS	4180186
1175765	FLUAV Ab/Pos cntrl Ser IA	4180186
1175765	 A  /:::::	4182948
1175770	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.PROMIS	4180186
1175771	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; Trouble paying attention to teacher	4180186
1175772	Finding; Findings; Ordinal; Othr; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1175773	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Ral-A; Random; Ras-related protein; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tumor marker	4180186
1175773	RalA Ab SerPl IA-aCnc	4180186
1175773	RalA :::/::	4182948
1175775	III; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; RAPID-3; Survey; SURVEY.GNHLTH	4180186
1175776	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175777	AFP Ab SerPl IA-aCnc	4180186
1175777	A1; ABS; Aby; AFP; AFP-1 Ab; Alfa; Alpha fetoprotein; Alphafetoprotein; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Feto; i; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tumor marker	4180186
1175777	Alpha-1- :::/::	4182948
1175779	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Myco; Mycobact; Mycobact prelim grow; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Tissue; Tissue, unspecified; Tuberculosis	4180186
1175779	Mycobact prelim grow Tiss Ql Cult	4180186
1175779	:::::	4182948
1175782	1 day; 24 hours; 24HR; Alb; DL &lt;= 3 mg/L; Kidney; Left; Levo; MA; Malb; Mass rate; Micro albumin; Microalbumin; mRate; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UR; URINALYSIS; Urn	4180186
1175782	Microalbumin 24h Ur DL<=3.0 mg/L-mRate	4180186
1175782	::24::: <= 3.0 mg/L	4182948
1175783	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175783	Fungal BT2 gene Lower resp Ql NAA+probe	4180186
1175783	 BT2 :::.::..	4182948
1175784	Consc sedation proc note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; post conscious sedation; Pre conscious sedation; Random; Visit note; w conscious sedation	4180186
1175784	Consc sedation proc note	4180186
1175784	:::{}::{}	4182948
1175788	AHI; Apnea+hypopnea; CAHI; Count/time; Lung; Neuro; Neurology; nRate; Number rate; Number Rate = Count/Time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1175788	Central apnea hypopnea index nRate	4180186
1175788	:::^:	4182948
1175790	ABS; Aby; Amiopep; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dipeptidyl peptidase-like protein 6; Dipeptidyl peptidase-like protein 6 Ab; DPPX; DPPX Ab; Indirect Fluorescence Antibody; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1175790	DPPX Ab CSF Ql CBA IFA	4180186
1175790	 6 :::::CBA IFA	4182948
1175791	After; Antiglob; BLOOD BANK; DAGT; DAT; DAT IgG-Sp Reag; DCT; Dir; Direct Coomb; Direct coombs test; Erythrocytes; Hematology; Heme; Immune globulin G; Immunoglobulin G; Ordinal; p transf; p transf rx; Point in time; PR; PST; QL; Qual; Qualitative; Random; React; Red blood cells; Red blood corpusles; Rxn; Screen; Spec; Transf React; Tx	4180186
1175791	DAT IgG-Sp Reag p transf rx RBC Ql	4180186
1175791	.IgG ^::::	4182948
1175792	Cardio; Cardiology; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Point in time; Random; Surg; Visit note	4180186
1175792	Cardiac surgery Phone Note	4180186
1175792	:::::	4182948
1175793	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Celbenin; Deoxyribonucleic acid; Dimethoxypenicillin; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Metacillin; Metin; Microbiology; MRSA; NAA+probe; NAAT; Nasal; NASBA; Nos; Nose (nasal passage); Nucleic acid sequence based analysis; o71; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S aureus; Screen; SDA; Smell; Staficyn; Staph; Staphicillin; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175793	MRSA DNA Nose Ql NAA+probe	4180186
1175793	. DNA:::::..	4182948
1175798	PERC score interp	4180186
1175798	CLIN; CLIN.RISK; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Ordinal; PERC score interp; Point in time; Pulm; Pulmonary Function Test; QL; Qual; Qualitative; Random; Screen	4180186
1175800	Bx; CAT scan; Chest Pleura; Chest.pleura; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Pleura-L; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
1175800	CT Guided Pleura-L Bx	4180186
1175800	:::>.::CT	4182948
1175802	C&S; Cult; Cultures; HPIV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Low; Lower resp; Lung; Microbiology; Nominal; Para; Parainflu; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec	4180186
1175802	HPIV Lower resp Cult	4180186
1175802	 :::.::	4182948
1175803	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175804	Addiction; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ectasule; GCMS; Illicit; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
1175804	Ephedrin SerPlBld Cfm-mCnc	4180186
1175804	::://::	4182948
1175805	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175806	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1175806	Fungal BT2 gene Spec Ql NAA+probe	4180186
1175806	 BT2 :::XXX::..	4182948
1175807	DRUG/TOXICOLOGY; Drugs; Geodon; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zeldox	4180186
1175807	Ziprasidone SerPl Ql Scn	4180186
1175807	:::/::	4182948
1175808	Bdy weight; bod; Bodies; Exchange; Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Replace; Wt	4180186
1175808	:::^:	4182948
1175809	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B burg; B burg bba64 gene; B burgdor; B burgdorferi; Bb; Blood; Burgdorf; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyme; Lyme disease; Lymes; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1175809	B burg bba64 gene Bld Ql NAA+non-probe	4180186
1175809	 bba64 :::::..	4182948
1175810	Anaero; Anaerobe; Anaerobe Cult; Blood product unit; Blood Product Unit (Pack); C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Platelet; Platelet adequacy; Platelet estimate; Plt; Plts; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrb; Thrombocyte; Thrombocytes	4180186
1175810	Microorg prel Plts BPU Ql Anaer Cult	4180186
1175810	:::^::	4182948
1175812	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Etx; IgE RAST; Immune globulin E; Immunoglobulin E; o71; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rh Blood Group System; Rm225; S aureus; S aureus Etx; S aureus Etx E; Screen; Serum; SR; Staph; Staphylococcal enterotoxin	4180186
1175812	 E .IgE.RAST ::::	4182948
1175812	Deprecated S aureus Etx E IgE RAST Ql	4180186
1175814	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Orthohantavirus; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; SNV; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175814	Hantavirus RNA Lower resp Ql NAA+probe	4180186
1175814	 RNA:::.::..	4182948
1175817	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Bos spp; Count/time; f026; f027; f26; f27; Last; month; nRate; Number rate; Number Rate = Count/Time; Pig; Porcine; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES; Sus spp; Swine	4180186
1175819	ADMIN; Nominal; Person name; Point in time; Random	4180186
1175819	Organization Contact name	4180186
1175819	::::	4182948
1175824	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175825	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; STI Pnl; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1175825	STI Pnl Spec NAA+probe	4180186
1175825	:-::XXX:-:..	4182948
1175826	1 week; QNT; Quan; Quant; Quantitative; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
1175827	Nuc Medicine Note	4180186
1175827	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nuc med; Nuc Medicine; Point in time; Random; Visit note	4180186
1175827	:::{}::	4182948
1175829	AHF; AHG; Antihemophilic factor; Antihemophilic globulin; Associated; bnd; Circulating anticoagulant; Coag; EIA; ELFA; ELISA; Enzyme immunoassay; F8; Fac; Fact; Fact VIII; Fact VIII.recomb.bound; Factor 8; Factor VIII clotting activity; FVIII; Hematology; Heme; IAA; MEIA; Normandy; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; SUDS; Thrombocyte cofactor A; Type 2 Normandy; VIII:C; Von will; Vonwillebrand; vWf; vWF:Ag	4180186
1175829	Fact VIII.recomb.bound/vWF Ag Plas IA	4180186
1175829	 VIII../von Willebrand  :::::	4182948
1175830	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175831	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec	4180186
1175831	Microorg prel grow Fld Ql Cult	4180186
1175831	:::::	4182948
1175833	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175834	Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Imaging; LE; LE-Bl; Leg; Low; Pelvic; Pelvis+LE; Pelvis+LE-Bl; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1175834	CT Pelvis+LE-Bl WO+W contr IV	4180186
1175834	^ & :::+.::CT	4182948
1175835	Public communication doc name	4180186
1175835	Ident; Identifier; Nominal; Point in time; Public communication doc name; Public Health; Public Health Documents; PUBLICHEALTH; Random	4180186
1175835	::::	4182948
1175839	Acd; Acid fast Stn; Acids; AFB stain; ID; Identity or presence; Infectious Disease; InfectiousDisease; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; St; Stains; Stn; Up; Upper resp	4180186
1175839	Acid fast Stn Upper resp	4180186
1175839	:::.::	4182948
1175842	Osteoporotic fracture 10Y prob FRAX	4180186
1175842	CLIN; CLIN.RISK; Fracture Risk Assessment; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk	4180186
1175843	Nominal; Point in time; Public Health; PUBLICHEALTH; Random; Typ	4180186
1175843	:::^:	4182948
1175851	ADMIN; Location; Nominal; Point in time; Random	4180186
1175851	:::^:	4182948
1175854	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175857	Donor bld study	4180186
1175857	Blood; DOC.MISC; Document; Donr; Finding; Findings; MISC; Point in time; Random; Study report; WB; Whole blood	4180186
1175857	:::^:	4182948
1175859	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175860	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; EpCAM; EpCAM Ab; Epi; Epith; Epithelia; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1175860	EpCAM Ab SerPl IA-aCnc	4180186
1175860	 :::/::	4182948
1175865	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175869	Primary care SW Note	4180186
1175869	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Primary care SW; Random; Social work; SW; Visit note	4180186
1175869	:::{}::.	4182948
1175872	Addiction med SW; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Social work; Substance abuse; SW; Visit note	4180186
1175872	Addiction med SW Note	4180186
1175872	:::{}::.	4182948
1175873	4 weeks; Cogn func; cognition; cognitive status; FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175875	Abd; Abdo; Abdomen+; Abdominal; Bx; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Nephric; Nephrology; Perc; Point in time; Pyelogram; Rad; Radiology; Random; Renal; without contrast	4180186
1175875	CT Guided Kidney Bx--WO contr	4180186
1175875	^:::>::CT	4182948
1175876	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Paraneoplastic syndrome; PCA-2; PCA-2 Ab; PCCA-2; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
1175876	PCA-2 Ab CSF Ql IF	4180186
1175876	 2  :::::	4182948
1175878	AIDS; Blood; Deoxyribonucleic acid; high-throughput sequencing; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; HIV1 proviral DNA RT + PR + IN; HTS; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Next generation sequencing; NGS; Nominal; PBMC; Peripheral blood mononuclear cells; Point in time; PR; Random; REV; RT; WB; Whole blood	4180186
1175878	HIV1 proviral DNA RT+PR+IN Bld MC-Seq	4180186
1175878	HIV 1  DNA :::::	4182948
1175879	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175880	Chemistry; Cl; Clear; Clearanc; Clearances; Clr; Flow; GFR; Iothal clear; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn; Volume rate; vRate	4180186
1175880	 :::+/:	4182948
1175882	HEDIS 2019-20 HPV Tests; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1175882	HEDIS 2019-20 HPV Tests	4180186
1175882	HEDIS 2019  - HPV :-::^:-	4182948
1175885	Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV 1+2 Ab.IgG & IgM panel; HSV1; HSV1+2; i; ID; II; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175885	HSV 1+2 Ab.IgG & IgM panel SerPl	4180186
1175885	 1  2 .IgG  IgM :-::/:-	4182948
1175886	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175887	Bdy weight; bod; Bodies; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Self-perception of body wgt; Wt	4180186
1175887	Self-perception of body wgt	4180186
1175887	:::^:	4182948
1175889	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; i; LDL1; LDL1c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1175889	LDL1c SerPl-sCnc	4180186
1175889	.LDL 1 :::/:	4182948
1175890	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Lower respiratory; Lung; Microbiology; Myco; Mycobact; Mycobact prelim grow; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Spec; Spt; Sputum; Tuberculosis	4180186
1175890	Mycobact prelim grow Spt Ql Cult	4180186
1175890	:::::	4182948
1175891	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175893	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175895	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1175896	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175897	clinical genomics; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genetic; Genomic; Medical Genetics; medical genomics; notes; Point in time; Random; Telemedicine; Visit note	4180186
1175897	:::::	4182948
1175899	Emergency med Telehealth Note	4180186
1175899	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1175899	:::::	4182948
1175902	Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175904	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175909	Lipoprotein metabolism Pnl SerPl	4180186
1175909	Chemistry; Lip; Lipoprot; Lipoprotein metabolism Pnl; Lipoproteins; LP; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175909	:-::/:-	4182948
1175910	Public comm target group	4180186
1175910	Nominal; Point in time; Public comm target group; Public Health; PUBLICHEALTH; Random; Typ	4180186
1175910	:::^:	4182948
1175911	CHC SW; Comm hlth care; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Social work; SW; Visit note	4180186
1175911	CHC SW Note	4180186
1175911	:::{}::.	4182948
1175912	Ab; HEDIS 2019 Toxoplasma Ab; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Toxo; Toxoplasmosis	4180186
1175912	HEDIS 2019 Toxoplasma Ab	4180186
1175912	HEDIS 2019  - :-::^:-	4182948
1175913	Amoeba; Bowel movement; Deoxyribonucleic acid; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; high-throughput sequencing; HTS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; species; spp; Stl; Stool = Fecal	4180186
1175913	Entamoeba DNA Stl Seq	4180186
1175913	 DNA:::::	4182948
1175915	Pregnancy summary Doc	4180186
1175915	DOC.MISC; Document; Finding; Findings; Gestation; Gestations; Gravida; MISC; Point in time; Pregnancies; Random	4180186
1175915	:::^:	4182948
1175916	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175917	Burn Consult note	4180186
1175917	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175917	:::{}::	4182948
1175919	CLIN; CLIN.RISK; Finding; Findings; Interp; Interpret; Interpt; Intrp; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1175919	Revised Geneva score interp	4180186
1175920	4 weeks; Cogn func; cognition; cognitive status; FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175923	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175923	Obesity med Consult note	4180186
1175923	:::{}::	4182948
1175925	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guidance.stereotactic for localization; Guide; Guided; Imaging; Local; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; Stereo; Str loc; To be specified in another part of the message; Unspecified; without contrast	4180186
1175925	CT Guided Str loc--WO contr	4180186
1175925	^:::XXX::CT	4182948
1175926	Blood; HEMATOLOGY/CELL COUNTS; i; II; NK; NK cyto IL2 0.9:1 E:T; PBMC; Peripheral blood mononuclear cells; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; RlACnc; WB; Whole blood	4180186
1175926	NK cyto IL2 0.9:1 E:T/Pos cntrl Bld MC	4180186
1175926	.IL-2  / 0.9:1/::::	4182948
1175927	QUEtiapine SerPl Ql Scn	4180186
1175927	DRUG/TOXICOLOGY; Drugs; Ketipinor; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Seroquel; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xeroquel	4180186
1175927	:::/::	4182948
1175932	10 minutes; Average; Avg; Count/time; Fetal; Gyn; Gynecology; Heart beat; HEART RATE.MOLEC; nRate; Number rate; Number Rate = Count/Time; OB; ObGyn; Obstetrics; Pulse; QNT; Quan; Quant; Quantitative	4180186
1175932	Fet 10M Mean Heart rate	4180186
1175932	::10^:^:	4182948
1175939	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; Pos; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175940	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175941	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; BIFL; Bile fluid; Biliary fluid; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Myco; Mycobact; Nominal; Point in time; Random; Spec; species; spp; Tuberculosis	4180186
1175941	Mycobacterium Bifl Cult	4180186
1175941	 :::::	4182948
1175943	1 week; Activity; Arterial Stenosis; Exercise; Finding; Findings; Health Assessment Questionnaire; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1175944	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Helminths; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Maggot; Maggots; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Worm; Worms	4180186
1175944	Worm Spec NAA+probe	4180186
1175944	 :::XXX::..	4182948
1175946	1 week; Last; Ordinal; Pain severity past W 0-10 (0.5 incr); Ql; Qual; Qualitative; Scale; Screen; Survey; SURVEY.GNHLTH	4180186
1175948	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDL4; LDL4c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1175948	LDL4c SerPl-sCnc	4180186
1175948	.LDL 4 :::/:	4182948
1175949	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; C pylori; Campylobacter pylori; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; H pyl; H pylori; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175949	H pylori DNA Stl Ql NAA+probe	4180186
1175949	 DNA:::::..	4182948
1175951	7OH-fluphenazine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1175951	7OH-fluphenazine Ur Cfm-mCnc	4180186
1175951	7-:::::	4182948
1175953	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; Othr; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES	4180186
1175954	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175956	Norquetiapine Ur Cfm-mCnc	4180186
1175956	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1175956	:::::	4182948
1175961	Addiction; Angel dust; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Ordinal; PCP; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sernylan	4180186
1175961	PCP Fld Ql Scn	4180186
1175961	:::::	4182948
1175965	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175966	Dental; Dentistry; Exam; Examination; Jaw; Mand; Nominal; Phys find; Physical findings of Mandible condyle; Point in time; Random; Typ	4180186
1175966	.::::	4182948
1175969	ABS; Aby; Antby; Anti; Antibodies; Antibody; Asp; Aspartic acid; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dextro; Encephalitis; Glutamate receptor ionotropic, NMDA 1; i; Indirect Fluorescence Antibody; NMDA receptor; NMDAR; NMDAR1; N-Methylaspartate Receptors; N-Methyl-D-aspartic Acid; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1175969	NMDAR1 Ab CSF Ql CBA IFA	4180186
1175969	N--D- 1 :::::CBA IFA	4182948
1175970	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175972	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random	4180186
1175972	CT Guided Pelvis Cryoablation	4180186
1175972	:::::CT	4182948
1175974	Blood; Connexin 26; Cx26; Deafness, autosomal dominant 3; Deafness, autosomal recessive 1; DFNA3; DFNA3A; DFNB1; DFNB1A; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Gap junction beta-2 protein gene; gap junction protein, beta 2, 26kDa; Genetics; GJB2 full mut analysis; Heredity; Heritable; HID; high-throughput sequencing; HTS; Inherited; KID; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; NSRD1; Point in time; PPK; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1175974	GJB2 gene Full Mut Anl Bld/T Seq	4180186
1175974	GJB2  :::/::	4182948
1175975	Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; ID; Infectious Disease; InfectiousDisease; notes; Point in time; Random; Telemedicine; Visit note	4180186
1175975	:::::	4182948
1175978	TPMT activity panel RBC	4180186
1175978	Activ; Actvty; Chemistry; Erythrocytes; Methyl transferase; Movements; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Red blood cells; Red blood corpusles; TPMT; TPMT activity panel	4180186
1175978	:-:::-	4182948
1175986	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmeth; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Tramadol metabolite	4180186
1175986	O-nortramadol Sal Cfm-mCnc	4180186
1175986	O-:::::	4182948
1175987	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV1; Human respirovirus 1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PCR; PI1; Point in time; Polymerase chain reaction; Pork; PPIV1; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load	4180186
1175987	PPIV1 RNA # Spec NAA+probe	4180186
1175987	 1 RNA:::XXX::..	4182948
1175991	Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.CDC; Trigger EOC response termination	4180186
1175992	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175996	Norfluvoxamine Ur Ql Scn	4180186
1175996	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1175996	:::::	4182948
1175997	Aripiprazole metabolite; DRUG/TOXICOLOGY; Drugs; OH-aripiprazole; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1175997	OH-aripiprazole Ur Ql Scn	4180186
1175997	:::::	4182948
1175998	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; II; LDL2; LDL2c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1175998	LDL2c SerPl-sCnc	4180186
1175998	.LDL 2 :::/:	4182948
1176002	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176003	Dermatologic; Epidermis; Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Integument; Microbiology; Nominal; Point in time; Random; Skn; St; Stains; Stn	4180186
1176003	Gram Stn Skin	4180186
1176003	:::::	4182948
1176006	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-R; Finding; Findings; Guid; Guide; Guided; Hip-R; Imaging; Inj; LE; Leg; LE-R; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; R; Rad; RADIOLOGY; Random; RLE; RT	4180186
1176006	CT Guided Hip-R Inj	4180186
1176006	:::.>::CT	4182948
1176008	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176009	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Podiatry Res; Point in time; Random; Visit note	4180186
1176009	Podiatry Res Note	4180186
1176009	:::{}::.	4182948
1176010	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1176010	:::::	4182948
1176011	Co-lead event managing group; Ident; Identifier; Nominal; Painter's colic; PB; Plumbism; Point in time; Random; Survey; SURVEY.CDC	4180186
1176012	ABO + Rh; ABO group and Rh type; ABO+Rh Gp; Blood; BLOOD BANK; D phenotyping; D typing; Hematology; Heme; Mat; Maternal; Matnl; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood	4180186
1176012	ABO + Rh Bld Mother	4180186
1176012	ABORh:::^:	4182948
1176014	Finding; Findings; II; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176015	Healthcare outside U.S. in past	4180186
1176015	Finding; Findings; H+P; H+P.HX; Healthcare outside U.S.; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; S prime; Screen	4180186
1176015	:::^:	4182948
1176017	Personnel Person generating report	4180186
1176017	ADMIN; Nominal; Person generating report; Person name; Persons; Point in time; Random	4180186
1176017	::::	4182948
1176018	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176020	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Farmers lung; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
1176020	Aspergillus DNA Tiss Ql NAA+probe	4180186
1176020	 DNA:::::..	4182948
1176022	Abd; Abdo; Abdomen+; Abdominal; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Kidney-R; Nephric; Nephrology; Point in time; Pyelogram; R; Rad; Radiology; Random; Renal; RT	4180186
1176022	CT Guided Kidney-R Ablation	4180186
1176022	:::>.::CT	4182948
1176024	Thromboemb Phone Note	4180186
1176024	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1176024	:::::	4182948
1176028	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; II; Imaging; Inj; Inj 2 levels; Jnt; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; Spinal; Spinal Cord; Spine FJ; To be specified in another part of the message; Unspecified; Zygapophysial Joint	4180186
1176028	CT Guided Spine FJ Inj 2 levels	4180186
1176028	2:::XXX>::CT	4182948
1176031	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176032	Address; ADMIN; Nominal; Point in time; Random	4180186
1176032	::::	4182948
1176038	Arth; Dis; Diseases; Dz; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Levels; Levl; LV; LVL; MDAS; Multi-biomarker disease activity score; Ordinal; Point in time; QL; Qual; Qualitative; RA; RA severity level; Random; RAPID-3; Screen; Survey; SURVEY.GNHLTH	4180186
1176045	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1176046	Clin Path Note	4180186
1176046	Clin Path; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Laboratory medicine; notes; Path; Point in time; Random; Visit note	4180186
1176046	:::{}::	4182948
1176050	4 weeks; Cnc; Conc; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176051	ADMIN; Chief of staff phone #; No; Nominal; Num; Phone #; Point in time; Random; Telecommunication number; Telephone number	4180186
1176051	Chief of staff phone #	4180186
1176051	::::	4182948
1176055	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176057	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1176059	4 weeks; Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176060	Abd; Abdo; Abdomen+; Abdominal; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Fld; Guid; Guide; Guided; I-disc; Imaging; L/sp; L-spine; L-spine disc; Lumbar; Lumbo; PC fluid asp; Perc; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord	4180186
1176060	CT Guided L-spine disc PC fluid asp	4180186
1176060	:::>.::CT	4182948
1176062	Antigen; Antigens; Breakbone fever; Dengue fever; Denv; DENV NS1; EIA; ELFA; ELISA; Enzyme immunoassay; Flavivirus; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; NS1; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1176062	DENV NS1 Ag SerPl Ql IA	4180186
1176062	 NS1 :::/::	4182948
1176063	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; K kingae; K kingella; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Moraxella kingae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1176063	K kingae DNA Bld Ql NAA+probe	4180186
1176063	 DNA:::::..	4182948
1176065	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Klebsiella pneumonia carbapenemase; KPC; Mero+Vab; Meronem; Merrem; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vabomere	4180186
1176065	Mero+Vab Islt Grad strip	4180186
1176065	+:::::	4182948
1176068	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176069	Alb; DL &lt;= 3 mg/L; Kidney; Left; Level; Levo; MA; Malb; Mass concentration; Micro albumin; Microalbumin; Nephrology; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urn	4180186
1176069	Microalbumin Ur DL<=3.0 mg/L-mCnc	4180186
1176069	::::: <= 3.0 mg/L	4182948
1176071	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1176074	Organization info pnl	4180186
1176074	ADMIN; Organization contact info Pnl; Pan; PANEL.ADMIN; Panl; Pnl; Point in time; Random	4180186
1176074	:-:::-	4182948
1176075	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1176075	Norquetiapine Ur Ql Scn	4180186
1176075	:::::	4182948
1176076	Brain; Cranial; Craniofacial anomalies orthodontic care; Cranium; Dental; Dentistry; Finding; Findings; Intracranial; Nominal; Point in time; Random; Skull	4180186
1176076	Craniofacial anomalies orthodontic care	4180186
1176076	::::	4182948
1176077	CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; PC drain cath replace; Perc; Point in time; Rad; RADIOLOGY; Random; Removal of fluid; Spec; To be specified in another part of the message; Unspecified	4180186
1176077	CT Guided PC drain cath replace	4180186
1176077	:::XXX::CT	4182948
1176078	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176079	Abd; Abd.reper; Abdo; Abdomen+; Abdominal; Absc drain+cath place; Absc drainage; CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Removal of fluid; Retroperitoneal	4180186
1176079	CT Guided Retroper Absc drain+cath plc	4180186
1176079	+:::>::CT	4182948
1176080	DOCUMENT.REF; Drugs; FDA compl action drug and list inact; FDA label; Narrative; Report	4180186
1176080	FDA-init label compl act drug list inact	4180186
1176080	FDA:-:-:^FDA :	4182948
1176081	Vilaz SerPl-mCnc	4180186
1176081	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Viibryd	4180186
1176081	:::/:	4182948
1176083	Abd; Abdo; Abdomen+; Abdominal; CAT scan; Cath; Cath place; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Peritoneal cavity; Plac of cath; Point in time; Rad; RADIOLOGY; Random	4180186
1176083	CT Guided Peritoneal space Cath place	4180186
1176083	:::>::CT	4182948
1176084	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176085	Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; SDOH; Survey; SURVEY.GNHLTH; Tx	4180186
1176087	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1176087	Fungal ITS region Low Resp Ql NAA+probe	4180186
1176087	:::.::..	4182948
1176093	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Loxitane; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1176093	Loxapine Ur Cfm-mCnc	4180186
1176093	:::::	4182948
1176096	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; breast cancer; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stiff Man Syndrome; Time Resolved Fluorescence; TRF	4180186
1176096	Amphiphysin Ab CSF Ql IF	4180186
1176096	 :::::	4182948
1176097	Benzodiaz Tiss Ql Scn	4180186
1176097	Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tissue; Tissue, unspecified	4180186
1176097	:::::	4182948
1176099	Assessment; Cardio; Cardiology; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; Heart Disease; Heart function; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
1176099	Heart failure Initial eval note	4180186
1176099	:::{}::	4182948
1176101	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-L; Finding; Findings; Guid; Guide; Guided; Hip-L; Imaging; Inj; L; LE; Leg; LE-L; LLE; Low; Lower extremity joint; LT; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random	4180186
1176101	CT Guided Hip-L Inj	4180186
1176101	:::.>::CT	4182948
1176107	EM plan name; Ident; Identifier; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
1176108	Report no events	4180186
1176108	Document; Finding; Findings; Point in time; Public Health; Public Health Documents; PUBLICHEALTH; Random	4180186
1176108	:::^:	4182948
1176114	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176119	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176120	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1176120	:::{}::	4182948
1176120	Burn Prog note	4180186
1176123	ABS; Aby; ACIF; ANNA 3; ANNA-3; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; FANA; Fluorescent antibody; Fluoresent; Hu; Hu3; IFA; III; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Neuronal nuclear type III; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
1176123	Hu3 Ab CSF Ql IF	4180186
1176123	 3  :::::	4182948
1176125	Emerg response capabilities; Finding; Findings; Narrative; Point in time; Random; Report; Survey; SURVEY.CDC	4180186
1176126	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1176126	Fungal BT2 gene Islt Ql NAA+probe	4180186
1176126	 BT2 :::::..	4182948
1176128	Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1176131	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P carinii; P jiroveci; PCP; PCR; Pneumocystis carinii; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1176131	P jiroveci DNA Low Resp Ql NAA+non-probe	4180186
1176131	 DNA:::.::..	4182948
1176132	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV1; HSV1+2; i; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
1176132	HSV1+2 IgG Ser Ql IA	4180186
1176132	 1+2  .IgG:::::	4182948
1176133	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176134	Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Fld; Guid; Guide; Guided; I-disc; Imaging; Misc; Miscellaneous; Other; PC fluid asp; Perc; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1176134	CT Guided I-disc PC fluid asp	4180186
1176134	:::XXX>::CT	4182948
1176136	C&S; Cult; Cultures; G vaginalis; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
1176136	G vaginalis Vag Ql Cult	4180186
1176136	:::::	4182948
1176141	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1176141	Allergy+Immunology Telehealth Note	4180186
1176141	:::::+	4182948
1176142	Finding; Findings; i; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176147	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1176149	CLIN; CLIN.RISK; Pan; PANEL.CLINICAL; Panl; PESI Pnl; Pnl; Point in time; Pulm; Pulmonary Function Test; Random	4180186
1176149	PESI panel	4180186
1176149	:-::^:-:PESI 	4182948
1176153	14-3-3 protein Tiss Ql NAA+probe	4180186
1176153	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CJ; CJD; Creutzfeldt-Jacob Disease; Creutzfeldt-Jakob Disease; DNA NUCLEIC ACID PROBE; DNA probe; III; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Prot; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Serology; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
1176153	14-3-3 :::::..	4182948
1176154	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
1176154	EV RNA Ur Ql NAA+probe	4180186
1176154	 RNA:::::..	4182948
1176157	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176158	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176164	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176165	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn Onc; notes; Oncology; Point in time; Random; Visit note	4180186
1176165	Gyn Onc Procedure note	4180186
1176165	:::{}::	4182948
1176166	Abd; Abdo; Abdomen+; Abdominal; Asp; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Pancr; Pancreatc; Pancreatic; Perc; Point in time; Rad; RADIOLOGY; Random; without contrast	4180186
1176166	CT Guided Pancreas Cyst asp--WO contr	4180186
1176166	^:::>::CT	4182948
1176168	ABO + Rh; ABO group and Rh type; ABO+Rh Gp; After; Blood; BLOOD BANK; D phenotyping; D typing; Hematology; Heme; Nominal; p transf; p transf rx; Point in time; PST; Random; React; Rh phenotyping; Rh typing; Rxn; Transf React; Tx; Typ; WB; Whole blood	4180186
1176168	ABO + Rh p transf rx Bld	4180186
1176168	ABORh^::::	4182948
1176170	ActF MA; Blood; COAGULATION; Hematology; Heme; Length; MA ActF; MA, ActF; Point in time; QNT; Quan; Quant; Quantitative; Random; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood	4180186
1176170	MA ActF Bld Res TEG	4180186
1176170	. F :::::.	4182948
1176171	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; RSV; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1176171	RSV RNA Lower resp Ql NAA+probe	4180186
1176171	 RNA:::.::..	4182948
1176179	Finding; Findings; Narrative; Point in time; Random; Report; Survey; SURVEY.CDC	4180186
1176181	:-::/:-	4182948
1176181	Chemistry; MPQU; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PR; Prot; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR	4180186
1176181	MPQU SerPl	4180186
1176182	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Exp; Finding; Findings; Imaging; In; Insp; Inspiratory; Point in time; Rad; RADIOLOGY; Random; Thorax; W insp+exp	4180186
1176182	CT Chest W insp+exp	4180186
1176182	^+:::::CT	4182948
1176183	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH; Tx	4180186
1176184	ADMIN; Pan; PANEL.ADMIN; Panl; Personnel contact info Pnl; Pnl; Point in time; Random	4180186
1176184	Personnel contact info Pnl	4180186
1176184	:-:::-	4182948
1176185	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176187	BIFL; Bile fluid; Biliary fluid; Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn	4180186
1176187	Gram Stn Bifl	4180186
1176187	:::::	4182948
1176194	Int control result	4180186
1176194	Built-in control; Int control result; Ordinal; Point in time; PR; Procedural control; QL; Qual; Qualitative; Random; Screen; Spec	4180186
1176194	::::	4182948
1176198	3 Self-Sustaining Sequence Replication; 3SR SR; A,B; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV + FLUBV; FLUAV + FLUBV Pnl; FLUAV+FLUBV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1176198	FLUAV + FLUBV Pnl CSF NAA+probe	4180186
1176198	 A  B  RNA :-:::-:..	4182948
1176199	PM+R SW Hosp Note	4180186
1176199	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; PM+R; PM+R SW; Point in time; Random; Social work; SW; Visit note	4180186
1176199	:::::.	4182948
1176202	6-hydroxybupropion; Bupropion metabolite; BW 306U; DRUG/TOXICOLOGY; Drugs; OH-bupropion; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1176202	OH-bupropion Ur Ql Scn	4180186
1176202	:::::	4182948
1176204	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1176208	bod; Bodies; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Local; Point in time; Rad; RADIOLOGY; Random; RN; RNC; Scan; Tum loc; W RNC IV; WB	4180186
1176208	SPECT+CT Guided WB Tum loc--W RNC IV	4180186
1176208	^:::::NM.SPECT+CT	4182948
1176209	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176210	Cardio; Cardiology; Gie Stn; GMS; Heart Disease; Identity or presence; Microbiology; Nominal; PCAR; Pericardial Fluid; Point in time; Random; St; Stains; Stn	4180186
1176210	Gie Stn Pcar	4180186
1176210	:::::	4182948
1176211	D/T task assigned	4180186
1176211	ADMIN; D/T task assigned; Date and time; Date+time; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
1176211	:::^:	4182948
1176212	ABC35; ABCC7; Blood; CBAVD; CF; CFA; CFTR Full Mut Anl; CFTR/MRP; Cystic fibrosis transmembrane conductance regulator; cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7); Cystic fibrosis transmembrane regulator; dJ760C5.1; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MRP7; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; TNR-CFTR; WB; Whole blood; Whole blood or Tissue	4180186
1176212	CFTR Full Mut Anl Bld/T Seq	4180186
1176212	CFTR  :::/::	4182948
1176216	Patient Fax #	4180186
1176216	ADMIN; ADMIN.PATIENT; No; Nominal; Num; Point in time; Random; Telecommunication number; Telephone number	4180186
1176216	:::^:	4182948
1176218	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176219	Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.CDC; Trigger EOC response activation	4180186
1176221	Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cath Tip; Catheter tip; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random	4180186
1176221	Bacteria Cath Tip Aerobe Cult	4180186
1176221	 :::::	4182948
1176225	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176226	1 week; Dextro; Finding; Findings; Integument; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
1176227	Blood; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorg prel grow det pnl; Microorganisms; Org; Organism; Organisms; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
1176227	Microorg prel grow det pnl Bld Cult	4180186
1176227	:-:::-:	4182948
1176230	CLIN; CLIN.RISK; Pan; Panel; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
1176231	Med Vd Calc	4180186
1176231	Calc; Calculation; Med Vd; MEDS; Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Volume	4180186
1176231	:::^::	4182948
1176235	Mat fetal med Phone Prog note	4180186
1176235	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mat fetal med; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1176235	:::::	4182948
1176236	Analysis pharmaceut needs region; Finding; Findings; Narrative; Point in time; Public Health; PUBLICHEALTH; Random; Report	4180186
1176236	Analysis pharmaceut needs region	4180186
1176236	:::^:	4182948
1176237	#/area; Artificial Intelligence; Automated detection; Comp Assist; Kidney; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UR; URINALYSIS; Urn	4180186
1176237	Pseudocasts #/area Ur Comp Assist	4180186
1176237	:::::	4182948
1176239	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1176241	F2-IsoPs Ur-mCnc	4180186
1176241	8-iso-prostaglandin F2alpha; Chemistry; F2-IsoPs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1176241	F2-::::	4182948
1176242	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C tropicls; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1176242	C tropicls DNA Ser Ql NAA+probe	4180186
1176242	 DNA:::::..	4182948
1176243	Abd; Abd ves; Abd ves+Pelvis ves; Abd+Pelv+LE ves; Abdo; Abdomen; Abdomen+; Abdominal; Ang; Angio; Angiography; Angm; Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; EXT; Extr ves; Extr-Bl; Finding; Findings; Imaging; LE; LE ves; LE ves-Bl; LE-Bl; Leg; Low; Pelvic; Point in time; Rad; Radiology; Random; Vesl; Vessels.XXX; W contr IV; WC	4180186
1176243	CTA Abd+Pelv+LE ves W contr IV	4180186
1176243	^:::> & > & .>::CT.	4182948
1176249	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal; Strattera	4180186
1176249	Atomoxetine Sal Cfm-mCnc	4180186
1176249	:::::	4182948
1176251	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; C&S; Cult; Cultures; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; T gondii; Toxo; Toxoplasmosis	4180186
1176251	T gondii Amn Ql Cult	4180186
1176251	:::::	4182948
1176252	1 week; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
1176255	Control; Finding; Findings; i; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176257	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp	4180186
1176257	HSV1 DNA Upper resp Ql NAA+probe	4180186
1176257	 1  DNA:::.::..	4182948
1176258	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Low; Lower resp; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec; species; spp	4180186
1176258	Nocardia Lower resp Cult	4180186
1176258	 :::.::	4182948
1176259	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176261	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176262	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1176263	PCA-1 Ab CSF Ql IF	4180186
1176263	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; i; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Paraneoplastic syndrome; PCA1; PCA-1; PCCA-1; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF; Yo Ab	4180186
1176263	 1  :::::	4182948
1176264	Clin Path Initial eval note	4180186
1176264	Assessment; Clin Path; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; Laboratory medicine; notes; Path; Point in time; Random; Visit note	4180186
1176264	:::{}::	4182948
1176265	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176268	DOC.MISC; EOC SOP ID; Ident; Identifier; MISC; Nominal; Point in time; Random	4180186
1176268	EOC SOP ID	4180186
1176268	::::	4182948
1176269	Thiothixene SerPl Ql Scn	4180186
1176269	DRUG/TOXICOLOGY; Drugs; Navane; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1176269	:::/::	4182948
1176272	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176273	Report distribution freq	4180186
1176273	Count/time; DOC.MISC; MISC; nRate; Number rate; Number Rate = Count/Time; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1176273	::::	4182948
1176274	Finding; Findings; II; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176275	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176276	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1176277	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Thoracic outlet; Thorax; W contr IV; WC	4180186
1176277	CT Brachial plexus W contr IV	4180186
1176277	^:::>::CT	4182948
1176278	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; React slower when play games; Screen; Survey; SURVEY.PROMIS	4180186
1176279	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176280	Blood; CD14 Cells; CD14-FLAER- cells; CD33 Cells; Cell; CELL MARKERS; Cellularity; Fluor 488-labeled mutant aerolysin; Glycosylphosphatidylinositol-linked proteins; gp67; LeuM3; Leu-M3; LeuM9; Leu-M9; LPS receptor; LPS-R; Mo2; Mo-2; My4; My-4; My9; My-9; Number fraction; p67; Paroxysmal nocturnal hemoglobinuria; Percent; PLINK; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1176280	CD14-FLAER- cells/100 cells.CD33 NFr Bld	4180186
1176280	.CD14-FLAER-/100 .CD33::::	4182948
1176282	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C burnet; C burnetii; Coxiella burnettii; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Implnt dev; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Prostheses; Prosthesis; Prosthetic; Q fev; Q fever; QBR; Qfever; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1176282	C burnet DNA Implnt dev Ql NAA+probe	4180186
1176282	 DNA:::::..	4182948
1176284	Addiction; BEC; BEG; Benz; Benzoylec; Benzoylmethylecgonine; BZE; Cocaine degradation production; Cocaine metabolite; Cocaine+BZE; Coke; Crack; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Snow; Tissue; Tissue, unspecified	4180186
1176284	Cocaine+BZE Tiss Ql Scn	4180186
1176284	+:::::	4182948
1176285	AIDS; Blood; high-throughput sequencing; HIV type 1; HIV type I; HIV1; HTS; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Next generation sequencing; NGS; Nominal; Pl; PlasBld; Plasma; Plsm; Point in time; PR; Random; Ribonucleic acid; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
1176285	HIV 1 RNA PR SerPlBld-Seq	4180186
1176285	HIV 1  RNA ::://::	4182948
1176287	MAG IgM Titr CSF IA	4180186
1176287	 .IgM:::::	4182948
1176287	ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; IAA; Immune globulin M; Immunoglobulin M; MAG; MAGM; MEIA; Neuro; Neurology; Point in time; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Titer; Titered; Titre; Ttr	4180186
1176290	Ac root; Ang; Angio; Angiography; Angm; c; Ca; Cal; Cardiac; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT + CTA; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; for Ca score WO cont; Hrt; Hrt+AR; Imaging; Point in time; Rad; Radiology; Random; Supraaortic valve area; Thorax; without contrast	4180186
1176290	CT Hrt+AR WO Ca score + CTA W contr IV	4180186
1176290	^WO contrast && Multisection^W contrast IV:::>+::CT && CT.	4182948
1176291	B-cell phenotyping panel Bld	4180186
1176291	B-:-:::-	4182948
1176291	B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; Blood; CELL MARKERS; Pan; PANEL.CELLMARK; Panl; Pheno; Phenotypic; Pnl; Point in time; Random; WB; Whole blood	4180186
1176293	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176294	DRUG/TOXICOLOGY; Drugs; Habitrol; Nicoderm; Nicotine metabolite; Nicotine+Cotinine; Nictoine; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1176294	Nicotine & Cotinine panel SerPl	4180186
1176294	:-::/:-	4182948
1176295	Abd; Abdo; Abdomen+; Abdominal; CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Drain+cath place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Peritoneal cavity; Point in time; Rad; RADIOLOGY; Random; Removal of fluid	4180186
1176295	CT Guided Peritoneal Drain+cath place	4180186
1176295	+:::>::CT	4182948
1176297	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176300	FCN; Func; Funct; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1176303	Alfa; Alpha globin genes + HS-40; Amplification; Blood; Del; Del+Dup; Deletions; Document; Dp; Finding; Findings; Genetics; HBA1 & HBA2 deletion; Heredity; Heritable; Inherited; LCR region; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELDUP; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1176303	Alpha globin genes + HS-40 Del+Dup Bld/T	4180186
1176303	Alpha  & HS-40  +:::/::	4182948
1176304	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176305	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1176306	Unique ID Initial sample	4180186
1176306	Ident; Identifier; Nominal; Point in time; Random; SPEC	4180186
1176306	::::	4182948
1176308	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1176312	:()::^:	4182948
1176312	Cnt; Count; Number; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
1176312	Total event-associated cases #	4180186
1176315	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1176318	Arthrogram; Arthrography; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-L; Finding; Findings; Imaging; intraarticular; intrasynovial; Jnt; L; LE; LE joint-L; Leg; LE-L; LLE; Low; LT; Point in time; Rad; RADIOLOGY; Random; W contr IS; WC	4180186
1176318	CT LE joint-L W contr IS	4180186
1176318	^:::.>::CT	4182948
1176319	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176321	Analysis of ED visits; ED visits; Finding; Findings; Narrative; Point in time; Random; Report; Survey; SURVEY.CDC	4180186
1176323	ADMIN; Nominal; Person name; Point in time; Random	4180186
1176323	::::	4182948
1176324	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; SUMF1 full mut analysis; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1176324	SUMF1 Full Mut Anl Bld/T Seq	4180186
1176324	SUMF1  :::/::	4182948
1176326	Gram Stn; ID; Identity or presence; Implnt dev; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Prostheses; Prosthesis; Prosthetic; Random; St; Stains; Stn	4180186
1176326	Gram Stn Implnt dev	4180186
1176326	:::::	4182948
1176328	Chronic Respiratory Questionnaire Self-Administered, Standardized Format; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
1176329	4 weeks; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1176333	1 day; 24 hours; 24HR; Chemistry; Cystinuria Pnl; Pan; PANEL.CHEMISTRY; Panl; Pnl; UA; UR; Urn	4180186
1176333	Cystinuria Pnl 24h Ur	4180186
1176333	:-:24::-	4182948
1176334	HEDIS 2019-20 Glucose Tests	4180186
1176334	Glu; Gluc; Glucoseur; HEDIS 2019-20 Glucose Tests; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1176334	HEDIS 2019  - :-::^:-	4182948
1176336	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Misc; Miscellaneous; Musc; Muscl; Other; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1176336	CT Guided Muscle Inj	4180186
1176336	:::XXX>::CT	4182948
1176337	4 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefodox; Cefpod 4.0 ug/mL; Cefpodoxime proxetil; ID; Infectious Disease; InfectiousDisease; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Orelox; Podomexef; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis; Vantin	4180186
1176337	Cefpodoxime 4 ug/mL Islt SlowMyco	4180186
1176337	 4.0 /:::::	4182948
1176339	Regular use of BC when got preg	4180186
1176339	Contraception; Contraceptive Method; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Regular use of BC when got preg; Screen	4180186
1176339	:::^:	4182948
1176340	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176341	Cnt; Count; Dental; Dentistry; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Teeth+gum	4180186
1176341	Crowded teeth	4180186
1176341	:():::	4182948
1176343	DOC.MISC; Document; Finding; Findings; LIVD mapping data set; Logical Observatrion Identifiers Names and Codes; MISC; Point in time; Random	4180186
1176343	 LOINC :::{}:	4182948
1176346	C&S; Cult; Cultures; ID; Identity or presence; Implnt dev; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Prostheses; Prosthesis; Prosthetic; Random; Spec; species; spp	4180186
1176346	Nocardia Implnt dev Cult	4180186
1176346	 :::::	4182948
1176349	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1176354	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1176355	C trach L1 IgG Titr Ser IA	4180186
1176355	 L1  .IgG:::::	4182948
1176355	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach L1; C tracho; C trachom L1 Ab.IgG; C trachomatis; Chlam; Chlam trac; Chlamid; CT; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Trachoma; Ttr	4180186
1176358	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; OP; Opi; Opiate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tissue; Tissue, unspecified	4180186
1176358	Opiates Tiss Ql Scn	4180186
1176358	:::::	4182948
1176359	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176360	Dental; Dentistry; History; Med cond impact orthodontic cond; Nominal; Point in time; Random	4180186
1176360	Hx of Med cond impact orthodontic cond	4180186
1176360	:::^:	4182948
1176361	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176362	BON; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; Radiofreq abl; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1176362	CT Guided Bone Radiofreq abl	4180186
1176362	:::XXX>::CT	4182948
1176366	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Autoimmune myelopathy; c707; Cerebral spinal fluid; Cerebrospinal Fl; GAD; GAD65; GAD-65; GADA; Glu; Glutamic acid; Glutamic acid decarboxylase-65; Insulin-Dependent Diabetes Mellitus; Neuro; Neurology; Paraneoplastic neurological syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1176366	GAD65 Ab CSF Line blot-aCnc	4180186
1176366	-65 :::::	4182948
1176367	Nuc Medicine Administrative note	4180186
1176367	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nuc med; Nuc Medicine; Point in time; Random; Visit note	4180186
1176367	:::{}::	4182948
1176368	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1176369	1 week; 2; 3; Activity; Exercise; Finding; Findings; Health Assessment Questionnaire; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1176370	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; H parasuis; H parasuis serotype; Haemoph; ID; Ident; Identifier; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Sertyp; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1176370	H parasuis Sertyp Spec NAA+probe	4180186
1176370	 :::XXX::..	4182948
1176372	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; Thoracic outlet; Thorax; without contrast	4180186
1176372	CT Brachial plexus WO contr	4180186
1176372	^:::>::CT	4182948
1176374	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176375	Spec collect setting type	4180186
1176375	Coll; Collect; Collected; Nominal; Point in time; Random; Spec; Typ	4180186
1176375	::::	4182948
1176377	Dentistry Res Note	4180186
1176377	Dentist; Dentistry Res; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1176377	:::{}::.	4182948
1176379	Cnt; Count; Ear Nose Throat; ENT; Lung; Number; Oto; Otolaryngology; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1176379	Num obstructive apnea	4180186
1176379	:()::^:	4182948
1176385	Abd; Abdo; Abdomen+; Abdominal; CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Pancr; Pancreatc; Pancreatic; Pcyst drain+cath place; Point in time; Pseudocyst drainage; Rad; RADIOLOGY; Random; Removal of fluid	4180186
1176385	CT Guided Pancreas Pcyst drain+cath plc	4180186
1176385	+:::>::CT	4182948
1176386	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Hep; Hep E; Hepatis; Hepatit; Hepatology; HEV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1176386	HEV RNA Stl Ql NAA+probe	4180186
1176386	 RNA:::::..	4182948
1176387	Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Lung; Lung-L; Perc; Point in time; Pulmonary; Pulmonology; Rad; RADIOLOGY; Random; Respiratory; Thorax	4180186
1176387	CT Guided Lung-L Cyst asp	4180186
1176387	:::>.::CT	4182948
1176388	Trying to get pregnant	4180186
1176388	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1176388	:::^:	4182948
1176392	Clinical sig updated info	4180186
1176392	Clinical impact; Clinical sig updated info; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1176392	:::^:	4182948
1176394	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176397	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH; Tx	4180186
1176398	ADMIN; Nominal; Person name; Point in time; Random	4180186
1176398	::::	4182948
1176399	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Human Calcivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Norovirus 1; Norovirus G1; Norovirus GI; Norwalk virus; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Regurgitation; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vom; Vomitus	4180186
1176399	Norovirus GI RNA Vom Ql NAA+probe	4180186
1176399	 I RNA:::::..	4182948
1176403	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176404	Abd; Abdo; Abdomen+; Abdominal; Asp; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Nephric; Nephrology; Perc; Point in time; Pyelogram; Rad; Radiology; Random; Renal; without contrast	4180186
1176404	CT Guided Kidney Cyst asp--WO contr	4180186
1176404	^:::>::CT	4182948
1176405	ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; Blt; Cerebral spinal fluid; Cerebrospinal Fl; gG; Glycoprot; Glycoproteins; GP; Immune blot; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin M; MAG; MAGM; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WB; WBLOT; West blot; West blt; Western blot	4180186
1176405	MAG IgM CSF Ql IB	4180186
1176405	 .IgM:::::	4182948
1176407	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1176408	4 weeks; Finding; Findings; Hard time keeping track of homework; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176409	Wound care management Phone Note	4180186
1176409	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1176409	:::::	4182948
1176413	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1176414	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS; T prime	4180186
1176416	Thymoma + MS Ab panel Ser	4180186
1176416	Ab; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Serum; SR; Thymoma + MS Ab panel	4180186
1176416	:-:::-	4182948
1176418	Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1176418	Barbiturates Hair Ql Scn	4180186
1176418	:::::	4182948
1176419	Abd; Abdo; Abdomen+; Abdominal; CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Drain+cath place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Removal of fluid	4180186
1176419	CT Guided Subphrenic Drain+cath place	4180186
1176419	+:::>::CT	4182948
1176423	Cnt; Count; Lung; Number; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; RERA; Resp effort; Resp effort-related arousal; Respiratory; Studies; Study; Sutdies	4180186
1176423	Num resp effort-related arousal	4180186
1176423	:()::^:	4182948
1176424	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guidance.stereotactic for localization; Guide; Guided; Imaging; Local; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; Stereo; Str loc; To be specified in another part of the message; Unspecified; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1176424	CT Guided Str loc--WO+W contr IV	4180186
1176424	^ & :::XXX::CT	4182948
1176426	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176427	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176428	B-raf Kinases; BRAF p.V600K; B-Raf proto-oncogene, serine/threonine kinase; B-raf, Proto-Oncogene Protein; BRAF1; B-RAF1; c.1798_1799delGTinsAA; Genetics; Heredity; Heritable; Inherited; Melanoma; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NS7; Ordinal; P prime; PCR; Point in time; PR; QL; Qual; Qualitative; RAFB1; Random; Screen; Tissue; Tissue, unspecified; v-raf	4180186
1176428	BRAF p.V600K Tiss Ql	4180186
1176428	BRAF .p.Val600Lys:::::	4182948
1176431	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1176434	Finding; Findings; Narrative; Point in time; Public Health; PUBLICHEALTH; Random; Report	4180186
1176434	Countermeasure description	4180186
1176434	:::^:	4182948
1176436	ADMIN; Nominal; Person name; Point in time; Random	4180186
1176436	::::	4182948
1176437	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; MA1; MA-1; Ma2; MATA; Neuro; Neurology; Ordinal; Paraneoplastic Ag Ma 1; Paraneoplastic syndrome; PNMA1; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
1176437	Ma+Ta Ab CSF Ql IF	4180186
1176437	Ma+Ta :::::	4182948
1176438	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176440	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176441	Arm; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-R; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; R; Rad; RADIOLOGY; Random; RT; RUE; Should-R; UE; UE-R; Up; Upper extremity joint	4180186
1176441	CT Guided Should-R Inj	4180186
1176441	:::.>::CT	4182948
1176445	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176446	4 weeks; Cogn func; cognition; cognitive status; FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1176449	Addiction; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Illicit; MDMA; Methamphet; Methamphet+MDMA; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tissue; Tissue, unspecified	4180186
1176449	Methamphet+MDMA Tiss Ql Scn	4180186
1176449	+:::::	4182948
1176450	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1176450	HSV2 DNA Aspirate Ql NAA+probe	4180186
1176450	 2  DNA:::::..	4182948
1176452	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; React slower when play games; Screen; Survey; SURVEY.PROMIS	4180186
1176453	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176454	Wound care Team Conf eval note	4180186
1176454	Conf eval note; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note; Wound care Team	4180186
1176454	:::{}::.	4182948
1176457	Molindone SerPl Ql Scn	4180186
1176457	DRUG/TOXICOLOGY; Drugs; Moban; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1176457	:::/::	4182948
1176458	Acd; Acid; Blood; C20:5w3; C22:5w3; C22:6w3; Cervonate; Cervonic acid; Chemistry; DHA; Docosahexaenoic acid; Docosapentaenic acid; DPA; Eicosapentaenoic acid; EPA; EPA+DPA+DHA; Fatty acid; Icosapentaenoate; Lipid; Mass fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Timnodonate; Timnodonic Acid; WB; Whole blood	4180186
1176458	EPA+DPA+DHA/Fatty acids.C14-C22 MFr Bld	4180186
1176458	+ w3+/.C14-C22::::	4182948
1176459	1 month; 1 month (30 days); 30 days; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES	4180186
1176460	Duke Anxiety Depression Scale; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey	4180186
1176462	Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-L; Finding; Findings; Fld; Guid; Guide; Guided; Hip-L; Imaging; L; LE; Leg; LE-L; LLE; Low; Lower extremity joint; LT; MSK; Musculoskeletal; Ortho; Orthopedics; PC fluid asp; Perc; Point in time; Rad; RADIOLOGY; Random	4180186
1176462	CT Guided Hip-L Arthrocentesis	4180186
1176462	:::.>::CT	4182948
1176465	ABS; Aby; Antby; Anti; Antibodies; Antibody; Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; i; Paraneoplastic syndrome; PCA1; PCA-1; PCCA-1; Point in time; Purkinje cell cytoplasmic antibody; Purkinje cells; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Yo Ab	4180186
1176465	PCA-1 Ab CSF Line blot-aCnc	4180186
1176465	 1  :::::	4182948
1176466	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mental health; MentalHealth; notes; Point in time; Psych; Psychiatric; Psychiatry; Random; Telemedicine; Visit note	4180186
1176466	Psychiatric Telehealth Note	4180186
1176466	:::::	4182948
1176469	Abd; Abdo; Abdomen+; Abdominal; Bx; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Nephric; Nephrogram; Nephrography; Nephrology; Perc; Point in time; Pyelogram; Rad; Radiology; Random; Renal; W contr IV; WC	4180186
1176469	CT Guided Kidney Bx--W contr IV	4180186
1176469	^:::>::CT	4182948
1176470	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1176471	Celexa; Cipralex; Cipramil; DRUG/TOXICOLOGY; Drugs; Lexamil; Lexapro; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Seroplex; UA; UR; Urn	4180186
1176471	Citalopram+Escitalopram Ur Ql Scn	4180186
1176471	+:::::	4182948
1176473	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176476	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nuc med; Nuc Medicine; Point in time; Random; Visit note	4180186
1176476	Nuc Medicine Phone Note	4180186
1176476	:::::	4182948
1176477	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1176478	Aer cult+Abx neut; Aerobe; Aerobe Cult; Aerobed; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
1176478	Microorg prel Fld Ql Aer cult + neut	4180186
1176478	:::::+	4182948
1176480	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nuc med; Nuc Medicine; Point in time; Random; Study report; Visit note	4180186
1176480	Nuc Medicine Diag study note	4180186
1176480	:::{}::	4182948
1176481	Arm; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-R; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; PC fluid asp; Perc; Point in time; R; Rad; Radiology; Random; RT; RUE; Should-R; UE; UE-R; Up; Upper extremity joint	4180186
1176481	CT Guided Should-R Arthrocentesis	4180186
1176481	:::.>::CT	4182948
1176486	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1176487	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1176488	ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; MeV; MeV IgG+IgM Pnl; Microbiology; Msls; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Rubeola; Serum; SR	4180186
1176488	MeV IgG+IgM Ql Pnl Ser	4180186
1176488	.IgG  IgM :-:::-	4182948
1176493	ADCC; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; PM+R; Point in time; Random; Visit note	4180186
1176493	PM+R ADCC Note	4180186
1176493	:::::	4182948
1176494	Abd; Abdo; Abdomen+; Abdominal; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; L/sp; L-spine; L-spine+Sacrum; Lumbar; Lumbo; Lumbosacral; Pelvic; Pelvis+L-spine; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1176494	CT L-spine+Sacrum WO+W contr IV	4180186
1176494	^ & :::>. & >::CT	4182948
1176496	NMDAR1 Ab Titr CSF CBA IFA	4180186
1176496	N--D- 1 :::::CBA IFA	4182948
1176496	ABS; Aby; Antby; Anti; Antibodies; Antibody; Asp; Aspartic acid; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dextro; Dilution factor; Dilution Factor (Titer); Encephalitis; Glutamate receptor ionotropic, NMDA 1; i; Indirect Fluorescence Antibody; NMDA receptor; NMDAR; NMDAR1; N-Methylaspartate Receptors; N-Methyl-D-aspartic Acid; Paraneoplastic syndrome; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr	4180186
1176497	CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Drain+cath place; EXT; Extr-L; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; L; LE; Leg; LE-L; LLE; Low; LT; Point in time; Rad; RADIOLOGY; Random; Removal of fluid	4180186
1176497	CT Guided LE-L Drain+cath place	4180186
1176497	+:::.::CT	4182948
1176499	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1176500	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1176500	Fungal ITS region Islt Ql NAA+probe	4180186
1176500	:::::..	4182948
1176501	B henselae+quintana IgG+IgM Pnl Titr Ser	4180186
1176501	.IgG  IgM ::::	4182948
1176501	B henselae; B henselae+quintana IgG+IgM Pnl; B quintana; Bacillary angiomaosis; Bacillary pelliosis; Cat Scratch Disease; Cat Scratch Fever; CSD; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; R henselae; R quintana; Random; Rochalimae quintana; Rochalimaea henselae; Rochalimaea quintana; Serum; SmQn; SR; Titer; Titered; Titre; Trench fever; Ttr	4180186
1176502	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1176504	Ab; HEDIS 2019 Rubella Ab; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1176504	HEDIS 2019 Rubella Ab	4180186
1176504	HEDIS 2019  - :-::^:-	4182948
1176505	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1176506	Arm; Arthrogram; Arthrography; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-R; Finding; Findings; Imaging; intraarticular; intrasynovial; Jnt; Point in time; R; Rad; RADIOLOGY; Random; RT; RUE; UE; UE joint-R; UE-R; Up; W contr IS; WC	4180186
1176506	CT UE joint-R W contr IS	4180186
1176506	^:::.>::CT	4182948
1176550	ITPA gene.g.9330C>A	4180186
1176576	ITPA gene.g.9381A>C	4180186
1176604	Cytomegalovirus gene	4180186
1176631	Bacterial tetracycline resistance tetK+tetM genes	4180186
1176638	Lower extremity.right>Lower extremity joint	4180186
1176649	Metallo beta-lactamase by meropenem to meropenem+EDTA inhibitory concentration ratio	4180186
1176656	Porcine reproductive and respiratory syndrome virus European & North American strains Ab.IgG panel	4180186
1176731	Epithelial cell adhesion molecule	4180186
1176784	Peak concentration post XXX challenge - baseline concentration increment	4180186
1176826	BRAF gene.p.Val600Lys	4180186
1176893	Cholesterol.in IDL	4180186
1176922	Pelvis>Lumbosacral plexus	4180186
1176946	Chest>Spine.thoracic facet joint	4180186
1176959	HIV 1 RNA genotype & phenotype	4180186
1177028	Upper extremity.right>Upper extremity joint	4180186
1177055	Bacterial carbapenem resistance blaOXA-48-like gene	4180186
1177059	Whole body>Skeletal system	4180186
1177060	Norovirus genogroup I & II	4180186
1177077	N-methyl-D-aspartate receptor subunit 1	4180186
1177116	Abdomen>Spine.lumbar facet joint	4180186
1177117	Chest>Pericardial space	4180186
1177149	Lower extremity.left>Lower extremity joint	4180186
1177161	Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio	4180186
1177397	This parent group contains a single group of LOINC terms for fetal body weight by any Method.	4180186
1177398	This parent group contains a single group of LOINC terms that represent the pregnancy due date by any Method.	4180186
1616283	Agg; Agglut; Agglutination; ID; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Sal; Salmonel; Salmonella spp Ab Pnl; Serum; SR	4180186
1616283	Salmonella spp Ab Pnl Ser Aggl	4180186
1616283	:-:::-:	4182948
1616284	 .IgM :::+:	4182948
1616284	VZV IgM Index Ser+CSF-aCnc	4180186
1616284	ABS; Aby; AI; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; Chicken pox; Chicken pox virus; Chickenpox; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Shingles; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR; VZ; VZV; VZV IgM Index; Zoster	4180186
1616295	Far VA test cond by Phoropter	4180186
1616295	by Phoropter; Distance; Eye; EYE.REFRACTION; Eyeball; Far VA; Far VA test cond; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Refraction; Typ; VA; Vision; Visual	4180186
1616295	:::::	4182948
1616296	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1616296	Eating disorders Prog note	4180186
1616296	:::{}::	4182948
1616297	Mephobarb + phenobarb Pnl SerPl	4180186
1616297	Addiction; Barbiturate; c417; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Luminal; Mebaral; Mephobarb + phenobarb Pnl; Methylphenobarbital; Nirvonal; Pan; PANEL.DRUG & TOXICOLOGY; Panl; PHBR; Phenitone; Phenobarb; Pl; Plasma; Plsm; Pnl; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1616297	:-::/:	4182948
1616300	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1616300	Sleep med D/C sum	4180186
1616300	:::{}::	4182948
1616301	Finding; Findings; Job; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES; T prime	4180186
1616302	Fodrin alpha IgG SerPl IA-aCnc	4180186
1616302	ABS; Aby; Alfa; alpha Spectrin; Alpha-II spectrin; alpha-Spectrin; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Fodrin alpha; Fodrin alpha IgG; IAA; Immune globulin G; Immunoglobulin G; MEIA; Pituitary glycoproteins; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sjogrens Syndrome; Spectrin alpha chain, non-erythrocytic 1; Spectrin, non-erythroid alpha subunit; SR; SUDS	4180186
1616302	.alpha  .IgG:::/::	4182948
1616303	:::::	4182948
1616303	Desmethylcyclobenzaprine Ur Ql Cfm	4180186
1616303	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; N-Desmethylcyclobenzaprine; Norcyclobenzaprine; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
1616304	/100,000 :::^:	4182948
1616304	Number fraction; People rcvd first dose of vaccine; Percent; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; World Heatlth Organization	4180186
1616304	Rcvd first dose of vaccine/100,00 pop	4180186
1616306	Finding; Findings; Local; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; SURG	4180186
1616306	Spine tumor loc	4180186
1616306	:::^:	4182948
1616313	.:::::	4182948
1616313	ANA nuclear dots Titr CSF IF	4180186
1616313	ACIF; ANA; ANA nuclear dots; ANA Pat; ANF; Anticomplement Immunofluorescence; Antinuclear antibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Nuc; Point in time; Random; Rheum; Rheumatology; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1616318	PALB2  +:::/::	4182948
1616318	PALB2 Del+Dup Bld/T	4180186
1616318	Amplification; Blood; Del; Del+Dup; Deletions; Dp; FANCN; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Nominal; partner and localizer of BRCA2; PCR; PNCA3; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1616319	:::{}::	4182948
1616319	Col+rec surg; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Surg; Visit note	4180186
1616319	Col+rec surg H&P note	4180186
1616320	Extent of spine lesion	4180186
1616320	bod; Bodies; Extent of lesion; Finding; Findings; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; SURG	4180186
1616320	:::^:	4182948
1616321	.:::::	4182948
1616321	Addiction; Anexsia; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; FR; HYDROcodone Free; Illicit; Non-protein bound; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Vicodin	4180186
1616321	HYDROcodone Free TissCo Ql Scn	4180186
1616324	.^:()::::.	4182948
1616324	After; Cnt; Count; FERTILITY TESTING; Genitourinary; GU; LM; Micro; Micros; Microscopic; Mot; Number; p ejac; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sperm; Sperm Motile; Sperm Motile p ejac; UA; UR; Urn; URO; Urology	4180186
1616324	Sperm Motile p ejac Ur Micro	4180186
1616325	C-19 + neg soc media due to race; Corona virus; Ethnicity; Finding; Findings; NEG; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1616327	5 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1616328	SOFA	4180186
1616328	CLIN; CLIN.RISK; Pan; Panel; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
1616328	:-::^:-:SOFA	4182948
1616329	ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; Count/time; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random; SDOH	4180186
1616329	Monthly household net income nRate	4180186
1616329	:::^:	4182948
1616331	CD154 Expr+Func Pnl T cells FC	4180186
1616331	CD154 Expr+Func Pnl; CD40 ligand; CD40L; CELL MARKERS; Dynamic; FC; FCN; Func; Funct; gp39; gp39 Antigen, T Cell; gp39 Antigen, T-Cell; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Random; T prime; T-BAM; T-Cell gp39 Antigen; TRAP; Tumor necrosis factor Related Activation Protein; X-linked hyper IgM	4180186
1616331	CD154 :-::T :-:	4182948
1616332	Current risk of (re)infection; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey	4180186
1616334	^2:::/:	4182948
1616334	120 min; 120 minutes; 120min; 2 hours; After; c162; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VANC; Vancocin; Vancor	4180186
1616334	Vancomycin 2h p SerPl-mCnc	4180186
1616335	 6+11+42+43+44  DNA:::::..	4182948
1616335	Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gen; Genital tract; Genital warts; HC; HPA; HPV; HPV Low Risk; HPV6; HPV6+11; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Papilloma virus low risk; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; Urogenit; Urogenital	4180186
1616335	HPV Low Risk DNA Genital Ql Prb+sig amp	4180186
1616338	 RNA:::XXX::..	4182948
1616338	TOSV RNA Spec Ql NAA+probe	4180186
1616338	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Phleboviruses; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Sand fly fever; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; TOSV; Transcription mediated amplification; Unspecified	4180186
1616339	R eye Prism base dir near by Phoropter	4180186
1616339	by Phoropter; Eye; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Prism base dir near; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1616339	:::.::	4182948
1616340	Audiology; Dx audio follow-up rec; Ear Nose Throat; ENT; Finding; Findings; Nominal; Oto; Otolaryngology; Point in time; Random	4180186
1616340	Dx audio follow-up rec	4180186
1616340	:::^:	4182948
1616341	.+ IIb-IIIa :::::.	4182948
1616341	MA TF ind+IIb-IIIa inh Bld Res TEG	4180186
1616341	Blood; COAGULATION; Fac; Fact; gG; Glycoprot; Glycoproteins; GP; Hematology; Heme; Length; MA TF ind+IIb-IIIa inh; Pl; Plat Gp; Plat Gp IIb/IIIa; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Res TEG; TEG; Thrombelastography; Thrombelastometry; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1616343	:::XXX:	4182948
1616343	ADMIN; Ident; Identifier; Misc; Miscellaneous; No; Nominal; Num; Other; Point in time; Random; Shipment tracking #; Spec; To be specified in another part of the message; Unspecified	4180186
1616343	Shipment tracking #	4180186
1616347	 Tr  ::::	4182948
1616347	PCA-Tr Ab Ser Ql	4180186
1616347	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cytopl; Cytoplas; Hodgkin's lymphoma; Limbic encephalopathy; Ordinal; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
1616349	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; Treatment postponed last 12Mo; Tx	4180186
1616352	:::::	4182948
1616352	Actiq; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sublimaze	4180186
1616352	fentaNYL TissCo Ql Scn	4180186
1616354	:::::	4182948
1616354	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1616355	:::^::SOFA	4182948
1616355	CLIN; Kidney; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
1616355	Renal Score SOFA	4180186
1616358	Continuity assessment record and evaluation; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; SDOH; SURVEY.GNHLTH	4180186
1616359	 .IgE::::	4182948
1616359	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c99; Immune globulin E; Immunoglobulin E; L-thyroxine; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616359	Levothyroxine IgE Qn	4180186
1616360	FLT3 :()::/::	4182948
1616360	FLT3 gene ITD length Bld/T	4180186
1616360	Blood; CD135; Cnt; Count; FL cytokine receptor precursor; FLK2; FLK-2; FLT3 gene ITD length; FLT3 ITD; fms-like tyrosine kinase 3; fms-related tyrosine kinase 3; Len; Molecular genetics; Molecular pathology; MOLPATH; Number; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem cell tyrosine kinase 1; STK1; STK-1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1616365	+:::::	4182948
1616365	D+L-methorphan TissCo Ql Scn	4180186
1616365	Addiction; D+L-methorphan; Dextro-methorphan; D-methorphan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1616367	C coli+jej+upsa DNA Stl Ql NAA+probe	4180186
1616367	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; C coli; C coli+jej+upsa; C coli+jejuni; Campy; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1616367	++ DNA:::::..	4182948
1616368	.:::::	4182948
1616368	Norbuprenorphine free TissCo Ql Scn	4180186
1616368	Addiction; Buprenorphine metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; FR; Illicit; NBU; Non-protein bound; norBUP; Norbuprenorphine free; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1616369	C&S; Campy; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; species; spp; To be specified in another part of the message; Unspecified	4180186
1616369	Campylobacter Spec Ql Cult	4180186
1616369	:::XXX::	4182948
1616372	Hepatology D/C sum	4180186
1616372	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1616372	:::{}::	4182948
1616373	::::	4182948
1616373	Chemistry; Lung; Mass fraction; O2; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SaO2; SAT; Satn; SO2; tO2	4180186
1616373	SaO2 % BldCV	4180186
1616375	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Srce; Survey	4180186
1616377	 ::::	4182948
1616377	CEA Aspirate-mCnc	4180186
1616377	Antigen; Antigens; Aspirate; CEA; Chemistry; Level; Mass concentration; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Tumor marker	4180186
1616378	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1616384	Ginkgo IgE Qn	4180186
1616384	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c138; Ginkgo IgE; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616384	 .IgE::::	4182948
1616385	.:::::	4182948
1616385	HYDROmorphone Free TissCo Ql Scn	4180186
1616385	Addiction; Dihydromorphinone; Dilaudid; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; FR; Hydromorphinone; HYDROmorphone Free; Illicit; Non-protein bound; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1616386	Finding; Findings; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; SURG	4180186
1616386	Implant	4180186
1616386	:::^:	4182948
1616388	:()::^:	4182948
1616388	# People in LTCFs fully vaccinated	4180186
1616388	Cnt; Count; Number; People LTCFs fully vaccinated; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; VACCINE; World Heatlth Organization	4180186
1616389	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Received $ since beg pandemic; Screen; Survey	4180186
1616391	by Phoropter; Eye; EYE.REFRACTION; Eyeball; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Typ; Vision; Visual	4180186
1616391	:::::	4182948
1616393	Epstein Barr  .IgM:::::	4182948
1616393	EBV EA IgM Titr Ser IF	4180186
1616393	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EA; EBV; EBV EA; Epstn; FA; Fluorescent antibody; Fluoresent; HHV-4; human herpesvirus 4; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Mono; Mononucleosis; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1616396	 .IgE::::	4182948
1616396	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Wild garlic	4180186
1616396	Wild garlic IgE Qn	4180186
1616398	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
1616399	 DNA:::::..	4182948
1616399	E faecalis DNA Snv Ql NAA+non-probe	4180186
1616399	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E faecalis; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SF; SNV; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1616401	1 year; 12Mos; Finding; Findings; month; Ordinal; Past; QL; Qual; Qualitative; Received $ last 12 Mo; Screen; Survey	4180186
1616404	:::::	4182948
1616404	Addiction; Carisoprodol metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1616404	Meprobamate TissCo Ql Scn	4180186
1616406	^^::::	4182948
1616406	Base ex; BE; BSE; Chemistry; EXS; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; SBE; std; Substance Concentration	4180186
1616406	Base excess std BldCV-sCnc	4180186
1616410	Cape gooseberry IgE Qn	4180186
1616410	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cape gooseberry; Cape gooseberry Ab; Cape gooseberry IgE; f359; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616410	 .IgE::::	4182948
1616413	 DNA:::::..	4182948
1616413	S lugdunensis DNA Snv Ql NAA+non-probe	4180186
1616413	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SF; SNV; Staph; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1616414	AHC HRSN; Asympt; Asymptomatic; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Scn; Survey; SURVEY.GNHLTH	4180186
1616415	Pan; PANEL.SURVEY.R-OUTCOMES; Panl; Pnl; Point in time; R prime; Random; Right; Survey; SURVEY.R-OUTCOMES	4180186
1616417	:::::	4182948
1616417	Fungus Prost fld Fungus Stn	4180186
1616417	EPS; expressed prostatic secretion; Fung; Fungal; Fungi; Fungus Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; Random; St; Stains; Stn	4180186
1616418	^^:::::	4182948
1616418	Base ex; BE; Bld cord; BSE; Calc; Calculation; Chemistry; Cord BldV; Cord venous blood; EXS; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; SBE; std; Substance Concentration	4180186
1616418	Base excess std BldCoV Calc-sCnc	4180186
1616419	6-.:::::	4182948
1616419	6 MAM; 6 mono acetyl morphine; 6-acetylmorphine; 6MAM; 6MAM Free; Acetylmorphine; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; FR; Heroin metabolite; Illicit; MAM; Non-protein bound; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1616419	6MAM Free TissCo Ql Scn	4180186
1616420	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Fuchsia spp IgE; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w64	4180186
1616420	Fuchsia spp IgE Qn	4180186
1616420	 .IgE::::	4182948
1616421	.CD45:::.::	4182948
1616421	CD45 Cells # Lower resp FC	4180186
1616421	#; ABS; absolute; absolutes; B220; CD45 Cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Dynamic; FC; LCA; Leukocyte common antigen; Low; Lower resp; Lung; Ly5; Number concentration; Number Concentration (count/vol); Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; T200	4180186
1616424	.::::	4182948
1616424	nRBC # BldCo	4180186
1616424	#; ABS; absolute; absolutes; Blood - (umbilical) cord; Cnt; Cord (umbilical) blood; Cord bld; Cord blood; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythroblasts; Erythrocyte; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Normoblasts; nRBC; nRBCs; Nuc; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells	4180186
1616428	HLA-A  B  C (I )  HLA-DP  DQ  DR (II ):::/::	4182948
1616428	2; A,B; Blood; HLA ANTIGEN; HLA class I; HLA Class I & II; HLA class II; HLA-A+B; HLA-A+B+C; HLA-A+B+C (class I); HLA-DP+DQ+DR; HLA-DP+DQ+DR (class II); Human Leukocyte Antigen; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
1616428	HLA Class I & II High Res	4180186
1616430	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; e216; Immune globulin E; Immunoglobulin E; Point in time; Propylparaben IgE; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616430	Propylparaben IgE Qn	4180186
1616430	 .IgE::::	4182948
1616431	by Phoropter; Eye; EYE.REFRACTION; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; V prism-up; V prism-up far; Vision; Visual	4180186
1616431	L eye V prism-up far by Phoropter	4180186
1616431	.:::.::	4182948
1616432	:::::	4182948
1616432	traMADol TissCo Ql Scn	4180186
1616432	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tramal; Ultram	4180186
1616433	:::::	4182948
1616433	Emergency med ED Admit H&P note	4180186
1616433	Admit H&P note; DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
1616439	:::^::SOFA	4182948
1616439	CNS Score SOFA	4180186
1616439	CLIN; CLIN.RISK; CNS; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
1616440	 .IgG:::::	4182948
1616440	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cerebral spinal fluid; Cerebrospinal Fl; ID; IMMUNE BLOT; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Syphilis; T pallidum; Treponemal; WB; WBLOT; West blot; West blt; Western blot	4180186
1616440	T pallidum IgG CSF Ql IB	4180186
1616441	Arugula IgE Qn	4180186
1616441	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Arugula; Autoantibodies; Autoantibody; f296; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; ssp	4180186
1616441	 .IgE::::	4182948
1616442	Burn D/C sum	4180186
1616442	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1616442	:::{}::	4182948
1616443	::24::	4182948
1616443	1 day; 24 hours; 24HR; Chemistry; Endocrine; Endocrinology; Levothyroxine; Levo-thyroxine; L-thyroxine; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4; UA; UR; Urn	4180186
1616443	T4 24h Ur-sRate	4180186
1616444	Postop ther goals not achieved	4180186
1616444	Finding; Findings; Nominal; Point in time; Postop ther goals not achieved; Random; SURG; Ther	4180186
1616444	:::^:	4182948
1616449	:::::{}	4182948
1616449	ED Admission notification	4180186
1616449	Admission notifctn note; DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1616450	 .IgE::::	4182948
1616450	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616450	Penicillamine IgE Qn	4180186
1616452	Colonoscopy+US Study; Document; Echography; Endo US study; Finding; Findings; GI.ENDOSCOPY; LGI; Low; Point in time; Random; Sonogram; Sonograph; Sonography; Study report; ULS; Ultrasound	4180186
1616452	:::::+	4182948
1616455	3,::3:^::TAPS	4182948
1616455	3 months; Drugs; Finding; Findings; H+P; H+P.HX; Last; Mental health; MentalHealth; Ordinal; Other illegal/recreation drug past 3Mo; Othr; P prime; Psych; Psychiatry; Ql; Qual; Qualitative; Screen	4180186
1616455	Other illegal/recreation drug past 3Mo	4180186
1616459	Breathing; Lung; Lungs; Point in time; predicted VC; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Relative volume; Respiratory; RS; VC; VC/VC.predicted	4180186
1616459	VC/predicted VC Respiratory Spirometry	4180186
1616459	/.:::::	4182948
1616460	Dynamic; FC; HEMATOLOGY/CELL COUNTS; Neut; Neut PMA DHR; Neut PMA stim DHR Pnl; Neutr; Neutrophil oxidative bursts; Neutrophils; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Phorbol myristate acetate stimulated; PMN; Pnl; PNM; Point in time; Random	4180186
1616460	Neut PMA stim DHR Pnl Patient FC	4180186
1616460	.PMA  DHR :-::^:-:	4182948
1616461	Finding; Findings; H+P; H+P.HX; Lower extremity; Ordinal; P prime; Pain/agit severity leg rigid; Pain/agitat; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1616461	Pain/agit severity leg rigid	4180186
1616461	/.:::^:	4182948
1616462	 E  beta :-:::-	4182948
1616462	APOE+ABeta Alz Risk Pnl CSF	4180186
1616462	APO; Apo E; ApoE; APOE+ABeta Alz Risk Pnl; Apolipo; Apolipoprot; Apolipoprotein Epsilon; Apolipoproteins; B; Beta-Amyloid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Neuro; Neurology; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; S prime; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1616464	2--1,5--3,3-:::::	4182948
1616464	EDDP TissCo Ql Cfm	4180186
1616464	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; EDDP; GCMS; i; II; III; Illicit; Methadone metabolite; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
1616470	17-Hydroxycorticosterone; After; Arg; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortisol+glucose+GH p arginine Pnl; Endocrine; Endocrinology; F; GH; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; Human growth hormone; hydrocortisone; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH; Stim	4180186
1616470	Cortisol+glucose+GH p arginine Pnl SerPl	4180186
1616470	:-::/:	4182948
1616473	:::^:	4182948
1616473	Endocrine; Endocrinology; Fam Mem; H+P; H+P.HX; History; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1616473	Family hx of Diabetes	4180186
1616474	5 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1616476	:::::	4182948
1616476	Midazolam TissCo Ql Scn	4180186
1616476	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Versed	4180186
1616478	14 days; 2 weeks; C-19 anxiety - paralzyed/frozen; Corona virus; Finding; Findings; Froz; Frozn; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
1616479	:::::	4182948
1616479	Thrombin peak sub PPP Qn Chro	4180186
1616479	Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance amount; Throm	4180186
1616480	Finding; Findings; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH; Work	4180186
1616481	Postop follow-up care decision	4180186
1616481	Finding; Findings; Nominal; Point in time; Postop follow-up care decision; Random; SURG	4180186
1616481	:::^:	4182948
1616482	 DNA:::::..	4182948
1616482	P anaerobius DNA Snv Ql NAA+non-probe	4180186
1616482	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; P anaerobius; P anaerobius DNA; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SF; SNV; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1616483	HLA-DP  DQ  DR (II ) .IgG :::/:	4182948
1616483	HLA Class II Ab.IgG Don Spec SerPl	4180186
1616483	2; HLA ANTIGEN; HLA class II; HLA Class II Ab.IgG Don Spec; HLA-DP+DQ+DR; HLA-DP+DQ+DR (class II); Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR	4180186
1616484	Finding; Findings; Inspection; Ordinal; Point in time; Postponed Dr. visits since pandemic; Ql; Qual; Qualitative; Random; S prime; Screen; Survey	4180186
1616486	Cardio+Pulm disease Prog note	4180186
1616486	:::{}::+	4182948
1616486	Cardio+Pulm disease; Cardiology; cards; CVD; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Pulmonary; Random; Respirology; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1616488	.::::	4182948
1616488	Blood - (umbilical) cord; Chemistry; Cord (umbilical) blood; Cord bld; Cord blood; FR; FreeT4; FT4; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; T4; T-4; T4 Free; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
1616488	T4 Free BldCo-sCnc	4180186
1616489	.  1:::::	4182948
1616489	M Protein 1 Ur Elph-mCnc	4180186
1616489	Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Hematology; Heme; i; Level; M Protein; M Protein 1; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Para protein; Paraprotein; PEUR; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; UA; UPEP; UR; Urn	4180186
1616490	by Phoropter; Eye; EYE.REFRACTION; Eyeball; L; L eye; Length; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; PD; PD monoc; PD monoc near; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1616490	L eye PD monoc near by Phoropter	4180186
1616490	.:::.::	4182948
1616493	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
1616494	C-19 perceived infected due to race; Corona virus; Ethnicity; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1616495	Total score OSIRIS	4180186
1616495	CLIN; CLIN.RISK; OSIRIS; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Tot; Totl	4180186
1616495	:::^::	4182948
1616499	AUDIO; Audiology; Ear Nose Throat; Ear-L; ENT; Hearing; HL config; L; LT; Nominal; Oto; Otolaryngology; Otologic; Point in time; Random; Typ	4180186
1616499	HL config Ear-L	4180186
1616499	:::.:	4182948
1616501	Used heroin past 3Mo	4180186
1616501	3 months; Finding; Findings; H+P; H+P.HX; Last; Mental health; MentalHealth; Ordinal; P prime; Psych; Psychiatry; QL; Qual; Qualitative; Screen; Used heroin past 3Mo	4180186
1616501	3,::3:^:	4182948
1616505	 DNA:::::..	4182948
1616505	E faecium DNA Snv Ql NAA+non-probe	4180186
1616505	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E faecium; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SF; SNV; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1616506	:::::	4182948
1616506	Noroxycodone TissCo Ql Scn	4180186
1616506	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1616509	:::::	4182948
1616509	Addiction; Amph; Amphet; Amphetam; Amphetamines; Ampht; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Speed	4180186
1616509	Amphet TissCo Ql Scn	4180186
1616511	Piper gurnard IgE Qn	4180186
1616511	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f173; Immune globulin E; Immunoglobulin E; Piper gurnard; Piper gurnard IgE; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616511	 .IgE::::	4182948
1616512	:-:::-	4182948
1616512	Necrotizing myopathy Ab pnl; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Serum; SR	4180186
1616512	Necrotizing myopathy Ab pnl Ser	4180186
1616513	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
1616514	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Srce; Survey	4180186
1616515	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; IC; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1616515	IC Prog note	4180186
1616515	:::{}::	4182948
1616516	Finding; Findings; H+P; H+P.HX; Mental health; MentalHealth; Ordinal; P prime; Point in time; Psych; Psychiatry; Ql; Qual; Qualitative; Random; Screen	4180186
1616516	:::^:	4182948
1616519	 RNA:::XXX::..	4182948
1616519	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; SSHV; SSHV RNA; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1616519	SSHV RNA Spec Ql NAA+probe	4180186
1616520	by Phoropter; Eye; EYE.REFRACTION; Eyeball; Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; PD; PD monoc; PD monoc near; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1616520	R eye PD monoc near by Phoropter	4180186
1616520	.:::.::	4182948
1616521	::::	4182948
1616521	Androst Fld-sCnc	4180186
1616521	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Endocrine; Endocrinology; Fl; Fld; FLU; Fluid; gamma-4-Androstenedione; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1616524	COMI Neck score; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
1616525	Average; Avg; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey	4180186
1616527	:::::	4182948
1616527	Iloperidone Ur Ql Cfm	4180186
1616527	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Fanapt; Fanapta; GCMS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Zomaril	4180186
1616528	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Stay home to avoid social contact; Survey	4180186
1616530	  (rVes v) 5 .IgG4::::	4182948
1616530	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common wasp; Common wasp (rVes v) 5; i209; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616530	Common wasp (rVes v) 5 IgG4-mCnc	4180186
1616531	:::::	4182948
1616531	Nordiazepam TissCo Ql Cfm	4180186
1616531	Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; GCMS; Madar; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Ordinal; Point in time; PR; Praxadium; Prazepam metabolite; QL; Qual; Qualitative; Random; Screen; Stilny; Tranxilium N; Vegesan	4180186
1616534	Finding; Findings; Job; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1616535	CLIN; I/E service grp size; Nominal; Point in time; Random; Typ	4180186
1616535	I/E service grp size	4180186
1616535	:::^:	4182948
1616536	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1616537	:::/::	4182948
1616537	Blood; Document; Finding; Findings; Gene; Gene panel; Gyn; Gynecology; Hereditary Cancer Multigene Anl; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; OB; ObGyn; Obstetrics; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1616537	Hereditary Cancer Multigene Anl Bld/T	4180186
1616543	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; Freq look for COVID-19 info; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1616544	(+++) .IgG:::::Multidisk 	4182948
1616544	A alternata; A tenuis; ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Allerscan; Alternaria tenuis; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C herbarum; Gm2; Gm6; Hormodendrum; Immune globulin G; Immunoglobulin G; Level; M racemosus; m001; m002; m004; m006; m1; m2; m4; m6; Mass concentration; Mold Allerg Mix6; P chrysogenum; P notatum; Point in time; QNT; Quan; Quant; Quantitative; Random; RGmx6; Serum; SR	4180186
1616544	Mold Allerg Mix6 IgG-mCnc	4180186
1616546	 DNA:::::..	4182948
1616546	Gp B Strep DNA Snv Ql NAA+non-probe	4180186
1616546	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GBS; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S agalactiae; Screen; SDA; SF; SNV; Steptococcus Group B; Strand Displacement Amplification; Strep; Strep B; Strep group B; Strept; Streptococci group B; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1616552	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Allerscan; Amer Beech; American beech; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; East White Pine; Eastern white pine; Immune globulin E; Immunoglobulin E; KX4; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Softwood Mix; Softwood Mix (Beech+Pine+Red cedar+Silver fir) Ab.IgE; SR; t005; t016; t16; t5; White pine	4180186
1616552	Softwood Mix IgE Qn	4180186
1616552	(+++) .IgE:::::Multidisk 	4182948
1616553	Prim etiology spine deform	4180186
1616553	Finding; Findings; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Prim etiology spine deform; Random; SURG	4180186
1616553	:::^:	4182948
1616554	:::::.FIB4	4182948
1616554	Calc; Calc.FIB4; Calculation; Chemistry; Hepatology; Liver; Liver fibr score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Serum; SR	4180186
1616554	Liver fibr score Ser Calc.FIB4	4180186
1616556	:::::	4182948
1616556	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hydrocodone metabolite; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1616556	Norhydrocodone TissCo Ql Scn	4180186
1616558	:::/::	4182948
1616558	PHI Score SerPl Calc	4180186
1616558	Calc; Calculation; Chemistry; PHI; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1616559	Comments re: postop complications; Finding; Findings; Nominal; Point in time; Random; SURG	4180186
1616559	Comments re: postop complications	4180186
1616559	:::^:	4182948
1616562	 .IgG :::::	4182948
1616562	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; ID; Identity or presence; Immune blot; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; RIBA; Serum; SR; Syphilis; T pallidum; Treponemal; WB; WBLOT; West blot; West blt; Western blot	4180186
1616562	T pallidum IgG bands Ser IB	4180186
1616563	D-ALA + PBG Pnl SerPl	4180186
1616563	5-ALA; 5-aminolevulinate; 5-aminolevulinic acid; ALA; Aminolevulinic acid; Amnolev; Amnolevuunc; Chemistry; D-ALA; D-ALA + PBG Pnl; Delta-ala; Delta-aminolevulinic acid; Pan; PANEL.CHEMISTRY; Panl; PBG; Pl; Plasma; Plsm; Pnl; Point in time; Porph; Porphobili; Porphoblngn; Porpoblngn; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1616563	Delta :-::/:-	4182948
1616564	Spine fusion lvl	4180186
1616564	Finding; Findings; Levels; Levl; LV; LVL; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; Spine fusion lvl; SURG	4180186
1616564	:::^:	4182948
1616566	.^::::	4182948
1616566	Diff cap.CO p BD	4180186
1616566	(Diff cap; After; Breathing; Diff cap; Diff cap.CO; Diff cap.CO^post bronchodilation; DL; DLCO; Fluid conductance; Lung; Lungs; p BD; Point in time; PST; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
1616567	 .IgE::::	4182948
1616567	Norfloxacin IgE Qn	4180186
1616567	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c175; Immune globulin E; Immunoglobulin E; Noroxin; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616570	.IgG  IgM :-:::-:	4182948
1616570	B burg; B burgdor; B burgdor IgG+IgM Pnl; B burgdorferi; Bb; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; MEIA; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
1616570	B burgdor IgG+IgM Pnl CSF IA	4180186
1616571	^:::/:	4182948
1616571	DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; DRUG/TOXICOLOGY; Drugs; Epanutin; Fenantoin; Lehydan; Level; Neuro; Neurology; Phenhydan; PHYT; Pl; Plasma; Plsm; Point in time; Post; Postdose; Post-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinergina; SR; Substance concentration; Zentropil	4180186
1616571	Phenytoin Peak SerPl-sCnc	4180186
1616572	by Phoropter; Eye; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; V prism-down; V prism-down near; Vision; Visual	4180186
1616572	R eye V prism-down near by Phoropter	4180186
1616572	.:::.::	4182948
1616578	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1616581	Arterial Stenosis; Emotional stability; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Srce; Survey	4180186
1616582	^:::^:	4182948
1616582	Finding; Findings; in Surg; Intra operative; Intraop; Intraoperative; Med complication^during surg; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; Surg	4180186
1616582	Medical complication in Surg	4180186
1616583	by Phoropter; Eye; EYE.REFRACTION; Eyeball; Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; View dist; Vision; Visual	4180186
1616583	Phoropter View dist	4180186
1616583	:::::	4182948
1616584	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1616584	:::^:	4182948
1616587	:::::	4182948
1616587	Zolpidem TissCo Ql Scn	4180186
1616587	Addiction; Adormix; Ambien; Ambien CR; Damixan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Edluar; Hypnogen; Illicit; Ivedal; Lioran; Myslee; Nasen; Nytamel; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sanval; Scn; Scr; Screen; Scrn; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; Zoldem; Zolpihexal; Zolpimist	4180186
1616588	.:::::	4182948
1616588	Addiction; BU; BUP; Bupe; Buprenex; Buprenorphine free; buprenorphine HCI; Buprex; Butrans; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Finobrin; FR; GCMS; Illicit; Non-protein bound; Norspan; Ordinal; Point in time; PotentialForAbuse; PR; Prefin; QL; Qual; Qualitative; Random; Screen; Suboxone; Subutex; Temgesic	4180186
1616588	Buprenorphine free TissCo Ql Cfm	4180186
1616589	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R; R prime; Random; Right; RT; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1616590	Sequencing study ID	4180186
1616590	Ident; Identifier; Microbiology; Nominal; Point in time; Random; Spec; Study report	4180186
1616590	::::	4182948
1616594	;:-::^:-:AAPCHO	4182948
1616594	AAPCHO I/E Pnl; CLIN; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random; SDOH	4180186
1616594	AAPCHO I/E Pnl	4180186
1616601	Finding; Findings; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH; Work	4180186
1616603	 .IgE::::	4182948
1616603	ABS; Aby; Albaxin; Allergen; Allergens; Allergy; ALLERGY TESTING; Ambacamp; Ambaxin; Amplibac; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bacacil; Bacampicillin IgE; Bacampicin; Bacocil; c119; Carampicillin; Immune globulin E; Immunoglobulin E; Penglobe; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Sprectrobid; SR; Velbacampin	4180186
1616603	Bacampicillin IgE Qn	4180186
1616604	2019 Novel Coronavirus; 2019-nCoV; After; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; PCFS grade; Point in time; PST; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1616606	:()::^:	4182948
1616606	People rcvd first dose of vaccine Pop	4180186
1616606	Cnt; Count; Number; People rcvd first dose of vaccine; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; World Heatlth Organization	4180186
1616607	:::{}::	4182948
1616607	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
1616607	Rheumatology H&P note	4180186
1616609	:::::	4182948
1616609	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Methamphet; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
1616609	Methamphet TissCo Ql Cfm	4180186
1616612	 :::::.	4182948
1616612	EPS; expressed prostatic secretion; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; LM; Micro; Microbiology; Micros; Microscopic; Nominal; Parasites; Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; Random	4180186
1616612	Parasite Prost fld Micro	4180186
1616614	T pall IgG + IgM + bands Pnl CSF IB	4180186
1616614	Blt; Cerebral spinal fluid; Cerebrospinal Fl; ID; IMMUNE BLOT; Immune globulin G; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; RIBA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Syphilis; T pall IgG + IgM + bands Pnl; T pallidum; Treponemal; WB; WBLOT; West blot; West blt; Western blot	4180186
1616614	.IgG  IgM :-:::-:	4182948
1616615	 .IgE::::	4182948
1616615	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c64; Immune globulin E; Immunoglobulin E; Piper; PIPJ; Pipracil; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616615	Piperacillin IgE Qn	4180186
1616618	5+ drinks 1D past 3Mo	4180186
1616618	3 months; 5+ drinks 1D past 3Mo; Finding; Findings; H+P; H+P.HX; Last; Ordinal; P prime; QL; Qual; Qualitative; Screen	4180186
1616618	3,::3:^:	4182948
1616620	::::	4182948
1616620	CA; Ca spec; Cancer of the corpus uteri; EC spec; Female reproductive organs; Oncology; Ordinal; Pathology; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Uterine cancer; Uterine Cancers	4180186
1616620	Omental involvement EC spec Ql	4180186
1616622	:::{}::	4182948
1616622	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1616622	Sleep med Procedure note	4180186
1616626	.::::	4182948
1616626	NSE Aspirate-mCnc	4180186
1616626	Aspirate; Chemistry; ENO2; enolase 2; Gamma-enolase; Level; Mass concentration; NSE; Oncology; Phosphopyruvate dehydratase; Phosphopyruvate hydratase.gamma subunit; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Tumor marker	4180186
1616630	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1616632	MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Primary spine degen type; Random; SURG; Typ	4180186
1616632	Primary spine degen type	4180186
1616632	.:::^:	4182948
1616633	by Phoropter; CYL; Eye; EYE.REFRACTION; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Typ; Vision; Visual	4180186
1616633	:::::	4182948
1616636	by Phoropter; Eye; EYE.REFRACTION; Eyeball; H prism-out; H prism-out far; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1616636	L eye H prism-out far by Phoropter	4180186
1616636	.:::.::	4182948
1616637	:::::	4182948
1616637	3,4-methylenedioxy-N-ethylcathinone; Addiction; Bath salts; bk-MDEA; Cat; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; MDEC; methylenedioxyethylcathinone; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1616637	bk-MDEA TissCo Ql Scn	4180186
1616638	SMN2 :::/::	4182948
1616638	BCD541; Blood; C-BCD541; Entitic; Entitic number; GEMIN1; Gemin-1; Molecular genetics; Molecular pathology; MOLPATH; No; Num; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; SMN; SMN2 copy num; SMNC; SMNT; survival of motor neuron 2, centromeric; TDRD16B; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1616638	SMN2 copy num EntNum Bld/T	4180186
1616639	.+::::	4182948
1616639	Clot angle kaolin+TF ind Bld	4180186
1616639	Blood; Clot angle kaolin+TF ind; COAGULATION; Fac; Fact; Hematology; Heme; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1616641	ACT-2; C-C motif chemokine 4; CCL4; Chemistry; G-26 T-lymphocyte-secreted protein; HC21; LAG-1; Level; Lymphocyte activation gene 1 protein; Macrophage inflammatory protein 1-beta; Mass concentration; MIP-1-beta; MIP-1-beta(1-69); PAT 744; Pl; Plasma; Plsm; Point in time; Protein H400; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SIS-gamma; Small-inducible cytokine A4; SR; T-cell activation protein 2	4180186
1616641	CCL4 SerPl-mCnc	4180186
1616641	 (C-C )  4:::/:	4182948
1616642	 .IgG4::::	4182948
1616642	Chicken Meat IgG4-mCnc	4180186
1616642	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f083; f83; Gallus spp; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616644	:::::	4182948
1616644	Addiction; c311; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Stesolid; Valium	4180186
1616644	diazePAM TissCo Ql Cfm	4180186
1616650	 DNA:::::..	4182948
1616650	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; CMV; Cnt; Count; Count/volume; CT; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Oral fluid; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Sal; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
1616650	CMV DNA # Sal NAA+probe	4180186
1616652	BMI score for risk calc	4180186
1616652	H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Scale; Screen	4180186
1616652	:::^:	4182948
1616654	::::	4182948
1616654	pO2 BldCV	4180186
1616654	Chemistry; Lung; O2; O2 partial pressure; Partial pressure; PO2; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; tO2	4180186
1616655	3 months; Benzoylmethylecgonine; Coke; Crack; Desoxyn; Ecgonine methyl ester benzoate; Finding; Findings; H+P; H+P.HX; Last; Mental health; MentalHealth; Methamphet; Ordinal; P prime; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Snow; Used cocaine/crack/meth once W past 3Mo	4180186
1616655	Used cocaine/crack/meth once W past 3Mo	4180186
1616655	3,::3:^:	4182948
1616656	^30:::/:	4182948
1616656	30M p Arg; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1616656	Glucose 30M p Arg SerPl-mCnc	4180186
1616657	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1616661	:::{}::	4182948
1616661	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hand Surgery; notes; Point in time; Random; Surg; Upper extremity; Visit note	4180186
1616661	Hand Surgery Procedure note	4180186
1616663	Surgeon Provider	4180186
1616663	Nominal; Person name; Point in time; Random	4180186
1616663	::::	4182948
1616664	 .IgE::::	4182948
1616664	Phenac IgE Qn	4180186
1616664	ABS; Aby; Aceto-p-phenetidide; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c111; Cratodin rectal; Gripponyl; Hemagene tailleur; Immune globulin E; Immunoglobulin E; Nevral; Phenacetin IgE; Point in time; Polypirine; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616665	a482; ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Black olive; f342; i; Level; Mass concentration; Olive; Olive (nOle e) 1; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t224	4180186
1616665	  (nOle e) 1 .IgG4::::	4182948
1616665	Olive (nOle e) 1 IgG4-mCnc	4180186
1616668	ADMIN; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1616668	:::XXX:	4182948
1616670	/.::::	4182948
1616670	COHgb MFr BldCV	4180186
1616670	Carbon monoxide.hemoglobin; Carbonmonoxyhemoglobin; Carbonyl haemoglobin; Carbonyl hemoglobin; Carbonyl Hgb; Carboxyhaemoglobin; Carboxyhemoglob; Chemistry; CO haemoglobin; CO hemoglobin; COHb; COHgb; Haemoglobin; Hb; HbCO; Hemoglobin bound with carbon dioxide; Hgb; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
1616671	--1,3--N-/:::::	4182948
1616671	Eutylone/Creat Ur Cfm	4180186
1616671	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
1616672	 .IgG:::/::	4182948
1616672	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; MPO; MPO - ANCA; Myeloperoxidase ANCA; p-ANCA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Vasculitis	4180186
1616672	Myeloperoxidase IgG SerPl IA-aCnc	4180186
1616673	 :::::..	4182948
1616673	Mold Islt NAA+probe	4180186
1616673	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Mould; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1616675	:::.:	4182948
1616675	Thyroglob Tiss FNA-sCnc	4180186
1616675	Chemistry; Endocrine; Endocrinology; Fine needle; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tg; Thyglobulin; Thyroglbn; Thyroglob; Tiss FNA; Tissue; Tissue fine needle aspirate; Tissue, unspecified; Tumor marker	4180186
1616676	by Phoropter; Eye; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1616676	R eye Prism far by Phoropter	4180186
1616676	:::.::	4182948
1616677	 I RNA:::XXX::..	4182948
1616677	Norovirus GI RNA Spec Ql NAA+probe	4180186
1616677	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Human Calcivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Norovirus 1; Norovirus G1; Norovirus GI; Norwalk virus; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1616678	 LcrV  :::::	4182948
1616678	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
1616678	Yersinia LcrV Ab Ser Ql Line blot	4180186
1616679	Difficult comm in usual lang; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH	4180186
1616681	 .IgE::::	4182948
1616681	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; m56; Point in time; QNT; Quan; Quant; Quantitative; Random; Ring worm; Serum; SR	4180186
1616681	M canis IgE Qn	4180186
1616683	:::{}::	4182948
1616683	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Multi-spec prog; notes; Point in time; Random; Visit note	4180186
1616683	Multi-spec prog Eval note	4180186
1616685	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Monilia; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SF; SNV; species; spp; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; Thrush; TMA; Transcription mediated amplification	4180186
1616685	Candida DNA Snv Ql NAA+non-probe	4180186
1616685	 DNA:::::..	4182948
1616686	1 year; 12Mos; Finding; Findings; Inspection; Ordinal; Past; Postponed Dr. visits last 12Mo; Ql; Qual; Qualitative; S prime; Screen; Survey	4180186
1616687	::::	4182948
1616687	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Exudate; Fl; Fld; FLU; Fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Transudate; Transudates and Exudates	4180186
1616687	Rivalta test Fld Ql	4180186
1616688	:-::^:-:Spine Tango	4182948
1616688	Hosp; Hospital stay pnl; Pan; PANEL.SURG; Panl; Pnl; Point in time; Random; SURG	4180186
1616688	Hospital stay pnl Spine Tango	4180186
1616694	 E :::::	4182948
1616694	YopE Ab Ser Ql Line blot	4180186
1616694	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Rh Blood Group System; Screen; Serum; SR; Yop; YopE	4180186
1616696	 .IgE::::	4182948
1616696	Mouse droppings IgE Qn	4180186
1616696	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; e89; Feces; Immune globulin E; Immunoglobulin E; Mice; Murine; Mus musculus; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; stool	4180186
1616699	 :::XXX::	4182948
1616699	B mandrillaris Ab Spec Ql IF	4180186
1616699	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B mandrillaris; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Time Resolved Fluorescence; To be specified in another part of the message; TRF; Unspecified	4180186
1616703	 .IgG4::::	4182948
1616703	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cod worm; Level; Mass concentration; p4; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616703	Anisakis IgG4-mCnc	4180186
1616707	BRAF .p.Val600 :::::	4182948
1616707	BRAF p.V600 mutations Tiss	4180186
1616707	BRAF p.V600 mutations; B-Raf proto-oncogene, serine/threonine kinase; BRAF1; B-RAF1; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Muts; Nominal; NS7; P prime; PCR; Point in time; RAFB1; Random; Tissue; Tissue, unspecified; v-raf	4180186
1616708	:::::	4182948
1616708	Meperidine TissCo Ql Scn	4180186
1616708	Addiction; Algil; Alodan; Centralgine; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Pethidine; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1616711	3 months; Arterial Stenosis; Finding; Findings; H+P; H+P.HX; Last; Mental health; MentalHealth; Misused anxiety/sleep meds past 3Mo; Ordinal; P prime; Psych; Psychiatry; Ql; Qual; Qualitative; Screen	4180186
1616711	Misused anxiety/sleep meds past 3Mo	4180186
1616711	3,::3:^:	4182948
1616714	 T- B-:-::.::	4182948
1616714	Lymph T + B-cell + NK subsets Pnl L Resp	4180186
1616714	B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; CELL MARKERS; Dynamic; FC; Low; Lower resp; Lung; Lymph T-cell + B-cell + NK subset Pn; Lymph T-cell + B-cell + NK subsets; NK; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; T cell; T prime; UCHL-1	4180186
1616716	Agents, Immunosuppressive; antirejection medications; Immunosuppressants; Immunosuppressions; Immunosuppressive drug; MEDS; Nominal; Point in time; Random; Typ	4180186
1616716	Immunosuppressive medication	4180186
1616716	:::^:	4182948
1616721	Corn starch IgE Qn	4180186
1616721	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Corn; Corn starch; Corn starch Ab; Corn starch Ab.IgE; f008; f141; f215; f8; Immune globulin E; Immunoglobulin E; Maize; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616721	 .IgE::::	4182948
1616722	Spine Tango  2017:-::^:-:Spine Tango	4182948
1616722	Spine Tango surgery f/u 2017 Spine Tango	4180186
1616722	MSK; Musculoskeletal; Ortho; Orthopedics; Pan; Panel; PANEL.SURG; Panl; Pnl; Point in time; Random; Spine Tango surgery f/u 2017; Surg	4180186
1616723	^4::::	4182948
1616723	Sodium 4h spec Dial fld-sCnc	4180186
1616723	Chemistry; Diaf; Dialysate; Dialysis fluid; Kidney; Level; Na; Na+; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Spec; Substance concentration	4180186
1616725	Cannot read/write prim lang; CLIN; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH	4180186
1616725	Cannot read/write prim lang	4180186
1616725	:::^:	4182948
1616726	by Phoropter; c; Contr; Contra; Contrast for near VA; Contrst; Eye; EYE.REFRACTION; Eyeball; Number fraction; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; Vision; Visual	4180186
1616726	Contrast for near VA by Phoropter	4180186
1616726	:::::	4182948
1616727	:::::{}	4182948
1616727	OP Visit notification	4180186
1616727	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Random; Visit note; Visit notifctn note	4180186
1616730	 DNA:::XXX::..	4182948
1616730	3 Self-Sustaining Sequence Replication; 3SR SR; Amoeba; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E moshkovskii; E moshkovskii DNA; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1616730	E moshkovskii DNA Spec Ql NAA+probe	4180186
1616731	CD3 Cells; CD3+CD16+ Cells; CD3+CD16+CD56+ Cells; CD3-CD16+ Cells; CD3-CD16+CD56+ Cells; Cell; CELL MARKERS; Cellularity; Dynamic; FC; FCGR3A; Leu11; Leu-11; Leu11b; Leu-11B; Leu19; Leu-19; Leu4; Leu-4; Low; Lower resp; Lung; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Natural killer cells; NCAM; Neural cell adhesion molecule; NKH1; Number fraction; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; T3	4180186
1616731	.CD3-CD16+CD56+/100 :::.::	4182948
1616731	CD3-CD16+CD56+ Cells/lymph NFr L resp FC	4180186
1616732	 SOFA :::^::SOFA.	4182948
1616732	CLIN; CLIN.RISK; Point in time; QNT; QSOFA; Quan; Quant; Quantitative; Random; Scale	4180186
1616732	QSOFA QSOFA	4180186
1616739	::24^:^:	4182948
1616739	1 day; 24 hours; 24HR; Average; Avg; BP; BP Pnl; Cardio; Cardiology; Heart Disease; Pan; PANEL.BP; Panl; Pnl; Pressure; QNT; Quan; Quant; Quantitative	4180186
1616739	BP Pnl 24h Mean	4180186
1616742	Chemistry; IL; IL-15; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1616742	IL-15 SerPl-mCnc	4180186
1616742	 15:::/:	4182948
1616744	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
1616747	.:::::	4182948
1616747	14-Hydroxydihydromorphinone; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; FR; Illicit; Non-protein bound; Numorphan; Numorphone; Opana; Ordinal; oxyMORphone Free; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1616747	oxyMORphone Free TissCo Ql Scn	4180186
1616748	VEGF-C SerPl-mCnc	4180186
1616748	Chemistry; Fac; Fact; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vascular endothelial growth factor A; vascular permeability factor; VEGF; VEGF-A; VEGF-C	4180186
1616748	 C:::/:	4182948
1616749	  (rPhl p) 1 .IgG4::::	4182948
1616749	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g006; g205; g6; i; Level; Mass concentration; P prime; Phleum pretense; Point in time; QNT; Quan; Quant; Quantitative; Random; Rg205; rph1; Serum; SR; Timothy; Timothy (rPhl p) 1; Timothy grass	4180186
1616749	Timothy (rPhl p) 1 IgG4-mCnc	4180186
1616751	:::{}::	4182948
1616751	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; IR; notes; Operative note; Point in time; Random; Surg; Visit note	4180186
1616751	IR Operative note	4180186
1616753	Beta 1 /.::24:::	4182948
1616753	1 day; 24 hours; 24HR; B; B1 globulin; Beta1 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Hematology; Heme; i; Mass fraction; Percent; PEUR; PR; Prot; QNT; Quan; Quant; Quantitative; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
1616753	Beta1 Glob 24h MFr Ur Elph	4180186
1616754	Blastomyces Ab Titr Spec CF	4180186
1616754	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blasto; Blastomycosis; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Other; Point in time; Random; SmQn; Spec; species; spp; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified	4180186
1616754	 :::XXX::	4182948
1616755	:::{}::	4182948
1616755	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Rec therapy; Visit note	4180186
1616755	Rec therapy H&P note	4180186
1616757	Repeat spine surg reason	4180186
1616757	Finding; Findings; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; Repeat surg reason; Surg	4180186
1616757	:::^:	4182948
1616758	 DNA:::::..	4182948
1616758	K kingae DNA Snv Ql NAA+non-probe	4180186
1616758	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; K kingae; K kingella; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Moraxella kingae; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SF; SNV; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1616761	:::{}::	4182948
1616761	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Fam Med; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
1616761	Fam Med Eval note	4180186
1616762	 .IgG:::/::	4182948
1616762	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SRP; Time Resolved Fluorescence; TRF	4180186
1616762	SRP IgG SerPl Ql IF	4180186
1616763	Disch; Finding; Findings; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Postop med compl before discharge; Random; SURG	4180186
1616763	Postop med compl before discharge	4180186
1616763	:::^:	4182948
1616764	:::::	4182948
1616764	Amphet TissCo Ql Cfm	4180186
1616764	Addiction; Amph; Amphet; Amphetam; Amphetamines; Ampht; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Speed	4180186
1616767	.:::::	4182948
1616767	14-Hydroxydihydromorphinone; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; FR; GCMS; Illicit; Non-protein bound; Numorphan; Numorphone; Opana; Ordinal; oxyMORphone Free; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
1616767	oxyMORphone Free TissCo Ql Cfm	4180186
1616769	 .IgE::::	4182948
1616769	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Assoral; Autoantibodies; Autoantibody; c161; Cirumycin; Claramid; Immune globulin E; Immunoglobulin E; Macrosil; Overal; Point in time; QNT; Quan; Quant; Quantitative; Random; Rossitrol; Rotesan; Rotramin; Roxithromycin IgE; Rulid; Serum; SR; Surlid	4180186
1616769	Roxithromycin IgE Qn	4180186
1616770	2,3- 11 beta- F2 alpha/::::	4182948
1616770	2,3-dinor 11B-PG F2a/Creat Ur	4180186
1616770	2,3-dinor 11B-PG F2a; 2,3-dinor-11beta-Prostaglandin F2a; 2,3-dinor-11b-PGF2alpha; 23BPG; 9S,11S,15S-Trihydroxy-2,3-dinor-5Z,13E-prostadienoic acid; Alfa; B; Chemistry; CR; Crea; Creat; Endocrine; Endocrinology; II; III; Mass concentration ratio; Mass ratio; MCRto; PG; PGF2; PGF2A; PGF2alpha; Point in time; Prostaglandin F2A; QNT; Quan; Quant; Quantitative; Random; Systemic Mastocytosis; UA; UCr; UR; Urn	4180186
1616774	:::::..	4182948
1616774	Fat #/area UrnS HPF	4180186
1616774	#/area; LM; Micro; Micros; Microscopic; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1616775	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1616780	::::	4182948
1616780	Bilirub BldC-sCnc	4180186
1616780	Bili; Bilirubins; Billirubin; Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Finger stick; Gastro; Gastroenterology; GI; Hematology; Heme; Hepatology; Level; Liver; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; TBIL	4180186
1616782	Cnt; Count; LN exam; Number; Oncology; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; R; R Pelvic LN examined; Random; RT; Spec	4180186
1616782	R Pelvic LN examined Spec	4180186
1616782	:():::	4182948
1616784	:()::^:	4182948
1616784	CLIN; Cnt; Count; Interv/enab serv min; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1616784	Interv/enab serv min	4180186
1616785	::24::	4182948
1616785	Vasopressin 24h Ur-sRate	4180186
1616785	1 day; 24 hours; 24HR; ADH; Adiuretin; Antidiuretic hormone; Arginine vasopressin hormone; AVH; Chemistry; Kidney; Nephrology; QNT; Quan; Quant; Quantitative; Renal; sRate; Substance Rate; UA; UR; Urn; VP	4180186
1616786	MVX ::::	4182948
1616786	Ident; Identifier; Nominal; Point in time; Random	4180186
1616787	:::::	4182948
1616787	DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Transfer sum note; Visit note	4180186
1616787	Emergency med ED Transfer sum note	4180186
1616788	 .IgG4::::	4182948
1616788	Turkey Meat IgG4-mCnc	4180186
1616788	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f284; Level; Mass concentration; Meleagis gallopavo; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616791	:::::	4182948
1616791	Butalbital TissCo Ql Cfm	4180186
1616791	Addiction; Allylbarbital; Allylbarbituric acid; Barbiturate; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fiorinal; GCMS; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
1616792	AUDIO; Audiology; Ear Nose Throat; Ear-L; ENT; Finding; Findings; Hearing; HL degree; HL degree.min; L; LT; Minimal; minimum; Ordinal; Oto; Otolaryngology; Otologic; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1616792	HL degree.min Ear-L	4180186
1616792	.:::.:	4182948
1616793	 125::::	4182948
1616793	Arbitrary concentration; Aspirate; CA; CA 125; Cancer Ag125; Cancer antigen 125; Carbohydrate antigen; Carbohydrate antigen 125; Chemistry; OC125; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Tumor marker	4180186
1616793	Cancer Ag125 Aspirate-aCnc	4180186
1616797	::24::	4182948
1616797	T3 24h Ur-mRate	4180186
1616797	1 day; 24 hours; 24HR; Chemistry; Endocrine; Endocrinology; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; T3; T-3; thyroid hormone; Total T3; Triodothyrne; UA; UR; Urn	4180186
1616798	 Lambert-Eaton :-:::-	4182948
1616798	MG and LES Ab Pnl Ser	4180186
1616798	MG and LES Ab Pnl; Neuro; Neurology; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Serum; SR	4180186
1616802	Cnt; Count; Number; Oncology; Para-aortic LN positive; PATHOLOGY; Point in time; Pos; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
1616802	Para-aortic LN positive Spec	4180186
1616802	:():::	4182948
1616804	3 months; Arterial Stenosis; Finding; Findings; H+P; H+P.HX; Last; Mental health; MentalHealth; Misused ADHD meds once W past 3Mo; Ordinal; P prime; Psych; Psychiatry; Ql; Qual; Qualitative; Screen	4180186
1616804	Misused ADHD meds once W past 3Mo	4180186
1616804	3,::3:^:	4182948
1616805	.+.:::::	4182948
1616805	DHC+Hydrocodol Free TissCo Ql Scn	4180186
1616805	Addiction; DF-118; DHC; DHC Free; DHC+Hydrocodol Free; DHCPlus; Drocode; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; FR; Illicit; Non-protein bound; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1616808	::::	4182948
1616808	Adulterant; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Oxidant; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1616808	Oxidants Ur-mCnc	4180186
1616809	Postop complication timing	4180186
1616809	Finding; Findings; Nominal; Point in time; Postop complication timing; Random; SURG	4180186
1616809	:::^:	4182948
1616813	 RNA:::XXX::..	4182948
1616813	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CTFV; CTFV RNA; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1616813	CTFV RNA Spec Ql NAA+probe	4180186
1616814	Cnt; Count; Levels; Levl; LV; LVL; MSK; Musculoskeletal; No; Num; Num prev surg at/near level; Number; Ortho; Orthopedics; Point in time; Prev; QNT; Quan; Quant; Quantitative; Random	4180186
1616814	Num prev surg at/near level	4180186
1616814	:()::^:	4182948
1616817	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
1616817	:::{}::	4182948
1616817	Cardiac surgery Prog note	4180186
1616819	:::{}::	4182948
1616819	Burn H&P note	4180186
1616819	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
1616821	 .IgE::::	4182948
1616821	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Asian Hornet; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616821	Asian Hornet IgE Qn	4180186
1616824	Blt; ID; IMMUNE BLOT; Immune globulin G; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; RIBA; Serum; SR; Syphilis; T pall IgG + IgM + bands Pnl; T pallidum; Treponemal; WB; WBLOT; West blot; West blt; Western blot	4180186
1616824	T pall IgG + IgM + bands Pnl Ser IB	4180186
1616824	.IgG  IgM :-:::-:	4182948
1616825	CT :::::	4182948
1616825	Calc; Calculation; Imaging; Point in time; QNT; Quan; Quant; Quantitative; Rad; Radiology; Random; Relative density	4180186
1616825	Calc CT global noise	4180186
1616828	::::	4182948
1616828	Arbitrary concentration; Hem; Hemolysis interf index; Point in time; QNT; Quan; Quant; Quantitative; Random; SPEC; UA; UR; Urn	4180186
1616828	Hemolysis interf index Ur-aCnc	4180186
1616831	CLIN; ODI score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
1616831	ODI score	4180186
1616836	AUDIO; Audiology; Ear Nose Throat; Ear-L; ENT; Finding; Findings; Hearing; HL degree; L; LT; Ordinal; Oto; Otolaryngology; Otologic; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1616836	HL degree Ear-L	4180186
1616836	:::.:	4182948
1616843	2-:::::	4182948
1616843	2-OH-Ethylfluraz; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; GCMS; Hydroxy ethylflurazepam; II; Level; Mass concentration; OH-Ethylfluraz; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1616843	2-OH-Ethylfluraz Ur Cfm-mCnc	4180186
1616844	%; Cancer; Mesenchymal; Oncology; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Sarcoma comp carcinosarcoma; tumors; tumour; tumours	4180186
1616844	Sarcoma comp carcinosarcoma %	4180186
1616844	::::	4182948
1616845	:::::	4182948
1616845	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Musc; Muscl; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
1616845	Muscle relaxants Sal Ql Cfm	4180186
1616847	L eye H prism-out near by Phoropter	4180186
1616847	by Phoropter; Eye; EYE.REFRACTION; Eyeball; H prism-out; H prism-out near; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1616847	.:::.::	4182948
1616849	:::::	4182948
1616849	arrCGH; Chrom analy; Chromosom; Chromosomes; Cytogenetics; Document; Finding; Findings; Gyn; Gynecology; Karyotype; Molecular pathology; MOLPATH; OB; ObGyn; Obstetrics; Point in time; Products of Conception; Random	4180186
1616849	Chrom analy POC Microarray	4180186
1616850	:-::/:-:	4182948
1616850	CPR bact ID + resistance Pnl Islt/Spm	4180186
1616850	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR bact ID + resistance Pnl; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; PCR; Pnl; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1616851	Finding; Findings; Hepatology; Liver; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1616853	HLA-A  B  C (I ) .IgG :::/:	4182948
1616853	HLA Class I Ab.IgG Don Spec SerPl	4180186
1616853	A,B; HLA ANTIGEN; HLA class I; HLA Class I Ab.IgG Don Spec; HLA-A+B; HLA-A+B+C; HLA-A+B+C (class I); Human Leukocyte Antigen; Identity or presence; Immune globulin G; Immunoglobulin G; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Spec; SR	4180186
1616855	/.::::	4182948
1616855	OxyHgb MFr BldCV	4180186
1616855	Chemistry; FO2Hb; Fractional hemoglobin; Haemoglobin; Haemoglobin oxygenated; Hb; HbO2; Hemoglobin oxygenated; Hgb; Lung; Mass Fraction; O2 saturation; O2Hb; Oxygen saturation; Oxygenated haemoglobin; Oxygenated hemoglobin; Oxyhaemoglobin; OxyHgb; OxyHgb %; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SO2; Tot; Totl	4180186
1616860	Ambroxol IgE Qn	4180186
1616860	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Ambroxol IgE; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c96; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616860	 .IgE::::	4182948
1616863	:::::	4182948
1616863	BEC; BEG; Benz; Benzoylec; BZE; Cfm; CNFR; CNFRM; Cocaine degradation production; Cocaine metabolite; Conf; Confirmation; Confirmatory; Crack metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
1616863	BZE TissCo Ql Cfm	4180186
1616865	 .IgE::::	4182948
1616865	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t12; White willow; White willow IgE	4180186
1616865	White willow IgE Qn	4180186
1616866	:::{}::	4182948
1616866	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Pharmacy; Point in time; Random; Visit note	4180186
1616866	Pharmacology H&P note	4180186
1616867	C3-L5 or S1 AO fracture type	4180186
1616867	C3-L5 or S1 AO fracture type; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; SURG; Typ	4180186
1616867	C3-L5  S1 AO :::^:	4182948
1616868	Vision dist tested by by Phoropter	4180186
1616868	by Phoropter; Eye; EYE.REFRACTION; Eyeball; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Random; Typ; Vision; Vision dist tested; Visual	4180186
1616868	:::::	4182948
1616870	:::::	4182948
1616870	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Nucynta; Ordinal; Palexia; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Tapal	4180186
1616870	Tapentadol TissCo Ql Cfm	4180186
1616871	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1616879	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Srce; Survey	4180186
1616880	^^:::::	4182948
1616880	Base ex; BE; Bld cord; BSE; Calc; Calculation; Chemistry; Cord arterial blood; Cord BldA; EXS; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; SBE; std; Substance Concentration	4180186
1616880	Base excess std BldCoA Calc-sCnc	4180186
1616883	Rigid stablization lvl	4180186
1616883	Finding; Findings; Levels; Levl; LV; LVL; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; Rigid stablization lvl; SURG	4180186
1616883	:::^:	4182948
1616885	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1616886	::::	4182948
1616886	AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1616886	Cycloheximide Islt Ql-Susc	4180186
1616887	:::::{}	4182948
1616887	OP Stroke prevention note	4180186
1616887	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Random; Visit note	4180186
1616888	/100 :::::	4182948
1616888	Promegakaryocytes NFr Mar Manual	4180186
1616888	BM; BON; Bone marrow; Cell; Cellularity; Gated cells; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Manl; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1616891	 .IgG4::::	4182948
1616891	European Hornet IgG4-mCnc	4180186
1616891	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; European hornet; i75; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616893	by Phoropter; Eye; EYE.REFRACTION; Eyeball; H prism-in; H prism-in far; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1616893	L eye H prism-in far by Phoropter	4180186
1616893	.:::.::	4182948
1616894	Hardwood Mix IgE Qn	4180186
1616894	Abachi wood dust; ABS; Aby; African maple tree; Allergen; Allergens; Allergy; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Hardwood Mix; Immune globulin E; Immunoglobulin E; k212; Oak; Obeche; Point in time; QNT; Quan; Quant; Quantitative; Random; Rk212; Samba; Serum; SR; t007; t7; White oak	4180186
1616894	(+++) .IgE:::::Multidisk 	4182948
1616895	L pneumophila IgG + IgM Pnl Ser	4180186
1616895	ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; L pneumo; L pneumonphila; L pneumophila IgG + IgM Pnl; Legion; Legionela; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pneu; pneum; Pneumophilia; Pnl; Point in time; Random; Serum; SR	4180186
1616895	.IgG  IgM :-:::-	4182948
1616897	Airway resist; Average; Avg; Breathing; Lung; Lungs; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; RAW; Resist; Resistanc; Resistant; Resistent; Respiratory; RS; Spec; Specific effective resistance of airflow; sReff; Studies; Study; Sutdies	4180186
1616897	sReff/Predicted Mean	4180186
1616897	./::^:.:	4182948
1616899	Finding; Findings; Neuro; Neurology; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1616902	:-::/:-:	4182948
1616902	ANTIBIOTIC SUSCEPTIBILITIES; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; o71; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; PCR; Pnl; Point in time; Random; Resist; Resistanc; Resistant; Resistent; S aureus; SA ID + resistance Pnl; Spec; Staph	4180186
1616902	SA ID + resistance Pnl Islt/Spm	4180186
1616906	:::::{}	4182948
1616906	ED Discharge notification	4180186
1616906	Disch; Discharge notifctn note; DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1616909	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1616911	^1::::	4182948
1616911	Urea 1h spec Dial fld-sCnc	4180186
1616911	1 hour; 1.0Hr; 60 min; 60 minutes; 60M; 60min; Chemistry; Diaf; Dialysate; Dialysis fluid; Kidney; Level; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Spec; Substance concentration	4180186
1616912	B +T :::+:	4182948
1616912	B+T cell XM Ser+Bld-Imp	4180186
1616912	B+T cell; B+T cell XM; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; Blood; Both serum and blood; HLA ANTIGEN; Human Leukocyte Antigen; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; SerBld; Serum; Serum or whole blood; SR; T Cell XM; T prime; UCHL-1; WB; Whole blood	4180186
1616913	CLIN; Finding; Findings; Gestation; Gestations; Gravida; Gyn; Gynecology; OB; ObGyn; Obstetrics; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen	4180186
1616913	:::^:	4182948
1616914	Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right; Scale; Survey; SURVEY.R-OUTCOMES; Tot; Totl	4180186
1616915	 II RNA:::XXX::..	4182948
1616915	2; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Human Calcivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Norovirus 2; Norovirus G2; Norovirus GII; Norwalk virus; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1616915	Norovirus GII RNA Spec Ql NAA+probe	4180186
1616916	ANA spindle fibers Titr CSF IF	4180186
1616916	.:::::	4182948
1616916	ACIF; ANA; ANA Pat; ANA spindle fibers; ANF; Anticomplement Immunofluorescence; Antinuclear antibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; FANA; Fiber; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Nuc; Point in time; Random; Rheum; Rheumatology; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1616917	:::^:	4182948
1616917	Nominal; Point in time; Random; Surg; Surgical tech used; Typ	4180186
1616917	Surgical tech used type	4180186
1616921	Pan; PANEL.SURVEY.R-OUTCOMES; Panl; Pnl; Point in time; R prime; Random; Right; Survey; SURVEY.R-OUTCOMES	4180186
1616922	:::::	4182948
1616922	Base excess BldCV Calc-sCnc	4180186
1616922	Base ex; BE; BSE; Calc; Calculation; Chemistry; EXS; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1616927	LACE :::^::LACE 	4182948
1616927	LACE score LACE	4180186
1616927	CLIN; CLIN.RISK; LACE score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
1616928	 :::::MS.MALDI-TOF	4182948
1616928	Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Microbiology; Nominal; Point in time; Random; Thrush	4180186
1616928	Fungus Islt MS.MALDI-TOF	4180186
1616931	:::::	4182948
1616931	Barbiturate; c417; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Luminal; Neuro; Neurology; Nirvonal; Ordinal; PHBR; Phenobarb; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
1616931	Phenobarb TissCo Ql Cfm	4180186
1616933	Salmonella DNA Stl Ql NAA+probe	4180186
1616933	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Sal; Salmonel; Screen; SDA; species; spp; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1616933	 DNA:::::..	4182948
1616935	  (rAra h) 3 .IgG4::::	4182948
1616935	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f013; f13; f424; III; Level; Mass concentration; NR1B1; Peanut; Peanut (rAra h) 3; Point in time; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; Serum; SR	4180186
1616935	Peanut (rAra h) 3 IgG4-mCnc	4180186
1616936	14 days; 2 weeks; C-19 anxiety - nausea/stomach prb; Corona virus; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
1616942	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bromhexine IgE; c97; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616942	Bromhexine IgE Qn	4180186
1616942	 .IgE::::	4182948
1616944	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; Job; Nominal; Occupation; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Survey	4180186
1616945	ID; Infectious Disease; InfectiousDisease; Islt; Isol; LM; Micro; Microbiology; Micros; Microscopic; Morphology; Mould; Nominal; Point in time; Random	4180186
1616945	Mold Islt Micro	4180186
1616945	:::::.	4182948
1616946	 .IgE::::	4182948
1616946	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c118; c409; Floxin; Immune globulin E; Immunoglobulin E; Ofloxacin IgE; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616946	Ofloxacin IgE Qn	4180186
1616947	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1616948	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Treatment postponed since pandemic; Tx	4180186
1616949	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1616951	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Srce; Survey	4180186
1616952	CD154 Function T cells Ql	4180186
1616952	Bind; Bp50; CD40 ligand; CD40L; CD40mulg; CD40ulg; CELL MARKERS; FCN; Func; Funct; gp39; gp39 Antigen, T Cell; gp39 Antigen, T-Cell; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T prime; T-BAM; T-Cell gp39 Antigen; TRAP; Tumor necrosis factor Related Activation Protein; X-linked hyper IgM	4180186
1616952	CD154  ( CD40):::T :	4182948
1616953	:::{}::	4182948
1616953	Solid Org Transplant Procedure note	4180186
1616953	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Solid Org Transplant; Visit note	4180186
1616958	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH	4180186
1616959	:::::	4182948
1616959	Emergency med ED Initial eval note	4180186
1616959	Assessment; DOC.ONT; Document; ED; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
1616960	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1616961	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c145; Echinacea IgE; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1616961	Echinacea IgE Qn	4180186
1616961	 .IgE::::	4182948
1616962	:::^:	4182948
1616962	Anterior access type	4180186
1616962	Anterior access; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; Surg; Typ	4180186
1616964	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
1616965	:::::	4182948
1616965	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Niravam; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Xanax	4180186
1616965	Alpraz TissCo Ql Cfm	4180186
1616967	 .IgG:::::	4182948
1616967	T pallidum IgG Titr CSF IF	4180186
1616967	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluorescent treponemal antibody; Fluoresent; FTA-ABS; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Syphilis; T pallidum; Time Resolved Fluorescence; Titer; Titered; Titre; Treponemal; TRF; Ttr	4180186
1616969	Hanta virus; Hantavir IgG+IgM Pnl; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Orthohantavirus; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR	4180186
1616969	Hantavir IgG+IgM Pnl SerPl	4180186
1616969	.IgG  IgM :-::/:-	4182948
1616970	.:::::	4182948
1616970	HYDROcodone Free TissCo Ql Cfm	4180186
1616970	Addiction; Anexsia; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; FR; GCMS; HYDROcodone Free; Illicit; Non-protein bound; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Vicodin	4180186
1616971	HLA-DP  DQ  DR (II ):::/::	4182948
1616971	HLA-DP+DQ+DR (class II) Low res	4180186
1616971	2; Blood; HLA ANTIGEN; HLA class II; HLA-DP+DQ+DR; HLA-DP+DQ+DR (class II); Human Leukocyte Antigen; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
1616973	Myoinvasive tumor from serosa EC spec	4180186
1616973	CA; Ca spec; Cancer of the corpus uteri; EC spec; Female reproductive organs; Length; Oncology; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Uterine cancer; Uterine Cancers	4180186
1616973	::::	4182948
1616974	Smkd 1+ cigarette past 3Mo	4180186
1616974	3 months; Finding; Findings; H+P; H+P.HX; Last; Ordinal; P prime; QL; Qual; Qualitative; Screen; Smkd 1+ cigarette past 3Mo; Smoke; Smokes; Smoking; Tobacco	4180186
1616974	3,::3:^:	4182948
1616976	Mg+Phos+Lact Pnl SerPl	4180186
1616976	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Chemistry; i Phos; Inorganic phosphate; Lact; Lactic acid; L-lactate; MAG; Magnes; Mg; Mg+Phos+Lact Pnl; Pan; PANEL.CHEMISTRY; Panl; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; Pl; Plasma; Plsm; Pnl; PO4; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1616976	:-::/:-	4182948
1616977	:::::	4182948
1616977	Emergency med ED Triage note	4180186
1616977	DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1616978	Coccidioides Ab Titr Spec CF	4180186
1616978	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Coccidiodes; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Other; Point in time; Random; San Joaquin Valley fever; SmQn; Spec; species; spp; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Valley fever	4180186
1616978	 :::XXX::	4182948
1616979	::12^::	4182948
1616979	Bdy temp 12h Mean Surface	4180186
1616979	12 hours; 12HR; Average; Avg; Bdy temp; bod; Bodies; BODY TEMPERATURE.MOLEC; QNT; Quan; Quant; Quantitative; Surf; Temp; Temperature	4180186
1616980	:::{}::	4182948
1616980	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Multi-spec prog; notes; Point in time; Random; Visit note	4180186
1616980	Multi-spec prog Procedure note	4180186
1616981	AUDIO; Audiology; Ear Nose Throat; Ear-R; ENT; Finding; Findings; Hearing; HL degree; HL degree.max; Largest; Maximal; Maximum; Ordinal; Oto; Otolaryngology; Otologic; Peak; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen	4180186
1616981	HL degree.max Ear-R	4180186
1616981	.:::.:	4182948
1616982	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH	4180186
1616987	Use AndOr advised cane or walker	4180186
1616987	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1616987	:::^:	4182948
1616988	. F ::::	4182948
1616988	ActF MA; Blood; COAGULATION; Hematology; Heme; Length; MA ActF; MA, ActF; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1616988	MA ActF Bld	4180186
1616989	::::	4182948
1616989	pCO2 BldCV	4180186
1616989	Carbonic anhydride; Chemistry; CO2; Partial pressure; PCO2; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1616992	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Tx	4180186
1616992	:::^:	4182948
1616994	by Phoropter; CYL; Eye; EYE.REFRACTION; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Typ; Vision; Visual	4180186
1616994	:::::	4182948
1616995	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
1616995	:::{}::	4182948
1616995	Spinal surgery Prog note	4180186
1616996	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Pan; Panl; Pnl; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Survey	4180186
1616998	HPA  HLA ::://:	4182948
1616998	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; Cytotoxic-lymphocytic antibody; HLA ANTIGEN; HPA+HLA; HPA+HLA Ab; Human Leukocyte Antigen; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lymphocyte antibody; Lymphocytotoxic antibody; Narrative; Panel Reactive AB; Panel Reactive antibody; Pl; PlasBld; Plasma; Plsm; Point in time; PRA; Random; Report; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
1616998	HPA+HLA Ab SerPlBld-Imp	4180186
1616999	  (rBet v) 1 .IgG4::::	4182948
1616999	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common silver birch; i; IFR; Isoflavone reductase; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rt215; Serum; Silver Birch; Silver Birch (rBet v) 1; SR; t215; t3	4180186
1616999	Silver Birch (rBet v) 1 IgG4-mCnc	4180186
1617002	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1617003	::::	4182948
1617003	ADMIN; Finding; Findings; HumanName.use; Nominal; Persons; Point in time; Random	4180186
1617004	 .IgE::::	4182948
1617004	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f228; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Wild boar meat IgE	4180186
1617004	Wild boar meat IgE Qn	4180186
1617006	Total score OST	4180186
1617006	CLIN; CLIN.RISK; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Tot; Totl	4180186
1617006	:::^::	4182948
1617007	 .IgM:::/::	4182948
1617007	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CHIKV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1617007	CHIKV IgM SerPl IA-aCnc	4180186
1617008	:::::	4182948
1617008	Oxazepam TissCo Ql Scn	4180186
1617008	Alepam; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; Prazepam metabolite; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Serax; Temazepam metabolite	4180186
1617010	HLA-A  B  C (I ):::/::	4182948
1617010	A,B; Blood; HLA ANTIGEN; HLA class I; HLA-A+B; HLA-A+B+C; HLA-A+B+C (class I); Human Leukocyte Antigen; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
1617010	HLA-A+B+C (class I) Low res	4180186
1617013	Finding; Findings; Nominal; Point in time; Random; SDOH; Survey; SURVEY.GNHLTH	4180186
1617014	DOC.ONT; Document; Finding; Findings; Pain assessment Rpt; Point in time; Random	4180186
1617014	Pain assessment Rpt	4180186
1617014	:::{}::{}	4182948
1617015	ABS; Aby; Acetylcysteine IgE; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c151; Immune globulin E; Immunoglobulin E; NAC; N-Acetylcysteine; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1617015	NAC IgE Qn	4180186
1617015	 .IgE::::	4182948
1617016	CA; Ca spec; Cancer of the corpus uteri; EC spec; Female reproductive organs; Oncology; Ordinal; Pathology; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Uterine cancer; Uterine Cancers; Uterine serosa involvmnt	4180186
1617016	Uterine serosa involvmnt EC spec Ql	4180186
1617016	::::	4182948
1617017	:-:::-	4182948
1617017	ADMIN; HumanName; Pan; PANEL.ADMIN; Panl; Persons; Pnl; Point in time; Random	4180186
1617018	Postop complication type	4180186
1617018	Finding; Findings; Nominal; Point in time; Postop complication type; Random; SURG	4180186
1617018	:::^:	4182948
1617022	:::{}::	4182948
1617022	Gyn Onc Operative note	4180186
1617022	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn Onc; notes; Operative note; Point in time; Random; Surg; Visit note	4180186
1617024	 Beta 42 / Beta 40 ::::	4182948
1617024	AL beta42/ABeta 40 CSF	4180186
1617024	A Beta42/A Beta 40 Ser; Ab40 peptide; Ab42 peptide; Abeta; Abeta 40; Abeta 42; ABeta 42/40; AL beta40; AL beta42; Alzheimer disease; Alzheimer's disease; B; Beta-amyloid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Mass concentration ratio; Mass ratio; MCRto; Neuro; Neurology; Pept; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1617025	Pan; PANEL.SURVEY.R-OUTCOMES; Panl; Persons; Pnl; Point in time; R prime; Random; Right; Spec; Survey; SURVEY.R-OUTCOMES	4180186
1617026	.^:::::	4182948
1617026	Fungal Color w Chrom Agar Islt Cult	4180186
1617026	Appearance; C&S; Colonies; Colour; Cult; Cultures; Fungal Color; Fungal Color Chrom Agar; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random; Typ; w Chrom Agar	4180186
1617027	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1617029	Streptococcus DNA Snv Ql NAA+non-probe	4180186
1617029	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SF; SNV; species; spp; Strand Displacement Amplification; Strep; Strept; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1617029	 DNA:::::..	4182948
1617030	CA; Ca spec; Cancer of the corpus uteri; EC spec; Female reproductive organs; MELF invasion pattern; Oncology; Ordinal; Pathology; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Uterine cancer; Uterine Cancers	4180186
1617030	MELF invasion pattern EC spec Ql	4180186
1617030	::::	4182948
1617032	:-::^:-:Spine Tango	4182948
1617032	Admission/path pnl Spine Tango	4180186
1617032	Admission/path pnl; Pan; PANEL.SURG; Panl; Path; Pnl; Point in time; Random; SURG	4180186
1617034	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Pan; Panl; Pnl; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Survey	4180186
1617036	.:::::	4182948
1617036	Addiction; c260; C300; Cfm; CNFR; CNFRM; Codeine Free; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; FR; GCMS; Illicit; Methylmorphine; Morphine methyl ether; Non-protein bound; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
1617036	Codeine Free TissCo Ql Cfm	4180186
1617038	::::	4182948
1617038	ADMIN; HumanName.prefix; Nominal; Person name; Persons; Point in time; Random	4180186
1617041	.^30:::::.	4182948
1617041	Lys kao ind clt 30M p MA LenFr Bl ResTEG	4180186
1617041	30M p MA; After; Blood; COAGULATION; Fibrinolysis of kaolin ind clot; Hematology; Heme; Length Fraction; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Reduction clot str kao 30M p max amp; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood	4180186
1617044	 .IgG4::::	4182948
1617044	Grey Alder IgG4-mCnc	4180186
1617044	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; European alder; Gray alder; Grey alder; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Speckled alder; SR; t2	4180186
1617046	/:::::	4182948
1617046	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; Desyrel; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Trazon; Trialodine; UA; UCr; UR; Urn	4180186
1617046	traZODone/Creat Ur Cfm	4180186
1617048	Tumor dist cerv resect margins EC	4180186
1617048	CA; Ca spec; Cancer of the corpus uteri; Cerv; Dist from cerv resect margins; EC spec; Female reproductive organs; Length; Oncology; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Uterine cancer; Uterine Cancers	4180186
1617048	::::	4182948
1617050	Surg assistant Provider	4180186
1617050	Nominal; Person name; Point in time; Random; Surg; Surg assistant	4180186
1617050	::::	4182948
1617054	Postop follow-up interval	4180186
1617054	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Postop follow-up interval; Random	4180186
1617054	:::^:	4182948
1617056	 RNA:::XXX::..	4182948
1617056	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Flavivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1617056	Rocio virus RNA Spec Ql NAA+probe	4180186
1617057	B burgdor IgG+IgM bands Pnl Ser IB	4180186
1617057	B burg; B burgdor; B burgdor IgG+IgM bands Pnl; B burgdorferi; Bb; Blt; Burgdorf; ID; IMMUNE BLOT; Immune globulin G; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; RIBA; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1617057	.IgG  IgM :-:::-:	4182948
1617059	by Phoropter; c; Contr; Contra; Contrast for far VA; Contrst; Eye; EYE.REFRACTION; Eyeball; Number fraction; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; Vision; Visual	4180186
1617059	Contrast for far VA Phoropter	4180186
1617059	:::::	4182948
1617060	HF+TC Prog note	4180186
1617060	:::{}::+	4182948
1617060	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart function; HF+TC; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; TC; Visit note	4180186
1617061	 8 :::::	4182948
1617061	CK8 Ag tiss Ql ImStn	4180186
1617061	Antigen; Antigens; Autoimmune hepatitis; CK; CK8; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; K8; Keratin, type II cytoskeletal 8; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Type-II keratin Kb8	4180186
1617065	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1617067	 DNA:::::..	4182948
1617067	C albicans DNA Snv Ql NAA+non-probe	4180186
1617067	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C albicans; C albicans DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m005; m5; Microbiology; Monilia; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SF; SNV; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; Thrush; TMA; Transcription mediated amplification	4180186
1617068	 DNA:::::..	4182948
1617068	F magna DNA Snv Ql NAA+non-probe	4180186
1617068	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; F magna; F magna DNA; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SF; SNV; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1617072	.:::::	4182948
1617072	Buprenorphine free TissCo Ql Scn	4180186
1617072	Addiction; BU; BUP; Bupe; Buprenex; Buprenorphine free; buprenorphine HCI; Buprex; Butrans; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Finobrin; FR; Illicit; Non-protein bound; Norspan; Ordinal; Point in time; PotentialForAbuse; PR; Prefin; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Suboxone; Subutex; Temgesic	4180186
1617074	:::::	4182948
1617074	clonazePAM TissCo Ql Scn	4180186
1617074	DRUG/TOXICOLOGY; Drugs; Klonopin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1617075	:::::	4182948
1617075	Thermotol Islt Cult	4180186
1617075	C&S; Cult; Cultures; Finding; Findings; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random	4180186
1617078	:::{}::	4182948
1617078	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
1617078	Hematology H&P note	4180186
1617080	OST	4180186
1617080	CLIN; CLIN.RISK; Pan; Panel; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
1617080	:-::^:-:	4182948
1617082	Arterial Stenosis; Emotional stability; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Srce; Survey	4180186
1617083	:::::	4182948
1617083	Cfm; Chlordiaz; Chlordiaze; Chlordiazep; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Librium; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
1617083	Chlordiazep TissCo Ql Cfm	4180186
1617088	IL-9 SerPl-mCnc	4180186
1617088	Chemistry; IL; IL-9; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1617088	 9:::/:	4182948
1617091	ABS; Aby; Alfa; alpha Spectrin; Alpha-II spectrin; alpha-Spectrin; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Fodrin alpha; Fodrin alpha IgA; IAA; Immune globulin A; Immunoglobulin A; MEIA; Pituitary glycoproteins; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sjogrens Syndrome; Spectrin alpha chain, non-erythrocytic 1; Spectrin, non-erythroid alpha subunit; SR; SUDS	4180186
1617091	Fodrin alpha IgA SerPl IA-aCnc	4180186
1617091	.alpha  .IgA:::/::	4182948
1617092	::::	4182948
1617092	Arbitrary concentration; Cerebral spinal fluid; Cerebrospinal Fl; Icteric interf index; Point in time; QNT; Quan; Quant; Quantitative; Random; SPEC; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1617092	Icteric interf index CSF-aCnc	4180186
1617097	Appearance; C&S; Colonies; Colour; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random; SDA; Typ; w SDA; Yeast Color; Yeast Color SDA	4180186
1617097	Yeast Color w SDA Islt Cult	4180186
1617097	.^:::::	4182948
1617099	.::::	4182948
1617099	Abn Prion Prot CSF Ql	4180186
1617099	abn; Abn Prion Prot; abnorm; Bovine spongiform encephalopathy; BSE; Cerebral spinal fluid; Cerebrospinal Fl; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; Prot; PrP; QL; Qual; Qualitative; Random; Scrapie; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1617101	Calc; Calculation; H+P; H+P.HX; P prime; QNT; Quan; Quant; Quantitative; Report period; Sensor usage %	4180186
1617101	Sensor usage %	4180186
1617101	:::^::	4182948
1617102	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1617106	Alpha-1-::::	4182948
1617106	AFP Aspirate-mCnc	4180186
1617106	A1; AFP; Alfa; Alpha fetoprotein; Alphafetoprotein; Aspirate; Chemistry; Feto; i; Level; Mass concentration; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Tumor marker	4180186
1617107	Bdy site; bod; Bodies; H+P; P prime; Pain severity + Body site Pnl; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random	4180186
1617107	Pain severity + Body site Pnl	4180186
1617107	:-::^:-	4182948
1617109	::24::	4182948
1617109	Vasopressin 24h Ur-mRate	4180186
1617109	1 day; 24 hours; 24HR; ADH; Adiuretin; Antidiuretic hormone; Arginine vasopressin hormone; AVH; Chemistry; Kidney; Mass Rate; mRate; Nephrology; QNT; Quan; Quant; Quantitative; Renal; UA; UR; Urn; VP	4180186
1617110	Sarcoma pattern carcinosarcoma	4180186
1617110	Cancer; Nominal; Oncology; PATHOLOGY; Point in time; Random; Sarcoma pattern carcinosarcoma; tumors; tumour; tumours; Typ	4180186
1617110	::::	4182948
1617111	Drink in morning to begin activities; Finding; Findings; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1617112	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1617116	::24::	4182948
1617116	T4 24h Ur-mRate	4180186
1617116	1 day; 24 hours; 24HR; Chemistry; Endocrine; Endocrinology; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass rate; mRate; QNT; Quan; Quant; Quantitative; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4; UA; UR; Urn	4180186
1617120	Second spine degen type	4180186
1617120	MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; Second spine degen type; SURG; Typ	4180186
1617120	.:::^:	4182948
1617122	:::::	4182948
1617122	Hgb BldCV Calc-mCnc	4180186
1617122	Calc; Calculation; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1617123	 RNA:::XXX::..	4182948
1617123	JCV RNA Spec Ql NAA+probe	4180186
1617123	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; JCV; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1617125	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey; Work	4180186
1617127	Neuro; Neurology; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
1617129	by Phoropter; Eye; EYE.REFRACTION; Eyeball; Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; PD binoc; PD binoc near; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1617129	Eye PD binoc near by Phoropter	4180186
1617129	.:::::	4182948
1617131	:::/:	4182948
1617131	Chemistry; Colonies; CSF; CSF-1; Fac; Fact; GM-CSF; Hematology; Heme; Lanimostim; Level; Mass concentration; MCSF; M-CSF; Oncology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1617131	GM-CSF SerPl-mCnc	4180186
1617133	AUDIO; Audiology; Ear Nose Throat; Ear-L; ENT; Finding; Findings; Hearing; HL degree; HL degree.max; L; Largest; LT; Maximal; Maximum; Ordinal; Oto; Otolaryngology; Otologic; Peak; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1617133	HL degree.max Ear-L	4180186
1617133	.:::.:	4182948
1617134	5 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1617136	 DNA:::::..	4182948
1617136	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification; V parahaem; V parahaemolyticus	4180186
1617136	V parahaem DNA Stl Ql NAA+probe	4180186
1617139	:::::	4182948
1617139	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; MDA; Methylenedioxymethamphetamine metabolite; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1617139	MDA TissCo Ql Scn	4180186
1617140	+ DNA:::::..	4182948
1617140	A prev+vag DNA Snv Ql NAA+non-probe	4180186
1617140	3 Self-Sustaining Sequence Replication; 3SR SR; A prev+vag; A prevotii+vaginalis; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SF; SNV; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1617143	 .IgE::::	4182948
1617143	P. expansum IgE Qn	4180186
1617143	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; P. expansum; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1617147	by Phoropter; Eye; EYE.REFRACTION; Eyeball; H prism-out; H prism-out far; Inverse Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1617147	R eye H prism-out far by Phoropter	4180186
1617147	.:::.::	4182948
1617149	Arterial Stenosis; Emotional stability; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Srce; Survey	4180186
1617150	 O157 DNA:::::..	4182948
1617150	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E coli O157; E coli O157 DNA; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1617150	E coli O157 DNA Stl Ql NAA+probe	4180186
1617151	.+::::	4182948
1617151	Blood; COAGULATION; Fac; Fact; Hematology; Heme; Length; MA kaolin+TF; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1617151	MA kaolin+TF Bld	4180186
1617152	 22q11.2 :-::.DNA+.cfDNA:-: cfDNA 	4182948
1617152	NIP aneu + 22q11.2 Pnl WBC.DNA+cfDNA	4180186
1617152	Chromosom; Chromosomes; Gyn; Gynecology; Leukocytes; Molecular pathology; MOLPATH; NIP aneu + 22q11.2 Pnl; OB; ObGyn; Obstetrics; Pan; Panel.molpath; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Spec; WBC.DNA+cfDNA; WBCs; White blood cells	4180186
1617155	:::::	4182948
1617155	Heart failure OP Note	4180186
1617155	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart function; notes; OP; Point in time; Random; Visit note	4180186
1617156	Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right; Scale; Survey; SURVEY.R-OUTCOMES	4180186
1617158	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
1617160	Audiology; CLIN; Dx audio result pnl; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
1617160	Dx audio result pnl	4180186
1617160	:-::^:-	4182948
1617162	PDGF B+BB SerPl-mCnc	4180186
1617162	Chemistry; Fac; Fact; Level; Mass concentration; PDGF B+BB; Pl; Plasma; Platelets; Platelt; Plsm; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thrombocyte; Thrombocytes	4180186
1617162	 B+BB:::/:	4182948
1617165	:::::	4182948
1617165	THC TissCo Ql Cfm	4180186
1617165	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Marijuana; Nabilone; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; THC	4180186
1617167	.+^30::::	4182948
1617167	Lysis kao+TF ind clot 30M p MA LenFr Bld	4180186
1617167	30M p MA; After; Blood; COAGULATION; Fac; Fact; Hematology; Heme; Length Fraction; Lysis of kao+TF ind clot; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1617169	::^:::	4182948
1617169	Ave Glucose Interstitial fld RptPeriod	4180186
1617169	Average; Avg; Calc; Calculation; Chemistry; Endocrine; Endocrinology; Glu; Gluc; Glucoseur; Interstitial fld; Level; Mass concentration; QNT; Quan; Quant; Quantitative; Report period	4180186
1617170	Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right; Scale; Survey; SURVEY.R-OUTCOMES	4180186
1617173	 .IgG4::::	4182948
1617173	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; European ash; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t25	4180186
1617173	European Ash IgG4-mCnc	4180186
1617176	Add; Finding; Findings; Need assist at visit; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH	4180186
1617179	::12^:::	4182948
1617179	12 hours; 12HR; ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Average; Avg; Blood arterial; Lung; Mass Fraction; O2; Percent; PULMONARY; Pulmonology; PulseOx; QNT; Quan; Quant; Quantitative; Respiratory; SaO2; SAT; Satn; SO2; SpO2; tO2	4180186
1617179	SaO2 12h Mean % BldA PulseOx	4180186
1617180	CCL20 SerPl-mCnc	4180186
1617180	Beta-chemokine exodus-1; CC chemokine LARC; C-C motif chemokine 20; CCL20; Chemistry; LARC; Level; Liver and activation-regulated chemokine; Macrophage inflammatory protein 3 alpha; Mass concentration; MIP-3-alpha; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Small-inducible cytokine A20; SR	4180186
1617180	 (C-C )  20:::/:	4182948
1617181	CARD11  :::/::	4182948
1617181	Blood; CARD-containing MAGUK protein 1; CARMA1; Caspase recruitment domain family member 11; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; Omenn syndrome; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1617181	CARD11 Mut Anl Bld/T	4180186
1617185	 IS1001 DNA:::.::..	4182948
1617185	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B parap IS1001; B parapert; B parapertussis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Whooping cough	4180186
1617185	B para IS1001 DNA L resp Ql NAA+non-prb	4180186
1617187	/:::^:	4182948
1617187	H+P; H+P.HX; History; Hx chronic diseases/immunodeficiency; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1617187	Hx chronic diseases/immunodeficiency	4180186
1617189	 .IgG4::::	4182948
1617189	Pellitory (judaic) IgG4-mCnc	4180186
1617189	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; Mass concentration; Pellitory (judaic); Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w21; Wall pellitory	4180186
1617192	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH	4180186
1617194	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1617196	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1617197	Dextro; Finding; Findings; Ordinal; Past; PH; Public Health; PublicHealth; Ql; Qual; Qualitative; Screen; Vacc last 14 days; VACCINE	4180186
1617197	Vacc last 14 D	4180186
1617197	14::14:^:	4182948
1617199	 DNA:::::..	4182948
1617199	P micra DNA Snv Ql NAA+non-probe	4180186
1617199	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; P micra; P micra DNA; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SF; SNV; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1617200	 16+18+31+33+35+39+45+51+52+56+58+59+68  DNA:::::..	4182948
1617200	Amplif; Amplification; Amplified; bDNA; Bdn-A; Branched Chain DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gen; Genital tract; Genital warts; HC; HPA; HPV; HPV I/H Risk 1; HPV IHR; HPV16; HPV16 and 18; HPV16+18; Human papillomavirus; Hybidization Protection Assay; Hybrid Capture; Hybrid Capture nucleic acid hybridization; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Papilloma virus high risk; Papilloma virus intermediate/high risk; Point in time; PR; Probe amp; Probe with ampification; Probe with signal amplification; Probe+sig amp; Ql; Qual; Qualitative; Random; Screen; Urogenit; Urogenital	4180186
1617200	HPV I/H Risk DNA Genital Ql Prb+sig amp	4180186
1617205	:::::	4182948
1617205	lamoTRIgine Ur Cfm-mCnc	4180186
1617205	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Lamictal; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1617207	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; PH; Point in time; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; Rcvd COVID-19 vaccine; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen	4180186
1617207	Rcvd COVID-19 vaccine	4180186
1617207	 COVID-19 :::^:	4182948
1617209	Finding; Findings; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; Surg; Ther	4180186
1617209	Therapeutic goals	4180186
1617209	:::^:	4182948
1617211	Finding; Findings; Hand wash/sanitze freq; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Upper extremity	4180186
1617212	Beta 2 /.::24:::	4182948
1617212	Beta2 Glob 24h MFr Ur Elph	4180186
1617212	1 day; 24 hours; 24HR; B; B2 globulin; Beta2 Glob; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; II; Mass fraction; Percent; PEUR; PR; Prot; QNT; Quan; Quant; Quantitative; Tot; Totl; TP; UA; UPEP; UR; Urn	4180186
1617214	 .IgG+IgM:::::	4182948
1617214	ABS; Aby; Acetylch; ACH; AChR; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Level; MEIA; nAChR; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Serum; SR; Substance concentration; SUDS	4180186
1617214	nAChR IgG+IgM Ser IA-sCnc	4180186
1617217	Finding; Findings; Hosp; Nominal; Point in time; Random; SURG	4180186
1617217	:::^:	4182948
1617219	:::{}::	4182948
1617219	Anesthesia; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
1617219	Anesthesiology H&P note	4180186
1617220	.:::::	4182948
1617220	Appearance; C&S; Colonies; Colour; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random; Typ; Yeast Color	4180186
1617220	Yeast Color Islt Cult	4180186
1617224	.:::::	4182948
1617224	5,8,11,14 Eicosatetraenoic acid; AA; Arachidonic acid; Arch acid; Blood; C20:4w6; Calc; Calculation; Clot strength AA inhib; COAGULATION; Eicosatetraenoate; Hematology; Heme; Length Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1617224	Clot strength AA inhib LenFr Bld Calc	4180186
1617226	Pan; PANEL.SURVEY.R-OUTCOMES; Panl; Pnl; Point in time; R prime; Random; Right; Survey; SURVEY.R-OUTCOMES	4180186
1617227	^:::/:	4182948
1617227	Adalimumab Trough SerPl-mCnc	4180186
1617227	DRUG/TOXICOLOGY; Drugs; Humira; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1617228	 DNA:::::..	4182948
1617228	ETEC DNA Stl Ql NAA+probe	4180186
1617228	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E coli; ETEC; Faecal; Faeces; Fecal; Feces; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1617229	 RNA:::XXX::..	4182948
1617229	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bunyamwera Vir RNA; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Orthobunyaviruses; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1617229	Bunyamwera virus RNA Spec Ql NAA+probe	4180186
1617231	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1617231	:::^:	4182948
1617235	 19-9::::	4182948
1617235	Cancer Ag19-9 Aspirate-aCnc	4180186
1617235	Arbitrary concentration; Aspirate; CA; CA 19-9; Cancer Ag19-9; Cancer antigen 19-9; Carbohydrate antigen; Carbohydrate antigen 19-9; Chemistry; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Tumor marker	4180186
1617237	 :::XXX::	4182948
1617237	H capsul Myc Ab Titr Spec CF	4180186
1617237	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); H capsul; H capsul Myc; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmin; Histoplasmos; Histoplasmosis; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Mycel; Other; Point in time; Random; SmQn; Spec; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified	4180186
1617240	 6  .IgG:::::	4182948
1617240	HHV6 IgG Ser IF-aCnc	4180186
1617240	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Arbitrary concentration; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; Herpesvirus; HHV; HHV6; HHV-6; Human herpes virus; Human herpes virus type 6; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Time Resolved Fluorescence; TRF	4180186
1617244	.:::::	4182948
1617244	Morphine Free TissCo Ql Cfm	4180186
1617244	Addiction; c260; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; FR; GCMS; Illicit; Morphine Free; Morphine sulfate; MS; MSO4; Non-protein bound; OMPH; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; unconjugated morphine	4180186
1617248	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH	4180186
1617249	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Blood; C&S; Cult; Cultures; Fung; Fung+Mycobact; Fung+Mycobact sp; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Myco; Mycobact; Nominal; Point in time; Random; Spec; species; spp; Tuberculosis; WB; Whole blood	4180186
1617249	Fung+Mycobact sp Bld Cult	4180186
1617249	 :::::	4182948
1617250	:::.::..	4182948
1617250	B pert.PT Prmt Lower resp Ql NAA+probe	4180186
1617250	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B pert; B pert.PT; B pert.PT Prmt; B pertussis; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pertussis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Whooping cough	4180186
1617252	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1617253	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES; Wt	4180186
1617254	Finding; Findings; Job; Occupation; Ordinal; Othr; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1617255	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1617256	:::::	4182948
1617256	Chlordiaz; Chlordiaze; Chlordiazep; DRUG/TOXICOLOGY; Drugs; Librium; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1617256	Chlordiazep TissCo Ql Scn	4180186
1617257	:::{}::.	4182948
1617257	cardiology; Cardiology Team; cards; Conf eval note; CVD; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1617257	Cardiology Team Conf eval note	4180186
1617259	/::::	4182948
1617259	CA; Ca spec; Cancer of the corpus uteri; Cerv; Cervical surface involvement; Crypt involvement; Depth stromal invasion; Dpth; EC spec; Female reproductive organs; Length Fraction; Oncology; PATHOLOGY; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Thick; Uterine cancer; Uterine Cancers	4180186
1617259	Depth stromal invasion/Cervical LenFr	4180186
1617260	L Pelvic LN examined Spec	4180186
1617260	Cnt; Count; L; L Pelvic LN examined; LN exam; LT; Number; Oncology; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
1617260	:():::	4182948
1617261	CDH1  +:::/::	4182948
1617261	CDH1 gene Del+Dup Bld/T	4180186
1617261	Amplification; Arc-1; Blood; Cadherin 1; cadherin 1, type 1, E-cadherin (epithelial); Calcium dependent adhesion protein epithelial; CD324; CDHE; Del; Del+Dup; Deletions; Dp; ECAD; E-cadherin gene; Identity or presence; LCAM; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; UVO; Uvomorulin; WB; Whole blood; Whole blood or Tissue	4180186
1617263	Drug use freq 12Mo	4180186
1617263	1 year; 12Mos; Count/time; Drug; Drug use freq 12Mo; H+P; H+P.HX; Last; nRate; Number rate; Number Rate = Count/Time; Ordinal; P prime; QL; Qual; Qualitative; Screen	4180186
1617263	12,::12:^:	4182948
1617265	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; Job; Nominal; Occupation; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Survey	4180186
1617266	:::::	4182948
1617266	Actiq; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyl fentanyl; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; GCMS; hydrochloride; Illicit; N- phenyl- N- [1- (2- phenylethyl)- 4- piperidinyl]- acetamide, monohydrochloride; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Sublimaze	4180186
1617266	Acetyl fentanyl TissCo Ql Cfm	4180186
1617268	Finding; Findings; Nominal; Point in time; Postop rehab; Random; SURG	4180186
1617268	Postop rehab	4180186
1617268	:::^:	4182948
1617269	.:::::	4182948
1617269	oxyCODONE Free TissCo Ql Cfm	4180186
1617269	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; FR; GCMS; Illicit; Lortab; Non-protein bound; Ordinal; oxyCODONE Free; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Vicodin	4180186
1617270	2--5-:::::	4182948
1617270	5-chloropyridin-2-amine; ACP; Amino chloropyridine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Eszopiclone; Eszopiclone metabolite; GCMS; II; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Zopiclone	4180186
1617270	ACP Ur Ql Cfm	4180186
1617271	:::{}::	4182948
1617271	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
1617271	IC H&P note	4180186
1617272	 VP1 :::::	4182948
1617272	Entero virus; EV; EV VP1 gene; high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random	4180186
1617272	EV VP1 gene Islt-Seq	4180186
1617273	Cryptosp Wat Ql IF	4180186
1617273	ACIF; Anticomplement Immunofluorescence; Crypt; Crypto; Cryptosporidiosis; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; Time Resolved Fluorescence; TRF; Wat	4180186
1617273	:::::	4182948
1617274	::::	4182948
1617274	CO2 BldCV-sCnc	4180186
1617274	Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; ctCO2; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; tCO2	4180186
1617276	:::XXX::	4182948
1617276	Microorganism Sequence Ql	4180186
1617276	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Microbiology; Microorganism sequence; Microorganisms; Misc; Miscellaneous; Next generation sequencing; NGS; Ordinal; Org; Organism; Organisms; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
1617280	:::::	4182948
1617280	Gender; Gyn; Gynecology; Molecular genetics; Molecular pathology; MOLPATH; Nominal; OB; ObGyn; Obstetrics; PCR; Point in time; Products of Conception; Random; Typ	4180186
1617280	Sex POC	4180186
1617281	.^:::::	4182948
1617281	After; Breathing; IC; IC^post bronchodilation; Lung; Lungs; p BD; Point in time; PST; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume	4180186
1617281	IC p BD Spirometry	4180186
1617282	Departure notifctn note; DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1617282	ED Departure notification	4180186
1617282	:::::{}	4182948
1617284	Goat milk cheese IgE Qn	4180186
1617284	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f205; f300; f409; f43; Goat milk cheese IgE; Goat's milk; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf300; Serum; SR	4180186
1617284	 .IgE::::	4182948
1617288	1 month; 1 month (30 days); 30 days; C-19 recommended hygiene past Mo; Finding; Findings; Last; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1617290	2019 Novel Coronavirus; 2019-nCoV; After; Coronavirus disease 2019; COVID19; Pan; Panel; Panl; Pnl; Point in time; PST; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Survey	4180186
1617291	.IL-2 :-:::-:	4182948
1617291	NK cyto IL2 Pnl Bld MC FC	4180186
1617291	Blood; CELL MARKERS; Dynamic; FC; II; NK; NK cyto IL2 Pnl; Pan; PANEL.CELLMARK; Panl; PBMC; Peripheral blood mononuclear cells; Pnl; Point in time; Random; WB; Whole blood	4180186
1617294	Vaccine administration loc	4180186
1617294	Nominal; PH; Point in time; Public Health; PublicHealth; Random; Typ	4180186
1617294	:::^:	4182948
1617295	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Reasons not accept COVID-19 vacc; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1617299	Diff cap.CO/Predicted	4180186
1617299	(Diff cap; Breathing; Diff cap; Diff cap.CO; Diff cap.CO/predicted; DL; DLCO; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS	4180186
1617299	./::::	4182948
1617300	^2::::	4182948
1617300	Sodium 2h spec Dial fld-sCnc	4180186
1617300	120 min; 120 minutes; 120min; 2 hours; Chemistry; Diaf; Dialysate; Dialysis fluid; Kidney; Level; Na; Na+; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Spec; Substance concentration	4180186
1617302	:::::	4182948
1617302	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fentanyl metabolite; GCMS; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
1617302	Norfentanyl TissCo Ql Cfm	4180186
1617304	CXCL1 SerPl-mCnc	4180186
1617304	Chemistry; C-X-C motif chemokine 1; CXCL1; GRO-alpha; GRO-alpha(1-73); Growth-regulated alpha protein; i; Level; Mass concentration; Melanoma growth stimulatory activity; MGSA; NAP-3; Neutrophil-activating protein 3; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1617304	 (C-X-C )  1:::/:	4182948
1617308	-L1 :-:::-	4182948
1617308	Chemistry; GFAP; GFAP + UCH-L1 Pnl; GFAP+UCH-L1; Neuro; Neurology; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PR; Prot; Random; Stroke; TBI (Traumatic Brain Injury); TBIs (Traumatic Brain Injury); Traumatic Brain Injuries; UCH-L1	4180186
1617308	GFAP + UCH-L1 Pnl Plas	4180186
1617309	MLH1 :::::	4182948
1617309	MLH1 Methyl Anl Tumor	4180186
1617309	Cancer; COCA2; DNA methylation; Document; FCC2; Finding; Findings; hMLH1; HNPCC; HNPCC2; Lynch syndrome; MGC5172; MLH1 Methyl Anl; Molecular genetics; Molecular pathology; MOLPATH; mutL homolog 1; MutL homolog 1, colon cancer, nonpolyposis type 2; PCR; Point in time; Random; tumors; tumour; tumours	4180186
1617310	C-C motif chemokine 11; CCL11; Chemistry; Eosinophil chemotactic protein; Eotaxin; Eotaxin-1; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Small-inducible cytokine A11; SR	4180186
1617310	CCL11 SerPl-mCnc	4180186
1617310	 (C-C )  11:::/:	4182948
1617311	:::::	4182948
1617311	Time to thrombin peak PPP Chro	4180186
1617311	Chromogenic assay; COAGULATION; ENZY; Enzymatic assay; Hematology; Heme; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Throm	4180186
1617312	1 year; 12Mos; Finding; Findings; month; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
1617313	:::XXX::	4182948
1617313	Amebic meningoencephalitis; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; N fowleri; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
1617313	N fowleri Spec Ql Cult	4180186
1617315	Additional pathology	4180186
1617315	Add; Additional pathology; Finding; Findings; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Path; Point in time; Random; SURG	4180186
1617315	:::^:	4182948
1617316	:::::	4182948
1617316	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Hydroxy triazolam; Illicit; OH-Triazolam; OHTRZ; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Triazolam metabolite	4180186
1617316	OH-Triazolam TissCo Ql Cfm	4180186
1617318	HPA :::/:	4182948
1617318	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; HLA ANTIGEN; Human Leukocyte Antigen; Human Platelet Antigen; Identity or presence; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1617318	HPA Ab SerPl	4180186
1617319	D/C sum; Disch; Discharge summary; DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1617319	Emergency med ED D/C sum	4180186
1617319	:::::	4182948
1617325	:::::	4182948
1617325	Megakaryocytes # Mar Manual	4180186
1617325	#; ABS; absolute; absolutes; BM; BON; Bone marrow; Cnt; Count; Count/volume; CT; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Manl; MAR; Marrow (bone); Megakar; Megakaryo; Megakaryocyte; minimal angle of resolution; Minimum angle of resolution; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1617326	:::::	4182948
1617326	#/area; c470; Choline phosphoglyceride; EPS; expressed prostatic secretion; FERTILITY TESTING; Manl; Number areic; Phosphatidylcholine; Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QNT; Quan; Quant; Quantitative; Random	4180186
1617326	Lecithin #/area Prost fld Manual	4180186
1617328	Epithelial comp carcinosarcoma %	4180186
1617328	%; Cancer; Epi; Epith; Epithelia; Epithelial comp carcinosarcoma; Oncology; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; tumors; tumour; tumours	4180186
1617328	::::	4182948
1617329	 beta- ESBL blaCTX-M-14 :::/::	4182948
1617329	ESBL blaCTX-M-14 gene Islt/Spm Ql	4180186
1617329	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
1617331	:::{}::	4182948
1617331	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
1617331	Radiology Eval note	4180186
1617332	 .IgG:::/::	4182948
1617332	CHIKV IgG SerPl IA-aCnc	4180186
1617332	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CHIKV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1617334	:::::	4182948
1617334	bk-MDEA TissCo Ql Cfm	4180186
1617334	3,4-methylenedioxy-N-ethylcathinone; Addiction; Bath salts; bk-MDEA; Cat; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; MDEC; methylenedioxyethylcathinone; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
1617338	:::{}::	4182948
1617338	Hand Surgery Operative note	4180186
1617338	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hand Surgery; notes; Operative note; Point in time; Random; Surg; Upper extremity; Visit note	4180186
1617339	ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Microbiology; Mould; Nominal; Point in time; Random	4180186
1617339	Mold Islt MS.MALDI-TOF	4180186
1617339	 :::::MS.MALDI-TOF	4182948
1617341	.CD19/100 :::.::	4182948
1617341	CD19 Cells/lymph NFr Lower resp FC	4180186
1617341	B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; CD19 Cells; Cell; CELL MARKERS; Cellularity; Dynamic; FC; HD-37; Leu12; Leu-12; Low; Lower resp; Lung; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory	4180186
1617342	American plague; ID; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Yel Fev Ab Pnl; yellow jack; YFV	4180186
1617342	Yel Fev Ab Pnl SerPl	4180186
1617342	:-::/:-	4182948
1617344	Arterial Stenosis; Emotional stability; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Srce; Survey	4180186
1617346	Candida Islt MS.MALDI-TOF	4180186
1617346	Cand; Candidiasis; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Monilia; Nominal; Point in time; Random; species; spp; Thrush	4180186
1617346	:::::MS.MALDI-TOF	4182948
1617347	:-::^:-:Spine Tango	4182948
1617347	Complications pnl; Pan; PANEL.SURG; Panl; Pnl; Point in time; Random; SURG	4180186
1617347	Complications pnl Spine Tango	4180186
1617349	  (rAra h) 8 .IgG4::::	4182948
1617349	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f013; f13; f352; Level; Mass concentration; NR1B1; Peanut; Peanut (rAra h) 8; Point in time; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; Serum; SR	4180186
1617349	Peanut (rAra h) 8 IgG4-mCnc	4180186
1617350	+:::/:	4182948
1617350	Amiodarone metabolite; Cardio; Cardiology; Cordarone; DEA; DRUG/TOXICOLOGY; Drugs; Heart Disease; Level; Noramiodarone; Pacerone; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1617350	Amiodarone+Deseth SerPl-sCnc	4180186
1617353	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH	4180186
1617354	.  1::24:::	4182948
1617354	M Protein 1 24h Ur Elph-mCnc	4180186
1617354	1 day; 24 hours; 24HR; Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Hematology; Heme; i; Level; M Protein; M Protein 1; Mass Concentration; M-band; Monoclonal band; Monoclonal spike; M-protein; M-spike; Para protein; Paraprotein; PEUR; PR; Prot; QNT; Quan; Quant; Quantitative; UA; UPEP; UR; Urn	4180186
1617355	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1617356	.^::^:.::.	4182948
1617356	After; Airway resist; Average; Avg; bod; Bodies; Breathing; Fluid resistance; Lung; Lungs; p BD; PST; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; RAW; Resist; Resistanc; Resistant; Resistent; Respiratory; RS; Spec; Specific airway resist; sRaw^post bronchodilation; Studies; Study; Sutdies	4180186
1617356	Spec airway resist p BD Mean Plethys	4180186
1617357	Eye PD binoc far by Phoropter	4180186
1617357	by Phoropter; Eye; EYE.REFRACTION; Eyeball; Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; PD binoc; PD binoc far; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1617357	.:::::	4182948
1617360	Asperg Color Islt Cult	4180186
1617360	Appearance; Asperg; Asperg Color; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; C&S; Colonies; Colour; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random; Typ	4180186
1617360	.:::::	4182948
1617361	Intravascular coag + fibrinolysis Pnl	4180186
1617361	BP; Coag; Hematology; Heme; Intravascular coag + fibrinolysis Pnl; Intravenous; IV; Pan; PANEL.COAGULATION; Panl; Pnl; Point in time; Random	4180186
1617361	:-::^:-	4182948
1617363	:-::.DNA+.cfDNA:-: cfDNA 	4182948
1617363	Chromosom; Chromosomes; Gyn; Gynecology; Leukocytes; Molecular pathology; MOLPATH; NIP fet aneu Pnl; NIPS; Non-invasive prenatal screening; Noninvasive prenatal testing; NPT; OB; ObGyn; Obstetrics; Pan; Panel.molpath; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Spec; WBC.DNA+cfDNA; WBCs; White blood cells	4180186
1617363	NIP fet aneu Pnl WBC.DNA+cfDNA	4180186
1617365	by Phoropter; Eye; EYE.REFRACTION; Eyeball; Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; PD; PD monoc; PD monoc far; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1617365	R eye PD monoc far by Phoropter	4180186
1617365	.:::.::	4182948
1617366	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; Job; Nominal; Occupation; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Survey; Work	4180186
1617367	.+:::::	4182948
1617367	ACT; ACT Kaolin+TF Ind; Activ; Activated coagulation time; Blood; Calc; Calculation; Clot; Clottable; COAGULATION; Coagulation activated; Coagulation time; Fac; Fact; Hematology; Heme; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; R-time; WB; Whole blood	4180186
1617367	ACT Kaolin+TF Ind Bld Calc	4180186
1617368	COMI Back; MSK; Musculoskeletal; Ortho; Orthopedics; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
1617374	C-19 cyberbullied due to race; Corona virus; Ethnicity; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1617377	Med causes light-headedness or fatigue	4180186
1617377	Finding; Findings; H+P; H+P.HX; Med causes light-headedness or fatigue; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1617377	:::^:	4182948
1617380	ED Arrival notification	4180186
1617380	Arrival notifctn note; DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1617380	:::::{}	4182948
1617381	  (rAra h) 1 .IgG4::::	4182948
1617381	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f013; f13; f422; i; Level; Mass concentration; NR1B1; Peanut; Peanut (rAra h) 1; Point in time; QNT; Quan; Quant; Quantitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; Serum; SR	4180186
1617381	Peanut (rAra h) 1 IgG4-mCnc	4180186
1617386	 RNA:::/::..	4182948
1617386	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1617386	EV RNA SerPl Ql NAA+non-probe	4180186
1617388	Internal Med Prog note	4180186
1617388	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1617388	:::{}::	4182948
1617389	CLIN; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Tot; Totl	4180186
1617391	.^:::::	4182948
1617391	Before; Breathing; IC; IC^pre bronchodilation; Lung; Lungs; Point in time; pre BD; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume	4180186
1617391	IC pre BD Spirometry	4180186
1617395	Finding; Findings; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; Surg	4180186
1617395	:::^:	4182948
1617396	.beta:::/:	4182948
1617396	IFN-B SerPl-mCnc	4180186
1617396	B; Betaferon; B-IFN 1A+1B; Chemistry; IFN; IFN-B; INF-B; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1617397	Endocrine; Endocrinology; Est; Estr; Estroge; Estrogens; Estrone+estradiol; Estrone+estradiol+estriol; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1617397	:::^:	4182948
1617398	.:::::	4182948
1617398	ANA Homogen Titr CSF IF	4180186
1617398	ACIF; ANA; ANA Homogen; ANA Pat; ANF; Anticomplement Immunofluorescence; Antinuclear antibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; FANA; Fluorescent antibody; Fluoresent; Homogen; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Nuc; Point in time; Random; Rheum; Rheumatology; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1617400	Finding; Findings; Levels; Levl; LV; LVL; Nominal; Point in time; Random; SURG	4180186
1617400	:::^:	4182948
1617401	:::::	4182948
1617401	Alzheimer's risk; Calc; Calculation; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dis; Diseases; Dz; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Scale; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1617401	Alzheimer's risk Score CSF Calc	4180186
1617406	Finding; Findings; Lung; MRC breathlessness scale grade; Ordinal; Point in time; PULMONARY; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen	4180186
1617406	MRC breathlessness scale grade	4180186
1617407	Hx for COVID -19 vaccine	4180186
1617407	2019 Novel Coronavirus; 2019-nCoV; Corona virus; Coronavirus disease 2019; COVID19; Dis; Diseases; Dz; Hx; Hx for COVID -19 vaccine; Immunizations; Pan; Panel; PANEL.VACCIN; Panl; Pnl; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Vaccine	4180186
1617407	 COVID-19  -  mRNA :-::^:-	4182948
1617408	Cancer Path Pnl EC spec	4180186
1617408	CA; Ca spec; Cancer of the corpus uteri; Cancer Path Pnl; EC spec; Female reproductive organs; Pan; PANEL.PATH; Panl; Path; Pathology; Pnl; Point in time; Random; Spec; Uterine cancer; Uterine Cancers	4180186
1617408	:-:::-	4182948
1617409	Stromal invasion EC spec Ql	4180186
1617409	CA; Ca spec; Cancer of the corpus uteri; Cervical surface involvement; Crypt involvement; EC spec; Female reproductive organs; Oncology; Ordinal; Pathology; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Uterine cancer; Uterine Cancers	4180186
1617409	::::	4182948
1617410	/.::::	4182948
1617410	DO-Hgb MFr BldCV	4180186
1617410	Chemistry; Deoxygenated hemoglobin; Deoxyhaemoglobin; DO-Hgb; Ferrohaemoglobin; Ferrohemoglobin; Haemoglobin; Hb; Hgb; HHb; Lung; Mass Fraction; Percent; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Reduced hemoglobin; Respiratory; RHB; Tot; Totl	4180186
1617414	/100 :::::	4182948
1617414	BM; BON; Bone marrow; Cell; Cellularity; Gated cells; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Manl; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1617414	Megakaryoblasts NFr Mar Manual	4180186
1617415	MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Osteo vertebral frac class; Point in time; Random; SURG; Typ	4180186
1617415	Osteo vertebral frac class	4180186
1617415	:::^:	4182948
1617420	DNA MMR Ca spec ImStn	4180186
1617420	CA; Ca spec; Deoxyribonucleic acid; DNA MMR; Finding; Findings; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Narrative; Oncology; PATHOLOGY; Point in time; Random; Report; Spec; St; Stains; Stn	4180186
1617420	DNA :::::	4182948
1617423	Finding; Findings; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; SURG	4180186
1617423	:::^:	4182948
1617427	SARS-CoV-2 ORF1a Resp Ql NAA+probe	4180186
1617427	SARS  2 ORF1a :::::..	4182948
1617427	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; PH; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Public Health; PublicHealth; QBR; QL; Qual; Qualitative; Random; RS; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 ORF1a; Screen; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
1617433	Pan; PANEL.NEONAT; Panl; Pnl; Point in time; Random	4180186
1617433	Deprecated NIPS	4180186
1617435	Paracoccidioides Ab Titr Spec CF	4180186
1617435	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Other; Paracocc sp Ab; Point in time; Random; SmQn; Spec; species; spp; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified	4180186
1617435	 :::XXX::	4182948
1617436	  (rPhl p) 1+5b .IgG4::::	4182948
1617436	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g006; g205; g213; g6; i; Level; Mass concentration; P prime; Phleum pretense; Point in time; QNT; Quan; Quant; Quantitative; Random; Rg205; rph1; Serum; SR; Timothy; Timothy (rPhl p) 1; Timothy (rPhl p) 1+5b; Timothy grass	4180186
1617436	Timothy (rPhl p) 1+5b IgG4-mCnc	4180186
1617437	^:::::.	4182948
1617437	#; ABS; absolute; absolutes; After; Cnt; Count; Count/volume; CT; FERTILITY TESTING; Genitourinary; GU; LM; Micro; Micros; Microscopic; Number concentration; Number Concentration (count/vol); p ejac; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sperm; Sperm p ejac; UA; UR; Urn; URO; Urology	4180186
1617437	Sperm p ejac # Ur Micro	4180186
1617440	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Srce; Survey	4180186
1617444	R Pelvic LN positive Spec	4180186
1617444	Cnt; Count; Number; Oncology; PATHOLOGY; Point in time; Pos; QNT; Quan; Quant; Quantitative; R; R Pelvic LN positive; Random; RT; Spec	4180186
1617444	:():::	4182948
1617446	:::^:	4182948
1617446	AE p vaccine	4180186
1617446	AE; AE p vaccine; Finding; Findings; Immunizations; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vaccine	4180186
1617447	pH^^::::	4182948
1617447	pH temp adj BldCV	4180186
1617447	adj; Chemistry; Log molar concentration; Point in time; Random; S prime; SmQn; Temp; temp adj	4180186
1617448	SARS  2 & SARS- RNA :-:::-:..	4182948
1617448	SARS-CoV-2+SARSr-CoV RNA pnl Sal NAA+prb	4180186
1617448	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Oral fluid; Pan; PANEL.MICROBIOLOGY; Panl; PCR; PH; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Public Health; PublicHealth; QBR; Random; Ribonucleic acid; Sal; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2+SARSr-CoV; SARS-CoV-2+SARSr-CoV RNA; SARS-CoV-2+SARSr-CoV RNA pnl; SARSr-CoV; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
1617450	Citrobac sp DNA Snv Ql NAA+non-probe	4180186
1617450	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Citrobac sp; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; SF; SNV; species; spp; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1617450	 DNA:::::..	4182948
1617453	 RNA:::::..	4182948
1617453	WNV RNA Ur Ql NAA+probe	4180186
1617453	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn; WNV	4180186
1617458	:::{}::	4182948
1617458	Radiology H&P note	4180186
1617458	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
1617460	 E::::	4182948
1617460	Apo E CSF-mCnc	4180186
1617460	APO; Apo E; ApoE; Apolipo; Apolipoprot; Apolipoprotein Epsilon; Apolipoproteins; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1617465	:::::	4182948
1617465	Disch; Discharge teach note; DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1617465	Emergency med ED Discharge teach note	4180186
1617466	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; MCS+progress note; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1617466	MCS+progress note	4180186
1617466	+:::{}::{}	4182948
1617468	Postop comp effect on recvry	4180186
1617468	Finding; Findings; Nominal; Point in time; Postop comp effect on recvry; Random; SURG	4180186
1617468	:::^:	4182948
1617473	.+::::	4182948
1617473	Blood; Clot init kaolin+TF ind; COAGULATION; Fac; Fact; Hematology; Heme; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1617473	Clot init kaolin+TF ind Bld	4180186
1617476	 H :::::	4182948
1617476	YopH Ab Ser Ql Line blot	4180186
1617476	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bombay AB; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serum; SR; Yop; YopH	4180186
1617479	MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; SURG; Typ	4180186
1617479	AO :::^:	4182948
1617480	Arterial Stenosis; Emotional stability; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Srce; Survey	4180186
1617483	L eye V prism-down far by Phoropter	4180186
1617483	by Phoropter; Eye; EYE.REFRACTION; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; V prism-down; V prism-down far; Vision; Visual	4180186
1617483	.:::.::	4182948
1617484	^1.5:::/:	4182948
1617484	Glucose 1.5h p Arg SerPl-mCnc	4180186
1617484	1 1/2 hours; 1 1/2 HR; 1.5h p Arg; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Arg; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1617485	:::::	4182948
1617485	MDMA TissCo Ql Cfm	4180186
1617485	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; GCMS; Illicit; MDMA; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
1617486	ERBB2  :::::FISH	4182948
1617486	Amplification; Cancer; CD340; c-erb B2; Document; Dp; ERBB2 duplication; erb-b2 receptor tyrosine kinase 2; Finding; Findings; Fluorescent in situ hybridization; Genetics; HER2; HER-2; HER-2/neu; Heredity; Heritable; Inherited; MLN 19; Molecular pathology; MOLPATH; NEU; NGL; Oncology; Point in time; Random; TKR1; tumors; tumour; tumours; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	4180186
1617486	ERBB2 gene Dp Tumor FISH	4180186
1617487	PCNA  :::::	4182948
1617487	ENA PCNA Ab Titr CSF IF	4180186
1617487	ABS; Aby; ACIF; ANA; ANF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Antinuclear antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); ENA; ENA PCNA; FA; FANA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; NA; Nuc; Point in time; Random; Rheum; Rheumatology; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1617491	#D cut down activities hlt cond 4W	4180186
1617491	4 weeks; Dextro; Finding; Findings; H+P; H+P.HX; Last; No; Num; Ordinal; P prime; QL; Qual; Qualitative; Screen	4180186
1617491	4,::4:^:	4182948
1617494	Nominal; PH; Point in time; Public Health; PublicHealth; Random; Typ	4180186
1617494	:::^:	4182948
1617496	:::{}::	4182948
1617496	Sleep med H&P note	4180186
1617496	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
1617497	/::::	4182948
1617497	Chemistry; CR; Crea; Creat; Kidney; Mass concentration ratio; Mass ratio; MCRto; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UCr; UR; Urn	4180186
1617497	Urea/Creat Ur	4180186
1617498	 21:::/:	4182948
1617498	IL-21 SerPl-mCnc	4180186
1617498	Chemistry; IL; IL-21; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1617499	 :::XXX::	4182948
1617499	H capsul Myc Ab Patrn Spec ID	4180186
1617499	Ab Patrn; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bands; bnd; H capsul; H capsul Myc; H capsul Myc Ab Patrn; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmin; Histoplasmos; Histoplasmosis; ID; Identity or presence; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Mycel; Nominal; Other; Patrn; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1617502	Vessels involved LVI Ca spec	4180186
1617502	CA; Ca spec; Cnt; Count; LVI; Number; Oncology; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Vessels involved LVI	4180186
1617502	:():::	4182948
1617503	Misused ADHD meds past 3Mo	4180186
1617503	3 months; Arterial Stenosis; Finding; Findings; H+P; H+P.HX; Last; Mental health; MentalHealth; Misused ADHD meds past 3Mo; Ordinal; P prime; Psych; Psychiatry; Ql; Qual; Qualitative; Screen	4180186
1617503	3,::3:^:	4182948
1617504	Finding; Findings; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Path; Path spine fracture cause; Point in time; Random; SURG	4180186
1617504	Path spine fracture cause	4180186
1617504	:::^:	4182948
1617507	:::::	4182948
1617507	Crypt; Crypto; Cryptoc Molec Typ; Cryptococcal; Cryptococcosis; Cryptococcosus; Cryptococcus genotype; Cryptococcus molecular type; Cryptococcus species (sp) subtype; high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Typ	4180186
1617507	Cryptoc Molec Typ Islt Seq	4180186
1617508	CT :::::	4182948
1617508	Calc; Calculation; CT size-adj dose; Energy content; Imaging; Point in time; QNT; Quan; Quant; Quantitative; Rad; Radiology; Random	4180186
1617508	Calc CT size-adj dose	4180186
1617509	$ prob since beg pandemic; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1617510	 M :::::	4182948
1617510	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; MNSs Blood Group System; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serum; SR; Yop; YopM	4180186
1617510	YopM Ab Ser Ql Line blot	4180186
1617512	Bowel control ability	4180186
1617512	CLIN; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1617512	 - :::^:	4182948
1617513	:::^:	4182948
1617513	MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; SURG; Typ	4180186
1617513	Spine infection type	4180186
1617515	Calc; Calculation; Chemistry; Endocrine; Endocrinology; Glu; Gluc; Glucoseur; GMI; Interstitial fld; Number Fraction; Percent; QNT; Quan; Quant; Quantitative; Report period	4180186
1617515	:::::	4182948
1617518	OMS D/C sum	4180186
1617518	:::{}::	4182948
1617518	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OMS; Point in time; Random; Surg; Visit note	4180186
1617520	-L1:::::	4182948
1617520	Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Neuro; Neurology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SUDS; TBI (Traumatic Brain Injury); UCH-L1	4180186
1617520	UCH-L1 Plas IA-mCnc	4180186
1617521	Audiology; Ear Nose Throat; ENT; Finding; Findings; Nominal; Oto; Otolaryngology; Point in time; Random; Reason Dx audio not performed	4180186
1617521	Reason Dx audio not performed	4180186
1617521	:::^:	4182948
1617522	Add; Add procedure post surg; Finding; Findings; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; Surg	4180186
1617522	Add procedure post surg	4180186
1617522	:::^:	4182948
1617525	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1617526	:::::	4182948
1617526	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fentanyl metabolite; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1617526	Norfentanyl TissCo Ql Scn	4180186
1617528	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Treatment cancelled since pandemic; Tx	4180186
1617529	CVX ::::	4182948
1617529	Ident; Identifier; Nominal; Point in time; Random	4180186
1617530	von Willebrand  /:::::	4182948
1617530	vWF Cp Act/Nor PPP IA	4180186
1617530	Act/Nor; ADAMTS13; ADAMTS-13; COAGULATION; Control; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; Hematology; Heme; IAA; MEIA; Plas; Platelet poor plasma; Point in time; PR; QNT; Quan; Quant; Quantitative; Random; RlCCnc; SUDS; TTP; Von will; Vonwillebrand; vWCP; vWf; vWF Cp; VWFCP; VWF-cp	4180186
1617531	 :::::..	4182948
1617531	Fungus Islt NAA+probe	4180186
1617531	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; Thrush; TMA; Transcription mediated amplification	4180186
1617532	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH	4180186
1617534	:::^::SOFA	4182948
1617534	Cardio Score SOFA	4180186
1617534	CLIN; CLIN.RISK; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
1617536	 22:::/:	4182948
1617536	IL-22 SerPl-mCnc	4180186
1617536	Chemistry; IL; IL-22; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1617537	 .IgE::::	4182948
1617537	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c154; c424; Deltasone; Depo-Medrol; Immune globulin E; Immunoglobulin E; Kenalog; Medrol; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Solu-Medrol; SR	4180186
1617537	prednisoLONE IgE Qn	4180186
1617539	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.MTLHLTH	4180186
1617541	:::::	4182948
1617541	Addiction; Angel dust; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ordinal; PCP; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Sernylan	4180186
1617541	PCP TissCo Ql Cfm	4180186
1617544	2019 Novel Coronavirus; 2019-nCoV; Aller react 1st COVID-19 dose; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; React; Rxn; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen	4180186
1617544	Aller react 1st COVID-19 dose	4180186
1617544	 COVID-19 :::^:	4182948
1617545	FLT3 .p.Asp835+Ile836 /:::/::	4182948
1617545	FLT3 p.D835+I836/Nor NFr Bld/T	4180186
1617545	Acute myeloid leukemia; AML; Blood; CD135; Control; FL cytokine receptor precursor; FLK2; FLK-2; FLT3 p.D835; FLT3 p.D835+I836; FLT3 p.D835+I836/Nor; FLT3 TKD; FLT3 tyrosine kinase domain; fms-like tyrosine kinase 3; fms-related tyrosine kinase 3; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutation; Muts; Number Fraction; P prime; PCR; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem cell tyrosine kinase 1; STK1; STK-1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1617548	:::::	4182948
1617548	In Vitro Conversion Yst Islt Cult	4180186
1617548	C&S; Cult; Cultures; ID; Identity or presence; In Vitro Conversion Yst; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random	4180186
1617549	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1617553	 DNA:::::..	4182948
1617553	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pneumo; S pneumoniae; S pneumoniase DNA; Screen; SDA; SF; SNV; Spn; Strand Displacement Amplification; Strep; Strept; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1617553	S pneum DNA Snv Ql NAA+non-probe	4180186
1617555	^3:::/:	4182948
1617555	3h p Glc; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; Human growth hormone; Level; Mass concentration; p dose; p Glc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH	4180186
1617555	GH 3h p Glc SerPl-mCnc	4180186
1617557	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1617558	7-:::::	4182948
1617558	7Aminoclonazepam TissCo Ql Scn	4180186
1617558	7-amino clonazepam; 7Aminoclonazepam; Addiction; Clonazepam metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1617559	::::	4182948
1617559	ADMIN; Given name; Nominal; Person name; Persons; Point in time; Random	4180186
1617559	First name Person	4180186
1617561	 .IgG:::XXX::	4182948
1617561	RABV IgG Spec Ql IF	4180186
1617561	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyssavirus; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Rabies; RABV; Random; Screen; Spec; Time Resolved Fluorescence; To be specified in another part of the message; TRF; Unspecified	4180186
1617563	:::::	4182948
1617563	Emergency med ED H&P note	4180186
1617563	DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
1617565	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; Nominal; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Survey	4180186
1617567	Acyl carnitine; Acylcarni; Acylcarnitine Pnl; Carnitine + acylcarnitine Pnl; Carnitine.total; Chemistry; FR; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
1617567	Carnitine + acylcarnitine Pnl SerPl	4180186
1617567	:-::/:-	4182948
1617570	Count/time; H+P; H+P.HX; nRate; Number rate; Number Rate = Count/Time; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Vegetable AndOr fruit frequency	4180186
1617570	/:::^:	4182948
1617571	Fracture/trauma; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Random; SURG; Typ	4180186
1617571	Fracture/trauma	4180186
1617571	:::^:	4182948
1617572	HIV 1 :-::/:-:	4182948
1617572	HIV 1 Ab Pnl SerPl IB	4180186
1617572	AIDS; Blt; HIV 1 Ab Pnl; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; IMMUNE BLOT; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; RIBA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1617573	Reporting protocol used	4180186
1617573	Nominal; Oncology; PATHOLOGY; Point in time; Random; Typ	4180186
1617573	::::	4182948
1617575	Arterial Stenosis; C-19 denied healthcare due to race; Corona virus; Ethnicity; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1617576	14 days; 2 weeks; C-19 anxiety - dizzy faint; Corona virus; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey	4180186
1617578	HL type Ear-R	4180186
1617578	AUDIO; Audiology; Ear Nose Throat; Ear-R; ENT; Hearing; HL type; Nominal; Oto; Otolaryngology; Otologic; Point in time; R; Random; RT; Typ	4180186
1617578	:::.:	4182948
1617579	Hibiscus tea IgE Qn	4180186
1617579	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f147; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1617579	 .IgE::::	4182948
1617581	Cnt; Count; Levels; Levl; LV; LVL; MSK; Musculoskeletal; No; Num; Num prev surg at other level; Number; Ortho; Orthopedics; Othr; Point in time; Prev; QNT; Quan; Quant; Quantitative; Random	4180186
1617581	Num prev surg at other level	4180186
1617581	:()::^:	4182948
1617588	:::::	4182948
1617588	DRUG/TOXICOLOGY; Drugs; Meperidine metabolite; Norpethidine; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1617588	Normeperidine TissCo Ql Scn	4180186
1617590	:::::	4182948
1617590	Methylone TissCo Ql Cfm	4180186
1617590	3,4-Methylenedioxy-N-Methylcathinone; Addiction; Bath salts; bk-MDMA; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; M1; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
1617591	CA; Ca spec; Cancer of the corpus uteri; EC spec; Female reproductive organs; Nominal; Oncology; PATHOLOGY; Point in time; Random; Spec; Typ; Uterine cancer; Uterine Cancers	4180186
1617591	Hormonal phase EC spec	4180186
1617591	::::	4182948
1617595	Cancer progression; CLIN; Dis; Diseases; Dz; Finding; Findings; Hematology; Heme; Nominal; Oncology; Point in time; Random	4180186
1617595	Cancer progression	4180186
1617595	:::^:	4182948
1617596	IgG  2::::	4182948
1617596	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; IgG 2; IgG2; II; Immune globulin G; Immunoglobulin G; Immunoglobulin G subclass 2; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Subclasses	4180186
1617596	IgG2 Fld-mCnc	4180186
1617597	:::::	4182948
1617597	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
1617597	Methadone TissCo Ql Cfm	4180186
1617599	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1617600	Aspergillus repens IgE Qn	4180186
1617600	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergillus repens IgE; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; m029; m29; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1617600	 .IgE::::	4182948
1617602	C-19 racial media bias; Corona virus; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1617603	/100,000 :::^:	4182948
1617603	Dose dist per 100,000; Number ratio; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1617603	Vac doses dist per 100,000	4180186
1617605	Used marijuana past 3Mo	4180186
1617605	3 months; Finding; Findings; H+P; H+P.HX; Last; Mental health; MentalHealth; Ordinal; P prime; Psych; Psychiatry; QL; Qual; Qualitative; Screen; Used marijuana past 3Mo	4180186
1617605	3,::3:^:	4182948
1617607	:-:::-	4182948
1617607	AGID Ab pnl; Gastro; Gastroenterology; GI; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Serum; SR	4180186
1617607	AGID Ab pnl Ser	4180186
1617608	TP53  +:::/::	4182948
1617608	Amplification; BCC7; Blood; Cellular tumor antigen p53; Del; Del+Dup; Deletions; Dp; Identity or presence; LFS1; Li-Fraumeni syndrome; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Nominal; P53; PCR; Point in time; Random; Tissue; Tissue, unspecified; TRP53; Tumor protein p53; WB; Whole blood; Whole blood or Tissue	4180186
1617608	TP53 gene Del+Dup Bld/T	4180186
1617612	MSK; Musculoskeletal; Ortho; Orthopedics; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
1617614	by Phoropter; Eye; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; V prism-up; V prism-up far; Vision; Visual	4180186
1617614	R eye V prism-up far by Phoropter	4180186
1617614	.:::.::	4182948
1617615	2019 Novel Coronavirus; 2019-nCoV; Arterial Stenosis; Coronavirus disease 2019; COVID19; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey	4180186
1617616	5 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1617619	 :::::	4182948
1617619	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Syphilis; T pallidum; Treponemal	4180186
1617619	T pallidum Ab CSF Ql IA	4180186
1617620	 DNA:::::..	4182948
1617620	S aureus DNA Snv Ql NAA+non-probe	4180186
1617620	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; Ortho; Orthopedics; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S aureus; Screen; SDA; SF; SNV; Staph; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1617621	:::^::	4182948
1617621	Zygosity in Fetuses	4180186
1617621	Fetal; Gyn; Gynecology; Molecular genetics; Molecular pathology; MOLPATH; Multiple Births; Nominal; OB; ObGyn; Obstetrics; PCR; Point in time; Random; Twin zygosity; Typ	4180186
1617625	^:::/:	4182948
1617625	Cortis p Dex overnight SerPl-sCnc	4180186
1617625	17-Hydroxycorticosterone; After; c350; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Decadron; Dexameth; Dexone; Endocrine; Endocrinology; F; Hexadrol; hydrocortisone; Level; p Dex; p Dex overnight; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1617626	.^:::::.	4182948
1617626	Sperm Motile p ejac # Ur Micro	4180186
1617626	#; ABS; absolute; absolutes; After; Cnt; Count; Count/volume; CT; FERTILITY TESTING; Genitourinary; GU; LM; Micro; Micros; Microscopic; Mot; Motile Sperm Concentration; MSC; Number concentration; Number Concentration (count/vol); p ejac; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sperm; Sperm Motile; Sperm Motile p ejac; UA; UR; Urn; URO; Urology	4180186
1617628	^:::/:	4182948
1617628	carBAMazepine Trough SerPl-sCnc	4180186
1617628	Carbamazapine; Carbamezapine; Carbazepine; CRBM; DRUG/TOXICOLOGY; Drugs; Epitol; Level; Neuro; Neurology; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tegretol; Teril	4180186
1617633	:::::	4182948
1617633	Addiction; Ativan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1617633	LORazepam TissCo Ql Scn	4180186
1617634	SARS  2 :::::.	4182948
1617634	2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Oral fluid; Ordinal; PH; Point in time; PR; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; Sal; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; Screen; Severe Acute Respiratory Syndrome; SUDS; Viral Pneumonias; Wuhan coronavirus	4180186
1617634	SARS-CoV-2 Ab Sal Ql IA.rapid	4180186
1617635	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH	4180186
1617637	 DNA:::::..	4182948
1617637	S pyo DNA Snv Ql NAA+non-probe	4180186
1617637	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; MSK; Musculoskeletal; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Ortho; Orthopedics; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pyogenes; Screen; SDA; SF; SNV; Steptococcus Group A; Strand Displacement Amplification; Strep; Strept; Streptococci group A; Streptococcus group A; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1617643	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
1617644	:::{}::	4182948
1617644	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Psychiatric; Random; Visit note	4180186
1617644	Psychiatric Eval note	4180186
1617645	by Phoropter; Eye; EYE.REFRACTION; Eyeball; H prism-in; H prism-in near; Inverse Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1617645	R eye H prism-in near by Phoropter	4180186
1617645	.:::.::	4182948
1617649	:::{}::	4182948
1617649	Hepatology Eval note	4180186
1617649	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
1617650	Tau . 181/ Beta 42 ::::	4182948
1617650	181P; Ab42 peptide; Abeta; Abeta 42; AL beta42; Alzheimer disease; Alzheimer's disease; B; Beta-amyloid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Neuro; Neurology; Pept; phospho T181; Point in time; PR; Prot; p-tau181; pThr181; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Thr181; threonine 181	4180186
1617650	p-tau181/AL beta42 CSF-Rto	4180186
1617652	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f192; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quail meat IgE; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1617652	Quail meat IgE Qn	4180186
1617652	 .IgE::::	4182948
1617653	p53 :::/::	4182948
1617653	p53 Ab SerPl IA-mCnc	4180186
1617653	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1617654	/.^^:::::	4182948
1617654	dRVVT/dRVVT cfm p DOAC neut Norm PPP-Rto	4180186
1617654	activated charcoal; After; Clot; Clottable; Coag; Coagulation assay; Coagulation dilute Russell viper venom induced confirmatory test; Dil; Dil Russell Vip Ven; Dilut; Direct oral anticoagulants; DOAC Remove; DOAC-Stop; dRVV; dRVVT; dRVVT cfm; dRVVT confirm; dRVVT confirmation test; dRVVT/dRVVT cfm; EXS; Hematology; Heme; Lipid; Neut; Neutr; Nrmlzd; p DOAC neut; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Rus; RVV; Screening test for lupus anticoagulant; Tilt tube	4180186
1617655	Finding; Findings; H+P; H+P.HX; Levels; Levl; LV; LVL; Ordinal; P prime; Point in time; Postop complication distress level; Ql; Qual; Qualitative; Random; Screen	4180186
1617655	Postop complication distress level	4180186
1617655	:::^:	4182948
1617656	:::/::.	4182948
1617656	Epi Cells #/area Cvx/Vag Micro	4180186
1617656	#/area; Cell; Cellularity; Cervix; Epi; Epi Cells; Epith; Epithelia; Genital tract; Genital vaginal; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Vag fld; Vag fluid; Vagina; Vaginal fluid	4180186
1617658	Nominal; Oncology; Path protocol sentinel nodes; PATHOLOGY; Point in time; Random; Spec; Typ	4180186
1617658	Path protocol sentinel nodes	4180186
1617658	::::	4182948
1617659	5 days; Finding; Findings; Job; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1617661	1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; Treatment cancelled last 12Mo; Tx	4180186
1617663	::::	4182948
1617663	Guanidinoacetate Ur-sCnc	4180186
1617663	Chemistry; GAA; glycocyamine; guanidinoacetic acid; guanidoacetic acid; Level; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
1617665	CCL5 SerPl-mCnc	4180186
1617665	C-C motif chemokine 5; CCL5; Chemistry; EoCP; Eosinophil chemotactic cytokine; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; RANTES; SerP; SerPl; SerPlas; Serum; Serum or plasma; SIS-delta; Small-inducible cytokine A5; SR; T cell-specific protein P228; T-cell-specific protein RANTES; TCP228	4180186
1617665	 (C-C )  5:::/:	4182948
1617667	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
1617669	:::::	4182948
1617669	DRUG/TOXICOLOGY; Drugs; Normison; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Restoril; Scn; Scr; Screen; Scrn	4180186
1617669	Temazepam TissCo Ql Scn	4180186
1617670	Health literacy; Insurance; Language; Pan; PANEL.SURVEY.R-OUTCOMES; Panl; Pnl; Point in time; Provider; R prime; Random; Right; SDH; SDH.Healthcare; SDOH; Survey; SURVEY.R-OUTCOMES	4180186
1617671	FGF2 SerPl-mCnc	4180186
1617671	Basic fibroblast growth factor; bFGF; Chemistry; Fac; Fact; FGF2; HBGF-2; Heparin-binding growth factor 2; II; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1617671	 2:::/:	4182948
1617672	.:::::	4182948
1617672	Codeine Free TissCo Ql Scn	4180186
1617672	Addiction; c260; C300; Codeine Free; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; FR; Illicit; Methylmorphine; Morphine methyl ether; Non-protein bound; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1617674	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Survey; SURVEY.GNHLTH; Sx	4180186
1617675	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1617676	Misused opiates past 3Mo	4180186
1617676	3 months; Arterial Stenosis; Finding; Findings; H+P; H+P.HX; Last; Mental health; MentalHealth; Misused opiates past 3Mo; Ordinal; P prime; Psych; Psychiatry; Ql; Qual; Qualitative; Rx; Screen	4180186
1617676	3,::3:^:	4182948
1617681	Arterial Stenosis; Emotional stability; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Srce; Survey	4180186
1617683	 21kD .IgG:::::	4182948
1617683	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdor21kD; B burgdorferi; Bb; Blt; Burgdorf; ID; IMMUNE BLOT; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1617683	B burgdor21kD IgG Ser Ql IB	4180186
1617686	 RNA:::XXX::..	4182948
1617686	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TAHV; TAHV RNA; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1617686	TAHV RNA Spec Ql NAA+probe	4180186
1617687	Finding; Findings; Injury to you or someone from drinking; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Ulcer	4180186
1617688	Optimal tissue block Ca spec	4180186
1617688	CA; Ca spec; Ident; Identifier; Nominal; Oncology; PATHOLOGY; Point in time; Random; Spec	4180186
1617688	::::	4182948
1617689	Finding; Findings; Job; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1617691	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w49; Wax begonia; Wax begonia IgE	4180186
1617691	Wax begonia IgE Qn	4180186
1617691	 .IgE::::	4182948
1617692	PTEN  +:::/::	4182948
1617692	PTEN gene Del+Dup Bld/T	4180186
1617692	10q23del; Amplification; Bannayan-Zonana syndrome; Blood; BZS; CWS1; DEC; Del; Del+Dup; Deletions; Dp; GLM2; Human mutated in multiple advanced cancers protein (MMAC1) mRNA, complete cds; Identity or presence; MGC11227; MHAM; MMAC1; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Mutated in multiple advanced cancers 1; Nominal; PCR; Phosphatase and tensin homolog; Point in time; PTEN1; Random; TEP1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1617696	:::::	4182948
1617696	clonazePAM TissCo Ql Cfm	4180186
1617696	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Klonopin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
1617700	 .IgE::::	4182948
1617700	Minocycline IgE Qn	4180186
1617700	ABS; Aby; Aknemin; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c128; Dentomycin; Immune globulin E; Immunoglobulin E; Klinomysin; Lederderm; Mestacine; Mino-50; Minocin; Minomycin; Mynocine; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1617702	:-:::-	4182948
1617702	Prion disease biomarker panel CSF	4180186
1617702	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dis; Diseases; Dz; ID; Infectious Disease; InfectiousDisease; Neuro; Neurology; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Transmissible Spongiform Encephalopathy	4180186
1617703	.^30::::	4182948
1617703	Lys of kao ind clot 30M p MA LenFr Bld	4180186
1617703	30M p MA; After; Blood; COAGULATION; Fibrinolysis of kaolin ind clot; Hematology; Heme; Length Fraction; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Reduction clot str kao 30M p max amp; WB; Whole blood	4180186
1617705	CLIN; CLIN.RISK; ORAI; Pan; Panel; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
1617705	ORAI	4180186
1617705	:-::^:-:	4182948
1617706	:::{}::	4182948
1617706	Neuropsych Procedure note	4180186
1617706	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1617707	Disch; Finding; Findings; MSK; Musculoskeletal; Nominal; Ortho; Orthopedics; Point in time; Postop surg comp before discharge; Random; Surg; Surg comp	4180186
1617707	Postop surg comp before discharge	4180186
1617707	:::^:	4182948
1617709	:::{}::	4182948
1617709	DOC.ONT; Document; Emotional stability; Finding; Findings; Point in time; Random	4180186
1617710	1 year; 12Mos; Count/time; H+P; H+P.HX; Last; nRate; Number rate; Number Rate = Count/Time; Ordinal; P prime; QL; Qual; Qualitative; Screen; Tobacco freq 12Mo	4180186
1617710	Tobacco freq 12Mo	4180186
1617710	12,::12:^:	4182948
1617711	::::	4182948
1617711	ADMIN; Nominal; Person name; Persons; Point in time; Random	4180186
1617713	:::::	4182948
1617713	Meperidine TissCo Ql Cfm	4180186
1617713	Addiction; Algil; Alodan; Centralgine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Demerol; Dispadol; Dolantin; Dolosal; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ordinal; Pethidine; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen	4180186
1617714	Reag Ab + T pall IgG + IgM + tot Pnl Ser	4180186
1617714	ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neurosyphilis; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Reagin Ab + T pall IgG + IgM + tot Pnl; Reagin+T pallidum; Serum; SR; Syphilis; T pallidum; Tot; Totl; Treponema; Treponemal	4180186
1617714	.IgG  IgM :-:::-	4182948
1617716	/:::::	4182948
1617716	% Glucose measurements in range	4180186
1617716	Calc; Calculation; Chemistry; Endocrine; Endocrinology; Glu; Gluc; Glucose levels in range; Glucose time in range; Glucoseur; Interstitial fld; Number Fraction; Percent; QNT; Quan; Quant; Quantitative; Report period; Rnge; TIR; Tot; Total measurements; Totl	4180186
1617718	 .IgE::::	4182948
1617718	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f198; f333; f98; Flax; Flaxseed; Flaxseed Ab; Flaxseed IgE; Immune globulin E; Immunoglobulin E; Linseed; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf333; Seeds; Serum; SR	4180186
1617718	Flaxseed IgE Qn	4180186
1617719	Activ; Actvty; Dextro; Finding; Findings; H+P; H+P.HX; Movements; Ordinal; P prime; Physical activity min 30 M/day; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1617719	Physical activity min 30 M/day	4180186
1617719	30:::^:	4182948
1617726	 .IgG:::::	4182948
1617726	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbovirus; Autoantibodies; Autoantibody; BFV; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
1617726	BFV IgG CSF Ql IA	4180186
1617729	:::::	4182948
1617729	Actiq; Addiction; Desmethyl fentanyl; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; hydrochloride; Illicit; N- phenyl- N- [1- (2- phenylethyl)- 4- piperidinyl]- acetamide, monohydrochloride; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sublimaze	4180186
1617729	Acetyl fentanyl TissCo Ql Scn	4180186
1617731	:::::.	4182948
1617731	Crys; Cryst; Crystal; Ejaculate; HEMATOLOGY/CELL COUNTS; Identity or presence; LM; Micro; Micros; Microscopic; Nominal; Point in time; Random; Sem; Seminal fluid; Smn; SMPLS	4180186
1617731	Crystals Smn Micro	4180186
1617733	:::::	4182948
1617733	Cocaine/Ethanol By-Product; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1617733	Cocaethylene TissCo Ql Scn	4180186
1617735	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1617738	 :::.>::X	4182948
1617738	1V; Document; EXT; Extr-R; Film; Finding; Findings; Great toe-R; Imaging; LE; Leg; LE-R; Low; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Phalange; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Single View; VW; Xray; X-ray	4180186
1617738	XR Great toe-R Obl	4180186
1617739	 ^:::.>::X	4182948
1617739	XR LE joint-R Views Lat W man stress	4180186
1617739	Document; EXT; Extr-R; Films; Finding; Findings; Imaging; Jnt; Lat; LE; LE joint-R; Leg; LE-R; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RLE; RT; View; VWS; W man stress; W Stress); Xray; X-ray	4180186
1617741	 :::.>::X	4182948
1617741	XR Humerus-R AP	4180186
1617741	1V; Anterio-Posterior; Anteroposterior; Arm; Document; EXT; Extr-R; Film; Finding; Findings; Humerus-R; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; RUE; Single View; UE; UE-R; Up; Upper extremity; VW; Xray; X-ray	4180186
1617745	:::.>::	4182948
1617745	Arm; Document; Echography; Elbow-R; EXT; Extr-R; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; MSK; Musculoskeletal; Olecranon; Ortho; Orthopedics; Point in time; R; Radiology; Random; RT; RUE; Sonogram; Sonograph; Sonography; UE; UE-R; ULS; Ultrasound; Up; Upper extremity joint	4180186
1617745	US Guided Elbow-R Inj	4180186
1617748	 :::.>+::X	4182948
1617748	XR Radius+Ulna-Bl AP	4180186
1617748	1V; Anterio-Posterior; Anteroposterior; Arm; Bil; Bilat; Both; Document; EXT; Extr-Bl; Film; Finding; Findings; Forearm; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Radius+Ulna-Bl; Random; Single View; UE; UE-Bl; Up; Upper extremity; VW; Xray; X-ray	4180186
1617752	 :::.>.::X	4182948
1617752	1V; 2nd; 2nd toe; Document; EXT; Extr-L; Film; Finding; Findings; Imaging; index toe; L; LE; Leg; LE-L; LLE; Low; LT; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; Single View; Toe 2nd-L; VW; Xray; X-ray	4180186
1617752	XR Toe 2nd-L Obl	4180186
1617755	 :::.>::X	4182948
1617755	1V; Anterio-Posterior; Anteroposterior; Arm; Bil; Bilat; Both; Carpal bone; Carpal bones; Carpal bones and joint; Document; EXT; Extr-Bl; Film; Finding; Findings; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; UE; UE-Bl; Up; Upper extremity joint; VW; Wrist-Bl; Wrists; Xray; X-ray	4180186
1617755	XR Wrist-Bl AP	4180186
1617756	  +  + :::.>.::X	4182948
1617756	XR Toe 2nd-L AP+Lat+Obl	4180186
1617756	2nd; 2nd toe; Anterio-Posterior; Anteroposterior; AP+Lat; AP+Lat+Obl; Document; EXT; Extr-L; Films; Finding; Findings; Imaging; index toe; L; Lat; LE; Leg; LE-L; LLE; Low; LT; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; Toe 2nd-L; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617757	 :::.>::X	4182948
1617757	1V; Arm; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; RUE; Should-R; Single View; UE; UE-R; Up; Upper extremity joint; VW; Xray; X-ray	4180186
1617757	XR Should-R Bernageau	4180186
1617759	XR Wrist-L Rev Oblique	4180186
1617759	1V; Arm; Carpal bone; Carpal bones; Carpal bones and joint; Document; EXT; Extr-L; Film; Finding; Findings; Imaging; L; LT; LUE; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; REV; Rev Oblique; Single View; UE; UE-L; Up; Upper extremity joint; VW; Wrist-L; Xray; X-ray	4180186
1617759	 :::.>::X	4182948
1617761	 :::.>.::X	4182948
1617761	1V; 4th; Anterio-Posterior; Anteroposterior; Arm; Document; EXT; Extr-R; Film; Finding; Findings; Finger.4th-R; Finger-R; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; RUE; Single View; UE; UE-R; Up; VW; Xray; X-ray	4180186
1617761	XR Finger.4th-R AP	4180186
1617762	XR Toe 4th-Bl Lat	4180186
1617762	1V; 4th; 4th toe; Bil; Bilat; Both; Document; EXT; Extr-Bl; Film; Finding; Findings; Imaging; Lat; LE; LE-Bl; Leg; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; ring toe; Single View; Toe 4th-Bl; VW; Xray; X-ray	4180186
1617762	 :::.>.::X	4182948
1617764	 :::.>+::X	4182948
1617764	XR Tib+Fib-Bl AP	4180186
1617764	1V; Anterio-Posterior; Anteroposterior; Bil; Bilat; Both; Document; EXT; Extr-Bl; Film; Finding; Findings; Imaging; LE; LE-Bl; Leg; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; Tib+Fib-Bl; Tib-Bl; VW; Xray; X-ray	4180186
1617765	 :::.>.::X	4182948
1617765	1V; 5th; Anterio-Posterior; Anteroposterior; Arm; Document; EXT; Extr-L; Film; Finding; Findings; Finger.5th-L; Finger-L; Imaging; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; UE; UE-L; Up; VW; Xray; X-ray	4180186
1617765	XR Finger.5th-L AP	4180186
1617767	 :::>.::X	4182948
1617767	XR SC joint-L Obl	4180186
1617767	1V; CXR; Document; Film; Finding; Findings; Imaging; Jnt; L; LT; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; SC joint; SC joint-L; SCJ; Single View; Thorax; Upper extremity joint; VW; Xray; X-ray	4180186
1617768	 :::.>::X	4182948
1617768	XR Great toe-L Obl	4180186
1617768	1V; Document; EXT; Extr-L; Film; Finding; Findings; Great toe-L; Imaging; L; LE; Leg; LE-L; LLE; Low; LT; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; Single View; VW; Xray; X-ray	4180186
1617769	1V; Arm; Carpal bone; Carpal bones; Carpal bones and joint; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Pisiform+Triquetrum-R; Plain Films; Point in time; R; Radiology; Random; RT; RUE; Single View; UE; UE-R; Up; Upper extremity joint; VW; Wrist-R; Xray; X-ray	4180186
1617769	XR Pisiform+Triquetrum-R 1V	4180186
1617769	:::.>.+::X	4182948
1617770	 :::+>.::X	4182948
1617770	XR TLJ AP	4180186
1617770	1V; Abd; Abdo; Abdomen+; Abdominal; Anterio-Posterior; Anteroposterior; AP abdomen; Chest + Abd; CXR; Document; Film; Finding; Findings; Imaging; Kidney-Ureter-Bladder; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; Spinal; Spinal Cord; Spine thoracolumbar junction; Thorax; TLJ; View AP KUB; VW; Xray; X-ray	4180186
1617771	  +  + :::.>.::X	4182948
1617771	3rd; 3rd toe; Anterio-Posterior; Anteroposterior; AP+Lat; AP+Lat+Obl; Document; EXT; Extr-L; Films; Finding; Findings; Imaging; L; Lat; LE; Leg; LE-L; LLE; Low; LT; middle toe; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; Toe 3rd-L; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617771	XR Toe 3rd-L AP+Lat+Obl	4180186
1617774	 :::.>.::X	4182948
1617774	XR Finger.4th-L AP	4180186
1617774	1V; 4th; Anterio-Posterior; Anteroposterior; Arm; Document; EXT; Extr-L; Film; Finding; Findings; Finger.4th-L; Finger-L; Imaging; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; UE; UE-L; Up; VW; Xray; X-ray	4180186
1617776	Broden limited; Calcaneous; Document; EXT; Extr-L; Films; Finding; Findings; Heel; Heel-L; III; Imaging; L; LE; LE 3V; LE 3V Broden; Leg; LE-L; Less than or equal to 3; Limited Broden; LLE; Low; LT; Maximum 3 views; MSK; Musculoskeletal; Ortho; Orthopedics; Os calcis; Oscalcis; Plain Films; Point in time; Radiology; Random; View; VWS; Xray; X-ray	4180186
1617776	XR Heel-L LE 3V Broden	4180186
1617776	 LE  Broden:::.>::X	4182948
1617778	 :::.>.::X	4182948
1617778	1V; 3rd; 3rd toe; Anterio-Posterior; Anteroposterior; Document; EXT; Extr-L; Film; Finding; Findings; Imaging; L; LE; Leg; LE-L; LLE; Low; LT; middle toe; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; Single View; Toe 3rd-L; VW; Xray; X-ray	4180186
1617778	XR Toe 3rd-L AP	4180186
1617781	 :::.>.::X	4182948
1617781	XR Toe 5th-R Lat	4180186
1617781	1V; 5th; 5th toe; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; Lat; LE; Leg; LE-R; little toe; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Single View; Toe 5th-R; VW; Xray; X-ray	4180186
1617783	 :::.>.::X	4182948
1617783	1V; 2nd; Arm; Document; EXT; Extr-R; Film; Finding; Findings; Finger.2nd-R; Finger-R; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Postero-Anterior; R; Radiology; Random; RT; RUE; Single View; UE; UE-R; Up; VW; Xray; X-ray	4180186
1617783	XR Finger.2nd-R PA	4180186
1617784	XR STT-Bl Views	4180186
1617784	Arm; Bil; Bilat; Both; Carpal bone; Carpal bones; Carpal bones and joint; Document; EXT; Extr-Bl; Films; Finding; Findings; Imaging; MSK; Musculoskeletal; Navicular (wrist); Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; STT-Bl; UE; UE-Bl; Up; Upper extremity joint; View; VWS; Wrist-Bl; Wrists; Xray; X-ray	4180186
1617784	:::.>.++::X	4182948
1617785	:::.>::	4182948
1617785	Arm; Document; Echography; Elbow-L; EXT; Extr-L; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; L; LT; LUE; MSK; Musculoskeletal; Olecranon; Ortho; Orthopedics; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; UE; UE-L; ULS; Ultrasound; Up; Upper extremity joint	4180186
1617785	US Guided Elbow-L Inj	4180186
1617788	  + :::.>.::X	4182948
1617788	3rd; 3rd toe; Anterio-Posterior; Anteroposterior; AP+Lat; Document; EXT; Extr-R; Films; Finding; Findings; Imaging; Lat; LE; Leg; LE-R; Low; middle toe; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Toe 3rd-R; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617788	XR Toe 3rd-R AP+Lat	4180186
1617789	 :::.>::X	4182948
1617789	1V; Arm; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; RUE; Single View; Thumb-R; UE; UE-R; Up; VW; Xray; X-ray	4180186
1617789	XR Thumb-R Obl	4180186
1617790	1V; Arm; Carpal bone; Carpal bones; Carpal bones and joint; Document; EXT; Extr-L; Film; Finding; Findings; Hamate-L; Imaging; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; UE; UE-L; Up; Upper extremity joint; VW; Wrist-L; Xray; X-ray	4180186
1617790	XR Hamate-L 1V	4180186
1617790	:::.>.::X	4182948
1617791	 :::.>+::X	4182948
1617791	XR Tib+Fib-Bl Lat	4180186
1617791	1V; Bil; Bilat; Both; Document; EXT; Extr-Bl; Film; Finding; Findings; Imaging; Lat; LE; LE-Bl; Leg; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; Tib+Fib-Bl; Tib-Bl; VW; Xray; X-ray	4180186
1617792	  +  + :::.>.::X	4182948
1617792	XR Toe 3rd-R AP+Lat+Obl	4180186
1617792	3rd; 3rd toe; Anterio-Posterior; Anteroposterior; AP+Lat; AP+Lat+Obl; Document; EXT; Extr-R; Films; Finding; Findings; Imaging; Lat; LE; Leg; LE-R; Low; middle toe; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Phalange; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Toe 3rd-R; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617793	 :::>::X	4182948
1617793	1V; Anterio-Posterior; Anteroposterior; Document; Film; Finding; Findings; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Pelvic; Plain Films; Point in time; Radiology; Random; Single View; VW; Xray; X-ray	4180186
1617795	 :::.>::X	4182948
1617795	XR Elbow-L AP	4180186
1617795	1V; Anterio-Posterior; Anteroposterior; Arm; Document; Elbow-L; EXT; Extr-L; Film; Finding; Findings; Imaging; L; LT; LUE; MSK; Musculoskeletal; Olecranon; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; UE; UE-L; Up; Upper extremity joint; VW; Xray; X-ray	4180186
1617800	  +  + :::.>.::X	4182948
1617800	4th; 4th toe; Anterio-Posterior; Anteroposterior; AP+Lat; AP+Lat+Obl; Document; EXT; Extr-L; Films; Finding; Findings; Imaging; L; Lat; LE; Leg; LE-L; LLE; Low; LT; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; ring toe; Toe 4th-L; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617800	XR Toe 4th-L AP+Lat+Obl	4180186
1617802	  + :::.>.::X	4182948
1617802	XR Toe 5th-R AP+Lat	4180186
1617802	5th; 5th toe; Anterio-Posterior; Anteroposterior; AP+Lat; Document; EXT; Extr-R; Films; Finding; Findings; Imaging; Lat; LE; Leg; LE-R; little toe; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Toe 5th-R; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617805	 :::.>::X	4182948
1617805	1V; Arm; Carpal bone; Carpal bones; Carpal bones and joint; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; Lat; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; RUE; Single View; UE; UE-R; Up; Upper extremity joint; VW; Wrist-R; Xray; X-ray	4180186
1617805	XR Wrist-R Lat	4180186
1617806	XR Heel-Bl LE 3V Broden	4180186
1617806	Bil; Bilat; Both; Broden limited; Calcanei; Calcaneous; Document; EXT; Extr-Bl; Films; Finding; Findings; Heel; Heel-Bl; Heels; III; Imaging; LE; LE 3V; LE 3V Broden; LE-Bl; Leg; Less than or equal to 3; Limited Broden; Low; Maximum 3 views; MSK; Musculoskeletal; Ortho; Orthopedics; Os calcis; Oscalcis; Plain Films; Point in time; Radiology; Random; View; VWS; Xray; X-ray	4180186
1617806	 LE  Broden:::.>::X	4182948
1617809	^:::+::MR	4182948
1617809	Abd; Abd+Pelvis; Abdo; Abdominal; c; Contr; Contra; Contrst; Document; Finding; Findings; Imaging; Mitral regurgitation maximum velocity; MRI; Pelvic; Point in time; Radiology; Random; without contrast	4180186
1617809	MR Abd+Pelvis WO contr	4180186
1617813	  +  + :::.>.::X	4182948
1617813	XR Toe 5th-R AP+Lat+Obl	4180186
1617813	5th; 5th toe; Anterio-Posterior; Anteroposterior; AP+Lat; AP+Lat+Obl; Document; EXT; Extr-R; Films; Finding; Findings; Imaging; Lat; LE; Leg; LE-R; little toe; Low; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Phalange; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Toe 5th-R; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617816	  + :::.>.::X	4182948
1617816	5th; 5th toe; Anterio-Posterior; Anteroposterior; AP+Lat; Document; EXT; Extr-L; Films; Finding; Findings; Imaging; L; Lat; LE; Leg; LE-L; little toe; LLE; Low; LT; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; Toe 5th-L; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617816	XR Toe 5th-L AP+Lat	4180186
1617819	 :::.>.::X	4182948
1617819	XR Finger.4th-L Lat	4180186
1617819	1V; 4th; Arm; Document; EXT; Extr-L; Film; Finding; Findings; Finger.4th-L; Finger-L; Imaging; L; Lat; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; UE; UE-L; Up; VW; Xray; X-ray	4180186
1617821	 :::.>.::X	4182948
1617821	XR Finger.3rd-R Lat	4180186
1617821	1V; 3rd; Arm; Document; EXT; Extr-R; Film; Finding; Findings; Finger.3rd-R; Finger-R; Imaging; Lat; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; RUE; Single View; UE; UE-R; Up; VW; Xray; X-ray	4180186
1617822	1V; Calcaneous; Document; EXT; Extr-L; Film; Finding; Findings; Heel; Heel-L; Imaging; Kelly; L; LE; Leg; LE-L; LLE; Low; LT; Modified AP; MSK; Musculoskeletal; Ortho; Orthopedics; Os calcis; Oscalcis; Plain Films; Point in time; Radiology; Random; Single View; VW; Xray; X-ray	4180186
1617822	XR Heel-L Canale	4180186
1617822	 Canale:::.>::X	4182948
1617823	  + :::>.::X	4182948
1617823	Anterio-Posterior; Anteroposterior; AP+Obl; Bil; Bilat; Both; Clavicle-Bl; Clavicles; CXR; Document; Films; Finding; Findings; Imaging; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Thorax; Upper extremity; View; Views & AP KUB; Views (AP; Views+AP; VWS; Xray; X-ray	4180186
1617823	XR Clavicle-Bl AP+Obl	4180186
1617824	 :::.>.::X	4182948
1617824	XR Finger.2nd-R AP	4180186
1617824	1V; 2nd; Anterio-Posterior; Anteroposterior; Arm; Document; EXT; Extr-R; Film; Finding; Findings; Finger.2nd-R; Finger-R; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; RUE; Single View; UE; UE-R; Up; VW; Xray; X-ray	4180186
1617825	 :::.>.::X	4182948
1617825	XR Finger.5th-R AP	4180186
1617825	1V; 5th; Anterio-Posterior; Anteroposterior; Arm; Document; EXT; Extr-R; Film; Finding; Findings; Finger.5th-R; Finger-R; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; RUE; Single View; UE; UE-R; Up; VW; Xray; X-ray	4180186
1617827	 :::.>.::X	4182948
1617827	1V; 5th; Arm; Document; EXT; Extr-R; Film; Finding; Findings; Finger.5th-R; Finger-R; Imaging; Lat; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; RUE; Single View; UE; UE-R; Up; VW; Xray; X-ray	4180186
1617827	XR Finger.5th-R Lat	4180186
1617828	 :::.>+::X	4182948
1617828	1V; Anterio-Posterior; Anteroposterior; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; LE; Leg; LE-R; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Single View; Tib+Fib-R; Tib-R; VW; Xray; X-ray	4180186
1617828	XR Tib+Fib-R AP	4180186
1617832	 :::.>+::X	4182948
1617832	XR Radius+Ulna-R Lat	4180186
1617832	1V; Arm; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; Lat; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Radius+Ulna-R; Random; RT; RUE; Single View; UE; UE-R; Up; Upper extremity; VW; Xray; X-ray	4180186
1617833	XR Wrist-Bl Radial deviation	4180186
1617833	Arm; Bil; Bilat; Both; Carpal bone; Carpal bones; Carpal bones and joint; Document; EXT; Extr-Bl; Films; Finding; Findings; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; UE; UE-Bl; Up; Upper extremity joint; View; VWS; Wrist-Bl; Wrists; Xray; X-ray	4180186
1617833	 :::.>::X	4182948
1617835	 :::.>::X	4182948
1617835	1V; Arm; Document; EXT; Extr-L; Film; Finding; Findings; Humerus-L; Imaging; L; Lat; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; UE; UE-L; Up; Upper extremity; VW; Xray; X-ray	4180186
1617835	XR Humerus-L Lat	4180186
1617836	 :::.>.::X	4182948
1617836	XR Toe 3rd-R AP	4180186
1617836	1V; 3rd; 3rd toe; Anterio-Posterior; Anteroposterior; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; LE; Leg; LE-R; Low; middle toe; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Single View; Toe 3rd-R; VW; Xray; X-ray	4180186
1617837	 :::.>::X	4182948
1617837	1V; Arm; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Postero-Anterior; R; Radiology; Random; RT; RUE; Single View; Thumb-R; UE; UE-R; Up; VW; Xray; X-ray	4180186
1617837	XR Thumb-R PA	4180186
1617842	 :::.>.::X	4182948
1617842	1V; 2nd; Anterio-Posterior; Anteroposterior; Arm; Bil; Bilat; Both; Document; EXT; Extr-Bl; Film; Finding; Findings; Finger.2nd-Bl; Finger-Bl; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; UE; UE-Bl; Up; VW; Xray; X-ray	4180186
1617842	XR Finger.2nd-Bl AP	4180186
1617843	 :::.>.::X	4182948
1617843	1V; 2nd; Arm; Bil; Bilat; Both; Document; EXT; Extr-Bl; Film; Finding; Findings; Finger.2nd-Bl; Finger-Bl; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Postero-Anterior; Radiology; Random; Single View; UE; UE-Bl; Up; VW; Xray; X-ray	4180186
1617843	XR Finger.2nd-Bl PA	4180186
1617846	  + :::.>.::X	4182948
1617846	5th; Anterio-Posterior; Anteroposterior; AP+Lat; Arm; Document; EXT; Extr-L; Films; Finding; Findings; Finger.5th-L; Finger-L; Imaging; L; Lat; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; UE; UE-L; Up; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617846	XR Finger.5th-L AP+Lat	4180186
1617848	XR T+L-Spine Views PA for Scoli W Stand	4180186
1617848	 ^:::>. & >.::X	4182948
1617848	Abd; Abdo; Abdomen+; Abdominal; CXR; Document; Dorsal spine; Films; Finding; Findings; Imaging; L/sp; L-spine; Lumbar; Lumbo; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Postero-Anterior; Radiology; Random; Spinal; Spinal Cord; Stand); T Spine+Ab; T+L-Spine; Th/sp; Thorax; T-spine; View; Views+PA; VWS; WB; Weight bearing; Xray; X-ray	4180186
1617851	 :::.>::X	4182948
1617851	XR Heel-R Lat	4180186
1617851	1V; Calcaneous; Document; EXT; Extr-R; Film; Finding; Findings; Heel; Heel-R; Imaging; Lat; LE; Leg; LE-R; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Os calcis; Oscalcis; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Single View; VW; Xray; X-ray	4180186
1617852	:::>.::X	4182948
1617852	Abd; Abdo; Abdomen+; Abdominal; Document; Films; Finding; Findings; Gastro; Gastroenterology; GI; Imaging; Plain Films; Point in time; Radiology; Random; UGI; Up; View; VWS; Xray; X-ray	4180186
1617852	XR UGI Views	4180186
1617853	:::>::	4182948
1617853	Brain; Cranial; Cranium; Document; Echoencephalogram; Echoencephalography; Echography; Eyeball; Finding; Findings; Imaging; Intracranial; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Radiology; Random; Skull; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vision; Visual	4180186
1617854	 :::.>.::X	4182948
1617854	XR Toe 3rd-R Obl	4180186
1617854	1V; 3rd; 3rd toe; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; LE; Leg; LE-R; Low; middle toe; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Phalange; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Single View; Toe 3rd-R; VW; Xray; X-ray	4180186
1617856	 :::.>.::X	4182948
1617856	1V; 2nd; 2nd toe; Anterio-Posterior; Anteroposterior; Bil; Bilat; Both; Document; EXT; Extr-Bl; Film; Finding; Findings; Imaging; index toe; LE; LE-Bl; Leg; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; Single View; Toe 2nd-Bl; VW; Xray; X-ray	4180186
1617856	XR Toe 2nd-Bl AP	4180186
1617859	 :::>.::X	4182948
1617859	XR SC joint-R Obl	4180186
1617859	1V; CXR; Document; Film; Finding; Findings; Imaging; Jnt; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; SC joint; SC joint-R; SCJ; Single View; Thorax; Upper extremity joint; VW; Xray; X-ray	4180186
1617863	 :::.>.::X	4182948
1617863	1V; 2nd; Arm; Document; EXT; Extr-L; Film; Finding; Findings; Finger.2nd-L; Finger-L; Imaging; L; Lat; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; UE; UE-L; Up; VW; Xray; X-ray	4180186
1617863	XR Finger.2nd-L Lat	4180186
1617867	 :::.>+::X	4182948
1617867	XR Tib+Fib-R Lat	4180186
1617867	1V; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; Lat; LE; Leg; LE-R; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Single View; Tib+Fib-R; Tib-R; VW; Xray; X-ray	4180186
1617868	 :::.>::X	4182948
1617868	1V; Anterio-Posterior; Anteroposterior; Arm; Carpal bone; Carpal bones; Carpal bones and joint; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; RUE; Single View; UE; UE-R; Up; Upper extremity joint; VW; Wrist-R; Xray; X-ray	4180186
1617868	XR Wrist-R AP	4180186
1617870	 :::.>::X	4182948
1617870	XR Great toe-L AP	4180186
1617870	1V; Anterio-Posterior; Anteroposterior; Document; EXT; Extr-L; Film; Finding; Findings; Great toe-L; Imaging; L; LE; Leg; LE-L; LLE; Low; LT; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; Single View; VW; Xray; X-ray	4180186
1617872	  + :::.>.::X	4182948
1617872	XR Finger.5th-R AP+Lat	4180186
1617872	5th; Anterio-Posterior; Anteroposterior; AP+Lat; Arm; Document; EXT; Extr-R; Films; Finding; Findings; Finger.5th-R; Finger-R; Imaging; Lat; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; RUE; UE; UE-R; Up; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617876	XR STT-L 1V	4180186
1617876	1V; Arm; Carpal bone; Carpal bones; Carpal bones and joint; Document; EXT; Extr-L; Film; Finding; Findings; Imaging; L; LT; LUE; MSK; Musculoskeletal; Navicular (wrist); Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; STT-L; UE; UE-L; Up; Upper extremity joint; VW; Wrist-L; Xray; X-ray	4180186
1617876	:::.>.++::X	4182948
1617878	 :::.>.::X	4182948
1617878	1V; 4th; Arm; Document; EXT; Extr-L; Film; Finding; Findings; Finger.4th-L; Finger-L; Imaging; L; LT; LUE; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; UE; UE-L; Up; VW; Xray; X-ray	4180186
1617878	XR Finger.4th-L Obl	4180186
1617880	 :::.>.::X	4182948
1617880	XR Toe 2nd-Bl Obl	4180186
1617880	1V; 2nd; 2nd toe; Bil; Bilat; Both; Document; EXT; Extr-Bl; Film; Finding; Findings; Imaging; index toe; LE; LE-Bl; Leg; Low; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; Single View; Toe 2nd-Bl; VW; Xray; X-ray	4180186
1617881	 :::>.::X	4182948
1617881	XR Clavicle-R Obl	4180186
1617881	1V; Clavicle-R; CXR; Document; Film; Finding; Findings; Imaging; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; Single View; Thorax; Upper extremity; VW; Xray; X-ray	4180186
1617883	 :::.>.::X	4182948
1617883	XR Toe 4th-Bl Obl	4180186
1617883	1V; 4th; 4th toe; Bil; Bilat; Both; Document; EXT; Extr-Bl; Film; Finding; Findings; Imaging; LE; LE-Bl; Leg; Low; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; ring toe; Single View; Toe 4th-Bl; VW; Xray; X-ray	4180186
1617884	XR Ft.Cuneiforms-Bl Views	4180186
1617884	Bil; Bilat; Both; Document; EXT; Extr-Bl; Films; Finding; Findings; Foot-Bl; Ft; Ft.Cuneiforms-Bl; Imaging; LE; LE-Bl; Leg; Low; Lower extremity; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; View; VWS; Xray; X-ray	4180186
1617884	:::.>.::X	4182948
1617885	 :::.>.::X	4182948
1617885	XR Finger.5th-L Lat	4180186
1617885	1V; 5th; Arm; Document; EXT; Extr-L; Film; Finding; Findings; Finger.5th-L; Finger-L; Imaging; L; Lat; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; UE; UE-L; Up; VW; Xray; X-ray	4180186
1617886	 :::.>+::X	4182948
1617886	XR Tib+Fib-L Lat	4180186
1617886	1V; Document; EXT; Extr-L; Film; Finding; Findings; Imaging; L; Lat; LE; Leg; LE-L; LLE; Low; LT; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; Tib+Fib-L; Tib-L; VW; Xray; X-ray	4180186
1617887	 :::.>::X	4182948
1617887	XR Wrist-L AP	4180186
1617887	1V; Anterio-Posterior; Anteroposterior; Arm; Carpal bone; Carpal bones; Carpal bones and joint; Document; EXT; Extr-L; Film; Finding; Findings; Imaging; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; UE; UE-L; Up; Upper extremity joint; VW; Wrist-L; Xray; X-ray	4180186
1617891	XR Thumb-L Radial deviation	4180186
1617891	Arm; Document; EXT; Extr-L; Films; Finding; Findings; Imaging; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Thumb-L; UE; UE-L; Up; View; VWS; Xray; X-ray	4180186
1617891	 :::.>::X	4182948
1617893	  + :::.>.::X	4182948
1617893	2nd; Anterio-Posterior; Anteroposterior; AP+Lat; Arm; Document; EXT; Extr-R; Films; Finding; Findings; Finger.2nd-R; Finger-R; Imaging; Lat; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; RUE; UE; UE-R; Up; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617893	XR Finger.2nd-R AP+Lat	4180186
1617895	 :::>.::X	4182948
1617895	1V; Anterio-Posterior; Anteroposterior; CXR; Document; Film; Finding; Findings; Imaging; Jnt; L; LT; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; SC joint; SC joint-L; SCJ; Single View; Thorax; Upper extremity joint; VW; Xray; X-ray	4180186
1617895	XR SC joint-L AP	4180186
1617898	  + :::.>.::X	4182948
1617898	XR Toe 2nd-L AP+Lat	4180186
1617898	2nd; 2nd toe; Anterio-Posterior; Anteroposterior; AP+Lat; Document; EXT; Extr-L; Films; Finding; Findings; Imaging; index toe; L; Lat; LE; Leg; LE-L; LLE; Low; LT; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; Toe 2nd-L; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617900	  +  + :::.>::X	4182948
1617900	Anterio-Posterior; Anteroposterior; AP+Lat; AP+Lat+Obl; Document; EXT; Extr-L; Films; Finding; Findings; Great toe-L; Imaging; L; Lat; LE; Leg; LE-L; LLE; Low; LT; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617900	XR Great toe-L AP+Lat+Obl	4180186
1617902	 :::>::X	4182948
1617902	CXR; Document; Films; Finding; Findings; Imaging; Obl; Plain Films; Point in time; Radiology; Random; Thorax; View; Views+Obl; VWS; Xiphoid; Xray; X-ray; Xyphoid	4180186
1617902	XR Sternum Views Obl	4180186
1617903	 :::.>.::X	4182948
1617903	1V; 4th; 4th toe; Anterio-Posterior; Anteroposterior; Document; EXT; Extr-L; Film; Finding; Findings; Imaging; L; LE; Leg; LE-L; LLE; Low; LT; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; ring toe; Single View; Toe 4th-L; VW; Xray; X-ray	4180186
1617903	XR Toe 4th-L AP	4180186
1617905	XR Stomach+Duodenum Views	4180186
1617905	Abd; Abdo; Abdomen+; Abdominal; Document; Films; Finding; Findings; Gastro; Gastroenterology; GI; Imaging; Plain Films; Point in time; Radiology; Random; View; VWS; Xray; X-ray	4180186
1617905	:::>+::X	4182948
1617906	 :::.>::X	4182948
1617906	XR Great toe-R AP	4180186
1617906	1V; Anterio-Posterior; Anteroposterior; Document; EXT; Extr-R; Film; Finding; Findings; Great toe-R; Imaging; LE; Leg; LE-R; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Single View; VW; Xray; X-ray	4180186
1617908	XR Pisiform+Triquetrum-L 1V	4180186
1617908	1V; Arm; Carpal bone; Carpal bones; Carpal bones and joint; Document; EXT; Extr-L; Film; Finding; Findings; Imaging; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Pisiform+Triquetrum-L; Plain Films; Point in time; Radiology; Random; Single View; UE; UE-L; Up; Upper extremity joint; VW; Wrist-L; Xray; X-ray	4180186
1617908	:::.>.+::X	4182948
1617909	Document; DOP; DUPLEX; Echography; EXT; Extr-L; Finding; Findings; Foot-L; Ft ves-L; Imaging; L; LE; Leg; LE-L; LLE; Low; Lower extremity; LT; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vesl; Vessels.XXX	4180186
1617909	DOP Ft ves-L	4180186
1617909	:::.>::.	4182948
1617911	Arm; Document; DOP; DUPLEX; Echography; EXT; Extr-R; Finding; Findings; Hand ves-R; Hand-R; Imaging; Point in time; R; Radiology; Random; RT; RUE; Sonogram; Sonograph; Sonography; UE; UE-R; ULS; Ultrasound; Up; Upper extremity; Vesl; Vessels.XXX	4180186
1617911	DOP Hand ves-R	4180186
1617911	:::.>::.	4182948
1617912	  :::>::X	4182948
1617912	XR Should AP ER	4180186
1617912	1V; Anterio-Posterior; Anteroposterior; AP ER; Arm; Document; EXT; Film; Finding; Findings; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; UE; Up; Upper extremity joint; VW; Xray; X-ray	4180186
1617917	XR Knee-Bl 1V W valgus stress	4180186
1617917	1V; Bil; Bilat; Both; Document; EXT; Extr-Bl; Film; Finding; Findings; Imaging; Kn; Knee-Bl; Knees; LE; LE-Bl; Leg; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; VW; Xray; X-ray	4180186
1617917	^:::.>::X	4182948
1617920	 :::.>.::X	4182948
1617920	1V; 3rd; Arm; Document; EXT; Extr-R; Film; Finding; Findings; Finger.3rd-R; Finger-R; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Postero-Anterior; R; Radiology; Random; RT; RUE; Single View; UE; UE-R; Up; VW; Xray; X-ray	4180186
1617920	XR Finger.3rd-R PA	4180186
1617921	 :::.>::X	4182948
1617921	XR Elbow-R Lat	4180186
1617921	1V; Arm; Document; Elbow-R; EXT; Extr-R; Film; Finding; Findings; Imaging; Lat; MSK; Musculoskeletal; Olecranon; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; RUE; Single View; UE; UE-R; Up; Upper extremity joint; VW; Xray; X-ray	4180186
1617922	Arm; Bil; Bilat; Both; Carpal bone; Carpal bones; Carpal bones and joint; Document; EXT; Extr-Bl; Films; Finding; Findings; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Pisiform+Triquetrum-Bl; Plain Films; Point in time; Radiology; Random; UE; UE-Bl; Up; Upper extremity joint; View; VWS; Wrist-Bl; Wrists; Xray; X-ray	4180186
1617922	XR Pisiform+Triquetrum-Bl Views	4180186
1617922	:::.>.+::X	4182948
1617924	1V; Ankle-Bl; Ankles; Bil; Bilat; Both; Document; EXT; Extr-Bl; Film; Finding; Findings; Grav; Imaging; LE; LE-Bl; Leg; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; True AP ankle; VW; Xray; X-ray	4180186
1617924	XR Ankle-Bl Mortise W gravity stress	4180186
1617924	 ^:::.>::X	4182948
1617929	Arm; Document; DOP; DUPLEX; Echography; EXT; Extr-L; Finding; Findings; Hand ves-L; Hand-L; Imaging; L; LT; LUE; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; UE; UE-L; ULS; Ultrasound; Up; Upper extremity; Vesl; Vessels.XXX	4180186
1617929	DOP Hand ves-L	4180186
1617929	:::.>::.	4182948
1617931	Art; Document; DOP; DUPLEX; Echography; EXT; Extr-L; Fem a; Fem a+Pop a-L; Fem a+Popliteal a; Fem a-L; Finding; Findings; Imaging; Knee Artery; L; LE; Leg; LE-L; LLE; Low; LT; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Thigh; ULS; Ultrasound	4180186
1617931	DOP Fem a+Pop a-L	4180186
1617931	:::.>+::.	4182948
1617932	 :::>::X	4182948
1617932	XR Sternum Views PA	4180186
1617932	CXR; Document; Films; Finding; Findings; Imaging; Plain Films; Point in time; Postero-Anterior; Radiology; Random; Thorax; View; Views+PA; VWS; Xiphoid; Xray; X-ray; Xyphoid	4180186
1617936	^:::>.::X	4182948
1617936	1V; C/sp; Cerv; C-spine; Document; Film; Finding; Findings; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Single View; Spinal; Spinal Cord; VW; W Flx; Xray; X-ray	4180186
1617936	XR C-spine 1V W Flx	4180186
1617938	 :::>+::X	4182948
1617938	Document; Films; Finding; Findings; Imaging; Lat; MSK; Musculoskeletal; Ortho; Orthopedics; Pelvic; Plain Films; Point in time; Radiology; Random; View; VWS; Xray; X-ray	4180186
1617938	XR Sacrum+Coccyx Views Lat	4180186
1617939	 :::.>::X	4182948
1617939	1V; Bil; Bilat; Both; Document; EXT; Extr-Bl; Film; Finding; Findings; Great toe-Bl; Imaging; Lat; LE; LE-Bl; Leg; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; Single View; VW; Xray; X-ray	4180186
1617939	XR Great toe-Bl Lat	4180186
1617941	 :::.>::X	4182948
1617941	1V; Bil; Bilat; Both; Calcanei; Calcaneous; Document; EXT; Extr-Bl; Film; Finding; Findings; Heel; Heel-Bl; Heels; Imaging; Lat; LE; LE-Bl; Leg; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Os calcis; Oscalcis; Plain Films; Point in time; Radiology; Random; Single View; VW; Xray; X-ray	4180186
1617941	XR Heel-Bl Lat	4180186
1617946	  + :::.>.::X	4182948
1617946	4th; Anterio-Posterior; Anteroposterior; AP+Lat; Arm; Document; EXT; Extr-L; Films; Finding; Findings; Finger.4th-L; Finger-L; Imaging; L; Lat; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; UE; UE-L; Up; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617946	XR Finger.4th-L AP+Lat	4180186
1617947	  + :::.>.::X	4182948
1617947	4th; 4th toe; Anterio-Posterior; Anteroposterior; AP+Lat; Document; EXT; Extr-R; Films; Finding; Findings; Imaging; Lat; LE; Leg; LE-R; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; R; Radiology; Random; ring toe; RLE; RT; Toe 4th-R; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617947	XR Toe 4th-R AP+Lat	4180186
1617950	 :::.>.::X	4182948
1617950	XR Toe 3rd-L Obl	4180186
1617950	1V; 3rd; 3rd toe; Document; EXT; Extr-L; Film; Finding; Findings; Imaging; L; LE; Leg; LE-L; LLE; Low; LT; middle toe; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; Single View; Toe 3rd-L; VW; Xray; X-ray	4180186
1617953	 :::.>::X	4182948
1617953	1V; Arm; Document; EXT; Extr-L; Film; Finding; Findings; Imaging; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Should-L; Single View; UE; UE-L; Up; Upper extremity joint; VW; Xray; X-ray	4180186
1617953	XR Should-L Bernageau	4180186
1617954	  + :::.>.::X	4182948
1617954	XR Finger.3rd-R AP+Lat	4180186
1617954	3rd; Anterio-Posterior; Anteroposterior; AP+Lat; Arm; Document; EXT; Extr-R; Films; Finding; Findings; Finger.3rd-R; Finger-R; Imaging; Lat; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; RUE; UE; UE-R; Up; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617956	 :::.>.::X	4182948
1617956	1V; 2nd; 2nd toe; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; index toe; Lat; LE; Leg; LE-R; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Single View; Toe 2nd-R; VW; Xray; X-ray	4180186
1617956	XR Toe 2nd-R Lat	4180186
1617957	 :::.>.::X	4182948
1617957	XR Toe 4th-Bl AP	4180186
1617957	1V; 4th; 4th toe; Anterio-Posterior; Anteroposterior; Bil; Bilat; Both; Document; EXT; Extr-Bl; Film; Finding; Findings; Imaging; LE; LE-Bl; Leg; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; ring toe; Single View; Toe 4th-Bl; VW; Xray; X-ray	4180186
1617963	 :::>.::X	4182948
1617963	XR Clavicle-R AP	4180186
1617963	1V; Anterio-Posterior; Anteroposterior; Clavicle-R; CXR; Document; Film; Finding; Findings; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; Single View; Thorax; Upper extremity; VW; Xray; X-ray	4180186
1617964	XR Forefoot-R Views	4180186
1617964	Document; EXT; Extr-R; Films; Finding; Findings; Forefoot-R; Imaging; LE; Leg; LE-R; Low; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RLE; RT; View; VWS; Xray; X-ray	4180186
1617964	:::.>::X	4182948
1617967	 :::>.::X	4182948
1617967	1V; CXR; Document; Film; Finding; Findings; Imaging; L; LT; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; Ribs-L; Single View; Thorax; VW; Xray; X-ray	4180186
1617967	XR Ribs-L Obl	4180186
1617968	Document; EXT; Extr-L; Films; Finding; Findings; Foot-L; Ft.Cuneiforms-L; Imaging; L; LE; Leg; LE-L; LLE; Low; Lower extremity; LT; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; Radiology; Random; View; VWS; Xray; X-ray	4180186
1617968	XR Ft.Cuneiforms-L Views	4180186
1617968	:::.>.::X	4182948
1617969	  +  + :::.>.::X	4182948
1617969	XR Toe 4th-R AP+Lat+Obl	4180186
1617969	4th; 4th toe; Anterio-Posterior; Anteroposterior; AP+Lat; AP+Lat+Obl; Document; EXT; Extr-R; Films; Finding; Findings; Imaging; Lat; LE; Leg; LE-R; Low; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Phalange; Plain Films; Point in time; R; Radiology; Random; ring toe; RLE; RT; Toe 4th-R; View; Views & AP KUB; Views (AP; Views AP KUB & lateral; Views+AP; VWS; Xray; X-ray	4180186
1617972	 :::.>.::X	4182948
1617972	XR Toe 3rd-Bl AP	4180186
1617972	1V; 3rd; 3rd toe; Anterio-Posterior; Anteroposterior; Bil; Bilat; Both; Document; EXT; Extr-Bl; Film; Finding; Findings; Imaging; LE; LE-Bl; Leg; Low; middle toe; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; Single View; Toe 3rd-Bl; VW; Xray; X-ray	4180186
1617975	 :::>.::X	4182948
1617975	1V; Clavicle-R; CXR; Document; Film; Finding; Findings; Imaging; MSK; Musculoskeletal; Ortho; Orthopedics; Plain Films; Point in time; R; Radiology; Random; RT; Single View; Skyline; Tangential; Thorax; Upper extremity; VW; Xray; X-ray	4180186
1617975	XR Clavicle-R Axial	4180186
1617977	:::.>::	4182948
1617977	Arm; Bil; Bilat; Both; Document; Echography; Elbow-Bl; EXT; Extr-Bl; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; MSK; Musculoskeletal; Olecranon; Ortho; Orthopedics; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; UE; UE-Bl; ULS; Ultrasound; Up; Upper extremity joint	4180186
1617977	US Guided Elbow-Bl Inj	4180186
1617979	 :::.>.::X	4182948
1617979	1V; 3rd; 3rd toe; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; Lat; LE; Leg; LE-R; Low; middle toe; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Single View; Toe 3rd-R; VW; Xray; X-ray	4180186
1617979	XR Toe 3rd-R Lat	4180186
1617982	DOP Fem a+Pop a-R	4180186
1617982	Art; Document; DOP; DUPLEX; Echography; EXT; Extr-R; Fem a; Fem a+Pop a-R; Fem a+Popliteal a; Fem a-R; Finding; Findings; Imaging; Knee Artery; LE; Leg; LE-R; Low; Point in time; R; Radiology; Random; RLE; RT; Sonogram; Sonograph; Sonography; Thigh; ULS; Ultrasound	4180186
1617982	:::.>+::.	4182948
1617983	 :::.>.::X	4182948
1617983	1V; 3rd; 3rd toe; Document; EXT; Extr-L; Film; Finding; Findings; Imaging; L; Lat; LE; Leg; LE-L; LLE; Low; LT; middle toe; MSK; Musculoskeletal; Ortho; Orthopedics; Phalange; Plain Films; Point in time; Radiology; Random; Single View; Toe 3rd-L; VW; Xray; X-ray	4180186
1617983	XR Toe 3rd-L Lat	4180186
1618094	Horizontal prism.in intermediate	4180186
1618185	Vertical prism.up intermediate	4180186
1618685	Vertical prism.down intermediate	4180186
1618763	PANEL.CLIN	4180186
1618939	PANEL.BP	4180186
1619025	Blood; BSA.pred; Chemistry; EGFR; Estimated GFR; GFR; GFR/1.73 sq M; Glom; Pl; PlasBld; Plasma; Plsm; Point in time; Pred GFR; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; Square Meter; SR; Volume rate/area; Volume Rate/Ratio; WB; Whole blood	4180186
1619025	eGFRcr SerPlBld CKD-EPI 2021	4180186
1619025	/1.73 .::://:: (CKD-EPI 2021)	4182948
1619027	SARS-CoV-2 S RBD NAb Titr SerPl IA	4180186
1619027	2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; NAb; Pl; Plasma; Plsm; Point in time; PR; Prot; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 S; SARS-CoV-2 S RBD; SARS-CoV-2 S RBD Nab; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SmQn; SR; SUDS; surrogate virus neutralization testing; sVNT; Titer; Titered; Titre; Ttr; Viral Pneumonias; Wuhan coronavirus	4180186
1619027	SARS  2  RBD .:::/::	4182948
1619028	%; % neut SARS-CoV-2 S RBD; % neut SARS-CoV-2 S RBD Nab; 2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; NAb; Neut; Neutr; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 S; SARS-CoV-2 S RBD; SARS-CoV-2 S RBD Nab; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SR; SUDS; surrogate virus neutralization testing; sVNT; Viral Pneumonias; Wuhan coronavirus	4180186
1619028	SARS-CoV-2 S RBD NAb SerPl IA-%	4180186
1619028	SARS  2  RBD  .:::/::	4182948
1619029	SARS-CoV-2 S RBD NAb SerPl IA-aCnc	4180186
1619029	2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; NAb; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 S; SARS-CoV-2 S RBD; SARS-CoV-2 S RBD Nab; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SR; SUDS; surrogate virus neutralization testing; sVNT; Viral Pneumonias; Wuhan coronavirus	4180186
1619029	SARS  2  RBD .:::/::	4182948
1619031	2019 Novel Coronavirus; 2019-nCoV; Arbitrary concentration; bckgrd cor; Blood; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; IFN; IGRA; II; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 IFN-g; SARS-CoV-2 IFN-g Lymphs; Severe Acute Respiratory Syndrome; SUDS; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus	4180186
1619031	SARS-CoV-2 IFN-g Lymphs Bld IA	4180186
1619031	 SARS  2  gamma ^^:::::	4182948
1619076	(Fagus grandifolia+Pinus strobus+Thuja plicata+Abies alba)	4180186
1619082	Physalis peruviana Ab.IgE	4180186
1619087	Paraphenylenediamine Ab.IgE	4180186
1619096	People of my race or ethnicity are more likely to get the coronavirus	4180186
1619099	Upper extremity.bilateral>Hand vessels	4180186
1619111	Normoblasts.oxyphilic+polychromatophilic/Normoblasts.total	4180186
1619122	Trouble paying heating bill &or electricity bill	4180186
1619124	Oxygen saturation & therapy panel	4180186
1619128	How often have you used illegal or recreational drugs in past 12Mo	4180186
1619131	Horizontal prism.in far	4180186
1619133	Illegal or recreational drug(s) used in past 3Mo	4180186
1619137	Dizzy, lightheaded, or faint, when exposed to news about the coronavirus in past 2W	4180186
1619139	Diatrizoate Ab.IgE	4180186
1619143	Acanthamoeba sp & Naegleria fowleri & Balamuthia mandrillaris DNA panel	4180186
1619144	Abdomen>Stomach+Duodenum	4180186
1619149	Nuclear Ab pattern.intercellular bridge	4180186
1619152	Lower extremity.bilateral>Foot.cuneiform bones	4180186
1619153	Linum usitatissimum seed Ab	4180186
1619154	HLA-A & B & C (class I) & HLA-DP & DQ & DR (class II) Ab	4180186
1619160	People of my race or ethnicity are more likely to lose their job because of the coronavirus	4180186
1619162	People of my race or ethnicity will not receive coronavirus healthcare as good as the care received by other groups	4180186
1619163	Pain severity & Body site panel	4180186
1619173	HLA-DP & DQ & DR (class II) Ab.IgG donor specific	4180186
1619182	Benzocaine Ab.IgE	4180186
1619184	CFTR gene & FMR1 gene CGG repeat & SMN1 gene mutation analysis	4180186
1619194	Phosphatidylethanol 16:0-18:2	4180186
1619201	Due to the coronavirus I have been cyberbullied because of my race or ethnicity	4180186
1619221	Vancomycin Ab.IgE	4180186
1619248	SARS coronavirus 2 S gene mutation detected	4180186
1619253	Smoked at least one cigarette containing tobacco in past 3Mo	4180186
1619254	Five or more drinks in 1D in the past 3Mo	4180186
1619261	Upper extremity.bilateral>Wrist.pisiform+triquetrum	4180186
1619284	Lower extremity.bilateral>Foot vessels	4180186
1619287	Begonia semperflorens Ab.IgE	4180186
1619312	Vegetable &or fruit frequency	4180186
1619324	Borrelia burgdorferi Ab.IgG & IgM bands panel	4180186
1619353	Noninvasive prenatal fetal aneuploidy & 22q11.2 deletion panel	4180186
1619356	Ofloxacin Ab.IgE	4180186
1619364	Zea mays starch Ab	4180186
1619367	Delta aminolevulinate & porphobilinogen panel	4180186
1619369	Spine degeneration.secondary	4180186
1619380	Natural killer & natural killer T cell subsets panel	4180186
1619384	Used medication for ADHD not as prescribed or not prescribed for you in past 3Mo	4180186
1619391	Nuclear Ab pattern.smooth nuclear envelope	4180186
1619400	Euphorbia spp.	4180186
1619401	Trigla spp Ab.IgE	4180186
1619405	Staphylococcus aureus identification & resistance panel	4180186
1619410	Used medication for ADHD not as prescribed or not prescribed for you at least once a week in past 3Mo	4180186
1619418	Financial problems in last 12 Mo	4180186
1619420	Upper extremity.bilateral>Wrist.hamate	4180186
1619436	Cantharellus cibarius Ab	4180186
1619440	Quality of life in past W	4180186
1619446	CVX code	4180186
1619452	Legionella pneumophila Ab.IgG & IgM panel	4180186
1619459	Sleep total score	4180186
1619461	Used heroin in past 3Mo	4180186
1619462	Visited nursing homes or long-term care facilities (outside of work duties)	4180186
1619468	Negative social media posts against people of my race or ethnicity have increased because of the coronavirus	4180186
1619478	Received any financial or material aid in last 12 Mo	4180186
1619480	Lost interest in eating when I thought about or was exposed to information about the coronavirus in past 2W	4180186
1619482	Erythrosine B Ab.IgE	4180186
1619512	Thermoactinomyces candidus Ab.IgE	4180186
1619514	Have you tried and failed to control, cut down or stop using an opiate pain reliever in past 3Mo	4180186
1619515	Has anyone expressed concern about your use of an opiate pain reliever in past 3Mo	4180186
1619516	Propylparaben Ab.IgE	4180186
1619518	Fodrin.alpha subunit Ab.IgA	4180186
1619529	In the past Mo, have recommendations for socially distancing caused stress for you	4180186
1619533	Microcystic elongated and fragmented invasion pattern	4180186
1619572	Cortisol & glucose & somatotropin post arginine stimulation panel	4180186
1619575	Jewish descent preconception &or prenatal carrier screening multigene analysis	4180186
1619586	Reduction in clot strength.kaolin+tissue factor induced	4180186
1619604	Upper extremity.left>Wrist.hamate	4180186
1619611	Number of D cut down on usual activities because of health condition in past 4W	4180186
1619624	Maximum clot strength amplitude.kaolin+tissue factor induced	4180186
1619628	Phosphatidylserine-prothrombin complex Ab.IgG & IgM panel	4180186
1619643	Lower extremity.left>Foot vessels	4180186
1619653	RFLP.rRNA	4180186
1619656	SARS coronavirus 2 S gene mutation	4180186
1619658	Problems accessing medication in last 12Mo	4180186
1619664	Salmonella spp Ab panel	4180186
1619667	Lower extremity.left>Femoral artery+Popliteal artery	4180186
1619673	Routine doctor's visits &or check-ups postponed in the last 12Mo	4180186
1619678	Fodrin.alpha subunit	4180186
1619720	Myasthenia gravis & Lambert-Eaton syndrome autoimmune Ab panel	4180186
1619729	At least one drink in past 3Mo	4180186
1619735	Blood product volume &or cell saver	4180186
1619740	Roxithromycin Ab.IgE	4180186
1619741	Parainfluenza virus 1 & 2 & 3 Ab panel	4180186
1619743	SARS coronavirus 2 variant interpretation	4180186
1619750	Lower extremity.bilateral>Toe.third	4180186
1619755	How often in the past Mo are you doing the recommended pandemic hygiene	4180186
1619759	HPA & HLA	4180186
1619764	Nauseous or had stomach problems when I thought about or was exposed to information about the coronavirus in past 2W	4180186
1619765	Treponema pallidum Ab.IgG & IgM & bands panel	4180186
1619770	Maximum clot strength amplitude.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited	4180186
1619794	Body weight.current fetus	4180186
1619810	I worry about people thinking I have the coronavirus simply because of my race or ethnicity	4180186
1619812	Would like help with paying heating &or electricity bill	4180186
1619815	Have you tried and failed to control, cut down or stop using heroin in past 3Mo	4180186
1619839	Borrelia burgdorferi Ab.IgG & IgM & total panel	4180186
1619844	Cardiovascular disease.team	4180186
1619866	Aspergillus repens Ab.IgE	4180186
1619869	Fodrin.alpha subunit Ab.IgG	4180186
1619877	Epinephrine Ab.IgE	4180186
1619885	Since the coronavirus I have seen a lot more cyberbullying of people of my race or ethnicity	4180186
1619902	Used prescription opiate pain reliever not as prescribed or not prescribed for you in past 3Mo	4180186
1619917	Lower extremity.left>Forefoot	4180186
1619919	Cantharellus cibarius Ab.IgE	4180186
1619950	Physalis peruviana Ab	4180186
1619957	Lower extremity.right>Foot.cuneiform bones	4180186
1619959	Reduction in clot strength.kaolin induced	4180186
1619963	Ambroxol Ab.IgE	4180186
1619975	Chronic diseases &or immunodeficiency	4180186
1619993	Corylus avellana recombinant (rCor a) 9	4180186
1619996	Physalis peruviana	4180186
1620008	Allium ursinum Ab.IgE	4180186
1620011	Fetal trisomy 13+trisomy 18+triploidy risk	4180186
1620022	View Canale	4180186
1620056	Routine doctor's visits &or check-ups postponed since the beginning of the pandemic	4180186
1620064	Cephalothin Ab.IgE	4180186
1620084	Acetylcysteine Ab.IgE	4180186
1620086	Clot strength.arachidonate inhibited	4180186
1620090	Upper extremity.right>Wrist.hamate	4180186
1620094	Clot angle.kaolin+tissue factor induced	4180186
1620099	SARS coronavirus 2 sequencing & identification panel	4180186
1620103	Echinacea Ab.IgE	4180186
1620112	Smoked cigarette within 30M after waking in past 3Mo	4180186
1620116	Used medication for anxiety or sleep not as prescribed or not prescribed for you in past 3Mo	4180186
1620138	Goat milk cheese Ab.IgE	4180186
1620141	Vaccinated in last 14 D	4180186
1620152	Calluna vulgaris	4180186
1620153	Hibiscus tea Ab.IgE	4180186
1620163	Bromhexine Ab.IgE	4180186
1620179	Eriobotrya japonica	4180186
1620190	Macrophage inflammatory protein 1.alpha	4180186
1620200	Quail meat Ab.IgE	4180186
1620228	Normoblasts.oxyphilic+polychromatophilic	4180186
1620241	Salix alba	4180186
1620242	Eriobotrya japonica Ab	4180186
1620259	Mechanical circulatory support+progress note	4180186
1620274	Zea mays starch Ab.IgE	4180186
1620284	Fungus & Mycobacterium sp	4180186
1620297	Anthriscus cerefolium Ab.IgE	4180186
1761079	DOC.ONT; Document; Emotional stability; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761079	Mental health Hosp Prog note	4180186
1761079	:::::	4182948
1761080	Trauma OP Prog note	4180186
1761080	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761080	:::::	4182948
1761081	Nephrology Hosp Prog note	4180186
1761081	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761081	:::::	4182948
1761083	Cardio+Pulm disease; Cardiology; cards; CVD; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Pulmonary; Random; Respirology; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761083	Cardio+Pulm disease Hosp Prog note	4180186
1761083	:::::+	4182948
1761088	Hand Surgery OP Prog note	4180186
1761088	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hand Surgery; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Upper extremity; Visit note	4180186
1761088	:::::	4182948
1761089	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761089	Sleep med Hosp Prog note	4180186
1761089	:::::	4182948
1761090	Orthotics prosthetics Hosp Prog note	4180186
1761090	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761090	:::::	4182948
1761092	Allergy+Immunology OP Prog note	4180186
1761092	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761092	:::::+	4182948
1761093	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761093	Breastfeeding Hosp Prog note	4180186
1761093	:::::	4182948
1761094	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; PEDS; Peds gastroenterology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761094	Peds gastroenterology OP Prog note	4180186
1761094	:::::	4182948
1761096	Clin Path OP Prog note	4180186
1761096	Clin Path; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Laboratory medicine; notes; OP; Path; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761096	:::::	4182948
1761100	Pain medicine Hosp Prog note	4180186
1761100	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761100	:::::	4182948
1761101	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; Neuro; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761101	Neurology Hosp Prog note	4180186
1761101	:::::	4182948
1761103	BM Transplant; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761103	BM Transplant Hosp Prog note	4180186
1761103	:::::	4182948
1761105	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Path; Point in time; Prog note; Random; Speech pathology; Speech therapy; Speech-lang path; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761105	Speech-lang path OP Prog note	4180186
1761105	:::::-	4182948
1761107	Mat fetal med OP Prog note	4180186
1761107	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mat fetal med; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761107	:::::	4182948
1761108	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; REI; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761108	REI OP Prog note	4180186
1761108	:::::	4182948
1761110	Peds infect disease Hosp Prog note	4180186
1761110	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; PEDS; Peds infect disease; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761110	:::::	4182948
1761111	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761111	Palliative care Hosp Prog note	4180186
1761111	:::::	4182948
1761112	Undersea+hyperbar D/C sum	4180186
1761112	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Undersea+hyperbar; Visit note	4180186
1761112	:::{}::	4182948
1761113	Heart failure OP Prog note	4180186
1761113	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart function; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761113	:::::	4182948
1761116	HF+TC Hosp Prog note	4180186
1761116	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart function; HF+TC; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; TC; Visit note	4180186
1761116	:::::+	4182948
1761117	OP COVID-19 Progress note	4180186
1761117	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; COVID-19 Progress note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761117	COVID-19+:::::{}	4182948
1761118	Vasc Neuro OP Prog note	4180186
1761118	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neuro; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Vasc Neuro; Visit note	4180186
1761118	:::::	4182948
1761120	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761120	Rapid response team Hosp Prog note	4180186
1761120	:::::	4182948
1761122	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761122	Pharmacogenomics Hosp Prog note	4180186
1761122	:::::	4182948
1761124	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761124	Thromboemb OP Prog note	4180186
1761124	:::::	4182948
1761125	Peds transpl hepato OP Prog note	4180186
1761125	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; PEDS; Peds transpl hepato; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761125	:::::	4182948
1761127	Podiatry Hosp Prog note	4180186
1761127	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761127	:::::	4182948
1761129	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Orthopedic; Orthopedic surgery; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
1761129	Orthopaedic surgery OP Prog note	4180186
1761129	:::::	4182948
1761130	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; IC; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761130	IC Hosp Prog note	4180186
1761130	:::::	4182948
1761133	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Otorhinolaryngology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761133	Otolaryngology Hosp Prog note	4180186
1761133	:::::	4182948
1761134	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neo peri med; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761134	Neo peri med OP Prog note	4180186
1761134	:::::	4182948
1761136	Heart failure Hosp Prog note	4180186
1761136	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart function; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761136	:::::	4182948
1761138	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761138	Audiology Hosp Prog note	4180186
1761138	:::::	4182948
1761145	Child neuro OP Prog note	4180186
1761145	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neuro; Neurology with special qualifications in child neurology; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761145	:::::	4182948
1761146	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1761146	Urgent care D/C sum	4180186
1761146	:::::{}	4182948
1761147	IR Hosp Prog note	4180186
1761147	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; IR; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761147	:::::	4182948
1761148	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; PT; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761148	PT OP Prog note	4180186
1761148	:::::	4182948
1761150	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; Social work; subsequent evaluation; subsequent visit evaluation; SW; Visit note	4180186
1761150	SW Hosp Prog note	4180186
1761150	:::::	4182948
1761151	Podiatry OP Prog note	4180186
1761151	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761151	:::::	4182948
1761152	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Geri med; Gerontology; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761152	Geri med OP Prog note	4180186
1761152	:::::	4182948
1761157	Plastic surgery OP Prog note	4180186
1761157	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
1761157	:::::	4182948
1761159	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note; WOC	4180186
1761159	WOC Hosp Prog note	4180186
1761159	:::::	4182948
1761160	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; IR; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761160	IR OP Prog note	4180186
1761160	:::::	4182948
1761161	Integrative medicine D/C sum	4180186
1761161	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Integrated medicine; notes; Point in time; Random; Visit note	4180186
1761161	:::{}::	4182948
1761162	Clinical Neurophys Hosp Prog note	4180186
1761162	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761162	:::::	4182948
1761163	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; COVID-19 Progress note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761163	Hosp COVID-19 Progress note	4180186
1761163	COVID-19+::::	4182948
1761165	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761165	OT OP Prog note	4180186
1761165	:::::	4182948
1761166	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Telemedicine; Visit note	4180186
1761166	Telehealth+Outpatient Prog note	4180186
1761166	:::+::{}	4182948
1761168	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note	4180186
1761168	Cardiac surgery D/C sum	4180186
1761168	:::{}::	4182948
1761171	Trauma Hosp Prog note	4180186
1761171	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761171	:::::	4182948
1761173	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; IR; notes; OP; Point in time; Random; Visit note	4180186
1761173	IR OP Note	4180186
1761173	:::::	4182948
1761175	Peds dermatology OP Prog note	4180186
1761175	Derm; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; PEDS; Peds dermatology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761175	:::::	4182948
1761177	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; PEDS; Peds infect disease; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761177	Peds infect disease OP Prog note	4180186
1761177	:::::	4182948
1761179	Child+teen psych; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Psychiatric; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761179	Child+teen psych Hosp Prog note	4180186
1761179	:::::	4182948
1761180	Infectious disease OP Prog note	4180186
1761180	Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761180	:::::	4182948
1761183	Nurse Hosp Prog note	4180186
1761183	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; nursing; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761183	:::::	4182948
1761184	Peds surgery Hosp Prog note	4180186
1761184	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; PEDS; Peds surgery; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
1761184	:::::	4182948
1761185	Col+rec surg OP Prog note	4180186
1761185	Col+rec surg; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
1761185	:::::	4182948
1761189	HemOnc OP Prog note	4180186
1761189	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology and Oncology; Hematology+Oncology; HemOnc; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761189	:::::+	4182948
1761191	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; PM+R; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761191	PM+R OP Prog note	4180186
1761191	:::::	4182948
1761192	Peds dermatology Hosp Prog note	4180186
1761192	Derm; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; PEDS; Peds dermatology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761192	:::::	4182948
1761193	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; REI; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761193	REI Hosp Prog note	4180186
1761193	:::::	4182948
1761194	Geri med Hosp Prog note	4180186
1761194	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Geri med; Gerontology; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761194	:::::	4182948
1761195	Allergy Hosp Prog note	4180186
1761195	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761195	:::::	4182948
1761196	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; PEDS; Peds hem-onc; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761196	Peds hem-onc OP Prog note	4180186
1761196	:::::-	4182948
1761198	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761198	Pastoral Care Hosp Prog note	4180186
1761198	:::::	4182948
1761201	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761201	Hepatology Hosp Prog note	4180186
1761201	:::::	4182948
1761202	Ophthalmol Hosp Prog note	4180186
1761202	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Eye care; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761202	:::::	4182948
1761203	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761203	Immunology OP Prog note	4180186
1761203	:::::	4182948
1761204	Pharmacogenomics OP Prog note	4180186
1761204	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761204	:::::	4182948
1761205	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761205	Immunology Hosp Prog note	4180186
1761205	:::::	4182948
1761209	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761209	Allergy OP Prog note	4180186
1761209	:::::	4182948
1761212	Neo peri med Hosp Prog note	4180186
1761212	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; Neo peri med; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761212	:::::	4182948
1761213	OP COVID-19 Intub+Progress	4180186
1761213	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; COVID-19 Intub+Progress; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761213	COVID-19++::::	4182948
1761214	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; PEDS; Peds endocrinology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761214	Peds endocrinology OP Prog note	4180186
1761214	:::::	4182948
1761216	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Path; Point in time; Prog note; Random; Speech pathology; Speech therapy; Speech-lang path; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761216	Speech-lang path Hosp Prog note	4180186
1761216	:::::-	4182948
1761218	Peds otolaryngology Hosp Prog note	4180186
1761218	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Otorhinolaryngology; PEDS; Peds otolaryngology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761218	:::::	4182948
1761219	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761219	Urology OP Prog note	4180186
1761219	:::::	4182948
1761220	Derm; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761220	Dermatology Hosp Prog note	4180186
1761220	:::::	4182948
1761221	Comm hlth care; Continuity assessment record and evaluation; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1761221	Comm hlth care D/C sum	4180186
1761221	:::{}::	4182948
1761222	Clinical genetics OP Prog note	4180186
1761222	clinical genomics; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genetic; Genomic; Medical Genetics; medical genomics; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761222	:::::	4182948
1761225	OT Hosp Prog note	4180186
1761225	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761225	:::::	4182948
1761226	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Metabolic and bariatric surgery; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
1761226	Bariatric surg OP Prog note	4180186
1761226	:::::	4182948
1761227	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; COVID-19 Intub+Progress; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761227	Hosp COVID-19 Intub+Progress	4180186
1761227	COVID-19++:::::{}	4182948
1761228	Orthopaedic surgery Hosp Prog note	4180186
1761228	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Orthopedic; Orthopedic surgery; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
1761228	:::::	4182948
1761229	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761229	Adolescent med Hosp Prog note	4180186
1761229	:::::	4182948
1761233	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; Neuro surgery; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
1761233	Neuro surgery Hosp Prog note	4180186
1761233	:::::	4182948
1761236	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; PEDS; Peds hem-onc; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761236	Peds hem-onc Hosp Prog note	4180186
1761236	:::::-	4182948
1761237	Nutr+diet OP Prog note	4180186
1761237	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nutr+diet; Nutrition+Dietetics; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761237	:::::	4182948
1761239	Sports medicine D/C sum	4180186
1761239	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1761239	:::{}::	4182948
1761240	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
1761240	Vascular surgery Hosp Prog note	4180186
1761240	:::::	4182948
1761242	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1761242	Podiatry D/C sum	4180186
1761242	:::{}::	4182948
1761251	Psychiatric OP Prog note	4180186
1761251	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Psychiatric; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761251	:::::	4182948
1761253	Consultant Hosp Prog note	4180186
1761253	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761253	:::::	4182948
1761254	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761254	Sleep med OP Prog note	4180186
1761254	:::::	4182948
1761259	Develop-behav peds; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Peds; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761259	Develop-behav peds OP Prog note	4180186
1761259	:::::	4182948
1761260	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761260	Burn OP Prog note	4180186
1761260	:::::	4182948
1761261	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; Mat fetal med; notes; Phone+Hosp; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761261	Mat fetal med Phone+Hosp Prog note	4180186
1761261	:::+::	4182948
1761263	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; PEDS; Peds cardiology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761263	Peds cardiology OP Prog note	4180186
1761263	:::::	4182948
1761264	Hematology OP Prog note	4180186
1761264	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761264	:::::	4182948
1761266	Pharmacology Hosp Prog note	4180186
1761266	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Pharmacy; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761266	:::::	4182948
1761267	Allergy+Immunology Hosp Prog note	4180186
1761267	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761267	:::::+	4182948
1761268	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Hosp; Inpatient; notes; OB; OBGYN; Obstetric; Point in time; Prenatal; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761268	OBGYN Hosp Prog note	4180186
1761268	:::::	4182948
1761271	Solid Org Transplant Hosp Prog note	4180186
1761271	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; Solid Org Transplant; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761271	:::::	4182948
1761274	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; Social work; subsequent evaluation; subsequent visit evaluation; SW; Visit note	4180186
1761274	SW OP Prog note	4180186
1761274	:::::	4182948
1761278	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Eye care; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761278	Ophthalmol OP Prog note	4180186
1761278	:::::	4182948
1761279	Attend OP Prog note	4180186
1761279	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761279	:::::	4182948
1761281	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; Neuro; Neurology with special qualifications in child neurology; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761281	Child neuro Hosp Prog note	4180186
1761281	:::::	4182948
1761282	Thromboemb Hosp Prog note	4180186
1761282	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761282	:::::	4182948
1761284	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; PEDS; Peds rheumatology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761284	Peds rheumatology Hosp Prog note	4180186
1761284	:::::	4182948
1761291	Dentist; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761291	Dentistry Hosp Prog note	4180186
1761291	:::::	4182948
1761293	Psych OP Prog note	4180186
1761293	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761293	:::::	4182948
1761294	Cardio+Pulm disease; Cardiology; cards; CVD; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Pulmonary; Random; Respirology; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761294	Cardio+Pulm disease OP Prog note	4180186
1761294	:::::+	4182948
1761296	Sports medicine OP Prog note	4180186
1761296	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761296	:::::	4182948
1761319	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761320	Blood; CD3 Cells; CD3+CD4+ Cells; CD3-CD4+; CD4+ T cells; Cell; Cellularity; Gated cells; Helper T cells; Inducer T cells; L3T4; Leu3; Leu-3; Leu4; Leu-4; Microbiology; Number Fraction; PBMC; Percent; Peripheral blood mononuclear cells; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; T4; T-4; T4 helper/inducer cells; W3/25; WB; Whole blood	4180186
1761320	CD3+CD4+ Cells Bld MC-NFr	4180186
1761320	.CD3+CD4+/100 ::::	4182948
1761324	HHV6 DNA Bld NAA+probe-Log#	4180186
1761324	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV6; HHV-6; Human herpes virus; Human herpes virus type 6; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood	4180186
1761324	 6  DNA:::::..	4182948
1761326	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761330	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1761331	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Otorhinolaryngology; PEDS; Peds otolaryngology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761331	Peds otolaryngology OP Prog note	4180186
1761331	:::::	4182948
1761332	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Deer meat; f120; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761332	Venison meat IgG Qn	4180186
1761332	 .IgG::::	4182948
1761335	Finding; Findings; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761336	CMV DNA Bld NAA+probe-Log IU	4180186
1761336	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log ACNC; Log IU; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood	4180186
1761336	 DNA:::::..	4182948
1761339	CLIN; Hearing; Otologic; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Pure tone air thresh Pnl; Random	4180186
1761339	Pure tone air thresh Pnl	4180186
1761339	:-:::-	4182948
1761343	AE; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761345	Horse Meat IgG Qn	4180186
1761345	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Equus spp; f321; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf321; Serum; SR	4180186
1761345	 .IgG::::	4182948
1761346	Orf virus DNA Spec Ql NAA+probe	4180186
1761346	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1761346	 DNA:::XXX::..	4182948
1761347	Dextro; QNT; Quan; Quant; Quantitative; Report period; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
1761350	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761351	Cnt; Count; H+P; H+P.HX; Number; P prime; QNT; Quan; Quant; Quantitative; Report period	4180186
1761351	Flights climbed RptPeriod	4180186
1761351	:()::^:	4182948
1761354	Before; KSS; Lower extremity joint; Ortho; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Systemic Coronary Risk Evaluation	4180186
1761358	Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right; Scale; SDOH; Survey; SURVEY.R-OUTCOMES	4180186
1761361	Finding; Findings; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Surf; Survey	4180186
1761365	Brexpiprazole SerPl-mCnc	4180186
1761365	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rexulti; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1761365	:::/:	4182948
1761366	Goose Meat IgG Qn	4180186
1761366	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f158; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761366	 .IgG::::	4182948
1761371	IDH2 exon 4 Mut Anl Bld/Mar Ql	4180186
1761371	Bld/Mar; Blood; BM; BON; Bone marrow; D2HGA2; ICD-M; IDH; IDH2 exon 4; IDHM; IDP; IDPM; isocitrate dehydrogenase (NADP(+)) 2, mitochondrial; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; mNADP-IDH; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood; Whole blood or Bone marrow	4180186
1761371	IDH2  4 :::/::	4182948
1761375	Finding; Findings; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Surg; Survey	4180186
1761376	Finding; Findings; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Surg; Survey	4180186
1761380	21DC sp5 p chal Ser-mCnc	4180186
1761380	21DC; 21-DF; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Serum; sp5; sp5 p chal; Spec; SR	4180186
1761380	21-^XXX5::::	4182948
1761382	#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Diaf; DiafP; Dialysate; Dialysis fluid; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Peritoneal Dialysis fluid; PMN; Point in time; Poly; Polys; QNT; Quan; Quant; Quantitative; Random; Segmented WBC	4180186
1761382	Polys # DiafP Auto	4180186
1761382	:::::	4182948
1761385	FCN; Finding; Findings; Func; Funct; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761393	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; chevre; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761393	Goat cheese IgG Qn	4180186
1761393	 .IgG::::	4182948
1761396	Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; IEF; M-spikes; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; PR; Prot; Random; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR	4180186
1761396	Oligoclonal Bands panel Ser+CSF IEF	4180186
1761396	.:-::+:-:	4182948
1761397	Oligoclonal Bands SerPl IEF	4180186
1761397	Chemistry; Cnt; Count; Frac; Fract; Fraction; Fractionated; Fractionation; IEF; M-spikes; Number; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1761397	.:()::/::	4182948
1761398	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allium porrum; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Leek; Leeks; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761398	Leeks IgG Qn	4180186
1761398	 .IgG::::	4182948
1761400	Blood; CD4 Cells; CD4 TNFa cells; CD4+TNFa+/CD4; CD4+TNFa+/CD4 stim COVID Spike; Cell; Cellularity; Fac; Fact; Helper T cells; ID; II; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu3; Leu-3; Microbiology; Number Fraction; p Stim COVID Spike; Pept; Percent; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; T4; T-4; TNF; W3/25; WB; Whole blood	4180186
1761400	CD4 TNFa/CD4 p Stim COVID Sp	4180186
1761400	.CD4. alfa /.CD4^ SARS  2 ::::	4182948
1761401	Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T prime; WB; Whole blood	4180186
1761401	NUDT15 gene c.415C>T Bld Ql	4180186
1761401	NUDT15  c.415C>T:::::	4182948
1761404	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1761404	:::^:	4182948
1761405	Crypto gp60 Spec	4180186
1761405	Crypt; Crypto; Crypto gp60; Cryptosporidiosis; Microbiology; Misc; Miscellaneous; Molecular genetics; Nominal; Other; PCR; Point in time; Random; Spec; To be specified in another part of the message; Typ; Unspecified	4180186
1761405	 gp60 :::XXX::	4182948
1761406	AE; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761407	Finding; Findings; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761410	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1761414	AP Macro SerPl Ql	4180186
1761414	Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; AP; AP Macro; Chemistry; Ordinal; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1761414	.:::/:	4182948
1761417	Finding; Findings; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761419	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1761421	Ur Cfm	4180186
1761421	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Metabolite; Metb; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Tramal; UA; Ultram; UR; Urn	4180186
1761421	:-:::-:	4182948
1761422	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761425	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; Breakbone fever; Denv; Flavivirus; Immune globulin G; Immunoglobulin G; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Microbiology; Nominal; Pl; PlasBld; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
1761425	DENV IgG SerPlBld-Imp	4180186
1761425	 .IgG::://:	4182948
1761429	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761430	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f248; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Rosemary; salvia rosmarinus; Serum; SR	4180186
1761430	Rosemary IgG Qn	4180186
1761430	 .IgG::::	4182948
1761433	from clin data; Point in time; PULMONARY; QNT; Quan; Quant; Quantitative; Random	4180186
1761433	Estimated lung age from clin data	4180186
1761433	:::^::	4182948
1761434	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Boutonneuse fever; IgG+IgM; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Mediterranean spotted fever; Microbiology; Nominal; Point in time; R conorii; Random; Ricket; Rickettsial; Serum; Spotted fever; SR	4180186
1761434	R conorii IgG+IgM Ser-Imp	4180186
1761434	 .IgG  IgM::::	4182948
1761435	Hepatology OP Prog note	4180186
1761435	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761435	:::::	4182948
1761436	Finding; Findings; Int rotation range of motion; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Rnge; Screen; Survey	4180186
1761437	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1761438	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Savoy cabbage; Serum; SR; Vine leaf var. Sabauda	4180186
1761438	Savoy cabbage IgG Qn	4180186
1761438	 .IgG::::	4182948
1761439	Alpha subunit free sp3 p chal SerPl-aCnc	4180186
1761439	After; Alfa; Alpha subunit free; Arbitrary Concentration; CHEMISTRY.CHALLENGE TESTING; FR; Non-protein bound; p chal; Pituitary glycoproteins; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; sp3 p chal; Spec; SR	4180186
1761439	Alpha .^XXX3:::/:	4182948
1761440	HHS; Lower extremity joint; Ortho; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Systemic Coronary Risk Evaluation	4180186
1761441	Loneliness ONS score; Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right; Scale; Survey; SURVEY.R-OUTCOMES	4180186
1761442	Assoc; Breath; ExG; Exhaled gas; Exhaled gas (=breath); Gas chromatography; Gases; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; PH; Point in time; PR; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; Screen; Severe Acute Respiratory Syndrome; VOCs (volatiles) SARS-CoV-2; Volatiles	4180186
1761442	VOCs (volatiles) SARS-CoV-2 ExG Ql GC-MS	4180186
1761442	 SARS  2 :::::-	4182948
1761445	Breathing; Lungs; Point in time; PULMONARY; QNT; Quan; Quant; Quantitative; Random; RS; Volume	4180186
1761445	Inspiratory reserve vol spirometry	4180186
1761445	:::::	4182948
1761447	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Bell bean; Broad bean; Fava bean; Field bean; Horse bean; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tic bean	4180186
1761447	Fava bean IgG Qn	4180186
1761447	 .IgG::::	4182948
1761448	Nonvar Orthpx DNA Spec Ql NAA+probe	4180186
1761448	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nonvar Orthpx; Nonvar Orthpx DNA; Nucleic acid sequence based analysis; Ordinal; Orthopox virus; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1761448	. DNA:::XXX::..	4182948
1761449	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761454	Finding; Findings; Levels; Levl; Lower extremity joint; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761455	Dental model prior auth Doc	4180186
1761455	ADMIN; DOC.ADMIN; Document; Finding; Findings; Point in time; Random	4180186
1761455	:::^:	4182948
1761456	alpha 2 microglobulin; alpha-2-microglobulin; Axerol; Axerophthol; Bind; Biosterol; Chemistry; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Ratios; RBP; Retinol Bind Prot; Rto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vit A; Vit A alcohol; Vit A/RBP; Vit A1; Vit A1 alcohol; Vitamin A; Vitamin A alcohol; Vitamin A binding protein; Vitamin A1	4180186
1761456	Vitamin A/Retinol Bind Prot SerPl-Rto	4180186
1761456	 A/:::/:	4182948
1761458	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes zoster; HHV-3; Human herpesvirus 3; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Shingles; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; VZ; VZV; Zoster	4180186
1761458	VZV DNA CSF NAA+probe-Log#	4180186
1761458	 DNA:::::..	4182948
1761461	Rifabutin+Ethambutol Susc Islt	4180186
1761461	Ansamycin; ANTIBIOTIC SUSCEPTIBILITIES; AST; Etambol; Ethamb; Inagen; Islt; Isol; Myambutol; Mycobutin; Mycobutol; Olbutam; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1761461	+::::	4182948
1761462	After; CHEMISTRY.CHALLENGE TESTING; Convalescent; FR; Level; Mass concentration; Non-protein bound; p chal; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; Serum; sp2; sp2 p chal; Spec; SR; Testo; Testos; Testost; Testost Free; Testosterone.unconjugated	4180186
1761462	Testost Free sp2 p chal Ser-mCnc	4180186
1761462	.^XXX2::::	4182948
1761465	M bovis reactn wheal 3D p Mam Tuberc Ql	4180186
1761465	3D p Mam Tuberc; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; After; Bovine TB; Bovine tuberculosis; Dermatologic; Diameter; Epidermis; Identifier; Integument; Intradermal; M bovis; Myco; Mycobact; Ordinal; p dose; Point in time; PPD; PST; Purified protein derivative; QL; Qual; Qualitative; Random; React; Rx wheal; Rxn; Screen; Skin test; SKIN TESTS; Skn; TB; Tuberculosis; Tuberculosis antigen; Vet; Veterinary	4180186
1761465	^3::::	4182948
1761466	S. aureus+MRSA screen Pnl Spec Cult	4180186
1761466	Asympt; Asymptomatic; C&S; Cult; Cultures; Microbiology; Misc; Miscellaneous; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; S. aureus+MRSA screen Pnl; Scn; Spec; To be specified in another part of the message; Unspecified	4180186
1761466	:-::XXX:-:	4182948
1761467	bod; Bodies; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761469	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761472	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761472	Chinese cabbage IgG Qn	4180186
1761472	 .IgG::::	4182948
1761473	CLIN; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Typ	4180186
1761473	:::^:	4182948
1761474	Cryptosp 18S rRNA Spec-Geno	4180186
1761474	Crypt; Crypto; Cryptosp 18S; Cryptosp 18S rRNA; Cryptosporidiosis; Microbiology; Misc; Miscellaneous; Molecular genetics; Nominal; Other; PCR; Point in time; Random; ribosomal RNA; Spec; To be specified in another part of the message; Unspecified	4180186
1761474	 18S rRNA:::XXX::	4182948
1761476	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; i; L pneumo; L pneumonphila; L pneumophila group; LAT; LCR; Legion; Legionela; Ligase chain reaction; Ligation-activated transcription; Lp-SG1; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Pneu; pneum; Pneumophilia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1761476	Lp-SG1 Spec Ql NAA+probe	4180186
1761476	 1:::XXX::..	4182948
1761477	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761477	Guineafowl IgG Qn	4180186
1761477	 .IgG::::	4182948
1761483	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Gen-Probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium rRNA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1761483	M genitalium rRNA Cvx Ql NAA+probe	4180186
1761483	 rRNA:::::..	4182948
1761485	Before; KSS; Lower extremity joint; Ortho; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SDOH; Survey; Systemic Coronary Risk Evaluation	4180186
1761486	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761490	Finding; Findings; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761492	Campylobacter Stl Ql Cult	4180186
1761492	Bowel movement; C&S; Campy; Cult; Cultures; Faecal; Faeces; Fecal; Feces; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; species; spp; Stl; Stool = Fecal	4180186
1761492	:::::	4182948
1761494	After; KSS; Lower extremity joint; Ortho; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Sx; Systemic Coronary Risk Evaluation	4180186
1761495	IES-R panel; Pan; Panl; Pnl; R prime; Right; Survey; SURVEY.MTLHLTH	4180186
1761496	CPR orders	4180186
1761496	CLIN; CPR; CPR orders; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1761497	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Ordinal; Paraneoplastic neurological syndrome; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Small Cell Lung Cancer; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Zic4; Zn	4180186
1761497	Zic4 Ab CSF Ql Line blot	4180186
1761497	 4 :::::	4182948
1761498	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV7; Human herpes virus; Human herpes virus type 7; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
1761498	HHV7 DNA SerPl NAA+probe-Log#	4180186
1761498	 7  DNA:::/::..	4182948
1761499	Finding; Findings; H+P; H+P.PX; Kn; Lower extremity joint; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Rnge; Screen	4180186
1761499	Extensor lag range Knee	4180186
1761499	::::	4182948
1761500	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; m11; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; R nigricans; Random; Rhizopus nigricans IgG4; Serum; SR	4180186
1761500	R nigricans IgG4-mCnc	4180186
1761500	 .IgG4::::	4182948
1761501	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH	4180186
1761502	Renin sp3 p chal Plas-mCnc	4180186
1761502	After; Angiotensin forming enzyme; Angiotensinogenase; CHEMISTRY.CHALLENGE TESTING; Direct renin; DRC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp3; sp3 p chal; Spec	4180186
1761502	^XXX3::::	4182948
1761503	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761505	GFAP Ser IA-mCnc	4180186
1761505	EIA; ELFA; ELISA; Enzyme immunoassay; GFAP; IAA; Level; Mass concentration; MEIA; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; Stroke; SUDS; TBI (Traumatic Brain Injury); Traumatic Brain Injuries	4180186
1761505	:::::	4182948
1761506	21DC; 21-DF; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Serum; sp4; sp4 p chal; Spec; SR	4180186
1761506	21DC sp4 p chal Ser-mCnc	4180186
1761506	21-^XXX4::::	4182948
1761507	Pan; PANEL.SURVEY.R-OUTCOMES; Panl; Pnl; Point in time; R prime; Random; Right; Survey; SURVEY.R-OUTCOMES	4180186
1761508	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761508	Emmental cheese IgG Qn	4180186
1761508	 .IgG::::	4182948
1761512	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761516	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; React; Rxn; Screen; Survey; SURVEY.MTLHLTH	4180186
1761517	Before; KSS; Lower extremity joint; Ortho; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Systemic Coronary Risk Evaluation	4180186
1761519	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761520	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Feta; Immune globulin G; Immunoglobulin G; Ovine; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761520	Sheep cheese IgG Qn	4180186
1761520	 .IgG::::	4182948
1761521	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1761522	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761524	Pan; PANEL.SURVEY.R-OUTCOMES; Panl; Pnl; Point in time; R prime; Random; Right; Survey; SURVEY.R-OUTCOMES	4180186
1761526	Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right; Scale; Survey; SURVEY.R-OUTCOMES	4180186
1761528	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
1761530	Arterial Stenosis; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761531	Pioglitazone SerPl Ql	4180186
1761531	Actos; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1761531	:::/:	4182948
1761534	Sunflower Seed IgG Qn	4180186
1761534	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f183; Immune globulin G; Immunoglobulin G; k84; Point in time; QNT; Quan; Quant; Quantitative; Random; Seeds; Serum; SR; Sunflower; Sunflower pip; Sunflower Seed	4180186
1761534	 .IgG::::	4182948
1761540	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUV; Fowl plague; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Oral fluid; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Sal; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1761540	FLUAV RNA Sal Ql NAA+probe	4180186
1761540	 A  RNA:::::..	4182948
1761543	Glucagon sp7 p chal SerPl-mCnc	4180186
1761543	^7th spec pst XXX chal; After; CHEMISTRY.CHALLENGE TESTING; HGF; Hyperglycemic factor; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR	4180186
1761543	^XXX7:::/:	4182948
1761544	B/F; BF; Bind; bod; Bodies; Body fluid; Body fluid, unsp; Ca; Cal; Chemistry; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; S100 Ca binding protein B; S-100B; S-100-beta	4180186
1761544	S100 Ca binding protein B Fld-mCnc	4180186
1761544	S100  B::::	4182948
1761545	Finding; Findings; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761547	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761549	ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp8; sp8 p chal; Spec; Substance concentration; VP	4180186
1761549	Vasopressin sp8 p chal Plas-sCnc	4180186
1761549	^XXX8::::	4182948
1761551	HHV7 DNA Bld NAA+probe-Log#	4180186
1761551	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV7; Human herpes virus; Human herpes virus type 7; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood	4180186
1761551	 7  DNA:::::..	4182948
1761552	Liver fibr score SerPl Agile3+	4180186
1761552	Calc; Calculation; Chemistry; Liver fibr score; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1761552	:::/::.Agile3+	4182948
1761557	Gynecology OP Prog note	4180186
1761557	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761557	:::::	4182948
1761558	C&S; c162; Cult; Cultures; Identity or presence; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified; VANC; Vancocin; Vancor; VRE; VRE screen	4180186
1761558	VRE Spec Cult	4180186
1761558	.:::XXX::	4182948
1761559	POLST panel	4180186
1761559	CLIN; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
1761560	Advanced; CLIN; directives; Finding; Findings; Nominal; Point in time; Portable medical order&or adv dir review; Random	4180186
1761560	Portable medical order&or adv dir review	4180186
1761561	Cocoa IgG Qn	4180186
1761561	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cacao; Cocoa; f93; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761561	 .IgG::::	4182948
1761567	:::^::	4182948
1761567	Synoptic report Surg Onc	4180186
1761567	Cancer; Finding; Findings; General surgical oncology; Narrative; Point in time; Random; Report; Surg; Surg Onc	4180186
1761569	Dextro; Pan; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Report period; Survey; SURVEY.MTLHLTH	4180186
1761570	After; KSS; KSS post-op; Lower extremity joint; Ortho; Pan; Panl; Pnl; Point in time; PST; Random; Survey; Systemic Coronary Risk Evaluation	4180186
1761571	Yst+Candida sp ID Pnl Spec Cult	4180186
1761571	C&S; Cand; Candidiasis; Cult; Cultures; Microbiology; Misc; Miscellaneous; Monilia; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spec; species; spp; Thrush; To be specified in another part of the message; Unspecified; Yst+Candida sp ID Pnl	4180186
1761571	:-::XXX:-:	4182948
1761574	Before; Finding; Findings; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Surg; Survey	4180186
1761575	Hep Ca Risk Score Patient GAAD	4180186
1761575	Chemistry; Hep Ca Risk; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
1761575	:::^::GAAD	4182948
1761578	Blood; Dis; Diseases; Dz; Gene dis anl carrier interp; Genetics; Genomic; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; Narrative; PCR; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1761578	Gene dis anl carrier interp Bld/T-Imp	4180186
1761578	:::/::	4182948
1761579	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761582	AE; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761583	HHS; Lower extremity joint; Ortho; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Systemic Coronary Risk Evaluation; Tot; Totl	4180186
1761584	CLIN; Clock time; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Started; To be specified in another part of the message; Unspecified	4180186
1761584	Start time Clock time Spec	4180186
1761584	:::XXX:	4182948
1761585	Finding; Findings; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761586	Loneliness ONS panel; Pan; PANEL.SURVEY.R-OUTCOMES; Panl; Pnl; Point in time; R prime; Random; Right; Survey; SURVEY.R-OUTCOMES	4180186
1761591	:::^::	4182948
1761591	Surgical synoptic rep	4180186
1761591	Finding; Findings; Narrative; Point in time; Random; Report; Surg	4180186
1761594	CT + NG + TV DNA Spec NAA+probe	4180186
1761594	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C trach+GC; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT + NG + TV; CT + NG + TV DNA; CT/GC; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gono; Gonorrhea; Identity or presence; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; Misc; Miscellaneous; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; T vaginalis; TMA; To be specified in another part of the message; Trachoma; Transcription mediated amplification; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; Unspecified	4180186
1761594	 &  &  DNA:::XXX::..	4182948
1761596	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761597	ABG; Amm; Ammon; Amon; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Gases; NH3; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random	4180186
1761597	BldA	4180186
1761597	:-:::-	4182948
1761598	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdor.VlsE1+pepC10; B burgdorferi; Bb; Burgdorf; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Lyme; Lyme disease; Lymes; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS	4180186
1761598	B burgdor.VlsE1+pepC10 Ab Ser IA-aCnc	4180186
1761598	.VlsE1+pepC10 :::::	4182948
1761601	NUDT15 gene c.50_55del Bld Ql	4180186
1761601	Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
1761601	NUDT15  c.50_55del:::::	4182948
1761602	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH	4180186
1761608	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761609	Hcys+Me-Malonate+2Me-citrate Pnl DBS	4180186
1761609	2Me-citrate; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; HCY; Hcys; Hcys+Me-Malonate+2Me-citrate Pnl; Hcyst; Homocyst(e)ine; homocystinuria; II; MCA; Methyl Citric Acid; Methylcitric acid; Methylmalonic acid; Methylmalonic Acidemia; MMA; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Propionic acidemia; Random; WB; Whole blood	4180186
1761609	 &  & 2-:-::.:-	4182948
1761610	FCGR3A gene.p.Phe176Val Bld/T Ql	4180186
1761610	Blood; CD16A; Fc gamma receptor IIIA; Fc gamma RIII; gamma RIII, Fc; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; P prime; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Receptors, gamma Fc; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1761610	FCGR3A .p.Phe176Val:::/::	4182948
1761613	Asympt; Asymptomatic; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn; SDOH screen report	4180186
1761613	SDOH screen report Doc	4180186
1761613	:::^:	4182948
1761616	CLIN; Misc; Miscellaneous; Other; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random; Spec; Started; Time start/end panel; To be specified in another part of the message; Unspecified	4180186
1761616	Time start/end panel Spec	4180186
1761616	:-::XXX:-	4182948
1761618	Abn Prot SerPl Elph-mCnc	4180186
1761618	abn; Abn Prot; abnorm; Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR	4180186
1761618	.:::/::	4182948
1761620	After; KSS; Lower extremity joint; Ortho; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Systemic Coronary Risk Evaluation	4180186
1761621	Finding; Findings; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761624	GGT Macro SerPl Ql	4180186
1761624	Chemistry; Gamma glutamyl transpeptidase; Gamma-GTP; GGT; GGT Macro; GGTP; GT; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1761624	Gamma .:::/:	4182948
1761625	CD4 TNFa/CD4 p COVID NuclCap	4180186
1761625	Blood; CD4 Cells; CD4 TNFa cells; CD4+TNFa+/CD4; Cell; Cellularity; Fac; Fact; Helper T cells; ID; II; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu3; Leu-3; Microbiology; Number Fraction; p COVID NuclCap; Pept; Percent; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; T4; T-4; TNF; W3/25; WB; Whole blood	4180186
1761625	.CD4. alfa /.CD4^ SARS  2 ::::	4182948
1761627	Med assisted nutrition orders	4180186
1761627	CLIN; Finding; Findings; Med assisted nutrition orders; Nominal; Point in time; Random; SDOH	4180186
1761629	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761630	Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right; Scale; Survey; SURVEY.R-OUTCOMES	4180186
1761631	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Tg; Thyglobulin; Thyroglbn; Thyroglob; Tumor marker	4180186
1761631	Thyroglob Fld-mCnc	4180186
1761631	::::	4182948
1761632	TPMT gene c.460G>A&c.719A>G Bld Ql	4180186
1761632	Ala154Thr; Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; rs1800460; Screen; thiopurine S-methyltransferase; Thiopurine S-methyltransferase gene; TPMT c.460G&gt;A; WB; Whole blood	4180186
1761632	TPMT  c.460G>A&c.719A>G:::::	4182948
1761634	AllergenMushroom mix 2 IgG Qn	4180186
1761634	ABS; Aby; Allergen; Allergen Mushroom mix 2 IgG; AllergenMushroom mix 2; Allergens; ALLERGY TESTING; Alrgen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; II; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761634	 2 (, ) .IgG::::	4182948
1761635	After; Alfa; Alpha subunit free; Arbitrary Concentration; CHEMISTRY.CHALLENGE TESTING; Convalescent; FR; Non-protein bound; p chal; Pituitary glycoproteins; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; sp2 p chal; Spec; SR	4180186
1761635	Alpha subunit free sp2 p chal SerPl-aCnc	4180186
1761635	Alpha .^XXX2:::/:	4182948
1761642	Cnt; Count; H+P; H+P.HX; Number; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Rep count	4180186
1761642	Rep count	4180186
1761642	:()::^:	4182948
1761645	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium rRNA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
1761645	M genitalium rRNA Ur Ql NAA+probe	4180186
1761645	 rRNA:::::..	4182948
1761646	After; KSS; Lower extremity joint; Ortho; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Scale; SDOH; Survey; Systemic Coronary Risk Evaluation	4180186
1761647	ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp5; sp5 p chal; Spec; Substance concentration; VP	4180186
1761647	Vasopressin sp5 p chal Plas-sCnc	4180186
1761647	^XXX5::::	4182948
1761649	CD4+154/CD4 stim COVID Spike	4180186
1761649	Blood; CD4 Cells; CD4+154 cells; CD4+154/CD4 stim COVID Spike; CD40 ligand; CD40L; Cell; Cellularity; gp39; Helper T cells; ID; II; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu3; Leu-3; Microbiology; Number Fraction; p Stim COVID Spike; Pept; Percent; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; T4; T-4; T-BAM; TRAP; Tumor necrosis factor Related Activation Protein; W3/25; WB; Whole blood; X-linked hyper IgM	4180186
1761649	.CD4+CD154+/.CD4^ SARS  2 ::::	4182948
1761651	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Ordinal; Orthopox virus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1761651	Orthopoxvirus IgG SerPl Ql IA	4180186
1761651	 .IgG:::/::	4182948
1761654	Blood; CD3 Cells; Cell; Cellularity; Gated cells; Leu4; Leu-4; Microbiology; Number Fraction; PBMC; Percent; Peripheral blood mononuclear cells; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; Whole blood	4180186
1761654	CD3 Cells Bld MC-NFr	4180186
1761654	.CD3/100 ::::	4182948
1761655	Pseudocowpox virus DNA Spec Ql NAA+probe	4180186
1761655	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1761655	 DNA:::XXX::..	4182948
1761656	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1761658	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761659	17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; Cortis F; CORTO; F; FR; hydrocortisone; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl	4180186
1761659	CORTO SerPl	4180186
1761659	:-::/:-	4182948
1761660	CD4 IFNg/CD4 p Stim COVID Sp	4180186
1761660	Blood; CD4 Cells; CD4 IFNg cells; CD4 IFNg cells/CD4 cells; CD4 IFNg cells/CD4 cells p Stim COVID Spike; Cell; Cellularity; G-INF; Helper T cells; ID; IFN; IGNF; II; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu3; Leu-3; Microbiology; Number Fraction; p Stim COVID Spike; Pept; Percent; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; T4; T-4; W3/25; WB; Whole blood	4180186
1761660	.CD4. gamma /.CD4^ SARS  2 ::::	4182948
1761666	AE; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761669	B19V DNA Bld NAA+probe-Log#	4180186
1761669	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B19 virus; B19V; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fifth Disease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Parvo; Parvo virus; Parvov; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood	4180186
1761669	 B19 DNA:::::..	4182948
1761674	After; KSS; Lower extremity joint; Ortho; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Systemic Coronary Risk Evaluation	4180186
1761676	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Chemistry; Dehydrog; Dehyrdogenase; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; LDH Macro; L-lactate; L-lactate dehydrogenase; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
1761676	LDH Macro SerPl Ql	4180186
1761676	.:::/:	4182948
1761677	21DC sp3 p chal Ser-mCnc	4180186
1761677	21DC; 21-DF; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Serum; sp3; sp3 p chal; Spec; SR	4180186
1761677	21-^XXX3::::	4182948
1761679	FCN; Finding; Findings; Func; Funct; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761683	Alignment W Stand Knee XR	4180186
1761683	CLIN; Finding; Findings; Kn; Lower extremity joint; Ordinal; Plain Films; Point in time; QL; Qual; Qualitative; Random; Screen; Stand); WB; Weight bearing; Xray; X-ray	4180186
1761683	^:::::X.	4182948
1761684	Bambusa vulgaris IgG Qn	4180186
1761684	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761684	 .IgG::::	4182948
1761688	Corn salad IgG Qn	4180186
1761688	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Corn salad; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761688	 .IgG::::	4182948
1761689	Finding; Findings; Job; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1761692	P jiroveci DNA Resp NAA+probe-Log#	4180186
1761692	 DNA:::::..	4182948
1761692	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; P carinii; P jiroveci; PCP; PCR; Pneumocystis carinii; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; RS; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
1761693	Gourd IgG Qn	4180186
1761693	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Gourd; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761693	 .IgG::::	4182948
1761695	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761696	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761697	Finding; Findings; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761698	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f010; f10; i; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Ses i 1; Ses I 1 Ab.IgE; Sesame Seed; Sesamum orientale; SR	4180186
1761698	Ses i 1 IgE Qn	4180186
1761698	 1 .IgE::::	4182948
1761699	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761700	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761702	MVPX Clade I DNA Spec Ql NAA+probe	4180186
1761702	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Congo Basin monkeypox virus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; MVPX; MVPX clade; MVPX Clade I; MVPX Clade I DNA; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1761703	Blood; CD3 Cells; CD3+CD8+ Cells; CD8 T cells; Cell; Cellularity; Gated cells; Leu2; Leu-2; Leu4; Leu-4; Microbiology; Number Fraction; PBMC; Percent; Peripheral blood mononuclear cells; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor; WB; Whole blood	4180186
1761703	CD3+CD8+ Cells Bld MC-NFr	4180186
1761703	.CD3+CD8+/100 ::::	4182948
1761704	FCN; Finding; Findings; Func; Funct; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761705	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761706	Blood; CD4 Cells; CD4 IFNg cells; CD4 IFNg cells/CD4 cells; Cell; Cellularity; G-INF; Helper T cells; ID; IFN; IGNF; II; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu3; Leu-3; Microbiology; Number Fraction; p COVID NuclCap; Pept; Percent; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; T4; T-4; W3/25; WB; Whole blood	4180186
1761706	CD4 IFNg/CD4 p COVID NuclCap	4180186
1761706	.CD4. gamma /.CD4^ SARS  2 ::::	4182948
1761707	Chick Pea IgG Qn	4180186
1761707	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Besan; Chick pea; Chickpea; f309; Garbanzo bean; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf309; Serum; SR	4180186
1761707	 .IgG::::	4182948
1761709	LDLc cor Lpa Cholest	4180186
1761709	Calc; Calculation; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; cor for Chol.in lipoprotein (a); LDLc; LDL-C; LDLc cor Lpa Cholest; Level; Lip; Lipid; Lipoprot; Lipoproteins; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; LP; Lp(a); LP(a) Cholesterol; LPa; Lpa Cholest; Lpa Cholesterol; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761709	.LDL ^ Lp(a) :::::	4182948
1761711	Finding; Findings; Levels; Levl; Lower extremity joint; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761713	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1761716	Activity; Asympt; Asymptomatic; Exercise; Pan; Panel; Panl; Pnl; Point in time; Random; Scn; Survey	4180186
1761718	CT.extr plt inhib Bld ROTEM	4180186
1761718	Activ; Blood; Clot; Clottable; Coag; Coagulation time; CT.extr plt inhib; CT.extrinsic; Platelet; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; ROTEM; R-time; TEG; TEM; Thrb; Thrombelastography; Thrombelastometry; Thrombocyte; Thrombocytes; Thromboelastometry; WB; Whole blood	4180186
1761718	..:::::.	4182948
1761722	CMV DNA Bld NAA+probe-aCnc	4180186
1761722	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Arbitrary concentration; Blood; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood	4180186
1761722	 DNA:::::..	4182948
1761723	P aeruginosa Lower resp Ql Cult	4180186
1761723	C&S; Cult; Cultures; Low; Lower resp; Microbiology; Ordinal; P aeruginosa; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec	4180186
1761723	:::.::	4182948
1761725	AE; Arterial Stenosis; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761726	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1761728	bod; Bodies; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761729	Finding; Findings; Lower extremity; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761732	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; Parapox virus; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1761732	Parapoxvirus DNA Spec Ql NAA+probe	4180186
1761732	 DNA:::XXX::..	4182948
1761733	Finding; Findings; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761734	LRBA deficiency panel Bld	4180186
1761734	Blood; CELL MARKERS; LRBA deficiency panel; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; PR; Prot; Random; WB; Whole blood	4180186
1761734	:-:::-	4182948
1761735	Antigen; Antigens; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Kallikrein 3; Level; Mass concentration; P-30 antigen; Point in time; PS; PSA; QNT; Quan; Quant; Quantitative; Random; Seminin; Spec; Tumor marker; WB; Whole blood	4180186
1761735	PSA DBS-mCnc	4180186
1761735	 :::.:	4182948
1761737	Cells.LRBA+/B Cells NFr Bld FC	4180186
1761737	B Cells; B220; B4; B-4; Blood; CD3 Cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cells.LRBA+/100 B-cells; Cellularity; Dynamic; FC; HD-37; LCA; Leu12; Leu-12; Leu4; Leu-4; Leukocyte common antigen; LeuM3; Leu-M3; LPS receptor; LPS-R; Ly5; Mo2; Mo-2; My4; My-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T200; T3; WB; Whole blood	4180186
1761737	.LRBA+/100 .CD3-CD14-CD19+CD45+:::::	4182948
1761738	EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; TBI (Traumatic Brain Injury); UCH-L1	4180186
1761738	UCH-L1 Ser IA-mCnc	4180186
1761738	-L1:::::	4182948
1761739	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761740	Activ; Actvty; EXCZ; Movements; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
1761741	JCPyV DNA SerPl NAA+probe-Log#	4180186
1761741	JC  DNA:::/::..	4182948
1761741	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
1761742	AE; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761744	Microalbumin ?Tm Ur-mCnc	4180186
1761744	?Tm; Alb; DL=20 mg/L; Left; Level; Levo; MA; Malb; Mass concentration; Micro albumin; Microalbumin; Protein.albumin; QNT; Quan; Quant; Quantitative; UA; UR; URINALYSIS; Urn	4180186
1761744	::XXX::: <= 20 mg/L	4182948
1761745	UGI capsule endo study Doc	4180186
1761745	Document; Finding; Findings; GI; GI.ENDOSCOPY; Point in time; Random; Study report; UGI capsule endo study; Up	4180186
1761745	:::^:	4182948
1761746	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Kale; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761746	Kale IgG Qn	4180186
1761746	 .IgG::::	4182948
1761747	Alpha subunit free sp5 p chal SerPl-aCnc	4180186
1761747	After; Alfa; Alpha subunit free; Arbitrary Concentration; CHEMISTRY.CHALLENGE TESTING; FR; Non-protein bound; p chal; Pituitary glycoproteins; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p chal; Spec; SR	4180186
1761747	Alpha .^XXX5:::/:	4182948
1761751	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin M; Immunoglobulin M; MEIA; Microbiology; Ordinal; Orthopox virus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1761751	Orthopoxvirus IgM SerPl Ql IA	4180186
1761751	 .IgM:::/::	4182948
1761752	FLUBV RNA Sal Ql NAA+probe	4180186
1761752	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUV; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Oral fluid; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Sal; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1761752	 B  RNA:::::..	4182948
1761753	Glucose BldMV-sCnc	4180186
1761753	Bld mixed venous; Blood - mixed venous; Chemistry; Glu; Gluc; Glucoseur; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1761753	::::	4182948
1761754	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Understand potent benefits of prod	4180186
1761756	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Cell Cnt + Diff Pnl; Diff; Diff Pnl; Differl; Differn; HEMATOLOGY/CELL COUNTS; Manl; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random	4180186
1761756	Cell Cnt + Diff Pnl Amn Manual	4180186
1761756	:-:::-:	4182948
1761757	Alleviating factors Reported	4180186
1761757	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
1761757	:::^::	4182948
1761762	PALB2 Mut Anl Bld/T	4180186
1761762	Blood; Document; FANCN; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mut Anl; Mutations; partner and localizer of BRCA2; PCR; PNCA3; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1761762	PALB2  :::/::	4182948
1761763	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761765	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anorectl; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium rRNA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rectum; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1761765	M genitalium rRNA Anorectl Ql NAA+probe	4180186
1761765	 rRNA:::::..	4182948
1761766	DRUG/TOXICOLOGY; Drugs; Intuniv; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1761766	Guanfacine SerPl-mCnc	4180186
1761766	:::/:	4182948
1761770	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Dengue type I; Dengue type I+II+III+IV; Dengue virus 1+2+3+4 (nsP1) IgG; DENV; DENV 1+2+3+4; DENV1; DENV1+2+3+4; DNV 1+2+3+4 nsP1; EIA; ELFA; ELISA; Enzyme immunoassay; Flavivirus; i; IAA; II; III; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; nsP1; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1761770	DNV 1+2+3+4 nsP1 IgG SerPl Ql IA	4180186
1761770	 1+2+3+4  1 (nsP1) .IgG:::/::	4182948
1761771	Vasopressin sp7 p chal Plas-sCnc	4180186
1761771	^7th spec pst XXX chal; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp7; sp7 p chal; Spec; Substance concentration; VP	4180186
1761771	^XXX7::::	4182948
1761773	Access to help prod of interest; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1761776	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761777	AE; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761779	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761782	Glucagon sp6 p chal SerPl-mCnc	4180186
1761782	After; CHEMISTRY.CHALLENGE TESTING; HGF; Hyperglycemic factor; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p chal; Spec; SR	4180186
1761782	^XXX6:::/:	4182948
1761783	Titin Ab Ser IA-aCnc	4180186
1761783	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Myasthenia gravis; Paraneoplastic neurological syndrome; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; Thymoma	4180186
1761783	 :::::	4182948
1761785	Colon capsule endo study Doc	4180186
1761785	Colon capsule endo study; Document; Finding; Findings; GI; GI.ENDOSCOPY; Point in time; Random; Study report	4180186
1761785	:::^:	4182948
1761787	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Level; m10; Mass concentration; Pleospora tarda; Point in time; QNT; Quan; Quant; Quantitative; Random; S botryosum; Serum; SR; Stemphylium botryosum IgG4	4180186
1761787	S botryosum IgG4-mCnc	4180186
1761787	 .IgG4::::	4182948
1761790	Cardiac; Cardiac LV SWM Pnl; Echography; Hrt; Hrt ventr; L; LT; LV; Pan; PANEL.CARDIAC; Panl; Pnl; Point in time; Random; Segment; Segment appearance; Sonogram; Sonograph; Sonography; SWM; ULS; Ultrasound; Ventricular; WM	4180186
1761790	Cardiac LV SWM Pnl LV US	4180186
1761790	:-::..:-:	4182948
1761793	CD4+154/CD4 p COVID NuclCap	4180186
1761793	Blood; CD4 Cells; CD4+154 cells; CD40 ligand; CD40L; Cell; Cellularity; gp39; Helper T cells; ID; II; Inducer T cells; Infectious Disease; InfectiousDisease; L3T4; Leu3; Leu-3; Microbiology; Number Fraction; p COVID NuclCap; Pept; Percent; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; T4; T-4; T-BAM; TRAP; Tumor necrosis factor Related Activation Protein; W3/25; WB; Whole blood; X-linked hyper IgM	4180186
1761793	.CD4+CD154+/.CD4^ SARS  2 ::::	4182948
1761794	Quail meat IgG Qn	4180186
1761794	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f192; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quail meat IgG; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761794	 .IgG::::	4182948
1761795	Arbitrary concentration; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Follicle stimulating hormone; FSH; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1761795	FSH Fld-aCnc	4180186
1761795	::::	4182948
1761796	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Point in time; Processed cheese IgG; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761796	Processed cheese IgG Qn	4180186
1761796	 .IgG::::	4182948
1761797	Calc; Calculation; Chemistry; Liver fibr score; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1761797	Liver fibr score SerPl Calculated.Agile4	4180186
1761797	:::/::.Agile4	4182948
1761798	Valerianella locusta	4180186
1761799	Finding; Findings; Ordinal; Persons; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1761800	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e084; e84; Epithelia; Golden hamster epithelium; Hamster epithelium IgG; Hmtr Epith; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761800	Hmtr Epith IgG-mCnc	4180186
1761800	 .IgG::::	4182948
1761801	Finding; Findings; Nominal; Persons; Point in time; Random; Survey; SURVEY.MTLHLTH	4180186
1761802	M2-PK Stl Ql	4180186
1761802	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; M2-PK; Ordinal; PK; PKM2; Point in time; PR; Pyruvic acid; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal	4180186
1761802	 M2::::	4182948
1761806	100WBC; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Myeloma cells; Number fraction; Percent; Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
1761806	Plasma Cells/leuk NFr Snv	4180186
1761806	/100 ::::	4182948
1761808	Abiraterone SerPl-mCnc	4180186
1761808	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1761808	:::/:	4182948
1761810	CLIN; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1761810	:::^:	4182948
1761811	Episode of care med rec Doc Transpl surg	4180186
1761811	DOC.MISC; Document; EOC; Episode of care med rec; Finding; Findings; MISC; Point in time; Random; Surg; Transpl surg	4180186
1761811	:::^::	4182948
1761812	Finding; Findings; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761813	Finding; Findings; Ordinal; Point in time; Prod of interest effectiveness; Ql; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1761818	Rosiglitazone SerPl Ql	4180186
1761818	Avandia; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1761818	:::/:	4182948
1761819	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Gen-Probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium rRNA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Urth	4180186
1761819	M genitalium rRNA Urth Ql NAA+probe	4180186
1761819	 rRNA:::::..	4182948
1761821	:::::	4182948
1761821	Cancer; Dermatologic; Epidermis; Finding; Findings; General surgical oncology; Integument; Narrative; Point in time; Random; Report; Skn; Surg; Surg Onc	4180186
1761821	Surg onc melanoma CA synoptic rep	4180186
1761824	21DC sp2 p chal Ser-mCnc	4180186
1761824	21DC; 21-DF; After; CHEMISTRY.CHALLENGE TESTING; Convalescent; Level; Mass concentration; p chal; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; Serum; sp2; sp2 p chal; Spec; SR	4180186
1761824	21-^XXX2::::	4182948
1761827	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1761828	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1761829	Control; Finding; Findings; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761830	After; KSS; Lower extremity joint; Ortho; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Systemic Coronary Risk Evaluation; Tot; Totl	4180186
1761831	Pan; PANEL.SURVEY.R-OUTCOMES; Panl; Pnl; Point in time; R prime; Random; Right; SDOH; Survey; SURVEY.R-OUTCOMES	4180186
1761837	MVPX DNA Spec Ql NAA+probe	4180186
1761837	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; MVPX; MVPX DNA; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1761837	 DNA:::XXX::..	4182948
1761840	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUABV + SARS-CoV-2; FLUABV+SARS-CoV-2 RNA Pnl; FLUAV; FLUB; FLUBV; FLUV; Fowl plague; ID; II; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; PH; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Public Health; PublicHealth; QBR; Random; Ribonucleic acid; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 RNA Pnl; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; To be specified in another...	4180186
1761840	FLUABV+SARS-CoV-2 RNA Pnl Spec NAA+probe	4180186
1761840	 A &  B & SARS  2 RNA :-::XXX:-:..	4182948
1761842	RUBV IgG Index Ser+CSF-aCnc	4180186
1761842	ABS; Aby; AI; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Both serum and cerebrospinal fluid; Cerebral spinal fluid; Cerebrospinal Fl; Congenital rubella syndrome; German measles; Immune globulin G; Immunoglobulin G; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; RUBV; RUBV IgG Index Ser+CSF-aCnc; Serum; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SR	4180186
1761842	 .IgG :::+:	4182948
1761844	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; PEDS; Peds pulmonology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761844	Peds pulmonology Hosp Prog note	4180186
1761844	:::::	4182948
1761847	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; OMS; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
1761847	OMS Hosp Prog note	4180186
1761847	:::::	4182948
1761849	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Forsythia IgE; golden bell; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761849	Forsythia IgE Qn	4180186
1761849	 .IgE::::	4182948
1761850	T-cells LRBA MFI Bld FC	4180186
1761850	Arbitrary; Average; Avg; B220; Blood; CD3 Cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cellularity; Dynamic; FC; LCA; Leu4; Leu-4; Leukocyte common antigen; LeuM3; Leu-M3; LPS receptor; LPS-R; Ly5; Mo2; Mo-2; My4; My-4; Point in time; QNT; Quan; Quant; Quantitative; Random; T200; T3; T-cells LRBA MFI; WB; Whole blood	4180186
1761850	.CD3+CD14-CD45+.LRBA :::::	4182948
1761851	Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
1761851	NUDT15 gene c.416G>A Bld Ql	4180186
1761851	NUDT15  c.416G>A:::::	4182948
1761857	Before; Finding; Findings; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Surg; Survey	4180186
1761858	Allerg Mushroom Mix 1 IgG Qn	4180186
1761858	ABS; Aby; Allerg Mushroom Mix 1; Allerg Mushroom Mix 1 IgG-aCnc; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f32; Immune globulin G; Immunoglobulin G; Oyster mushroom; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761858	(+++) .IgG::::	4182948
1761859	Vasopressin sp10 p chal Plas-sCnc	4180186
1761859	ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp10; sp10 p chal; Spec; Substance concentration; VP	4180186
1761859	^XXX10::::	4182948
1761860	Flexion contracture range Knee	4180186
1761860	Finding; Findings; H+P; H+P.PX; Kn; Lower extremity joint; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Rnge; Screen	4180186
1761860	::::	4182948
1761864	Bovine Tub comp cervical tst panel Skin	4180186
1761864	Beef; Bovine Tub comp cervical tst panel; Cerv; CHEMISTRY.CHALLENGE TESTING; Dermatologic; Epidermis; Integument; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; Random; Skn; TB	4180186
1761864	:-:::-	4182948
1761865	Arbitrary; Average; Avg; B220; B4; B-4; B-cells LRBA MFI; Blood; CD3 Cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cellularity; Dynamic; FC; HD-37; LCA; Leu12; Leu-12; Leu4; Leu-4; Leukocyte common antigen; LeuM3; Leu-M3; LPS receptor; LPS-R; Ly5; Mo2; Mo-2; My4; My-4; Point in time; QNT; Quan; Quant; Quantitative; Random; T200; T3; WB; Whole blood	4180186
1761865	B-cells LRBA MFI Bld FC	4180186
1761865	.CD3-CD14-CD19+CD45+.LRBA :::::	4182948
1761868	Lipid panel SerPl	4180186
1761868	Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1761868	:-::/:-	4182948
1761869	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M genitalium; M genitalium rRNA; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmoides genitalium; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1761869	M genitalium rRNA Spec Ql NAA+probe	4180186
1761869	 rRNA:::XXX::..	4182948
1761870	Blood; Document; Finding; Findings; Gene; Gene panel; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; Next generation sequencing; NGS; Pl; Platelets; Platelt; Plt; Plt disorder gene anal; Point in time; Random; Thrombocyte; Thrombocytes; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1761870	Plt disorder gene anal Bld/T Seq	4180186
1761870	:::/::	4182948
1761871	Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1761871	8(9)-Cholestenol SerPl-mCnc	4180186
1761871	8(9)-:::/:	4182948
1761875	H/O; H+P; H+P.HX; History; Hx; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Ulcer	4180186
1761875	:::^:	4182948
1761876	Calc; Calculation; Chemistry; NASH score; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1761876	NASH score SerPl Calculated.FAST	4180186
1761876	:::/::.FAST	4182948
1761877	:::::	4182948
1761877	Surg onc colon CA synoptic rep	4180186
1761877	Cancer; Finding; Findings; General surgical oncology; LGI; Narrative; Point in time; Random; Report; Surg; Surg Onc	4180186
1761878	Finding; Findings; Lower extremity joint; Ordinal; Ortho; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1761879	Bact; C&S; Cult; Cultures; GP bact; GP bact identified; Identity or presence; Islt; Isol; Isolated; Microbiology; Nominal; Point in time; Pos; Random; Spec	4180186
1761879	GP bact Islt Cult	4180186
1761879	 :::::	4182948
1761880	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rel; Screen; Survey; SURVEY.MTLHLTH	4180186
1761882	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1761882	Eating disorders OP Prog note	4180186
1761882	:::::	4182948
1761884	AE; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey; SURVEY.MTLHLTH	4180186
1761887	Enterobac Carb Resis Pnl Anal Cult	4180186
1761887	Anus; C&S; CPR; Cult; Cultures; Enterobac Carb Resis Pnl; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Rectal specimen; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1761887	.:-:::-:	4182948
1761891	Other cells # Amn Manual	4180186
1761891	#; ABS; absolute; absolutes; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Cell; Cellularity; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Othr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1761891	:::::	4182948
1761892	Duck Meat IgG Qn	4180186
1761892	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f157; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1761892	 .IgG::::	4182948
1761893	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EBV; Epstn; HHV-4; human herpesvirus 4; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; Mono; Mononucleosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
1761893	EBV DNA SerPl NAA+probe-Log#	4180186
1761893	Epstein Barr  DNA:::/::..	4182948
1761894	After; Angiotensin forming enzyme; Angiotensinogenase; CHEMISTRY.CHALLENGE TESTING; Convalescent; Direct renin; DRC; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; sp2; sp2 p chal; Spec	4180186
1761894	Renin sp2 p chal Plas-mCnc	4180186
1761894	^XXX2::::	4182948
1761896	CT.extr plt inhib Bld ROTEM	4180186
1761896	Activ; Activated clotting time; Blood; CFT; CFT.extrinsic; Clot time; Coag; CT.extr plt inhib; Kinetics; k-time; Platelet; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; ROTEM; TEG; TEM; Thrb; Thrombelastography; Thrombelastometry; Thrombocyte; Thrombocytes; Thromboelastometry; WB; Whole blood	4180186
1761896	..:::::.	4182948
1761897	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1761898	Bronchial endo US study; Document; Endo US study; ENDO.PULM; Finding; Findings; Point in time; PULMONARY; Random; Study report	4180186
1761898	EBUS study	4180186
1761898	:::^:	4182948
1761905	MR Guided Bone Cryoablation	4180186
1761905	BON; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Mitral regurgitation maximum velocity; MRI; Other; Point in time; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1761905	:::XXX>::MR	4182948
1761907	1V; Brain; Cranial; Cranium; Document; Film; Finding; Findings; Imaging; Intracranial; Lat; Plain Films; Point in time; Radiology; Random; Single View; Skull; ST; VW; Xray; X-ray	4180186
1761907	XR ST Lat	4180186
1761907	 :::>::X	4182948
1761908	US Heart Transesophageal in surgery	4180186
1761908	CARD.US; Cardiac; Cardiac Echo; Cardiology; Document; Echography; Finding; Findings; Hrt; in Surg; Intra operative; Intraop; Intraoperative; Point in time; Random; Sonogram; Sonograph; Sonography; Surg; Thorax; ULS; Ultrasound	4180186
1761908	^:::>::	4182948
1761909	Abd; Abdo; Abdomen+; Abdominal; Bx; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney-L; L; LT; Mitral regurgitation maximum velocity; MRI; Nephric; Perc; Point in time; Radiology; Random; Renal	4180186
1761909	MR Guided Kidney-L Bx	4180186
1761909	:::>.::MR	4182948
1761910	MR Guided Kidney-R Bx	4180186
1761910	Abd; Abdo; Abdomen+; Abdominal; Bx; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney-R; Mitral regurgitation maximum velocity; MRI; Nephric; Perc; Point in time; R; Radiology; Random; Renal; RT	4180186
1761910	:::>.::MR	4182948
1761911	BMD; Bone density Qn US; Den; Document; Finding; Findings; Imaging; Point in time; Radiology; Random; Study report	4180186
1761911	Bone density QUS	4180186
1761911	:::^:	4182948
1761956	Brassica oleracea var. Sabauda	4180186
1762070	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P pestis; Pasturella pestis; PCR; Plague; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; Y pestis	4180186
1762070	Y pestis DNA Bld Pos Ql NAA+non-probe	4180186
1762070	 DNA:::.::..	4182948
1762075	B anthracis DNA Bld Pos Ql NAA+non-probe	4180186
1762075	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anthrax; B anthracis; Bld Pos; Blood; Charbon; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Malignant carbuncle; Malignant pustule; Microbiology; Milzbrand; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Splenic fever; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; Woolsorters disease	4180186
1762075	 DNA:::.::..	4182948
1762076	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; C burnet; C burnetii; Coxiella burnettii; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Q fev; Q fever; QBR; Qfever; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1762076	C burnet DNA Bld Ql NAA+non-probe	4180186
1762076	 DNA:::::..	4182948
1762077	EBOV RNA Bld Ql NAA+non-probe	4180186
1762077	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; EBO; EBOV; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1762077	 RNA:::::..	4182948
1762079	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; F tular; F tularensis; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Tularemia; WB; Whole blood	4180186
1762079	F tular DNA Bld Ql NAA+non-probe	4180186
1762079	 DNA:::::..	4182948
1762081	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anthrax; B anthracis; B anthracis plasmid pXO1; B anthracis plasmid pXO1 DNA; Blood; Charbon; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Malignant carbuncle; Malignant pustule; Microbiology; Milzbrand; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Splenic fever; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; Woolsorters disease	4180186
1762081	B anthracis plsmd pXO1 DNA Bld Ql NAA+	4180186
1762082	B anthracis plsmd pXO2 DNA Bld Ql NAA+	4180186
1762082	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anthrax; B anthracis; B anthracis plasmid pXO2; B anthracis plasmid pXO2 DNA; Blood; Charbon; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Malignant carbuncle; Malignant pustule; Microbiology; Milzbrand; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Splenic fever; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; Woolsorters disease	4180186
1762086	high-throughput sequencing; HTS; Microbiology; Misc; Miscellaneous; MVPX; MVPX sequencing panel; Next generation sequencing; NGS; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1762086	MVPX sequencing panel Spec Seq	4180186
1762086	:-::XXX:-:	4182948
1762095	Exercise activity & pain severity panel	4180186
1762123	Legionella pneumophila non serogroup 1	4180186
1762131	Able to notice thoughts &or feelings without being overwhelmed	4180186
1762145	Dengue virus 1+2+3+4 non-structural protein 1 (nsP1)	4180186
1762173	(Agaricus bisporus+Pleurotus ostreatus+Lentinula edodes+Cantharellus)	4180186
1762177	Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA	4180186
1762206	NCHC	4180186
1762209	Cortisol free & total panel	4180186
1762210	Time period start & end panel	4180186
1762211	traMADol & Metabolites Panel	4180186
1762288	Beta vulgaris Ab.IgG	4180186
1762324	Galactose-alpha-1,3-galactose panel	4180186
1762340	Easy to describe thoughts &or feelings	4180186
1762368	Glycyrrhiza glabra	4180186
1762372	Difficult to describe thoughts &or feelings	4180186
1762449	GC-MS	4180186
1762451	Aware of emotions affect on thoughts &or behavior	4180186
1762485	Mannose-6-phosphate isomerase & phosphomannomutase 1 panel	4180186
1762490	Recover quickly from distressing thoughts &or images	4180186
1762554	Orthopoxvirus IgG & IgM Ab panel	4180186
1988068	Dist from nerve stim to record site; Length; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; Stim	4180186
1988068	Dist from nerve stim to record site	4180186
1988068	::::	4182948
1988069	Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Replace; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1988070	CLIN; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Tx	4180186
1988070	:::^:	4182948
1988071	CLIN; Kidney; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; RRT circuit	4180186
1988071	Return pressure RRT circuit	4180186
1988071	::::	4182948
1988075	Centers for Medicare and Medicaid Assessment; Form version; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1988076	Eyeball; L; L eye; LT; Nominal; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Random; Vision; Visual	4180186
1988076	L eye Fixation point [Angle]	4180186
1988076	:::.:	4182948
1988079	HBV surface Ag SerPl IA-Log IU	4180186
1988079	Antigen; Antigens; Australia antigen; EIA; ELFA; ELISA; Enzyme immunoassay; HBs; HBsAG; HBV; HBV surface; Hep; Hep B; Hep Bs; Hepatis; Hepatit; HepB; IAA; Log ACNC; Log IU; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Surf	4180186
1988079	 :::/::	4182948
1988081	Hct VFr.DF BldCo Auto	4180186
1988081	Auto; Automated detection; Blood - (umbilical) cord; Cord (umbilical) blood; Cord bld; Cord blood; Elec; Elect; Electr; Hct; HEMATOLOGY/CELL COUNTS; PCV; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1988081	:.::::	4182948
1988083	Artificial Intelligence; Automated detection; Comp Assist; Lip; Lipid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988083	Lipids UrnS Ql Comp Assist	4180186
1988083	:::::	4182948
1988084	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Carp; Carp (rCyp c) 1; Carp (rCyp c) 1 Ab.IgG4; f333; f355; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1988084	Carp (rCyp c) 1 IgG4-mCnc	4180186
1988084	  (rCyp c) 1 .IgG4::::	4182948
1988086	Bother lvl dble images w best corr p 7D; EYE; EYE.HX; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
1988086	Bother lvl dble images w best corr p 7D	4180186
1988086	7::7:^:	4182948
1988087	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Endocrine; Endocrinology; Indirect Fluorescence Antibody; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; TBA; Thyroid stimulating hormone; Thyrotropic hormone; TSH; TSH Block	4180186
1988087	TSH Block Ab Ser Ql CBA IFA	4180186
1988087	 :::::CBA IFA	4182948
1988091	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OB; OB Midwife; Obstetric; Point in time; Prenatal; Random; Visit note	4180186
1988091	OB Midwife D/C sum	4180186
1988091	:::{}::.	4182948
1988093	CoV-2 SocEcon - school-age children; II; Pan; Panel; Panl; Pnl; Point in time; Random; Severe Acute Respiratory Syndrome; Survey	4180186
1988097	Cultivated Corn IgG-mCnc	4180186
1988097	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corn; Cultivated Corn; f008; f141; f8; g202; Immune globulin G; Immunoglobulin G; Level; Maize; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1988097	 .IgG::::	4182948
1988101	Effluent pressure RRT circuit	4180186
1988101	CLIN; Kidney; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; RRT circuit	4180186
1988101	::::	4182948
1988102	SNAP amplitude L MACN	4180186
1988102	Electrical potential; L; L MACN; LT; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; SNAP amplitude; Voltage	4180186
1988102	:::.::	4182948
1988107	Blurry vision past 7D	4180186
1988107	Blurry vision past 7D; EYE; EYE.HX; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
1988107	7::7:^:	4182948
1988108	SFV NAb Titr Spec Nt	4180186
1988108	 .:::XXX::	4182948
1988108	ABS; Aby; Alphaviruses; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SFV; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
1988113	Activ; Actvty; Finding; Findings; Levels; Levl; LV; LVL; Movements; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH; Ulcer	4180186
1988117	Progest Ovarian asp-sCnc	4180186
1988117	Aspirate; Chemistry; Level; P4; Point in time; Prog; Proges; Progest; Progestin; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1988117	::::	4182948
1988118	Temp pacemaker Ventric stim threshold	4180186
1988118	Cardiac pacemaker; Device, Heart-Assist; Point in time; Prosthetic; QNT; Quan; Quant; Quantitative; Random; Stim; Temp pacemaker; Ventric stim threshold	4180186
1988118	:::.:	4182948
1988119	Diff lvl b/c glare w/o corr lens pst 7D; Finding; Findings; Last; Levels; Levl; LV; LVL; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1988120	Experienced glare past 7D	4180186
1988120	Experienced glare past 7D; EYE; EYE.HX; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
1988120	7::7:^:	4182948
1988122	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988124	Dysmorphic RBC UrnS Ql Comp Assist	4180186
1988124	Artificial Intelligence; Automated detection; Comp Assist; D Cells; DE; Discocytes; Dysmorphic RBC; Erthrocyte; Erythrocyte; Glomerular erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988124	.:::::	4182948
1988127	Eye H prism-in far Sheard by Phoropter	4180186
1988127	by Phoropter; EYE.REFRACTION; Eyeball; H prism-in; H prism-in far; H prism-in far Sheard; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988127	.Sheard:::::	4182948
1988128	MTX 5M p dose SerPl-sCnc	4180186
1988128	5M p dose; After; Amethoperin; Amethopterin; DRUG/TOXICOLOGY; Drugs; Level; Methotrexat; MTX; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1988128	^5:::/:	4182948
1988135	Finding; Findings; NEG; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988136	Ej Ab Ser Line blot-aCnc	4180186
1988136	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CADM; Clinically amyopathic DM; Dermatomyositis, Adult Type; Glycyl tRNA synthetase; Point in time; Polymyositis, Idiopathic; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
1988136	Ej :::::	4182948
1988140	Cardiac; Girth; Hrt; Length; Misc; Miscellaneous; Other; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1988140	Circumf Valve	4180186
1988140	:::..XXX:	4182948
1988144	Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1988145	:::^:	4182948
1988145	ADMIN; Location; Nominal; Point in time; Random	4180186
1988146	L; L sural n; LT; NEURO; Pan; PANEL.NEURO; Panl; Pnl; Point in time; Random; Sensory NC Pnl	4180186
1988146	Sensory NC Pnl L sural n	4180186
1988146	:-::.:-	4182948
1988149	L eye Far VA--uncorr	4180186
1988149	Distance; Eye; EYE.REFRACTION; Eyeball; Far VA; L; L eye; Length Ratio; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; Vision; Visual	4180186
1988149	.^:::.:	4182948
1988150	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988150	:::::	4182948
1988152	Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1988153	Dif lvl bc dbl image w/o corr lens p 7D	4180186
1988153	Dif lvl bc dbl image w/o corr lens p 7D; EYE; EYE.HX; Finding; Findings; Last; Levels; Levl; LV; LVL; Ordinal; Ql; Qual; Qualitative; Screen	4180186
1988153	7::7:^:	4182948
1988154	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SLP; Survey; SURVEY.SLP	4180186
1988155	Contract; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1988156	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SLP; Survey; SURVEY.SLP	4180186
1988158	14 days; 2 weeks; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Satisfact w/sleep last 2W; Screen; Survey; SURVEY.GNHLTH	4180186
1988159	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bilharziasis; blood fluke; Blt; Cercarial dermatitis; Immune blot; Immunobl; Immunoblot; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Schistosomiasis; Screen; Serum; species; spp; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1988159	Schistosoma sp 10kD Ab Ser Ql IB	4180186
1988159	 10kD :::::	4182948
1988162	Blood; Document; Erythrocytosis; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; JAK2 exon 12; Janus kinase 2; Janus kinase 2 gene; JTK10; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Polycythemia vera; PV; Random; sequencing of entire coding region; THCYT3; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1988162	JAK2 exon 12 Full Mut Anl Bld/T Seq	4180186
1988162	JAK2  12 :::/::	4182948
1988165	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988167	2; MPSS; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey	4180186
1988168	Exam finding location Chest	4180186
1988168	Finding; Findings; H+P; H+P.PX; Nominal; P prime; Point in time; Random; Thorax	4180186
1988168	::::	4182948
1988169	B cells expressing CD19 as a percent of total lymphocytes; B29; B4; B-4; Blood; CD19 Cells; Cell; CELL MARKERS; Cellularity; Gated cells; HD-37; Ig beta; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1988169	Cells.CD19+CD79b+ NFr Bld	4180186
1988169	.CD19+CD79b+/100 ::::	4182948
1988174	Peak motor NC latency Time Nerve	4180186
1988174	NEURO; Peak motor NC latency; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1988174	:::::	4182948
1988176	Corneal; EYE; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; RT	4180186
1988176	R cornea Coefficient of variation	4180186
1988176	:/::.:	4182948
1988180	Italian Cypress IgG-mCnc	4180186
1988180	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Funeral cypress; Immune globulin G; Immunoglobulin G; Italian cypress; Level; Mass concentration; Mediterranean cypress; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t023; t23	4180186
1988180	 .IgG::::	4182948
1988181	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Tx	4180186
1988182	by Phoropter; EYE.REFRACTION; Eyeball; Far infra recovery; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988182	Far infra recovery by Phoropter	4180186
1988182	:::::	4182948
1988183	Prcnt chng AP amp p rptv stim Muscle	4180186
1988183	After; Exchange; Musc; Muscl; NEURO; p rptv stim; Point in time; Prcnt chng AP amp; PST; QNT; Quan; Quant; Quantitative; Random; Ratios; Replace; Rto; Stim	4180186
1988183	^::::	4182948
1988184	Freq double images w/o corr lens pst 7D	4180186
1988184	EYE; EYE.HX; Finding; Findings; Freq double images w/o corr lens pst 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
1988184	7::7:^:	4182948
1988186	C psittaci Ab Pnl Ser	4180186
1988186	Avian chlamydiosis; C psittaci; C psittaci Ab Pnl; Chlamydia; Chlamydia psittaci; Chlamydial abortion; CPS; Enzootic abortion of ewes; Microbiology; Ornithosis; Ovine chlamydiosis; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Psittacosis; Random; Serum; SR	4180186
1988186	:-:::-	4182948
1988188	Amorph Phos Cry # UrnS Comp Assist	4180186
1988188	#; ABS; absolute; absolutes; AM; Amorph; Amorph Cry; Amorph Phos Cry; Amorphic; Artificial Intelligence; Automated detection; Cnt; Comp Assist; Count; Count/volume; Crys; Cryst; Crystal; CT; i Phos; Inorganic phosphate; Number concentration; Number Concentration (count/vol); Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988188	.:::::	4182948
1988189	L eye Add inter by Phoropter	4180186
1988189	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988189	:::.::	4182948
1988190	Norepineph SerPl-mCnc	4180186
1988190	Chemistry; Level; Mass concentration; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1988190	:::/:	4182948
1988191	2S albumin; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cashew; Cashew nut; Cashew nut (rAna o) 3; f202; f443; III; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1988191	Cashew nut (rAna o) 3 IgG4-mCnc	4180186
1988191	  (rAna o) 3 .IgG4::::	4182948
1988192	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SLP; Survey; SURVEY.SLP	4180186
1988195	SNAP area AUC L median n	4180186
1988195	AUC; L; L median n; LT; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; SNAP area	4180186
1988195	:::.::	4182948
1988196	ANTIBIOTIC SUSCEPTIBILITIES; AST; Atavaquone; Islt; Isol; Mepron; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1988196	Atovaquone Susc Islt	4180186
1988196	::::	4182948
1988197	SNAP area AUC R median n	4180186
1988197	AUC; NEURO; Point in time; QNT; Quan; Quant; Quantitative; R; R median n; Random; RT; SNAP area	4180186
1988197	:::.::	4182948
1988200	After; Disease; Disorder; Finding; Findings; Ordinal; Point in time; PST; QL; Qual; Qualitative; Random; Screen; Survey; Virus	4180186
1988201	Assessment; DOC.ONT; Document; ED; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; Geri med; Gerontology; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
1988201	Geri med ED Eval note	4180186
1988201	:::::	4182948
1988202	SARS-CoV-2 S IgG SerPl Ql IA	4180186
1988202	2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; PH; Pl; Plasma; Plsm; Point in time; PR; Prot; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 S; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SR; SUDS; Viral Pneumonias; Wuhan coronavirus	4180186
1988202	SARS  2  .IgG:::/::	4182948
1988203	Color blindness Eye	4180186
1988203	Appearance; Colour; Eye; Eyeball; H+P; H+P.PX; Nominal; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; P prime; Point in time; Random; Typ; Vision; Visual	4180186
1988203	::::	4182948
1988204	Mat fetal med H&P note	4180186
1988204	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; Mat fetal med; notes; Point in time; Random; Visit note	4180186
1988204	:::{}::	4182948
1988205	Cardiac pacemaker; Device, Heart-Assist; Finding; Findings; Nominal; Point in time; Prosthetic; Random; Temp pacemaker	4180186
1988205	Temp pacemaker Wire status	4180186
1988205	:::.:	4182948
1988206	#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid	4180186
1988206	Nuc cell # Snv Auto	4180186
1988206	:::::	4182948
1988213	Chloride/Creat 24h Ur-sRto	4180186
1988213	1 day; 24 hours; 24HR; Chemistry; Cl; Cl-; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
1988213	/::24::	4182948
1988216	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988217	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S. saprophyticus; Screen; SDA; Staph; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
1988217	S. saprophyticus DNA Ur Ql NAA+probe	4180186
1988217	 DNA:::::..	4182948
1988218	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS	4180186
1988219	F-wave motor NC Pnl Nerve	4180186
1988219	F-wave motor NC Pnl; Motor NC Pnl; NEURO; Pan; PANEL.NEURO; Panl; Pnl; Point in time; Random	4180186
1988219	F:-:::-	4182948
1988222	14 days; 2 weeks; Able to accept body appear last 2W; Appear; Appr; bod; Bodies; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1988224	ADMIN; Pan; PANEL.ADMIN; Panl; Pnl; Point in time; Random; Telecom panel	4180186
1988224	Entity Telecom panel	4180186
1988224	:-::^:-	4182948
1988226	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SLP; Survey; SURVEY.SLP	4180186
1988227	Contract; Finding; Findings; Ordinal; Painter's colic; PB; Plumbism; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1988229	AC/A ratio; by Phoropter; EYE.REFRACTION; Eyeball; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Vision; Visual	4180186
1988229	:::::	4182948
1988232	by Phoropter; EYE.REFRACTION; Eyeball; Far supra recovery; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988232	Far supra recovery by Phoropter	4180186
1988232	:::::	4182948
1988234	Disease; Disorder; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Virus	4180186
1988235	Bills; Debt; Employment; Expenses; Finding; Findings; Income; Job; Loans; Occupation; Ordinal; Point in time; Prob w/ child care- wk/stdy difficult; Ql; Qual; Qualitative; Random; Screen; SDH; SDH.Economics; SDOH; Study report; Survey; Unemployed; Unemployment	4180186
1988237	Motor NC velocity R median n	4180186
1988237	Motor NC velocity; NEURO; Point in time; QNT; Quan; Quant; Quantitative; R; R median n; Random; RT; Vel; Velocity	4180186
1988237	:::.::	4182948
1988240	14 days; 2 weeks; Avail info needed in daily life last 2W; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1988242	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988244	L eye V prism-up far phor by Phoropter	4180186
1988244	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; V prism-up; V prism-up far phor; Vision; Visual	4180186
1988244	.:::.::	4182948
1988245	Cnt; Count; No; Num; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH	4180186
1988246	Avg freq primary pain past 4W	4180186
1988246	4 weeks; Avg freq primary pain past 4W; Finding; Findings; H+P; H+P.HX; Last; Ordinal; P prime; QL; Qual; Qualitative; Screen	4180186
1988246	4::4:^:	4182948
1988249	by Phoropter; EYE.REFRACTION; Eyeball; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Prism base dir for far fix disparity; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988249	R eye Prism dir for far fix disp Phor	4180186
1988249	:::.::	4182948
1988251	MRGN classification Islt Ql	4180186
1988251	ANTIBIOTIC SUSCEPTIBILITIES; Islt; Isol; MDRO; MRGN; MRGN classification; NEG; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Typ	4180186
1988251	::::	4182948
1988252	Electrical potential; L; L LACN; Lat; LT; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; SNAP amplitude; Voltage	4180186
1988252	SNAP amplitude L LACN	4180186
1988252	:::.::	4182948
1988255	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
1988255	:::^:	4182948
1988256	Sten deg LenFr LM Autopsy	4180186
1988256	Art; Coronary segment 5; L; Length Fraction; LM; LT; Pathology; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
1988256	:::::	4182948
1988257	Auto; Automated detection; Bact; Elec; Elect; Electr; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988257	Bacilliform bact UrnS Ql Auto	4180186
1988257	:::::	4182948
1988259	VGCC Ab CSF IA-sCnc	4180186
1988259	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ca; Cal; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Lamblia intestinalis; LEMS; Level; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; SUDS; VDCC; VG; V-G; VGCC; VGCCA; Voltage-dependent calcium channels	4180186
1988259	 :::::	4182948
1988260	CARD.RISK; Cardiology; CVD; CVD 10Y risk; Dis; Diseases; Dz; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk	4180186
1988260	CVD 10Y risk Qn	4180186
1988260	 10 :::^:	4182948
1988262	#/area; Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Elec; Elect; Electr; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Nuc; Nuc cell; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1988262	Nuc cell #/area Fld Auto	4180186
1988262	:::::	4182948
1988263	CRL; H+P; H+P.PX; Len; Length; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1988263	CRL Measured	4180186
1988263	.:::^::	4182948
1988267	C immitis IgG Spec IA-aCnc	4180186
1988267	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; Coccidioides esteriformis; Coccidiomycosis; Coccio; EIA; ELFA; ELISA; Enzyme immunoassay; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Misc; Miscellaneous; Other; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; Pseudococcidioides mazzai; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; Spec; SUDS; T proteolyticum; To be specified in another part of the message; Trichosporon proteolyticum; Unspecified; Valley fever	4180186
1988267	 .IgG:::XXX::	4182948
1988268	Pan; PANEL.SURVEY.R-OUTCOMES; Panl; Pnl; Point in time; R prime; Random; Right; Survey; SURVEY.R-OUTCOMES	4180186
1988269	AAG CRIM tiss Ql IB	4180186
1988269	AAG CRIM; Acd; Acid A-Glucosidase; Acid maltase; Acids; Alfa; Alpha galactosidase; Alpha-1,4-glucosidase; Blt; Chemistry; CRIM; GAA; Glucoinvertase; Glucosidosucrase; Immune blot; Immunobl; Immunoblot; Immunol; Maltase; Maltase-glucoamylase; Ordinal; Point in time; Pompe disease; PR; QL; Qual; Qualitative; Random; Reac; React; RIBA; Screen; WB; WBLOT; West blot; West blt; Western blot	4180186
1988269	 alpha :::::	4182948
1988270	Add bin accom lag; by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988270	L eye Add bin accom lag by Phoropter	4180186
1988270	:::.::	4182948
1988272	Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1988275	After; Exchange; Musc; Muscl; NEURO; p rptv stim; Point in time; Prcnt chng AP area; PST; QNT; Quan; Quant; Quantitative; Random; Ratios; Replace; Rto; Stim	4180186
1988275	Prcnt chng AP area p rptv stim Muscle	4180186
1988275	^::::	4182948
1988276	EYE; EYE.HX; Finding; Findings; Less active sports/outdoor due to vision; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1988276	Less active sports/outdoor due to vision	4180186
1988276	:::^:	4182948
1988278	Entity Addr type	4180186
1988278	Addr type; ADMIN; Nominal; Point in time; Random; Typ	4180186
1988278	:::^:	4182948
1988280	by Phoropter; EYE.REFRACTION; Eyeball; H prism-out; H prism-out mon acc lag; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988280	L eye H prism-out mon acc lag Phoropter	4180186
1988280	.:::.::	4182948
1988281	RABV IgM Titr Spec IF	4180186
1988281	 .IgM:::XXX::	4182948
1988281	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyssavirus; Microbiology; Misc; Miscellaneous; Other; Point in time; Rabies; RABV; Random; SmQn; Spec; Time Resolved Fluorescence; Titer; Titered; Titre; To be specified in another part of the message; TRF; Ttr; Unspecified	4180186
1988282	Activ; Actvty; Cardiac pacemaker; Device, Heart-Assist; Finding; Findings; Movements; Ordinal; Point in time; Prosthetic; QL; Qual; Qualitative; Random; Screen; Vent elec activ sensed	4180186
1988282	Pacemaker Vent elec activ sensed	4180186
1988282	::::	4182948
1988284	Peak Sensory NC latency Time R MACN	4180186
1988284	NEURO; Peak Sensory NC latency; Point in time; QNT; Quan; Quant; Quantitative; R; R MACN; Random; RT	4180186
1988284	:::.::	4182948
1988289	R eye H prism-in for near fix disp Phor	4180186
1988289	by Phoropter; EYE.REFRACTION; Eyeball; H prism-in; H prism-in for near fix disparity; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988289	.:::.::	4182948
1988290	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS	4180186
1988293	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988296	#; ABS; absolute; absolutes; Artificial Intelligence; Automated detection; Cast; Cnt; Comp Assist; Count; Count/volume; CT; Gran Casts; Hyln-grnlr casts; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988296	Hyln-grnlr casts # UrnS Comp Assist	4180186
1988296	:::::	4182948
1988298	Disease; Disorder; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Virus	4180186
1988299	Lower extremity joint; Pan; Panel; PANEL.SURVEY.LKSS; Panl; Pnl; Point in time; Random; Survey	4180186
1988300	AUC; L; L radial n; LT; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; SNAP area	4180186
1988300	SNAP area AUC L radial n	4180186
1988300	:::.::	4182948
1988301	Lost weight in last 3Mo	4180186
1988301	3 months; CLIN; CLIN.RISK; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Wt	4180186
1988301	3::3:^:	4182948
1988302	AUC; L; L sural n; LT; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; SNAP area	4180186
1988302	SNAP area AUC L sural n	4180186
1988302	:::.::	4182948
1988303	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988306	Activ; Actvty; Atrial electric activity sensd; Cardiac pacemaker; Device, Heart-Assist; Finding; Findings; Movements; Ordinal; Point in time; Prosthetic; QL; Qual; Qualitative; Random; Screen	4180186
1988306	Pacemaker Atrial electric activity sensd	4180186
1988306	::::	4182948
1988307	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; species; spp; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1988307	Fasciola sp 8-9kD IgG Ser Ql IB	4180186
1988307	 8-9kD .IgG:::::	4182948
1988308	by Phoropter; EYE.REFRACTION; Eyeball; H prism-in; H prism-in far phor; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988308	R eye H prism-in far phor by Phoropter	4180186
1988308	.:::.::	4182948
1988310	L inter Djasim Ab Titr Ser Aggl	4180186
1988310	 Djasiman  :::::	4182948
1988310	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); L inter; L inter Djasim; L interrogans; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
1988311	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rexulti; Screen; UA; UR; Urn	4180186
1988311	Brexpiprazole Ur Ql Cfm	4180186
1988311	:::::	4182948
1988312	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Green nimitti; i72; Level; Mass concentration; Midge; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sudan fly	4180186
1988312	Green Nimitti IgG4-mCnc	4180186
1988312	 .IgG4::::	4182948
1988314	acryloylfentanyl; Addiction; C22H26N2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Egyptenyl; GCMS; Illicit; N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]prop-2-enamide; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Synthetic opioid; UA; UR; Urn	4180186
1988314	Acrylfentanyl Ur Ql Cfm	4180186
1988314	:::::	4182948
1988316	R eye Prism inter by Phoropter	4180186
1988316	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988316	:::.::	4182948
1988318	Pan; Panel.devices; Panl; Pnl; Point in time; Random	4180186
1988318	:-::^:-	4182948
1988321	AUC; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; SNAP area	4180186
1988321	SNAP area AUC Nerve	4180186
1988321	:::::	4182948
1988323	Cholest Cry # UrnS Comp Assist	4180186
1988323	#; ABS; absolute; absolutes; Artificial Intelligence; Automated detection; Chol; Choles; Cholest; Cholest Cry; Cholesterol total; Cholesterols; Cnt; Comp Assist; Count; Count/volume; Crys; Cryst; Crystal; CT; Lipid; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988323	:::::	4182948
1988324	5,8,11,14 Eicosatetraenoic acid; 5,8,11-eicosatrienoic acid 20:3 w9; AA; Arachidonic acid; Arch acid; C20:4w6; Chemistry; Eicosatetraenoate; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Scrto; Substance concentration ratio; Substance ratio; Trienoic acid	4180186
1988324	Trienoate/AA RBC.lysate-sRto	4180186
1988324	/:::.:	4182948
1988326	Deep trans cells #/area UrnS Comp Assist	4180186
1988326	#/area; Artificial Intelligence; Automated detection; Cell; Cellularity; Comp Assist; Deep trans cells; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Trans Cells; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988326	.:::::	4182948
1988327	Carbacot; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Robaxin; Skelex; UA; UR; Urn	4180186
1988327	Methocarbamol Ur Cfm-mCnc	4180186
1988327	:::::	4182948
1988331	Disease; Disorder; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Virus	4180186
1988332	Eye seeing larger in vert aniseikonia; EYE.REFRACTION; Finding; Findings; Nominal; Point in time; Random; Vert aniseikonia	4180186
1988332	Eye seeing larger in vert aniseikonia	4180186
1988332	:::^:	4182948
1988339	by Phoropter; EYE.REFRACTION; Eyeball; Far div recovery; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988339	Far div recovery by Phoropter	4180186
1988339	:::::	4182948
1988342	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Chagas disease; Immune blot; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; T cruzi; T cruzi 160kD; Trypanosomiasis; Trypanosomosis; WB; WBLOT; West blot; West blt; Western blot	4180186
1988342	T cruzi 160kD IgG Ser Ql IB	4180186
1988342	 160kD .IgG:::::	4182948
1988344	Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
1988345	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; PT; Random; Telemedicine; Visit note	4180186
1988345	PT Telehealth Note	4180186
1988345	:::::	4182948
1988347	Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1988350	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1988353	MPSS; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
1988356	QNT; Quan; Quant; Quantitative; Scale; SLP; Survey; SURVEY.SLP	4180186
1988358	Atyp crystals # UrnS Comp Assist	4180186
1988358	#; ABS; absolute; absolutes; Artificial Intelligence; Atyp; Atyp crystals; Automated detection; Cnt; Comp Assist; Count; Count/volume; Crys; Cryst; Crystal; CT; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Reactive; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988358	:::::	4182948
1988359	Bunyamwera virus NAb Titr Spec Nt	4180186
1988359	 .:::XXX::	4182948
1988359	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Orthobunyaviruses; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
1988360	Blood; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1988360	SMAD4 gene Mut Anl Bld/T	4180186
1988360	SMAD4  :::/::	4182948
1988361	Dysauto autoimmune Ab pnl Ser	4180186
1988361	Dysauto autoimmune Ab pnl; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Serum; SR	4180186
1988361	:-:::-	4182948
1988362	Cath; CLIN; Dialy; Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Volume	4180186
1988362	Venous lumen vol Dialysis catheter	4180186
1988362	::::	4182948
1988363	Ephedrin Ur Ql Scn	4180186
1988363	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ectasule; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1988363	:::::	4182948
1988364	14 days; 2 weeks; QNT; Quan; Quant; Quantitative; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
1988365	Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right; Scale; Survey; SURVEY.R-OUTCOMES; Tot; Totl	4180186
1988366	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988366	:::::	4182948
1988367	Nerve seg measured	4180186
1988367	Anatomy; Nerve seg measured; NEURO; Nominal; Point in time; Random; Vel	4180186
1988367	::::	4182948
1988369	Recorded sex/gender	4180186
1988369	ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; Gender; Nominal; Point in time; Random; Recorded sex/gender; Sex; Typ	4180186
1988369	:::^:	4182948
1988370	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR	4180186
1988370	Ku Ab Ser Line blot-aCnc	4180186
1988370	Ku :::::	4182948
1988372	Finding; Findings; Len; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1988374	Camplybactr sp Ab Pnl; Campy; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; species; spp; SR	4180186
1988374	Camplybactr sp Ab Pnl Ser	4180186
1988374	:-:::-	4182948
1988379	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; D microceras; d3; HDM; House dust mite; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1988379	D microceras IgG4-mCnc	4180186
1988379	 .IgG4::::	4182948
1988382	Pt transport disposition EMS unit	4180186
1988382	Emergency Medical Service(s); Nominal; Point in time; Pt transport disposition; Random; TRAUMA; Typ	4180186
1988382	::::	4182948
1988383	Ethambutol+rifAMPin Susc Islt	4180186
1988383	ANTIBIOTIC SUSCEPTIBILITIES; AST; c301; Etambol; Ethamb; Inagen; Islt; Isol; Myambutol; Mycobutol; Olbutam; Point in time; Random; RIF; Rifadin; Rifampicin; Rimactane; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1988383	+::::	4182948
1988384	NRS 2002	4180186
1988384	Asympt; Asymptomatic; CLIN; CLIN.RISK; NRS 2002; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random; Scn; SDOH	4180186
1988384	 2002 :-::^:-:NRS_2002	4182948
1988385	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1988387	ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Panipenum; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1988387	Panipenem Susc Islt	4180186
1988387	::::	4182948
1988388	14 days; 2 weeks; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Satisf access transportation last 2W; Screen; Survey; SURVEY.GNHLTH	4180186
1988390	B cinerea IgG4-mCnc	4180186
1988390	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B cinerea; Level; m7; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1988390	 .IgG4::::	4182948
1988393	Motor NC Pnl R tibial n	4180186
1988393	Motor NC Pnl; NEURO; Pan; PANEL.NEURO; Panl; Pnl; Point in time; R; R tibial n; Random; RT	4180186
1988393	:-::.:-	4182948
1988395	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Barcelona nut; Cob nut; f017; f17; Filbert; Filbert tree; Hazel nut; Hazel nut tree; Hazelnut; Hazelnut Pollen Ab.IgG; Hazelnut Poln; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t004; t040; t4; t40	4180186
1988395	Hazelnut Poln IgG-mCnc	4180186
1988395	 .IgG::::	4182948
1988400	Culex mosquito IgG-mCnc	4180186
1988400	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Culex mosquito; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Mosquito; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1988400	 .IgG::::	4182948
1988401	by Phoropter; EYE.REFRACTION; Eyeball; H prism-in; H prism-in far; H prism-in far Perc; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988401	Eye H prism-in far Perc by Phoropter	4180186
1988401	.Percival:::::	4182948
1988402	Artificial Intelligence; Automated detection; Bilharziasis; Comp Assist; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S haematobium; Schistosomiasis; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988402	S haematobium UrnS Ql Comp Assist	4180186
1988402	:::::	4182948
1988405	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1988406	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; S prime; Screen; Survey; SURVEY.PNDS	4180186
1988414	Finding; Findings; Nonverb vocal complaints while at rest; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Survey; SURVEY.CNPI	4180186
1988415	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1988421	K. aerogenes DNA Ur Ql NAA+probe	4180186
1988421	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enterobacter aerogenes; K. aerogenes; K. aerogenes DNA; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
1988421	 DNA:::::..	4182948
1988425	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1988431	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988433	ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Point in time; Protionamide; PTH; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1988433	Prothionamide Susc Islt	4180186
1988433	::::	4182948
1988434	Fac; Fact; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey	4180186
1988435	7-dehydrocholesterol reductase; 7-DHC reductase; Blood; D7SR; delta-7-dehydrocholesterol reductase; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Putative sterol reductase SR-2; Random; sequencing of entire coding region; SLOS; Smith-Lemli-Opitz syndrome; Sterol Delta(7)-reductase; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1988435	DHCR7 gene Full Mut Anl Bld/T Seq	4180186
1988435	DHCR7  :::/::	4182948
1988442	L eye H prism-in for near fix disp Phor	4180186
1988442	by Phoropter; EYE.REFRACTION; Eyeball; H prism-in; H prism-in for near fix disparity; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988442	.:::.::	4182948
1988444	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1988444	:::^:	4182948
1988446	FBXW7 gene Mut Anl Bld/T	4180186
1988446	AGO; Blood; CDC4; F-box and WD repeat domain containing 7; FBW6; FBW7; FBX30; FBXO30; FBXW6; hAgo; hCdc4; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; SEL10; SEL-10; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1988446	FBXW7  :::/::	4182948
1988447	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1988449	100 RBC; Auto; Automated detection; D Cells; DE; Discocytes; Dysmorphic RBC; Elec; Elect; Electr; Erthrocyte; Erythrocyte; Glomerular erythrocytes; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; UA; UR; URINALYSIS; Urn	4180186
1988449	Dysmorphic RBC/100 RBC NFr Ur Auto	4180186
1988449	./100 :::::	4182948
1988450	Neuts Band/leuk NFr Plr Manual	4180186
1988450	100WBC; Bands; bnd; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number Fraction; Percent; Pleural; Pleural fluid; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells	4180186
1988450	./100 :::::	4182948
1988451	Disease; Disorder; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH; Sx; Virus	4180186
1988453	Level of bother blurry vision 7D	4180186
1988453	EYE; EYE.HX; Finding; Findings; Last; Level of bother blurry vision 7D; Ordinal; QL; Qual; Qualitative; Screen	4180186
1988453	7::7:^:	4182948
1988454	Volun activity pattern Muscle EMG	4180186
1988454	Activ; Actvty; Finding; Findings; Movements; Musc; Muscl; NEURO; Nominal; Point in time; Random; Volun activity pattern	4180186
1988454	:::::EMG	4182948
1988455	Finding; Findings; Nominal; Othr; Point in time; Random; Survey	4180186
1988456	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Black olive; f342; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Olive; Olive Pollen Ab.IgG; Olive Poln; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t009; t9	4180186
1988456	Olive Poln IgG-mCnc	4180186
1988456	 .IgG::::	4182948
1988457	L; L fibular n; LT; Motor NC Pnl; NEURO; Pan; PANEL.NEURO; Panl; Pnl; Point in time; Random	4180186
1988457	Motor NC Pnl L fibular n	4180186
1988457	:-::.:-	4182948
1988458	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1988461	Sensory NC Pnl L radial n	4180186
1988461	L; L radial n; LT; NEURO; Neurology; Pan; PANEL.NEURO; Panl; Pnl; Point in time; Random; Sensory NC Pnl	4180186
1988461	:-::.:-	4182948
1988462	HLH multigene analysis Bld/T	4180186
1988462	Blood; Document; Finding; Findings; Gene; Gene panel; HLH multigene analysis; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1988462	:::/::	4182948
1988463	Pacemaker Atrial electric activity capt	4180186
1988463	Activ; Actvty; Atrial electric activity capt; Cardiac pacemaker; Device, Heart-Assist; Finding; Findings; Movements; Ordinal; Point in time; Prosthetic; QL; Qual; Qualitative; Random; Screen	4180186
1988463	::::	4182948
1988464	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S epidermidis; Screen; SDA; Staph; Staph epi; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
1988464	S epidermidis DNA Ur Ql NAA+probe	4180186
1988464	 DNA:::::..	4182948
1988465	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c2; Immune globulin G; Immunoglobulin G; Level; Mass concentration; PCN; Pen; Penicilloyl; Phenoxymethylpenicillin; Point in time; QNT; Quan; Quant; Quantitative; Random; Rh Blood Group System; Serum; SR; Wycillin	4180186
1988465	Penicillin V IgG-mCnc	4180186
1988465	 V .IgG::::	4182948
1988466	Heel toe length Ft Measured	4180186
1988466	Ft; H+P; H+P.PX; Heel toe length; Len; Length; Lower extremity; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1988466	.-:::::	4182948
1988469	by Phoropter; Dpth; EYE.REFRACTION; Eyeball; Finding; Findings; Occular; Oculis; Ophthalmologic; Optic globe; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vision; Visual	4180186
1988469	:::::	4182948
1988475	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Pan; Panl; Pnl; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Survey	4180186
1988477	Cells.CD19+FMC7+ NFr Bld	4180186
1988477	B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; Cell; CELL MARKERS; Cellularity; FMC-7; Gated cells; HD-37; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1988477	.CD19+FMC7+/100 ::::	4182948
1988480	Duration muscle exercise	4180186
1988480	Durat; Duration muscle exercise; EXCZ; Musc; Muscl; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1988480	::::	4182948
1988481	Distance; Eye; EYE.REFRACTION; Eyeball; Far VA; L; L eye; Length Ratio; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; Vision; Visual	4180186
1988481	L eye Far VA--corr	4180186
1988481	.^:::.:	4182948
1988482	Acd; Acid; Chemistry; Erythrocytes; Fatty acid; Level; Lipid; Point in time; Polyunsat FA; PUFA; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration	4180186
1988482	Polyunsat FA RBC.lysate-sCnc	4180186
1988482	.:::.:	4182948
1988486	A-Tumor Necrosis Fact CSF-mCnc	4180186
1988486	Alfa; A-Tumor Necrosis Fact; Cachectin; Cachectine; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Fac; Fact; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; TNF	4180186
1988486	.Alpha::::	4182948
1988487	R eye VA--uncorr	4180186
1988487	Eye; EYE.REFRACTION; Eyeball; Length Ratio; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; Refraction; RT; VA; Vision; Visual	4180186
1988487	^:::.:	4182948
1988488	EYE; EYE.HX; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Use of corr lens in typical day	4180186
1988488	Use of corr lens in typical day	4180186
1988488	:::^:	4182948
1988491	4 weeks; Finding; Findings; Fluct of primary pain intensity past 4W; H+P; H+P.HX; Last; Ordinal; P prime; QL; Qual; Qualitative; Screen	4180186
1988491	Fluct of primary pain intensity past 4W	4180186
1988491	4::4:^:	4182948
1988495	T putrescentiae IgG4-mCnc	4180186
1988495	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; d72; Level; Mass concentration; Mite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Storage mite; T putrescentiae	4180186
1988495	 .IgG4::::	4182948
1988502	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988504	Crystal casts UrnS Ql Comp Assist	4180186
1988504	Artificial Intelligence; Automated detection; Cast; Comp Assist; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988504	:::::	4182948
1988507	Finding; Findings; H+P; H+P.PX; Lower extremity joint; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1988507	:::^:	4182948
1988508	Peritoneal dialysis fluid infused Vol	4180186
1988508	CLIN; Dialy; Fld; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
1988508	:::^:	4182948
1988514	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Fam Med; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1988514	Fam Med D/C sum	4180186
1988514	:::{}::	4182948
1988515	Blood; Hsh155; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; PRP10; PRPF10; Random; SAP155; SF3b155; splicing factor 3b subunit 1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1988515	SF3B1 gene Mut Anl Bld/T	4180186
1988515	SF3B1  :::/::	4182948
1988516	R eye V prism-down near phor Phoropter	4180186
1988516	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; V prism-down; V prism-down near phor; Vision; Visual	4180186
1988516	.:::.::	4182948
1988519	R eye H prism-in bin acc lag Phoropter	4180186
1988519	by Phoropter; EYE.REFRACTION; Eyeball; H prism-in; H prism-in bin acc lag; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988519	.:::.::	4182948
1988520	K oxytoca DNA Ur Ql NAA+probe	4180186
1988520	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; K oxytoca; K oxytoca DNA; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
1988520	 DNA:::::..	4182948
1988526	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988528	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES; Tx	4180186
1988531	Exp; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1988532	Diff lvl b/c glare w best corr lens p 7D	4180186
1988532	Diff lvl b/c glare w best corr lens p 7D; EYE; EYE.HX; Finding; Findings; Last; Levels; Levl; LV; LVL; Ordinal; Ql; Qual; Qualitative; Screen	4180186
1988532	7::7:^:	4182948
1988534	R eye V prism-up inter by Phoropter	4180186
1988534	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; V prism-up; V prism-up inter; Vision; Visual	4180186
1988534	.:::.::	4182948
1988535	mSI Calc	4180186
1988535	Calc; Calculation; CLIN; CLIN.RISK; mSI; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; SI	4180186
1988535	:::^::	4182948
1988539	L cornea Endothelial cell area.mean	4180186
1988539	Average; Avg; Corneal; EYE; L; L cornea; LT; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1988539	.:::.:	4182948
1988540	Anatomy; NEURO; Nominal; Point in time; Random	4180186
1988540	::::	4182948
1988548	Sensory NC velocity L sural n	4180186
1988548	L; L sural n; LT; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; Sensory NC velocity; Vel; Velocity	4180186
1988548	:::.::	4182948
1988550	Il12 CSF-mCnc	4180186
1988550	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Edodekin Alfa; IL; IL12; IL-12; Level; Mass concentration; Natural Killer Cell Stimulatory Factor; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1988550	 12::::	4182948
1988552	Finding; Findings; Nominal; Othr; Point in time; Random; Survey	4180186
1988553	ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1988553	Cefcapene Susc Islt	4180186
1988553	::::	4182948
1988555	by Phoropter; EYE.REFRACTION; Eyeball; H prism-out; H prism-out for near fix disparity; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988555	R eye H prism-out for near fix disp Phor	4180186
1988555	.:::.::	4182948
1988556	ADMIN; Pan; PANEL.ADMIN; Panl; Pnl; Point in time; Random	4180186
1988556	:-::^:-	4182948
1988559	Anionic Neutrophil-Activating Peptide; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Chemotactic Factor, Macrophage-Derived; Chemotactic Factor, Neutrophil; Chemotactic Factor, Neutrophil, Monocyte-Derived; IL; Il8; IL-8; Leukocyte Adhesion Inhibitor; Level; Mass concentration; Neutrophil Activation Factor; Neutrophil-Activating Peptide, Lymphocyte-Derived; Neutrophil-Activating Peptide, Monocyte-Derived; Neutrophil-Activating Peptides, Fibroblast-Derived; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1988559	Il8 CSF-mCnc	4180186
1988559	 8::::	4182948
1988560	Cocci # UrnS Auto	4180186
1988560	#; ABS; absolute; absolutes; Auto; Automated detection; Bact; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988560	:::::	4182948
1988564	L kirschneri Cynopteri Ab Titr Ser Aggl	4180186
1988564	 Cynopteri  :::::	4182948
1988564	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); L kirschneri Cynopteri; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
1988566	Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
1988568	B7 homolog 1; B7-H1; CD274; Cluster of differentiation 274; Document; Finding; Findings; i; Oncology; PATHOLOGY; PDL1; PD-L1; PD-L1 by SP263; Point in time; Random; Tissue; Tissue, unspecified	4180186
1988568	PD-L1 by SP263 Tiss Doc	4180186
1988568	 SP263  1::::	4182948
1988570	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Amox; Amoxicilloyl; Amoxil; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bristamox; c204; c6; Larotid; Level; Mass concentration; Moxalin; Point in time; Polymox; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sumox; Trimox; Wymox	4180186
1988570	Amoxicillin IgG4-mCnc	4180186
1988570	 .IgG4::::	4182948
1988571	#; ABS; absolute; absolutes; Artificial Intelligence; Automated detection; Cnt; Comp Assist; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythrocyte; Isomorphic RBC; Non-dys RBC; Nondysmorphic RBC; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988571	Non-dys RBC # UrnS Comp Assist	4180186
1988571	.:::::	4182948
1988573	AAFP Social Needs; AAFP Social Needs - short form; Asympt; Asymptomatic; Pan; Panel; Panl; Pnl; Point in time; Random; Scn; Survey	4180186
1988575	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Benzylpenicillin; c1; Level; Mass concentration; PCN; Pen; Penicilloyl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Wycillin	4180186
1988575	Penicillin G IgG4-mCnc	4180186
1988575	 G .IgG4::::	4182948
1988578	Schist sp 15-16kD Ab Ser Ql IB	4180186
1988578	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bilharziasis; blood fluke; Blt; Cercarial dermatitis; Immune blot; Immunobl; Immunoblot; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Schist sp 15-16kD; Schist sp 15-16kD Ab; Schistosomiasis; Screen; Serum; species; spp; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1988578	 15-16kD :::::	4182948
1988580	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988584	Disease; Disorder; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Virus	4180186
1988585	Expect clear vision after LASIK; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1988586	R eye Add bin accom lag by Phoropter	4180186
1988586	Add bin accom lag; by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988586	:::.::	4182948
1988587	Horse Hair+Dander IgG-mCnc	4180186
1988587	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e003; e3; Equus spp; Horse Hair+Dander; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1988587	+ .IgG::::	4182948
1988588	Artificial Intelligence; Automated detection; Comp Assist; FR; Non-protein bound; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988588	Lipid droplets UrnS Ql Comp Assist	4180186
1988588	:::::	4182948
1988589	14 days; 2 weeks; Ability to get around last 2W; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1988590	CLIN; QNT; Quan; Quant; Quantitative; Vol; Volume	4180186
1988590	:::^:	4182948
1988592	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; V prism-down; V prism-down for near fix disparity; Vision; Visual	4180186
1988592	R eye V prism-down - near fix disp Phor	4180186
1988592	.:::.::	4182948
1988594	AUTS9; Blood; DFNB97; HGFR; Identity or presence; MET proto-oncogene, receptor tyrosine kinase; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; RCCP2; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1988594	MET gene Mut Anl Bld/T	4180186
1988594	MET  :::/::	4182948
1988602	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1988604	Cardiac; Hrt; Hrt ventr; Length; Pathology; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; RV; Thick; Ventricular	4180186
1988604	Thickness RV	4180186
1988604	:::..:	4182948
1988605	Pan; PANEL.SURVEY.R-OUTCOMES; Panl; Pnl; Point in time; R prime; Random; Right; Survey; SURVEY.R-OUTCOMES	4180186
1988610	Bld flow rate RRT circuit	4180186
1988610	Bld flow; Bld flow rate; CLIN; Dynamic; Flow; Kidney; Point in time; QNT; Quan; Quant; Quantitative; Random; RRT circuit; Volume Rate; vRate	4180186
1988610	::::	4182948
1988612	Bdy temp; bod; Bodies; Body temp.max; H+P; H+P.HX; Largest; Maximal; Maximum; P prime; Peak; QNT; Quan; Quant; Quantitative; Report period; Temp; Temperature	4180186
1988612	Body temp.max RptPeriod	4180186
1988612	.:::^:	4182948
1988613	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1988613	:::^:	4182948
1988614	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f325; f43; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Ovine; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf325; Serum; SR	4180186
1988614	Sheep Milk IgG-mCnc	4180186
1988614	 .IgG::::	4182948
1988615	R eye Prism for near pt accom Phoropter	4180186
1988615	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Prism for near pt accom; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988615	:::.::	4182948
1988616	Peak Sensory NC latency Time L LACN	4180186
1988616	L; L LACN; Lat; LT; NEURO; Peak Sensory NC latency; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1988616	:::.::	4182948
1988618	AV interval; Cardiac pacemaker; Device, Heart-Assist; Point in time; Prosthetic; QNT; Quan; Quant; Quantitative; Random	4180186
1988618	Pacemaker AV interval	4180186
1988618	::::	4182948
1988619	CLIN; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random; SDOM panel	4180186
1988619	SDOM panel	4180186
1988624	L; L MACN; LT; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; Sensory NC velocity; Vel; Velocity	4180186
1988624	Sensory NC velocity L MACN	4180186
1988624	:::.::	4182948
1988626	Impaired nutrition status	4180186
1988626	Finding; Findings; H+P; H+P.HX; Impaired nutrition status; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1988626	:::^:	4182948
1988628	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1988630	WBC clumps Fld Ql Auto	4180186
1988630	Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Elec; Elect; Electr; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocytes; Lkcs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WBC; WBC clumps; WBCs; White blood cell; White blood cells	4180186
1988630	:::::	4182948
1988632	R eye Near VA--uncorr	4180186
1988632	Eye; EYE.REFRACTION; Eyeball; Length Ratio; Near VA; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; Refraction; RT; VA; Vision; Visual	4180186
1988632	.^:::.:	4182948
1988634	Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1988635	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Kala azar; Leishmaniasis; Leishmaniosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; species; spp; SR; Visceral leishmaniasis; WB; WBLOT; West blot; West blt; Western blot	4180186
1988635	Leishmania sp 16kD IgG Ser Ql IB	4180186
1988635	 16kD .IgG:::::	4182948
1988636	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS	4180186
1988638	CLIN; Fld; Kidney; Nominal; Point in time; Random; RRT circuit; Typ	4180186
1988638	Dialysate fluid RRT circuit	4180186
1988638	::::	4182948
1988639	AAG CRIM WBC Ql IB	4180186
1988639	AAG CRIM; Acd; Acid A-Glucosidase; Acid maltase; Acids; Alfa; Alpha galactosidase; Alpha-1,4-glucosidase; Blt; Chemistry; CRIM; GAA; Glucoinvertase; Glucosidosucrase; Immune blot; Immunobl; Immunoblot; Immunol; Leukocytes; Maltase; Maltase-glucoamylase; Ordinal; Point in time; Pompe disease; PR; QL; Qual; Qualitative; Random; Reac; React; RIBA; Screen; WB; WBCs; WBLOT; West blot; West blt; Western blot; White blood cells	4180186
1988639	 alpha :::::	4182948
1988643	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E coli K1; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1988643	E coli K1 DNA CSF Ql NAA+probe	4180186
1988643	 K1 DNA:::::..	4182948
1988645	R eye Sphere inter by Phoropter	4180186
1988645	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988645	:::.::	4182948
1988647	After; Finding; Findings; Len; Levels; Levl; LV; LVL; Ordinal; Point in time; PST; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1988648	T cruzi Ab bands Pnl Ser IB	4180186
1988648	Blt; Chagas disease; Immune blot; Immunobl; Immunoblot; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; RIBA; Serum; SR; T cruzi; T cruzi Ab bands Pnl; Trypanosomiasis; Trypanosomosis; WB; WBLOT; West blot; West blt; Western blot	4180186
1988648	:-:::-:	4182948
1988649	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1988649	Deschloroetizolam Ur Cfm-mCnc	4180186
1988649	:::::	4182948
1988652	dfrA5 Islt/Spm Ql	4180186
1988652	ANTIBIOTIC SUSCEPTIBILITIES; Bact; c202; c242; C62; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; Polytrim; PR; Primsol; Proloprim; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; TMP; Trimeth; Trimpex	4180186
1988652	 dfrA5 :::/::	4182948
1988655	Durat; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1988658	:::^:	4182948
1988658	ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; Gender; Nominal; Point in time; Random; SFCU; SPCU; Typ	4180186
1988658	SPCU	4180186
1988659	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Prism for far fix disparity; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988659	R eye Prism for far fix disparity Phor	4180186
1988659	:::.::	4182948
1988660	Perm pacemaker Atrial stim setting	4180186
1988660	Atrial stim setting; Cardiac pacemaker; Device, Heart-Assist; Electrical potential; Perm pacemaker; Point in time; Prosthetic; QNT; Quan; Quant; Quantitative; Random; Stim; Voltage	4180186
1988660	:::.:	4182948
1988661	Address; ADMIN; Nominal; Point in time; Random	4180186
1988661	:::^:	4182948
1988663	Cariprazine Ur Cfm-mCnc	4180186
1988663	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; RGH 188; UA; UR; Urn; Vraylar	4180186
1988663	:::::	4182948
1988667	Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1988672	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Tx	4180186
1988674	Ever driven	4180186
1988674	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1988674	:::^:	4182948
1988675	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; Want assistance w/ personal needs	4180186
1988676	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bilharziasis; blood fluke; Blt; Cercarial dermatitis; Immune blot; Immunobl; Immunoblot; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Schistosomiasis; Screen; Serum; species; spp; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1988676	Schistosoma sp 120kD Ab Ser Ql IB	4180186
1988676	 120kD :::::	4182948
1988677	Finding; Findings; H+P; H+P.HX; Job; Occupation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1988677	:::^:	4182948
1988679	Finding; Findings; Ordinal; Othr; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1988680	cfDNA.donor/cfDNA.total p card trnsplt	4180186
1988680	After; cfDNA.dnr; cfDNA.donor/cfDNA.total p card trnsplt; Deoxyribonucleic acid; FR; Molecular pathology; MOLPATH; Non-protein bound; Number fraction; p card trnsplt; Percent; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
1988680	cfDNA./cfDNA.^:::.cfDNA:	4182948
1988682	R eye Prism base dir inter by Phoropter	4180186
1988682	by Phoropter; EYE.REFRACTION; Eyeball; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Prism base dir inter; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988682	:::.::	4182948
1988688	ONN virus NAb Titr Spec Nt	4180186
1988688	 .:::XXX::	4182948
1988688	ABS; Aby; Alphaviruses; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; ONN virus; O'nyong-nyong virus; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
1988690	L; L ulnar n; LT; NEURO; Peak Sensory NC latency; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1988690	Peak Sensory NC latency Time L ulnar n	4180186
1988690	:::.::	4182948
1988691	14 days; 2 weeks; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; SDOH; Survey; SURVEY.GNHLTH; WHOQOL-BREF; World Heatlth Organization	4180186
1988692	Mercury CSF-sCnc	4180186
1988692	Cerebral spinal fluid; Cerebrospinal Fl; DRUG/TOXICOLOGY; Drugs; HG; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
1988692	::::	4182948
1988693	Cnt; Count; No; Num; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH	4180186
1988694	Cnt; Count; Disease; Disorder; No; Num; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH; Virus	4180186
1988698	Finding; Findings; Nominal; Point in time; Random; SLP; Survey; SURVEY.SLP	4180186
1988700	Peri dialysis fld infu start time	4180186
1988700	CLIN; Clock time; Dialy; Fld; Peri dialysis fld infu start tme; Point in time; QNT; Quan; Quant; Quantitative; Random; Started	4180186
1988700	:::^:	4182948
1988704	by Phoropter; EYE.REFRACTION; Eyeball; H prism-out; H prism-out far phor; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988704	R eye H prism-out far phor by Phoropter	4180186
1988704	.:::.::	4182948
1988706	L eye Prism dir near phor by Phoropter	4180186
1988706	by Phoropter; EYE.REFRACTION; Eyeball; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Prism dir near phor; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988706	:::.::	4182948
1988707	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988708	Assessment; Emergency Medical Service(s); Eval; H&P; History and physical; Nominal; Patient eval disposition; Point in time; Random; TRAUMA; Typ	4180186
1988708	Patient eval disposition EMS unit	4180186
1988708	::::	4182948
1988709	H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Sx	4180186
1988709	:-::^:-	4182948
1988712	NEURO; Peak motor NC latency; Point in time; QNT; Quan; Quant; Quantitative; R; R median n; Random; RT	4180186
1988712	Peak motor NC latency Time R median n	4180186
1988712	:::.::	4182948
1988715	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Srce; Survey; SURVEY.PNDS; Ulcer	4180186
1988716	After; Pan; Panl; Pnl; Point in time; PROWL post-op; PST; Random; Survey	4180186
1988717	CRRT mode RRT circuit	4180186
1988717	CLIN; CRRT mode; Kidney; Nominal; Point in time; Random; RRT circuit; Typ	4180186
1988717	::::	4182948
1988720	Haem influ DNA CSF Ql NAA+probe	4180186
1988720	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influenza; H influenzae; Haem influ; Haemoph; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1988720	 DNA:::::..	4182948
1988721	Admin info; Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1988723	14 days; 2 weeks; Feel safe in daily life last 2W; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1988727	by Phoropter; EYE.REFRACTION; Eyeball; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Prism dir near phor; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988727	R eye Prism dir near phor by Phoropter	4180186
1988727	:::.::	4182948
1988729	Peach (rPru p) 3 IgG4-mCnc	4180186
1988729	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f095; f420; f95; III; Level; Mass concentration; P prime; Peach; Peach (rPru p) 3; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1988729	  (rPru p) 3 .IgG4::::	4182948
1988730	N men DNA CSF Ql NAA+probe	4180186
1988730	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1988730	 DNA:::::..	4182948
1988731	CLIN; Fld; QNT; Quan; Quant; Quantitative; Volume	4180186
1988731	Hemodialysis fluid removed Vol	4180186
1988731	:::^:	4182948
1988734	AUC; Lat; NEURO; Point in time; QNT; Quan; Quant; Quantitative; R; R LACN; Random; RT; SNAP area	4180186
1988734	SNAP area AUC R LACN	4180186
1988734	:::.::	4182948
1988735	T cruzi 45-47kD IgG Ser Ql IB	4180186
1988735	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Chagas disease; Immune blot; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; T cruzi; T cruzi 45-47kD; T cruzi 45-47kD Ab.IgG; Trypanosomiasis; Trypanosomosis; WB; WBLOT; West blot; West blt; Western blot	4180186
1988735	 45-47kD .IgG:::::	4182948
1988736	Auto; Automated detection; Elec; Elect; Electr; EXT; Nominal; Point in time; Random; TRAUMA; Typ	4180186
1988736	Provider of AED	4180186
1988736	:::^:	4182948
1988740	Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.RMDQ	4180186
1988744	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; L monocytog; L monocytogenes; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Listeriosis; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1988744	L monocytog DNA CSF Ql NAA+probe	4180186
1988744	 DNA:::::..	4182948
1988745	Temp pacemaker Atrial stim threshold	4180186
1988745	Atrial stim threshold; Cardiac pacemaker; Device, Heart-Assist; Point in time; Prosthetic; QNT; Quan; Quant; Quantitative; Random; Stim; Temp pacemaker	4180186
1988745	:::.:	4182948
1988748	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bilharziasis; blood fluke; Blt; Cercarial dermatitis; Immune blot; Immunobl; Immunoblot; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Schistosomiasis; Screen; Serum; species; spp; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1988748	Schistosoma sp 70kD Ab Ser Ql IB	4180186
1988748	 70kD :::::	4182948
1988749	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Fire ant; i070; i70; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red Imp Fire Ant; Red imported fire ant; Serum; SR	4180186
1988749	Red Imp Fire Ant IgG-mCnc	4180186
1988749	 .IgG::::	4182948
1988751	Finding; Findings; H+P; H+P.PX; Lower extremity joint; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1988751	:::^:	4182948
1988752	L; L median n; LT; NEURO; Pan; PANEL.NEURO; Panl; Pnl; Point in time; Random; Sensory NC Pnl	4180186
1988752	Sensory NC Pnl L median n	4180186
1988752	:-::.:-	4182948
1988754	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988755	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CNPI	4180186
1988758	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CADM; Clinically amyopathic DM; Dermatomyositis, Adult Type; PL7; Point in time; Polymyositis, Idiopathic; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; Serology; Serum; SR; Threonyl tRNA Synthetase	4180186
1988758	PL7 Ab Ser Line blot-aCnc	4180186
1988758	Pl-7 :::::	4182948
1988759	Blt; Fasciola sp Ab IB Pnl; IMMUNE BLOT; Immunobl; Immunoblot; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; RIBA; Serum; species; spp; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1988759	Fasciola sp Ab IB Pnl Ser IB	4180186
1988759	:-:::-:	4182948
1988761	WBC Fld Ql Auto	4180186
1988761	Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Elec; Elect; Electr; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WBC; WBCs; White blood cell; White blood cells	4180186
1988761	:::::	4182948
1988762	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; S prime; Screen; Survey; SURVEY.PNDS	4180186
1988763	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
1988763	Thromboemb H&P note	4180186
1988763	:::{}::	4182948
1988768	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1988775	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988779	100 RBC; Acanthocyte; Artificial Intelligence; Automated detection; Comp Assist; Discocytes; Erthrocyte; Erythrocyte; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Spur cells; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988779	Acanthocytes/100 RBC NFr UrnS Com Assist	4180186
1988779	/100 :::::	4182948
1988782	Sten deg LenFr pRCA Autopsy	4180186
1988782	Art; Coronary segment 1; Length Fraction; PATHOLOGY; Percent; Point in time; pRCA; QNT; Quan; Quant; Quantitative; R; Random; RT; Sten deg	4180186
1988782	:::::	4182948
1988783	L eye Prism base dir inter by Phoropter	4180186
1988783	by Phoropter; EYE.REFRACTION; Eyeball; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Prism base dir inter; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988783	:::.::	4182948
1988786	14 days; 2 weeks; Enough energy for everyday life last 2W; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1988789	Deglutition; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SLP; Survey; SURVEY.SLP	4180186
1988790	by Phoropter; EYE.REFRACTION; Eyeball; H prism-in; H prism-in inter; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988790	R eye H prism-in inter by Phoropter	4180186
1988790	.:::.::	4182948
1988792	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; NEG; NRA blur; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Rel; Vision; Visual	4180186
1988792	NRA blur by Phoropter	4180186
1988792	:::::	4182948
1988796	Non-dys RBC UrnS Ql Comp Assist	4180186
1988796	Artificial Intelligence; Automated detection; Comp Assist; Discocytes; Erthrocyte; Erythrocyte; Isomorphic RBC; Non-dys RBC; Nondysmorphic RBC; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988796	.:::::	4182948
1988798	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SLP; Survey; SURVEY.SLP	4180186
1988800	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1988801	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; g001; g1; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Sw Vernal grass; Sweet vernal grass	4180186
1988801	Sw Vernal grass IgG-mCnc	4180186
1988801	 .IgG::::	4182948
1988802	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common wasp; Common wasp (rVes v) 1; i; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1988802	Common wasp (rVes v) 1 IgG-mCnc	4180186
1988802	  (rVes v) 1 .IgG::::	4182948
1988805	CNPI movement panel; Nonverb pain ind; Pan; Panl; Pnl; Point in time; Random; Survey; SURVEY.CNPI	4180186
1988806	Artifact # UrnS Comp Assist	4180186
1988806	#; ABS; absolute; absolutes; Artificial Intelligence; Automated detection; Cnt; Comp Assist; Count; Count/volume; CT; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988806	:::::	4182948
1988809	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SLP; Survey; SURVEY.SLP	4180186
1988811	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Australian parrot; Autoantibodies; Autoantibody; Budgeriar; Budgie; Budgie Drop; e77; Feces; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; stool	4180186
1988811	Budgie Drop IgG-mCnc	4180186
1988811	 .IgG::::	4182948
1988813	R eye H prism-out bin acc lag Phoropter	4180186
1988813	by Phoropter; EYE.REFRACTION; Eyeball; H prism-out; H prism-out bin acc lag; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988813	.:::.::	4182948
1988814	Art; Coronary segment 7; L; Length Fraction; LT; mLAD; PATHOLOGY; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
1988814	Sten deg LenFr mLAD Autopsy	4180186
1988814	:::::	4182948
1988815	Cnt; Count; No; Num; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH	4180186
1988816	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1988818	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1988819	Med add to peri dialysis fld Vol	4180186
1988819	CLIN; Dialy; Fld; Med; Med added to peritoneal dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
1988819	::::	4182948
1988821	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Filarial; Filariasis; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Microfilaria; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
1988821	Filaria IgG Ser Ql IA	4180186
1988821	 .IgG:::::	4182948
1988824	Cnt; Count; No; Num; Number; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1988825	Centers for Medicare and Medicaid Assessment; Deglutition; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1988826	EYE.PX; Eyeball; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Random; Vision; Visual; Worth 4 dot far	4180186
1988826	Eye Worth 4 dot far [Imp]	4180186
1988826	 Worth ::::	4182948
1988827	B1, Benzodiazepine; Cfm; Cl-DMDZ; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1988827	Delorazepam Ur Cfm-mCnc	4180186
1988827	:::::	4182948
1988828	2019 Novel Coronavirus; 2019-nCoV; bckgrd cor; Blood; Cell; Cellularity; Cnt; Corona virus; Count; COVID19; COVID-19; ID; IFN; IGRA; II; Infectious Disease; InfectiousDisease; Microbiology; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 IFN-g; SARS-CoV-2 IFN-g T cells; SARSCoV2 IGRA Spike Ct; Severe Acute Respiratory Syndrome; T prime; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus	4180186
1988828	SARSCoV2 IGRA Spike Ct bckgrd cor Bld	4180186
1988828	T- SARS  2  gamma .^^:():::	4182948
1988829	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1988830	Cocoa IgG4-mCnc	4180186
1988830	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cacao; Cocoa; f93; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1988830	 .IgG4::::	4182948
1988832	NEURO; Point in time; QNT; Quan; Quant; Quantitative; R; R median n; Random; RT; Sensory NC velocity; Vel; Velocity	4180186
1988832	Sensory NC velocity R median n	4180186
1988832	:::.::	4182948
1988835	Persons; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
1988836	R eye Cylinder inter by Phoropter	4180186
1988836	by Phoropter; CYL; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988836	:::.::	4182948
1988837	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
1988837	:::^:	4182948
1988838	Centers for Medicare and Medicaid Assessment; Form version; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Started; Survey	4180186
1988839	TGF-beta SerPl-mCnc	4180186
1988839	B; Chemistry; Fac; Fact; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TGF-beta	4180186
1988839	 beta:::/:	4182948
1988843	Bilharziasis; blood fluke; Blt; Cercarial dermatitis; Immune blot; Immunobl; Immunoblot; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; RIBA; Schistosoma sp Ab IB Pnl; Schistosomiasis; Serum; species; spp; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1988843	Schistosoma sp Ab IB Pnl Ser IB	4180186
1988843	:-:::-:	4182948
1988845	NEURO; Point in time; QNT; Quan; Quant; Quantitative; R; R radial n; Random; RT; Sensory NC velocity; Vel; Velocity	4180186
1988845	Sensory NC velocity R radial n	4180186
1988845	:::.::	4182948
1988846	Cnt; Count; No; Num; Number; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1988847	Peak Sensory NC latency Time L median n	4180186
1988847	L; L median n; LT; NEURO; Peak Sensory NC latency; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1988847	:::.::	4182948
1988850	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS; Ulcer	4180186
1988851	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common wasp; Common wasp (rVes v) 1; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1988851	Common wasp (rVes v) 1 IgG4-mCnc	4180186
1988851	  (rVes v) 1 .IgG4::::	4182948
1988852	L eye H prism-in for far fix disp Phor	4180186
1988852	by Phoropter; EYE.REFRACTION; Eyeball; H prism-in; H prism-in for far fix disparity; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988852	.:::.::	4182948
1988855	#/area; Auto; Automated detection; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Elec; Elect; Electr; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
1988855	WBC #/area Fld Auto	4180186
1988855	:::::	4182948
1988856	Contract; Disease; Disorder; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Virus	4180186
1988859	AUC; NEURO; Point in time; QNT; Quan; Quant; Quantitative; R; R ulnar n; Random; RT; SNAP area	4180186
1988859	SNAP area AUC R ulnar n	4180186
1988859	:::.::	4182948
1988860	NEURO; Peak Sensory NC latency; Point in time; QNT; Quan; Quant; Quantitative; R; R sural n; Random; RT	4180186
1988860	Peak Sensory NC latency Time R sural n	4180186
1988860	:::.::	4182948
1988864	Lipids #/area UrnS Comp Assist	4180186
1988864	#/area; Artificial Intelligence; Automated detection; Comp Assist; Lip; Lipid; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988864	:::::	4182948
1988867	Finding; Findings; Nonverb complaint during movement; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CNPI	4180186
1988869	Eye Vert aniseikonia by Phoropter	4180186
1988869	by Phoropter; EYE.REFRACTION; Eyeball; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vert aniseikonia; Vision; Visual	4180186
1988869	:::::	4182948
1988871	L; L median n; LT; Motor NC velocity; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; Vel; Velocity	4180186
1988871	Motor NC velocity L median n	4180186
1988871	:::.::	4182948
1988872	Cells.CD19+FMC7+ NFr Mar	4180186
1988872	B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; BM; BON; Bone marrow; CD19 Cells; Cell; CELL MARKERS; Cellularity; FMC-7; Gated cells; HD-37; Leu12; Leu-12; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1988872	.CD19+FMC7+/100 ::::	4182948
1988873	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Latuda; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
1988873	Lurasidone Ur Ql Cfm	4180186
1988873	:::::	4182948
1988875	Alfa; Arbitrary concentration; A-Tumor Necrosis Fact; Cachectin; Cachectine; Chemistry; Fac; Fact; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TNF	4180186
1988875	A-Tumor Necrosis Fact SerPl-aCnc	4180186
1988875	.Alpha:::/:	4182948
1988878	R eye H prism-out inter by Phoropter	4180186
1988878	by Phoropter; EYE.REFRACTION; Eyeball; H prism-out; H prism-out inter; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1988878	.:::.::	4182948
1988882	14 days; 2 weeks; Enjoyment of life 2W; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1988883	Electrical potential; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; SNAP amplitude; Voltage	4180186
1988883	SNAP amplitude Nerve	4180186
1988883	:::::	4182948
1988884	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS	4180186
1988888	GRP SerPl-aCnc	4180186
1988888	Arbitrary concentration; Chemistry; Gastrin releasing peptide; GRP; Mammalian bombesin; Pl; Plasma; Plsm; Point in time; Polypeptides; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total gastrins; Zollinger-Ellison syndrome	4180186
1988888	:::/:	4182948
1988893	FCN; Finding; Findings; Func; Funct; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SLP; Survey; SURVEY.SLP	4180186
1988896	ANTIBIOTIC SUSCEPTIBILITIES; AST; c212; EES; Erygel; Erythro+Ethamb; Erythromycn; Etambol; Ethamb; Ilosone; Ilotycin; Iltycin; Inagen; Islt; Isol; Myambutol; Mycobutol; Olbutam; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1988896	Erythro+Ethamb Susc Islt	4180186
1988896	+::::	4182948
1988897	Diff lvl bc dbl image w best cor lens 7D	4180186
1988897	Diff lvl bc dbl image w best cor lens 7D; EYE; EYE.HX; Finding; Findings; Last; Levels; Levl; LV; LVL; Ordinal; Ql; Qual; Qualitative; Screen	4180186
1988897	7::7:^:	4182948
1988899	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pneumo; S pneumoniae; S pneumoniase DNA; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Spn; Strand Displacement Amplification; Strep; Strept; TMA; Transcription mediated amplification	4180186
1988899	S pneum DNA CSF Ql NAA+probe	4180186
1988899	 DNA:::::..	4182948
1988901	Corneal; EYE; L; L cornea; LT; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio	4180186
1988901	L cornea Hexagonality	4180186
1988901	:::.:	4182948
1988911	Exp; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1988915	Grey Alder IgG-mCnc	4180186
1988915	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; European alder; Gray alder; Grey alder; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Speckled alder; SR; t2	4180186
1988915	 .IgG::::	4182948
1988917	1 year; 12Mos; CoV-2 SocEcon - children 12Mo; CoV-2 SocEcon - school-age children; II; Pan; Panel; Panl; Pnl; Severe Acute Respiratory Syndrome; Survey	4180186
1988918	14 days; 2 weeks; Finding; Findings; Job; Occupation; Ordinal; Past; QL; Qual; Qualitative; Satisfact w/capacity for work last 2W; Screen; Survey; SURVEY.GNHLTH	4180186
1988920	Dis nerve stim to muscle record site; Length; Musc; Muscl; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; Stim	4180186
1988920	Dist nerve stim to muscle record site	4180186
1988920	:::+:	4182948
1988921	Grass Allerg Mix1 IgG-mCnc	4180186
1988921	(++++) .IgG::::	4182948
1988921	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cocksfoot; Festuca elator; Festuca pratensis; g003; g004; g005; g006; g008; g3; g4; g5; g6; g8; Gg6; Grass Allerg Mix1; Grass mix (early flowering); gx1; Immune globulin G; Immunoglobulin G; Italian Ryegrass; June blue grass; June grass; June Kentucky blue grass; Junegrass; Kent blue grass; Kentucky blue grass; Kentucky bluegrass; Level; Mass concentration; Meadow Fescue; Meadow grass; Orchard grass; Per rye grass; Perennial ryegrass; Phleum pretense; Point in time; QNT; Quan; Quant; Quantitative; Random; Rye grass; Ryegrass; Serum; SR; Timothy; Timothy grass	4180186
1988925	BIRC3 gene Mut Anl Bld/T	4180186
1988925	Blood; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1988925	BIRC3  :::/::	4182948
1988928	Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; MPO; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS	4180186
1988928	Myeloperoxidase Ser IA-mCnc	4180186
1988928	:::::	4182948
1988929	Volume Pl space-L	4180186
1988929	L; LT; Pathology; Pl space; Pl space-L; Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Volume	4180186
1988929	:::.:	4182948
1988930	Haptoglob MFr SerPl Elph	4180186
1988930	Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haptoglob; HEMATOLOGY/CELL COUNTS; HP; Hpt; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP	4180186
1988930	/.:::/::	4182948
1988932	S haematobium # UrnS Comp Assist	4180186
1988932	#; ABS; absolute; absolutes; Artificial Intelligence; Automated detection; Bilharziasis; Cnt; Comp Assist; Count; Count/volume; CT; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; S haematobium; Schistosomiasis; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988932	:::::	4182948
1988934	Metaneph Free 24h Ur-sRate	4180186
1988934	1 day; 24 hours; 24HR; Chemistry; FR; Metaneph; Metaneph Free; Metanephrne; Metenephrine; Non-protein bound; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; Unconjugated metanephrine; UR; Urn	4180186
1988934	.::24::	4182948
1988935	Schistosoma sp 95kD Ab Ser Ql IB	4180186
1988935	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bilharziasis; blood fluke; Blt; Cercarial dermatitis; Immune blot; Immunobl; Immunoblot; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Schistosomiasis; Screen; Serum; species; spp; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1988935	 95kD :::::	4182948
1988938	14 days; 2 weeks; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Satisf w/cond of living place last 2W; Screen; Survey; SURVEY.GNHLTH	4180186
1988939	L interrogans Mankarso Ab Titr Ser Aggl	4180186
1988939	 Mankarso  :::::	4182948
1988939	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); L inter; L interrogans; L interrogans Mankarso; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
1988941	ADMIN; Location; Nominal; Point in time; Random	4180186
1988941	:::^:	4182948
1988942	Pseudoephedrine Ur Ql Scn	4180186
1988942	Cenafed; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; Pseudoephed; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sudafed; UA; UR; Urn	4180186
1988942	:::::	4182948
1988943	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988944	Peak Sensory NC latency Time R median n	4180186
1988944	NEURO; Peak Sensory NC latency; Point in time; QNT; Quan; Quant; Quantitative; R; R median n; Random; RT	4180186
1988944	:::.::	4182948
1988945	ENA SS-A 52kD Ab Ser Line blot-aCnc	4180186
1988945	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ENA; ENA SS-A; ENA SS-A 52kD; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ro; Ro AB; Serology; Serum; Sjogren; SR; SS; SSA; SS-A	4180186
1988945	Sjogrens -a  52kD :::::	4182948
1988946	Microorganism casts #/area UrnS AI Asst	4180186
1988946	#/area; Artificial Intelligence; Automated detection; Cast; Comp Assist; Microorg casts; Microorganisms; Number areic; Org; Organism; Organisms; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1988946	:::::	4182948
1988949	ALK gene Mut Anl Bld/T	4180186
1988949	ALK receptor tyrosine kinase; Anaplastic lymphoma kinase (Ki-1); Blood; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; NBLST3; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1988949	ALK  :::/::	4182948
1988950	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Prism for far fix disparity; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1988950	L eye Prism for far fix disparity Phor	4180186
1988950	:::.::	4182948
1988951	OF Pnl RBC	4180186
1988951	Erythrocytes; Frag; Fragil; HEMATOLOGY/CELL COUNTS; OF; OF Pnl; Osmo; Osmo Frag; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; Red blood cells; Red blood corpusles	4180186
1988951	:-:::-	4182948
1988952	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988953	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; V prism-up; V prism-up for near fix disparity; Vision; Visual	4180186
1988953	L eye V prism-up for near fix disp Phor	4180186
1988953	.:::.::	4182948
1988954	Avoid recreation/sports due to vision	4180186
1988954	Avoid recreation/sports due to vision; EYE; EYE.HX; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1988954	:::^:	4182948
1988960	Paper wasp (rPol d) 5 IgG4-mCnc	4180186
1988960	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dextro; i004; i210; i4; Level; Mass concentration; Paper Wasp; Paper wasp (rPol d) 5; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1988960	  (rPol d) 5 .IgG4::::	4182948
1988961	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E faecalis; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
1988961	E faecalis DNA Ur Ql NAA+probe	4180186
1988961	 DNA:::::..	4182948
1988964	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common silver birch; IFR; II; Isoflavone reductase; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rt216; Serum; Silver Birch; Silver Birch (rBet v) 2; SR; t216; t3	4180186
1988964	Silver Birch (rBet v) 2 IgG4-mCnc	4180186
1988964	  (rBet v) 2 .IgG4::::	4182948
1988965	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SLP; Survey; SURVEY.SLP	4180186
1988966	Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1988968	R eye V prism-down for far fix disp Phor	4180186
1988968	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; V prism-down; V prism-down for far fix disparity; Vision; Visual	4180186
1988968	.:::.::	4182948
1988969	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; flubromazolam; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1988969	Flubromazolam Ur Cfm-mCnc	4180186
1988969	:::::	4182948
1988970	Diff daily activities due to vision	4180186
1988970	Diff daily activities due to vision; EYE; EYE.HX; Finding; Findings; Nominal; Point in time; Random	4180186
1988970	:::^:	4182948
1988971	Corneal; EYE; Minimal; minimum; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; RT	4180186
1988971	R cornea Endothelial cell area.min	4180186
1988971	.:::.:	4182948
1988977	SNAP area AUC R radial n	4180186
1988977	AUC; NEURO; Point in time; QNT; Quan; Quant; Quantitative; R; R radial n; Random; RT; SNAP area	4180186
1988977	:::.::	4182948
1988978	H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ	4180186
1988978	:::^:	4182948
1988979	Hearing loss multigene analy Bld/T	4180186
1988979	Blood; Deafness multi-Gene study; Document; Finding; Findings; Gene; Gene panel; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; Otogenetics Deafness Panel; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1988979	:::/::	4182948
1988981	Finding; Findings; Last; O2; Ordinal; Patient Reported Outcomes Information System; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; tO2	4180186
1988982	14 days; 2 weeks; Activ; Actvty; Extent phy pain prevents activity 2W; Finding; Findings; Movements; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1988983	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1988986	Epi Cells BAL Ql Micro	4180186
1988986	Bronchial alveolar lavage; Bronchoalveolar lavage; Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
1988986	:::::.	4182948
1988987	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; T canis; T canis 24-35kD; T canis 24-35kD Ab.IgG; Visceral larva migrans; WB; WBLOT; West blot; West blt; Western blot	4180186
1988987	T canis 24-35kD IgG Ser Ql IB	4180186
1988987	 24-35kD .IgG:::::	4182948
1988989	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Pirazolam; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1988989	Pyrazolam Ur Cfm-mCnc	4180186
1988989	:::::	4182948
1988990	Antigen; Antigens; B/F; BF; Blasto; Blastomycosis; bod; Bodies; Body fluid; Body fluid, unsp; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; species; spp; SUDS	4180186
1988990	Blastomyces Ag Fld IA-mCnc	4180186
1988990	 :::::	4182948
1988991	Anatomy; NEURO; Nominal; Point in time; Random; Stim	4180186
1988991	::::	4182948
1988995	Motor NC velocity R fibular n	4180186
1988995	Motor NC velocity; NEURO; Point in time; QNT; Quan; Quant; Quantitative; R; R fibular n; Random; RT; Vel; Velocity	4180186
1988995	:::.::	4182948
1988998	Blood; FBH; FBH2; FHH2; G protein subunit alpha 11; GNA-11; HHC2; HYPOC2; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1988998	GNA11 gene Mut Anl Bld/T	4180186
1988998	GNA11  :::/::	4182948
1988999	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Srce; Survey; SURVEY.PNDS; Ulcer	4180186
1989003	SNAP area AUC L LACN	4180186
1989003	AUC; L; L LACN; Lat; LT; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; SNAP area	4180186
1989003	:::.::	4182948
1989004	Distance; Eye; EYE.REFRACTION; Eyeball; Far VA; Length Ratio; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; Refraction; RT; VA; Vision; Visual	4180186
1989004	R eye Far VA--uncorr	4180186
1989004	.^:::.:	4182948
1989008	Silver Birch IgG-mCnc	4180186
1989008	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Common silver birch; Gt3; IFR; Immune globulin G; Immunoglobulin G; Isoflavone reductase; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Silver Birch; SR; t3	4180186
1989008	 .IgG::::	4182948
1989011	Motor NC Pnl; NEURO; Pan; PANEL.NEURO; Panl; Pnl; Point in time; R; R ulnar n; Random; RT	4180186
1989011	Motor NC Pnl R ulnar n	4180186
1989011	:-::.:-	4182948
1989012	PRA blur by Phoropter	4180186
1989012	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Pos; PRA blur; QNT; Quan; Quant; Quantitative; Random; Rel; Vision; Visual	4180186
1989012	:::::	4182948
1989014	L cornea Endothelial cell area.min	4180186
1989014	Corneal; EYE; L; L cornea; LT; Minimal; minimum; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1989014	.:::.:	4182948
1989017	14 days; 2 weeks; Able to concentrate last 2W; Cnc; Conc; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1989018	Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1989021	Cardiac; Hrt; Hrt ventr; L; Length; LT; LV; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick; Ventricular	4180186
1989021	Thickness LV	4180186
1989021	:::..:	4182948
1989023	NEG; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1989026	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SLP; Survey; SURVEY.SLP	4180186
1989029	Emergency Medical Service(s); Nominal; Point in time; Random; TRAUMA; Typ	4180186
1989029	Crew disposition EMS unit	4180186
1989029	::::	4182948
1989030	Electrical potential; L; L median n; LT; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; SNAP amplitude; Voltage	4180186
1989030	SNAP amplitude L median n	4180186
1989030	:::.::	4182948
1989031	Finding; Findings; Ordinal; PF; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS	4180186
1989033	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; PH; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Public Health; PublicHealth; QBR; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 strain; SARS-CoV-2 variant; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Typ; Unspecified; Viral Pneumonias; VOC 202012/01; Wuhan coronavirus	4180186
1989033	SARS-CoV-2 variant Spec NAA+probe	4180186
1989033	SARS  2 :::XXX::..	4182948
1989035	14 days; 2 weeks; Finding; Findings; Money to meet needs last 2W; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1989036	Disease; Disorder; Exp; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Virus	4180186
1989038	Centers for Medicare and Medicaid Assessment; Form version; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1989039	Difficulty w small print; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1989039	Difficulty w small print	4180186
1989039	:::^:	4182948
1989040	Proteus sp DNA Ur Ql NAA+probe	4180186
1989040	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
1989040	 DNA:::::..	4182948
1989042	NEURO; Point in time; QNT; Quan; Quant; Quantitative; R; R MACN; Random; RT; Sensory NC velocity; Vel; Velocity	4180186
1989042	Sensory NC velocity R MACN	4180186
1989042	:::.::	4182948
1989044	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immunobl; Immunoblot; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; T gondii; T gondii 40kD; T gondii 40kD Ab; Toxo; Toxoplasmosis; WB; WBLOT; West blot; West blt; Western blot	4180186
1989044	T gondii 40kD Ab Ser Ql IB	4180186
1989044	 40kD :::::	4182948
1989045	CD19+CD38+ Cells NFr Mar	4180186
1989045	ADP-ribosyl cyclase; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; BM; BON; Bone marrow; CD19 Cells; CD19+CD38+ Cells; Cell; CELL MARKERS; Cellularity; Cyclic ADP-ribose hydrolase; Gated cells; HD-37; Leu12; Leu-12; Leu17; Leu-17; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T10	4180186
1989045	.CD19+CD38+/100 ::::	4182948
1989046	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1989048	L; L radial n; LT; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; Sensory NC velocity; Vel; Velocity	4180186
1989048	Sensory NC velocity L radial n	4180186
1989048	:::.::	4182948
1989049	Wt Pancreas Qn	4180186
1989049	Pancr; Pancreatc; Pancreatic; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
1989049	::::	4182948
1989052	AUC; NEURO; Point in time; QNT; Quan; Quant; Quantitative; R; R sural n; Random; RT; SNAP area	4180186
1989052	SNAP area AUC R sural n	4180186
1989052	:::.::	4182948
1989053	Sensory NC velocity L ulnar n	4180186
1989053	L; L ulnar n; LT; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; Sensory NC velocity; Vel; Velocity	4180186
1989053	:::.::	4182948
1989054	L eye H prism-out for near fix disp Phor	4180186
1989054	by Phoropter; EYE.REFRACTION; Eyeball; H prism-out; H prism-out for near fix disparity; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1989054	.:::.::	4182948
1989056	NEURO; Peak Sensory NC latency; Point in time; QNT; Quan; Quant; Quantitative; R; R radial n; Random; RT	4180186
1989056	Peak Sensory NC latency Time R radial n	4180186
1989056	:::.::	4182948
1989058	Amt of school lost; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
1989059	Disch; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS	4180186
1989060	Tri-Phos Cry #/area UrnS Comp Assist	4180186
1989060	#/area; Artificial Intelligence; Automated detection; Comp Assist; Crys; Cryst; Crystal; i Phos; Inorganic phosphate; Magnesium ammonium phosphate; MAP; MgNH4PO4.6H2O; Number areic; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Strive; Struvite; Tri; Trip; Tri-Phos; Tri-Phos Cry; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1989060	:::::	4182948
1989062	Art; Coronary segment 6; L; Length Fraction; LT; Pathology; Percent; pLAD; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
1989062	Sten deg LenFr pLAD Autopsy	4180186
1989062	:::::	4182948
1989063	L santarosai Borincana Ab Titr Ser Aggl	4180186
1989063	 Borincana  :::::	4182948
1989063	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); L santarosai Borincana; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
1989064	L; L radial n; LT; NEURO; Peak Sensory NC latency; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1989064	Peak Sensory NC latency Time L radial n	4180186
1989064	:::.::	4182948
1989065	Ab; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Ther; Typ; Type of therap Ab administered	4180186
1989065	Type of therap Ab administered	4180186
1989065	:::^:	4182948
1989067	Esophageal pH monitoring study Doc	4180186
1989067	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Study report	4180186
1989067	 pH :::^:	4182948
1989068	Visual acuity Pnl	4180186
1989068	Eye; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Pan; PANEL.EYE; Panl; Pnl; Point in time; Random; Refraction; VA; Vision; Visual; Visual acuity Pnl	4180186
1989068	:-:::-	4182948
1989069	Activ; Actvty; Finding; Findings; Movements; Musc; Muscl; NEURO; Ordinal; Point in time; Pos; QL; Qual; Qualitative; Random; Screen; Spont activity; Spont activity.PSWs	4180186
1989069	Spont activity.PSWs Muscle EMG	4180186
1989069	.:::::EMG	4182948
1989070	Acpt vis if drive w/o corr lens; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1989072	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS; Ulcer	4180186
1989073	Addiction; Alfa; A-OH flubromazolam; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; flubromazolam; GCMS; Hydrox; Illicit; Level; Mass concentration; OH; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1989073	A-OH flubromazolam Ur Cfm-mCnc	4180186
1989073	Alpha-:::::	4182948
1989074	Compx; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SLP; Survey; SURVEY.SLP	4180186
1989075	L; L LACN; Lat; LT; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; Sensory NC velocity; Vel; Velocity	4180186
1989075	Sensory NC velocity L LACN	4180186
1989075	:::.::	4182948
1989076	Contract; Finding; Findings; Job; Occupation; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1989078	Prolactin 45M p TRH IV SerPl-sCnc	4180186
1989078	45M p TRH IV; After; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Level; Mammatropic hormone; Mammotropin; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1989078	^TRH45:::/:	4182948
1989079	Access pressure RRT circuit	4180186
1989079	CLIN; Kidney; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; RRT circuit	4180186
1989079	::::	4182948
1989080	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Level; Mass concentration; Point in time; pre haptoglobin 2; pre-HP2; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
1989080	Zonulin Stl-mCnc	4180186
1989080	::::	4182948
1989083	Volume GB	4180186
1989083	Gall bladder; GB; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Volume	4180186
1989083	::::	4182948
1989084	Ca; Cal; Chemistry; CR; Crea; Creat; Fetal; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
1989084	Calcium/Creat Ur Fetus	4180186
1989084	/:::^:	4182948
1989086	Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1989087	Eye H prism-out far Sheard by Phoropter	4180186
1989087	by Phoropter; EYE.REFRACTION; Eyeball; H prism-out; H prism-out far; H prism-out far Sheard; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1989087	.Sheard:::::	4182948
1989088	Band 3 RBC Ql FC	4180186
1989088	AE1 Anion Exchanger; Bands; bnd; Dynamic; Erythrocytes; FC; HEMATOLOGY/CELL COUNTS; III; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
1989088	3:::::	4182948
1989091	H worked in past 7D Time	4180186
1989091	H+P; H+P.HX; Last; P prime; QNT; Quan; Quant; Quantitative	4180186
1989091	7::7:^:	4182948
1989092	by Phoropter; EYE.REFRACTION; Eyeball; H prism-in; H prism-in near phor; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1989092	R eye H prism-in near phor by Phoropter	4180186
1989092	.:::.::	4182948
1989094	Disease; Disorder; Exp; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Virus	4180186
1989095	by Phoropter; EYE.REFRACTION; Eyeball; H prism-out; H prism-out near; H prism-out near Sheard; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1989095	Eye H prism-out near Sheard by Phoropter	4180186
1989095	.Sheard:::::	4182948
1989099	by Phoropter; c; Contr; Contra; Contrast for inter VA; Contrst; EYE.REFRACTION; Eyeball; Number fraction; Occular; Oculis; Ophthalmologic; Optic globe; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; Vision; Visual	4180186
1989099	Contrast for inter VA by Phoropter	4180186
1989099	:::::	4182948
1989100	Pan; PANEL.SURVEY.RMDQ; Panl; Pnl; Point in time; Random; RMDQ panel; Survey; SURVEY.RMDQ	4180186
1989101	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1989106	Blood; D2HGA2; ICD-M; Identity or presence; IDH; IDHM; IDP; IDPM; isocitrate dehydrogenase (NADP(+)) 2, mitochondrial; mNADP-IDH; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1989106	IDH2 gene Mut Anl Bld/T	4180186
1989106	IDH2  :::/::	4182948
1989107	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bilharziasis; blood fluke; Blt; Cercarial dermatitis; Immune blot; Immunobl; Immunoblot; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Schist sp 30-34kD; Schist sp 30-34kD Ab; Schistosomiasis; Screen; Serum; species; spp; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1989107	Schist sp 30-34kD Ab Ser Ql IB	4180186
1989107	 30-34kD :::::	4182948
1989111	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS; T prime	4180186
1989112	HEMATOLOGY/CELL COUNTS; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random	4180186
1989112	Hemoglobinopathy panel Patient	4180186
1989112	:-::^:-	4182948
1989113	TOSV NAb Titr Spec Nt	4180186
1989113	 .:::XXX::	4182948
1989113	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Phleboviruses; Point in time; Random; Sand fly fever; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; TOSV; TOSV Ab; Ttr; Unspecified; Virus neutralization test; VNT	4180186
1989114	Eye Near VA.binoc--corr	4180186
1989114	Eye; EYE.REFRACTION; Eyeball; Length Ratio; Near VA.binoc; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; VA.binoc; Vision; Visual	4180186
1989114	.^::::	4182948
1989115	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1989116	IT multigene analysis Bld/T	4180186
1989116	Blood; Document; Finding; Findings; Gene; Gene panel; IT multigene analysis; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1989116	:::/::	4182948
1989117	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; m209; Mass concentration; P frequentans; Point in time; QNT; Quan; Quant; Quantitative; Random; Rm209; Serum; SR	4180186
1989117	P frequentans IgG-mCnc	4180186
1989117	 .IgG::::	4182948
1989118	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Resting; Screen; Survey; SURVEY.CNPI	4180186
1989119	Centers for Medicare and Medicaid Assessment; Deglutition; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1989120	Exchange; Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Replace; Right; Scale; Survey; SURVEY.R-OUTCOMES; Tot; Totl	4180186
1989122	Disease; Disorder; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Virus	4180186
1989127	Anatomy; CLIN; Dialy; Nominal; Point in time; Random	4180186
1989127	:::^:	4182948
1989128	Cardiac pacemaker; Device, Heart-Assist; Electrical potential; Point in time; Prosthetic; QNT; Quan; Quant; Quantitative; Random; Voltage	4180186
1989128	::::	4182948
1989129	Compx; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SLP; Survey; SURVEY.SLP	4180186
1989130	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1989131	S aureus DNA Ur Ql NAA+probe	4180186
1989131	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S aureus; Screen; SDA; Staph; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
1989131	 DNA:::::..	4182948
1989134	Aspirate; Chemistry; Level; Mass concentration; P4; Point in time; Prog; Proges; Progest; Progestin; QNT; Quan; Quant; Quantitative; Random	4180186
1989134	Progest Ovarian asp-mCnc	4180186
1989134	::::	4182948
1989136	CLIN; Dialy; Fld; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
1989136	Peritoneal dialysis fluid drained Vol	4180186
1989136	:::^:	4182948
1989137	Non-dysmorphic RBC #/area UrnS AI Assis	4180186
1989137	#/area; Artificial Intelligence; Automated detection; Comp Assist; Discocytes; Erthrocyte; Erythrocyte; Isomorphic RBC; Non-dys RBC; Nondysmorphic RBC; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1989137	.:::::	4182948
1989138	Aminoglycoside Susc Islt	4180186
1989138	Amikacin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; c288; Gentamicin; Islt; Isol; Neomycin; Point in time; Random; Streptomycin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tobramycin	4180186
1989138	::::	4182948
1989139	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Chagas disease; Immune blot; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; T cruzi; T cruzi 21-22kD; T cruzi 21-22kD Ab.IgG; Trypanosomiasis; Trypanosomosis; WB; WBLOT; West blot; West blt; Western blot	4180186
1989139	T cruzi 21-22kD IgG Ser Ql IB	4180186
1989139	 21-22kD .IgG:::::	4182948
1989142	4 weeks; Finding; Findings; H+P; H+P.HX; Last; Ordinal; P prime; QL; Qual; Qualitative; Screen	4180186
1989142	Pain distribution in past 4W	4180186
1989142	4::4:^:	4182948
1989143	Rocio virus NAb Titr Spec Nt	4180186
1989143	 .:::XXX::	4182948
1989143	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Flavivirus; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
1989144	Penicillin V IgG4-mCnc	4180186
1989144	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c2; Level; Mass concentration; PCN; Pen; Penicilloyl; Phenoxymethylpenicillin; Point in time; QNT; Quan; Quant; Quantitative; Random; Rh Blood Group System; Serum; SR; Wycillin	4180186
1989144	 V .IgG4::::	4182948
1989145	EYE; EYE.HX; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
1989145	Seen double images in past 7D	4180186
1989145	7::7:^:	4182948
1989146	a165; ABS; Aby; Alb; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Beef; Bos spp; BSA; e204; Fraction V; Immune globulin G; Immunoglobulin G; Level; Mass concentration; nBos d 6; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Re204; Ser; Serum; SR	4180186
1989146	BSA IgG-mCnc	4180186
1989146	 .IgG::::	4182948
1989150	Cells.CD19+CD79b+ NFr Mar	4180186
1989150	B cells expressing CD19 as a percent of total lymphocytes; B29; B4; B-4; BM; BON; Bone marrow; CD19 Cells; Cell; CELL MARKERS; Cellularity; Gated cells; HD-37; Ig beta; Leu12; Leu-12; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1989150	.CD19+CD79b+/100 ::::	4182948
1989158	Cardiac pacemaker; Cnt; Count; Device, Heart-Assist; Number; Point in time; Prosthetic; QNT; Quan; Quant; Quantitative; Random	4180186
1989158	:():::	4182948
1989159	Sensory NC Pnl R sural n	4180186
1989159	NEURO; Pan; PANEL.NEURO; Panl; Pnl; Point in time; R; R sural n; Random; RT; Sensory NC Pnl	4180186
1989159	:-::.:-	4182948
1989164	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; Kala azar; Leishmaniasis; Leishmaniosis; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; SUDS; Visceral leishmaniasis	4180186
1989164	Leishmania IgG Ser Ql IA	4180186
1989164	 .IgG:::::	4182948
1989165	Bother level of glare w/o corr past 7D	4180186
1989165	Bother level of glare w/o corr past 7D; EYE; EYE.HX; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
1989165	7::7:^:	4182948
1989168	L santarosai Alexi Ab Titr Ser Aggl	4180186
1989168	 Alexi  :::::	4182948
1989168	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); L santarosai Alexi; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
1989169	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1989172	1 year; 12Mos; Able to partic remote learn last 12Mo; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey	4180186
1989173	2-OPP; 2-oxopropylpiperidine-2-carobylic acid; 2S,6S-/2S,6R-oxopropylpiperidine-2-carboxylic acid; 6(R+S)-OPP; 6-oxo-PIP + 6(R+S)-OPP; 6-oxo-pipecolic acid; 6-oxo-piperidine-2-carboxylic acid; Chemistry; II; Pan; PANEL.CHEMISTRY; Panl; PDE-ALDH7A1; Pl; Plasma; Plsm; Pnl; Point in time; Pyridoxine-dependent epilepsy; R prime; Random; Right; S prime; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn	4180186
1989173	6-oxo-PIP + 6(R+S)-OPP Ur+SerPl	4180186
1989173	6---2- 6(R+S)---2-:-::+/:-	4182948
1989174	Motor NC Pnl L ulnar n	4180186
1989174	L; L ulnar n; LT; Motor NC Pnl; NEURO; Pan; PANEL.NEURO; Panl; Pnl; Point in time; Random	4180186
1989174	:-::.:-	4182948
1989176	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Tot; Totl	4180186
1989178	#; ABS; absolute; absolutes; Artificial Intelligence; Automated detection; Ca; CaC2O4; CaC2O4.H2O; Cal; CaOx; Cnt; COM Cry; Comp Assist; Count; Count/volume; Crys; Cryst; Crystal; CT; Ethanedioate; Ethanedioic acid; Monohydrt; Number concentration; Number Concentration (count/vol); Oxal; Oxalic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; Whewelite; Whewellite	4180186
1989178	COM Cry # UrnS Comp Assist	4180186
1989178	:::::	4182948
1989179	by Phoropter; EYE.REFRACTION; Eyeball; Inter VA; L; L eye; Length Ratio; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; Vision; Visual	4180186
1989179	L eye Inter VA by Phoropter	4180186
1989179	.:::.::	4182948
1989180	1 year; 12Mos; Amt of school lost; Amt of school lost in last 12Mo; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
1989182	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS	4180186
1989185	Eye Sphere far Sheard by Phoropter	4180186
1989185	by Phoropter; Distance; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Sphere far Sheard; Vision; Visual	4180186
1989185	Sheard:::::	4182948
1989186	Cancer Ag50 Fld-aCnc	4180186
1989186	Arbitrary concentration; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; CA; CA 50; Cancer Ag50; Carbohydrate antigen; Carbohydrate antigen 50; Chemistry; Fl; Fld; FLU; Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Tumor marker	4180186
1989186	 50::::	4182948
1989187	by Phoropter; EYE.REFRACTION; Eyeball; H prism-in; H prism-in for far fix disparity; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1989187	R eye H prism-in for far fix disp Phor	4180186
1989187	.:::.::	4182948
1989189	B dermat IgG CSF IA-aCnc	4180186
1989189	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B dermat; B dermatitidis; Blasto; Blastomycosis; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
1989189	 .IgG:::::	4182948
1989190	CLIN; Kidney; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; RRT circuit	4180186
1989190	Transmembrane pressure RRT circuit	4180186
1989190	::::	4182948
1989191	Circumf MV	4180186
1989191	Girth; Length; MV; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1989191	::::	4182948
1989193	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1989194	1 year; 12Mos; Finding; Findings; Nominal; Past; Reason not partic remote learn last 12Mo; Reason not participate remote learning; Survey	4180186
1989195	Corneal; EYE; L; L cornea; LT; Meth; Method of; Micro; Micros; Microscopic; Nominal; Point in time; Random; Typ	4180186
1989195	L cornea Analysis method	4180186
1989195	:::.::	4182948
1989196	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Prism far phor; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1989196	L eye Prism far phor by Phoropter	4180186
1989196	:::.::	4182948
1989198	E maynei IgG-mCnc	4180186
1989198	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; d74; E maynei; HDM; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Mite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1989198	 .IgG::::	4182948
1989201	AC/A ratio; by Phoropter; EYE.REFRACTION; Eyeball; Nominal; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Random; Typ; Vision; Visual	4180186
1989201	:::::	4182948
1989202	B; B-Globulin; Chemistry; GLB; Glob; Glob%; Globul; Globulins; IFE; Ifix; Immunofixation electrophoresis; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Protein beta globulin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1989202	B-Globulin SerPl IFE-mCnc	4180186
1989202	Beta :::/::	4182948
1989203	# household mem in preschool/daycare; Cnt; Count; Disease; Disorder; No; Num; Number; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Virus	4180186
1989204	Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
1989205	Pan; PANEL.SURVEY.SLP; Panl; Pnl; Point in time; Random; SLP; Survey; SURVEY.SLP	4180186
1989209	Delay med care b/c distance/transport; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1989210	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1989211	1 month; 1 month (30 days); 30 days; Finding; Findings; H+P; H+P.HX; Last; Missed med past Mo; month; Ordinal; P prime; QL; Qual; Qualitative; Screen	4180186
1989211	Missed med past Mo	4180186
1989211	::1:^:	4182948
1989213	Near supra recovery by Phoropter	4180186
1989213	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Near supra recovery; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1989213	:::::	4182948
1989215	KCNN4 gene Full Mut Anl Bld/T Seq	4180186
1989215	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1989215	KCNN4  :::/::	4182948
1989216	CLIN; Dialy; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
1989216	:-::^:-	4182948
1989217	3; Drugs; MPSS; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey	4180186
1989218	Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1989222	#; ABS; absolute; absolutes; Auto; Automated detection; Bronchial alveolar lavage; Bronchoalveolar lavage; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
1989222	WBC # BAL Auto	4180186
1989222	:::::	4182948
1989223	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1989224	EYE.HX; Finding; Findings; Freq of thinking about eyesight/vision; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1989224	Freq of thinking about eyesight/vision	4180186
1989224	:::^:	4182948
1989226	Schistosoma Ab Titr Ser HA	4180186
1989226	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bilharziasis; blood fluke; Cercarial dermatitis; Dilution factor; Dilution Factor (Titer); Hemagglutination; IHA; Microbiology; Point in time; Random; Schistosomiasis; Serum; SmQn; species; spp; SR; Titer; Titered; Titre; Ttr	4180186
1989226	 :::::	4182948
1989227	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1989230	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; d74; E maynei; HDM; Level; Mass concentration; Mite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1989230	E maynei IgG4-mCnc	4180186
1989230	 .IgG4::::	4182948
1989236	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Trajectory deviation.AP; Wnd	4180186
1989236	Trajectory deviation.AP Wnd	4180186
1989236	.::::	4182948
1989238	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; V prism-up; V prism-up inter; Vision; Visual	4180186
1989238	L eye V prism-up inter by Phoropter	4180186
1989238	.:::.::	4182948
1989239	Freq notice glar w/o corr lens p 7D	4180186
1989239	EYE; EYE.HX; Finding; Findings; Freq notice glar w/o corr lens p 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
1989239	7::7:^:	4182948
1989240	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1989241	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1989242	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ENA; ENA Jo1; Histidyl-tRNA synthease; i; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; Serology; Serum; SR	4180186
1989242	ENA Jo1 Ab Ser Line blot-aCnc	4180186
1989242	Jo-1  :::::	4182948
1989244	Lab Device; Point in time; Pos; PPV; QNT; Quan; Quant; Quantitative; Random; Risk	4180186
1989244	Lab Device PPV	4180186
1989244	::::	4182948
1989245	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1989246	Finding; Findings; GU; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS	4180186
1989247	Volume Pericardial space	4180186
1989247	Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Volume	4180186
1989247	::::	4182948
1989251	KLHL11 IgG Ser Ql CBA IFA	4180186
1989251	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; KLHL11; Neuro; Neurology; Oncology; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
1989251	Kelch  .IgG:::::CBA IFA	4182948
1989257	6OH-buspirone; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1989257	6OH-buspirone Ur Cfm-mCnc	4180186
1989257	6-:::::	4182948
1989258	RVFV NAb Titr Spec Nt	4180186
1989258	 .:::XXX::	4182948
1989258	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bunyavirus; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Rift valley fever; RVFV; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
1989263	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CNPI	4180186
1989264	ABS; Aby; Acetylch; ACH; AChR; AChR Mod; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dynamic; FC; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR	4180186
1989264	AChR Mod Ab Ser Ql FC	4180186
1989264	 :::::	4182948
1989268	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Chagas disease; Immune blot; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; T cruzi; T cruzi 15-16kD; T cruzi 15-16kD Ab.IgG; Trypanosomiasis; Trypanosomosis; WB; WBLOT; West blot; West blt; Western blot	4180186
1989268	T cruzi 15-16kD IgG Ser Ql IB	4180186
1989268	 15-16kD .IgG:::::	4182948
1989269	Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1989270	Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1989275	Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1989278	Bdy temp; bod; Bodies; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rnge; Screen; Survey; SURVEY.PNDS; Temp	4180186
1989279	Clin trial vaccine received	4180186
1989279	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1989279	:::^:	4182948
1989281	Eye H prism-in near Sheard by Phoropter	4180186
1989281	by Phoropter; EYE.REFRACTION; Eyeball; H prism-in; H prism-in near; H prism-in near Sheard; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1989281	.Sheard:::::	4182948
1989282	EYE.PX; Eyeball; Meth; Method of; Nominal; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Random; Typ; Vision; Visual	4180186
1989282	::::	4182948
1989283	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Sheep Sorrel; SR; w018; w18	4180186
1989283	Sheep Sorrel IgG-mCnc	4180186
1989283	 .IgG::::	4182948
1989284	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bilharziasis; blood fluke; Blt; Cercarial dermatitis; Immune blot; Immunobl; Immunoblot; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Schist sp 14-15kD; Schist sp 14-15kD Ab; Schistosomiasis; Screen; Serum; species; spp; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1989284	Schist sp 14-15kD Ab Ser Ql IB	4180186
1989284	 14-15kD :::::	4182948
1989286	Finding; Findings; Meth; Method of; Nominal; Point in time; Random; Survey	4180186
1989288	by Phoropter; EYE.REFRACTION; Eyeball; Inter VA; Length Ratio; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; Refraction; RT; VA; Vision; Visual	4180186
1989288	R eye Inter VA by Phoropter	4180186
1989288	.:::.::	4182948
1989290	L eye Prism inter by Phoropter	4180186
1989290	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1989290	:::.::	4182948
1989292	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bilharziasis; blood fluke; Blt; Cercarial dermatitis; Immune blot; Immunobl; Immunoblot; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Schist sp 18-19kD; Schist sp 18-19kD Ab; Schistosomiasis; Screen; Serum; species; spp; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1989292	Schist sp 18-19kD Ab Ser Ql IB	4180186
1989292	 18-19kD :::::	4182948
1989297	Edinburgh Postnatal Depression Scale; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.EPDS; Tot; Totl	4180186
1989299	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SLP; Survey; SURVEY.SLP	4180186
1989300	R eye V prism-up for far fix disp Phor	4180186
1989300	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; V prism-up; V prism-up for far fix disparity; Vision; Visual	4180186
1989300	.:::.::	4182948
1989302	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Tx	4180186
1989304	Eye H prism-in near Perc by Phoropter	4180186
1989304	by Phoropter; EYE.REFRACTION; Eyeball; H prism-in; H prism-in near; H prism-in near Perc; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1989304	.Percival:::::	4182948
1989306	Pacemaker Ventric sensitivity threshold	4180186
1989306	Cardiac pacemaker; Device, Heart-Assist; Electrical potential; Point in time; Prosthetic; QNT; Quan; Quant; Quantitative; Random; Ventric sensitivity threshold; Voltage	4180186
1989306	::::	4182948
1989308	Expect perfect vision after LASIK; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1989309	L; L tibial n; LT; Motor NC Pnl; NEURO; Pan; PANEL.NEURO; Panl; Pnl; Point in time; Random	4180186
1989309	Motor NC Pnl L tibial n	4180186
1989309	:-::.:-	4182948
1989312	Coccidioides Ag Fld IA-mCnc	4180186
1989312	Antigen; Antigens; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; Fl; Fld; FLU; Fluid; IAA; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; species; spp; SUDS; Valley fever	4180186
1989312	 :::::	4182948
1989313	K pneumon DNA Ur Ql NAA+probe	4180186
1989313	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; K pneumon; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
1989313	 DNA:::::..	4182948
1989315	Siderocytes NFr Bld/Mar Prus Bl St	4180186
1989315	Bld/Mar; Blood; BM; BON; Bone marrow; HEMATOLOGY/CELL COUNTS; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; Prus Bl St; QNT; Quan; Quant; Quantitative; Random; St; Stains; Stn; WB; Whole blood; Whole blood or Bone marrow	4180186
1989315	/100 :::/::	4182948
1989320	Chicken Meat IgG-mCnc	4180186
1989320	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f083; f83; Gallus spp; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1989320	 .IgG::::	4182948
1989321	JEV IgG Ser Ql IA	4180186
1989321	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Flavivirus; IAA; Immune globulin G; Immunoglobulin G; Japanese B encephalitis; Japanese encephalitis; JBE; JE virus; JEV; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
1989321	 .IgG:::::	4182948
1989322	Acd; Acid; Chemistry; Erythrocytes; Fatty acid; Level; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Sat FA; Substance Concentration	4180186
1989322	Sat FA RBC.lysate-sCnc	4180186
1989322	.:::.:	4182948
1989325	CLIN; Dialy; QNT; Quan; Quant; Quantitative	4180186
1989325	:::^:	4182948
1989326	Peak motor NC latency Time L median n	4180186
1989326	L; L median n; LT; NEURO; Peak motor NC latency; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1989326	:::.::	4182948
1989330	Contract; Disease; Disorder; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Virus	4180186
1989333	PCA-2 Ab CSF Ql Line blot	4180186
1989333	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; II; Ordinal; Paraneoplastic syndrome; PCA-2; PCA-2 Ab; PCCA-2; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1989333	 2  :::::	4182948
1989334	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1989340	L eye H prism-in far phor by Phoropter	4180186
1989340	by Phoropter; EYE.REFRACTION; Eyeball; H prism-in; H prism-in far phor; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1989340	.:::.::	4182948
1989341	Cerebral; Cerebrum; Head; Intracranial; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
1989341	Wt Brain Qn	4180186
1989341	::::	4182948
1989343	Arbitrary concentration; CA; CA 242; Cancer Ag242; Carbohydrate antigen; Carbohydrate antigen 242; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
1989343	Cancer Ag242 SerPl-aCnc	4180186
1989343	 242:::/:	4182948
1989345	Disease; Disorder; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Virus; World Heatlth Organization	4180186
1989346	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
1989346	:::^:	4182948
1989348	Cell; Cellularity; Cnt; Corneal; Count; EYE; L; L cornea; LT; Number; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1989348	L cornea Endothelial cells counted	4180186
1989348	:()::.:	4182948
1989351	Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Replace; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1989352	IL-17 CSF-mCnc	4180186
1989352	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; IL; IL-17; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1989352	 17::::	4182948
1989353	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1989354	Satisfaction level w/ vision	4180186
1989354	EYE; EYE.HX; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Satisfaction level w/ vision; Screen	4180186
1989354	:::^:	4182948
1989355	#; ABS; absolute; absolutes; Auto; Automated detection; Bact; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1989355	Bacilliform bact # UrnS Auto	4180186
1989355	:::::	4182948
1989357	w6 FA RBC.lysate-sCnc	4180186
1989357	Acd; Acid; Chemistry; Erythrocytes; Fatty acid; Level; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration; w6 FA	4180186
1989357	.Omega 6:::.:	4182948
1989358	R eye H prism-out for far fix disp Phor	4180186
1989358	by Phoropter; EYE.REFRACTION; Eyeball; H prism-out; H prism-out for far fix disparity; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Vision; Visual	4180186
1989358	.:::.::	4182948
1989359	Document; Finding; Findings; GI; GI.ENDOSCOPY; Point in time; Random; Study report	4180186
1989359	:::^:	4182948
1989360	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SLP; Survey; SURVEY.SLP	4180186
1989361	Disease; Disorder; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Virus	4180186
1989362	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Near con blur; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1989362	Near con blur by Phoropter	4180186
1989362	:::::	4182948
1989367	APAP-Cysteine SerPl LC/MS/MS-sCnc	4180186
1989367	3-(cystein-S-yl)-acetaminophen; ACET; Acetamidophenol; Acetaminoph; Acetaminophen-cysteine conjugate; Acetominophen; APAP; APAP-CYS; APAP-Cysteine; c209; C55; Cys; DRUG/TOXICOLOGY; Drugs; Hepatotoxicity; Hydroxyacetanilide; Level; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; N-acetyl-p-benzoquinone imine (NAPQI); p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tylenol; u209	4180186
1989367	-:::/::LC/MS/MS	4182948
1989369	#; ABS; absolute; absolutes; Artificial Intelligence; Automated detection; Cast; Cnt; Comp Assist; Count; Count/volume; CT; Microorg casts; Microorganisms; Number concentration; Number Concentration (count/vol); Org; Organism; Organisms; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1989369	Microorg casts # UrnS Comp Assist	4180186
1989369	:::::	4182948
1989371	Corneal; EYE; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; Relative ratio; RT	4180186
1989371	R cornea Hexagonality	4180186
1989371	:::.:	4182948
1989372	Finding; Findings; H+P; H+P.PX; Lower extremity joint; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1989372	:::^:	4182948
1989373	Freq notice glar w best corr lens p 7D	4180186
1989373	EYE; EYE.HX; Finding; Findings; Freq notice glar w best corr lens p 7D; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
1989373	7::7:^:	4182948
1989377	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1989378	Decision-making; Pan; PANEL.SURVEY.R-OUTCOMES; Panl; Pnl; Point in time; R prime; Random; Right; Survey; SURVEY.R-OUTCOMES	4180186
1989379	R cornea Cell area.sd	4180186
1989379	Cell area.sd; Corneal; EYE; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; RT	4180186
1989379	.:::.:	4182948
1989382	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1989382	Flubromazepam Ur Cfm-mCnc	4180186
1989382	:::::	4182948
1989384	Post-filter replace fld rate RRT circuit	4180186
1989384	After; CLIN; Fld; Flow; Kidney; Point in time; Post-filter replace fld rate; PST; QNT; Quan; Quant; Quantitative; Random; RRT circuit; Volume Rate; vRate	4180186
1989384	::::	4182948
1989385	PRA recovery by Phoropter	4180186
1989385	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Pos; PRA recovery; QNT; Quan; Quant; Quantitative; Random; Rel; Vision; Visual	4180186
1989385	:::::	4182948
1989388	Cardiac pacemaker; Device, Heart-Assist; Nominal; Point in time; Prosthetic; Random; Typ	4180186
1989388	::::	4182948
1989389	Disease; Disorder; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH; Virus	4180186
1989391	Peak Sensory NC latency Time L MACN	4180186
1989391	L; L MACN; LT; NEURO; Peak Sensory NC latency; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1989391	:::.::	4182948
1989393	by Phoropter; EYE.REFRACTION; Eyeball; Min stereo angle; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1989393	Eye Min stereo angle by Phoropter	4180186
1989393	:::::	4182948
1989396	Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1989397	Titratable Acidity 24h Ur-sCnc	4180186
1989397	1 day; 24 hours; 24HR; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; Titratable Acidity; UA; UR; Urn	4180186
1989397	.::24::	4182948
1989399	Cryptoc Ag Pnl Ser	4180186
1989399	Crypt; Crypto; Cryptoc Ag Pnl; Cryptococcal; Cryptococcosis; Cryptococcosus; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; species; spp; SR	4180186
1989399	:-:::-	4182948
1989400	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
1989405	Brightness during test; EYE.PX; Eyeball; Levels; Levl; LV; LVL; Nominal; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Random; Typ; Vision; Visual	4180186
1989405	Type of Brightness during test	4180186
1989405	::::	4182948
1989406	14 days; 2 weeks; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Satisf w/support from friends last 2W; Screen; Survey; SURVEY.GNHLTH	4180186
1989410	Finding; Findings; H+P; H+P.PX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1989410	:::^:	4182948
1989413	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1989414	Eye covered w red lens; EYE.PX; Eyeball; Finding; Findings; Nominal; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Random; Vision; Visual	4180186
1989414	Eye covered w red lens	4180186
1989414	::::	4182948
1989415	SNAP area AUC R MACN	4180186
1989415	AUC; NEURO; Point in time; QNT; Quan; Quant; Quantitative; R; R MACN; Random; RT; SNAP area	4180186
1989415	:::.::	4182948
1989416	Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1989417	Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
1989418	Cell; Cellularity; Cnt; Corneal; Count; EYE; Number; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; RT	4180186
1989418	R cornea Endothelial cells counted	4180186
1989418	:()::.:	4182948
1989419	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; T prime	4180186
1989422	DOC.MISC; Document; Finding; Findings; MISC; Patient resource info; Point in time; Random	4180186
1989422	Patient resource info	4180186
1989422	:::^:	4182948
1989424	Takes routine med	4180186
1989424	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
1989424	:::^:	4182948
1989425	Wt Liver Qn	4180186
1989425	Hepar; Hepatic; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Wt	4180186
1989425	::::	4182948
1989430	Optochin Susc Islt	4180186
1989430	ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1989430	::::	4182948
1989433	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS	4180186
1989434	#; ABS; absolute; absolutes; Artificial Intelligence; Automated detection; Cnt; Comp Assist; Count; Count/volume; Crys; Cryst; Crystal; CT; i Phos; Inorganic phosphate; Magnesium ammonium phosphate; MAP; MgNH4PO4.6H2O; Number concentration; Number Concentration (count/vol); Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Strive; Struvite; Tri; Trip; Tri-Phos; Tri-Phos Cry; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1989434	Tri-Phos Cry # UrnS Comp Assist	4180186
1989434	:::::	4182948
1989435	Chemistry; FR; Level; Metaneph; Metaneph Free; Metanephrne; Metenephrine; Non-protein bound; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; Unconjugated metanephrine; UR; Urn	4180186
1989435	Metaneph Free Ur-sCnc	4180186
1989435	.::::	4182948
1989440	Electrical potential; Lat; NEURO; Point in time; QNT; Quan; Quant; Quantitative; R; R LACN; Random; RT; SNAP amplitude; Voltage	4180186
1989440	SNAP amplitude R LACN	4180186
1989440	:::.::	4182948
1989442	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1989444	Auto; Automated detection; Bands; Blood; bnd; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number fraction; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
1989444	Neuts Band NFr.DF Bld Auto	4180186
1989444	./:.::::	4182948
1989447	Contract; Disease; Disorder; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Virus; World Heatlth Organization	4180186
1989450	E coli DNA Ur Ql NAA+probe	4180186
1989450	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E coli; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
1989450	 DNA:::::..	4182948
1989452	#/area; Artificial Intelligence; Automated detection; Ca; CaC2O4; CaC2O4.H2O; Cal; CaOx; COM Cry; Comp Assist; Crys; Cryst; Crystal; Ethanedioate; Ethanedioic acid; Monohydrt; Number areic; Oxal; Oxalic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS; Whewelite; Whewellite	4180186
1989452	COM Cry #/area UrnS Comp Assist	4180186
1989452	:::::	4182948
1989453	SARS-CoV-2 IFN-g Bld-Imp	4180186
1989453	2019 Novel Coronavirus; 2019-nCoV; Blood; Corona virus; COVID19; COVID-19; ID; IFN; IGRA; II; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 IFN-g; Screen; Severe Acute Respiratory Syndrome; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus	4180186
1989453	SARS  2  gamma ::::	4182948
1989454	Mercury Dial fld-sCnc	4180186
1989454	Diaf; Dialysate; Dialysis fluid; DRUG/TOXICOLOGY; Drugs; HG; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1989454	::::	4182948
1989457	Fasciola sp 27-28kD IgG Ser Ql IB	4180186
1989457	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; species; spp; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1989457	 27-28kD .IgG:::::	4182948
1989458	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RGH 188; Screen; UA; UR; Urn; Vraylar	4180186
1989458	Cariprazine Ur Ql Cfm	4180186
1989458	:::::	4182948
1989461	#; ABS; absolute; absolutes; Bronchial alveolar lavage; Bronchoalveolar lavage; Cnt; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells	4180186
1989461	RBC # BAL Manual	4180186
1989461	:::::	4182948
1989462	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1989465	CRRT panel	4180186
1989465	CLIN; CRRT panel; Kidney; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
1989465	:-::^:-	4182948
1989466	Amylase IgG-mCnc	4180186
1989466	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Alpha amylase; Ams; Amyl; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Diastase; Immune globulin G; Immunoglobulin G; k87; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1989466	 .IgG::::	4182948
1989468	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS; T prime	4180186
1989470	Hemodialysis fluid removal goal Vol	4180186
1989470	CLIN; Extraction; Fld; QNT; Quan; Quant; Quantitative; Remove; Volume	4180186
1989470	:::^:	4182948
1989471	Lung-R; PATHOLOGY; Point in time; Pulmonary; QNT; Quan; Quant; Quantitative; R; Random; RT; Wt	4180186
1989471	Wt Lung-R Qn	4180186
1989471	:::.:	4182948
1989478	Eye H prism-out far Perc by Phoropter	4180186
1989478	by Phoropter; EYE.REFRACTION; Eyeball; H prism-out; H prism-out far; H prism-out far Perc; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1989478	.Percival:::::	4182948
1989479	ADMIN; Nominal; Point in time; Random; Typ	4180186
1989479	:::^:	4182948
1989480	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1989481	Motor NC Pnl R median n	4180186
1989481	Motor NC Pnl; NEURO; Pan; PANEL.NEURO; Panl; Pnl; Point in time; R; R median n; Random; RT	4180186
1989481	:-::.:-	4182948
1989482	Art; Coronary segment 8; dLAD; L; Length Fraction; LT; Pathology; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sten deg	4180186
1989482	Sten deg LenFr dLAD Autopsy	4180186
1989482	:::::	4182948
1989483	Motor NC Pnl Nerve	4180186
1989483	Motor NC Pnl; NEURO; Pan; PANEL.NEURO; Panl; Pnl; Point in time; Random	4180186
1989483	:-:::-	4182948
1989486	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Past; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1989486	:::^:	4182948
1989491	Spont activity.fasciculation Muscle EMG	4180186
1989491	Activ; Actvty; Finding; Findings; Movements; Musc; Muscl; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Spont activity; Spont activity.fasciculation	4180186
1989491	.:::::EMG	4182948
1989493	DOC.MISC; Document; Electrocardiogram; Finding; Findings; MISC; Point in time; Random; Study report	4180186
1989493	Cardiac stress EKG study Doc	4180186
1989493	:::^:	4182948
1989494	UTI pathogens Pnl Ur NAA+probe	4180186
1989494	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Infection, Urinary Tract; Infections, Urinary Tract; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn; Uropathogens; UTI pathogens Pnl	4180186
1989494	:-:::-:..	4182948
1989496	Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1989498	CLIN; Kidney; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; RRT circuit	4180186
1989498	Filter pressure RRT circuit	4180186
1989498	::::	4182948
1989499	Sensory NC Pnl Nerve	4180186
1989499	NEURO; Pan; PANEL.NEURO; Panl; Pnl; Point in time; Random; Sensory NC Pnl	4180186
1989499	:-:::-	4182948
1989500	Finding; Findings; Nominal; Report period; Sought med attention for symp; Survey; SURVEY.GNHLTH; Sx	4180186
1989501	Finding; Findings; GI; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS	4180186
1989502	Eye Accom using minus lens by Phoropter	4180186
1989502	Accom using minus lens; by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
1989502	:::::	4182948
1989507	Crystal casts # UrnS Comp Assist	4180186
1989507	#; ABS; absolute; absolutes; Artificial Intelligence; Automated detection; Cast; Cnt; Comp Assist; Count; Count/volume; CT; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1989507	:::::	4182948
1989508	Sol Il2 Recep CSF-mCnc	4180186
1989508	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Costimulator; II; IL; IL2; IL-2; IL2R; IL-2R; Il2Recep; ILR2; Level; Lymphocyte Mitogenic Factor; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; sIL-2R; Sol Il2 Recep; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T-Cell Growth Factor; T-Cell Stimulating Factor; TCGF; Thymocyte Stimulating Factor	4180186
1989508	 2 .::::	4182948
1989509	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SLP; Survey; SURVEY.SLP	4180186
1989512	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Conjunct; Conjunctiva; Conjunctival; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen-Probe; Gono; Gonorrhea; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Palpebral sac; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1989512	N gonorrhoea rRNA Conjunct Ql NAA+probe	4180186
1989512	 rRNA:::::..	4182948
1989518	Blood; HEL-216; HEL-S-26; IDCD; Identity or presence; IDPC; isocitrate dehydrogenase (NADP(+)) 1, cytosolic; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; PICD; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1989518	IDH1 gene Mut Anl Bld/T	4180186
1989518	IDH1  :::/::	4182948
1989520	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1989521	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1989522	Temp pacemaker Atrial stim setting	4180186
1989522	Atrial stim setting; Cardiac pacemaker; Device, Heart-Assist; Point in time; Prosthetic; QNT; Quan; Quant; Quantitative; Random; Stim; Temp pacemaker	4180186
1989522	:::.:	4182948
1989526	A flavus; ABS; Aby; Antby; Anti; Antibodies; Antibody; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Farmers lung; Immune globulin G; Immunoglobulin G; Level; m228; m311; m54; Mass concentration; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1989526	A flavus IgG Ser-mCnc	4180186
1989526	 .IgG::::	4182948
1989530	R eye V prism-down far phor by Phoropter	4180186
1989530	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; V prism-down; V prism-down far phor; Vision; Visual	4180186
1989530	.:::.::	4182948
1989532	B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; B6; B-6; BLAST-2; BM; BON; Bone marrow; CD19 Cells; CD19+CD23+ Cells; Cell; CELL MARKERS; Cellularity; FceRII; Gated cells; HD-37; Leu12; Leu-12; Leu20; Leu-20; Low affinity IgE receptor; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1989532	CD19+CD23+ Cells NFr Mar	4180186
1989532	.CD19+CD23+/100 ::::	4182948
1989533	CLIN; Dynamic; Flow; Kidney; Point in time; QNT; Quan; Quant; Quantitative; Random; RRT circuit; Volume Rate; vRate	4180186
1989533	Dialysate flow rate RRT circuit	4180186
1989533	::::	4182948
1989539	L cornea Coefficient of variation	4180186
1989539	Corneal; EYE; L; L cornea; LT; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1989539	:/::.:	4182948
1989542	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; NEG; NRA recovery; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Rel; Vision; Visual	4180186
1989542	NRA recovery by Phoropter	4180186
1989542	:::::	4182948
1989544	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1989546	Finding; Findings; H+P; H+P.HX; No; Num; Num surgical procedures for pain; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Surg; Surg proc	4180186
1989546	Num surgical procedures for pain	4180186
1989546	:::^:	4182948
1989549	Cnt; Count; Disease; Disorder; No; Num; Number; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Virus	4180186
1989550	Arbitrary concentration; CG; Chemistry; Choriogonadotropins total; Chorionic gonadotropin; HCG; HCG-TM; Human chorionic gonadotropin; Mark; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; Tumor marker	4180186
1989550	HCG-TM Plr-aCnc	4180186
1989550	.::::	4182948
1989551	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R prime; Random; Right; Screen; Survey; SURVEY.R-OUTCOMES	4180186
1989553	Eye; EYE.REFRACTION; Eyeball; L; L eye; Length Ratio; LT; Near VA; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Refraction; VA; Vision; Visual	4180186
1989553	L eye Near VA--corr	4180186
1989553	.^:::.:	4182948
1989555	Motor NC Pnl R fibular n	4180186
1989555	Motor NC Pnl; NEURO; Pan; PANEL.NEURO; Panl; Pnl; Point in time; R; R fibular n; Random; RT	4180186
1989555	:-::.:-	4182948
1989556	Bother lvl double images w/o corr pst 7D; EYE; EYE.HX; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen	4180186
1989556	Bother lvl double images w/o corr pst 7D	4180186
1989556	7::7:^:	4182948
1989564	PCA-2 Ab Ser Ql Line blot	4180186
1989564	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cytopl; Cytoplas; II; Ordinal; Paraneoplastic syndrome; PCA-2; PCA-2 Ab; PCCA-2; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
1989564	 2  :::::	4182948
1989567	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
1989567	:::^:	4182948
1989569	Pacemaker Ventric sensitivity setting	4180186
1989569	Cardiac pacemaker; Device, Heart-Assist; Electrical potential; Point in time; Prosthetic; QNT; Quan; Quant; Quantitative; Random; Ventric sensitivity setting; Voltage	4180186
1989569	::::	4182948
1989573	Tri-Phos Cry UrnS Ql Comp Assist	4180186
1989573	Artificial Intelligence; Automated detection; Comp Assist; Crys; Cryst; Crystal; i Phos; Inorganic phosphate; Magnesium ammonium phosphate; MAP; MgNH4PO4.6H2O; Ordinal; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Strive; Struvite; Tri; Trip; Tri-Phos; Tri-Phos Cry; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
1989573	:::::	4182948
1989574	Napsin A Ag Tiss Ql ImStn	4180186
1989574	Antigen; Antigens; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Oncology; Ordinal; Pathology; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
1989574	Napsin A :::::	4182948
1989575	Axis IV: Use of the health care system score; MPSS; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey	4180186
1989578	CG; Chemistry; Choriogonadotropins total; Chorionic gonadotropin; HCG; Human chorionic gonadotropin; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1989578	HCG Ur-mCnc	4180186
1989578	::::	4182948
1989581	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; V prism-up; V prism-up for near fix disparity; Vision; Visual	4180186
1989581	R eye V prism-up for near fix disp Phor	4180186
1989581	.:::.::	4182948
1989582	cfDNA.donor/cfDNA.ttl p kid trnsplt	4180186
1989582	After; cfDNA.dnr; cfDNA.donor/cfDNA.total p kid trnsplt; Deoxyribonucleic acid; FR; Molecular pathology; MOLPATH; Non-protein bound; Number fraction; p kdny trnsplt; Percent; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
1989582	cfDNA./cfDNA.^:::.cfDNA:	4182948
1989584	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bilharziasis; blood fluke; Blt; Cercarial dermatitis; Immune blot; Immunobl; Immunoblot; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Schist sp 22-24kD; Schist sp 22-24kD Ab; Schistosomiasis; Screen; Serum; species; spp; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
1989584	Schist sp 22-24kD Ab Ser Ql IB	4180186
1989584	 22-24kD :::::	4182948
1989591	B-HCG heterph Ab intrf Pnl Ser	4180186
1989591	B; B HCG; Beta HCG; Beta human chorionic gonadotropin; B-HCG; B-HCG heterph Ab intrf; B-HCG heterph Ab intrf Pnl; CG; Chemistry; Choriogonadotropin beta chain; Choriogonadotropins total; Chorionic gonadotropin; Epstein-Barr virus; HCG; Hetero; Heteroph; Hetr; Human chorionic gonadotropin; Mono screen; Mono slide; Mono spot; Mono test; Mononucleosis screen; Mononucleosis test; Monospot; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Serum; SR; Tumor marker	4180186
1989591	.Beta :-:::-	4182948
1989592	Glucose/Creat 24h Ur-sRto	4180186
1989592	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; Glu; Gluc; Glucoseur; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
1989592	/::24::	4182948
1989593	Cardiac; Hrt; IS; IVS; Length; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick	4180186
1989593	Thickness IVS	4180186
1989593	:::.:	4182948
1989595	Finding; Findings; H+P; H+P.HX; Made arrangment for refill; Nominal; P prime; Point in time; Random	4180186
1989595	Made arrangment for refill	4180186
1989595	:::^:	4182948
1989597	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Pan; Panl; Pnl; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Survey	4180186
1989599	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1989601	Rec therapy Procedure note	4180186
1989601	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Rec therapy; Visit note	4180186
1989601	:::{}::	4182948
1989602	Disease; Disorder; Exp; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH; Virus	4180186
1989605	Copper Wat-sCnc	4180186
1989605	Cu; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Wat	4180186
1989605	::::	4182948
1989610	cfDNA.donor/cfDNA.total p lung trnsplt	4180186
1989610	After; cfDNA.dnr; cfDNA.donor/cfDNA.total p lung trnsplt; Deoxyribonucleic acid; FR; Molecular pathology; MOLPATH; Non-protein bound; Number fraction; p lung trnsplt; Percent; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
1989610	cfDNA./cfDNA.^:::.cfDNA:	4182948
1989612	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cacao; Cocoa; f93; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1989612	Cocoa IgG-mCnc	4180186
1989612	 .IgG::::	4182948
1989613	Disease; Disorder; Finding; Findings; Nominal; Report period; Survey; SURVEY.GNHLTH; Virus	4180186
1989614	Change physician responsible for pain tx	4180186
1989614	Change physician responsible for pain tx; Exchange; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Tx	4180186
1989614	:::^:	4182948
1989615	CLIN; Clock time; Dialy; Drain; Exudate; Fld; Peritoneal dialysis fld drain start tme; Point in time; QNT; Quan; Quant; Quantitative; Random; Removal of fluid; Started	4180186
1989615	Peritoneal dialysis fld drain start tme	4180186
1989615	:::^:	4182948
1989617	Contract; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1989621	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1989624	Insertional activity Muscle EMG	4180186
1989624	Activ; Actvty; Finding; Findings; Movements; Musc; Muscl; NEURO; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1989624	:::::EMG	4182948
1989626	Hemodialysis fluid removed 1h Vol	4180186
1989626	1 hour; 1.0Hr; 1HR; 60 min; 60 minutes; 60M; 60min; CLIN; Fld; QNT; Quan; Quant; Quantitative; Volume	4180186
1989626	::1:^:	4182948
1989628	Arterial Stenosis; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1989629	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Level; London plane; Maple leaf sycamore; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t11	4180186
1989629	London Plane IgG-mCnc	4180186
1989629	 .IgG::::	4182948
1989630	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Fam Med; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
1989630	Fam Med H&P note	4180186
1989630	:::{}::	4182948
1989632	L; L median n; LT; NEURO; Point in time; QNT; Quan; Quant; Quantitative; Random; Sensory NC velocity; Vel; Velocity	4180186
1989632	Sensory NC velocity L median n	4180186
1989632	:::.::	4182948
1989634	Contract; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1989636	Reason missed meds past Mo	4180186
1989636	1 month; 1 month (30 days); 30 days; Finding; Findings; H+P; H+P.HX; Last; month; Nominal; P prime; Reason missed meds past Mo	4180186
1989636	::1:^:	4182948
1989637	Motor NC velocity R tibial n	4180186
1989637	Motor NC velocity; NEURO; Point in time; QNT; Quan; Quant; Quantitative; R; R tibial n; Random; RT; Vel; Velocity	4180186
1989637	:::.::	4182948
1989638	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enzootic pneumonia; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M pneumo; M pneumonia; M pneumoniae; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1989638	M pneumo DNA CSF Ql NAA+probe	4180186
1989638	 DNA:::::..	4182948
1989641	Appear; Appearance; Appr; CLIN; Dialy; Nominal; Point in time; Random	4180186
1989641	:::^:	4182948
1989642	T putrescentiae IgG-mCnc	4180186
1989642	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; d72; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Mite; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Storage mite; T putrescentiae	4180186
1989642	 .IgG::::	4182948
1989644	T solium 6-8kD Ab Ser Ql IB	4180186
1989644	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cysticercosis; Cysticercus; Immune blot; Immunobl; Immunoblot; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; T sol; T sol lar; T solium; T solium 6-8kD; T solium 6-8kD Ab; Tapeworm; WB; WBLOT; West blot; West blt; Western blot	4180186
1989644	 6-8kD :::::	4182948
1989646	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PNDS; Ulcer	4180186
1989647	Lat; NEURO; Point in time; QNT; Quan; Quant; Quantitative; R; R LACN; Random; RT; Sensory NC velocity; Vel; Velocity	4180186
1989647	Sensory NC velocity R LACN	4180186
1989647	:::.::	4182948
1989655	TBEV NAb Titr Spec Nt	4180186
1989655	 .:::XXX::	4182948
1989655	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Enc; Enceph; Encephalomyelitis; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; TBEV; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
1989656	European paper wasp IgG4-mCnc	4180186
1989656	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; European paper wasp; i77; Level; Mass concentration; Mediterranean paper wasp; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1989656	 .IgG4::::	4182948
1989657	Num of pain related stays at tx facility	4180186
1989657	Finding; Findings; H+P; H+P.HX; No; Num; Num of pain related stays at tx facility; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Tx	4180186
1989657	:::^:	4182948
1989658	Muscle state nerve stim Muscle	4180186
1989658	Finding; Findings; Musc; Muscl; Muscle state nerve stim; NEURO; Nominal; Point in time; Random; Stim	4180186
1989658	::::	4182948
1989659	Nominal; Point in time; Random; Survey	4180186
1989661	KLHL11 IgG Titr Ser IF	4180186
1989661	Kelch  .IgG:::::	4182948
1989661	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; KLHL11; Neuro; Neurology; Oncology; Point in time; PR; Prot; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1989662	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1989663	Pan; Panl; PNDS outcomes panel; Pnl; Point in time; Random; Survey; SURVEY.PNDS	4180186
1989664	L eye V prism-down for far fix disp Phor	4180186
1989664	by Phoropter; EYE.REFRACTION; Eyeball; Inverse Length; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; V prism-down; V prism-down for far fix disparity; Vision; Visual	4180186
1989664	.:::.::	4182948
1989665	Leptospira sp Ab Pnl Ser Aggl	4180186
1989665	Agg; Agglut; Agglutination; Leptospira sp Ab Pnl; Leptospirosis; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; species; spp; SR	4180186
1989665	:-:::-:	4182948
1989666	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1989667	6-oxo-pipecolic acid; 6-oxo-piperidine-2-carb/Creatinine; 6-oxo-piperidine-2-carboxylic acid; Chemistry; CR; Crea; Creat; II; PDE-ALDH7A1; Point in time; Pyridoxine-dependent epilepsy; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
1989667	6-oxo-PIP/Creat Ur-sRto	4180186
1989667	6---2-/::::	4182948
1989668	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; T prime	4180186
1989670	Brain; Cerebral; Cerebrum; Cranial; Cranium; Document; Finding; Findings; Head; Imaging; Intracranial; Mitral regurgitation maximum velocity; MR tractography; MRI; Point in time; Radiology; Random; Skull	4180186
1989670	:::>::MR.	4182948
1989672	Abd; Abd+Pelvis; Abdo; Abdominal; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; Pelvic; Point in time; Radiology; Random; W contr PO; WC	4180186
1989672	CT Abd+Pelvis W contr PO	4180186
1989672	^:::+::CT	4182948
1989673	CT Hrt WO+W contr IV	4180186
1989673	c; Cardiac; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Hrt; Imaging; Point in time; Radiology; Random; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1989673	^ & :::>::CT	4182948
1989675	1V; Document; EXT; Extr-R; Film; Finding; Findings; Hip-R; Imaging; Judet Ext Obl; LE; Leg; LE-R; Low; Lower extremity joint; Obl; Plain Films; Point in time; R; Radiology; Random; RLE; RT; Single View; VW; Xray; X-ray	4180186
1989675	XR Hip-R Judet Ext Obl	4180186
1989675	 Judet :::.>::X	4182948
1989678	Brain; Cranial; Cranium; Document; Echoencephalogram; Echoencephalography; Echography; Eyeball; Finding; Findings; Imaging; Intracranial; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; Radiology; Random; Skull; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vision; Visual	4180186
1989678	:::>::.A-	4182948
1989679	Document; DOP; DUPLEX; Echography; EXT; Extr v; Extr-R; Finding; Findings; Imaging; LE; LE v; LE v-R; Leg; LE-R; Low; Point in time; R; Radiology; Random; RLE; RT; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ven; Venous	4180186
1989679	DOP LE v-R for venous map	4180186
1989679	:::.>::.	4182948
1989683	MRA Subclavian ves-Bl WO+W contr IV	4180186
1989683	Ang; Angio; Angiography; Bil; Bilat; Both; c; Contr; Contra; Contrst; Document; Finding; Findings; Imaging; Magnetic Resonance Angiographies; Magnetic resonance imaging; Mitral regurgitation maximum velocity; MR angiography; MRA; MRI; MRI.angio; Point in time; Radiology; Random; Subclavian ves-Bl; Thorax; Vesl; Vessels.XXX; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1989683	^ & :::>.::MR.	4182948
1989685	XR Pelvis and Hip-R V Abd+IR	4180186
1989685	Document; EXT; Extr-R; Films; Finding; Findings; Hip-R; Imaging; LE; Leg; LE-R; Low; Lower extremity joint; MSK; Musculoskeletal; Ortho; Orthopedics; Pelvic; Pelvis + Hip-R; Pelvis and Hip-R; Pelvis+LE; Plain Films; Point in time; R; Radiology; Random; RLE; RT; V Abd+IR; View; VWS; Xray; X-ray	4180186
1989685	  + ::: & .>::X	4182948
1989687	Brain; Cerebral; Cerebrum; Cranial; Cranium; Document; Finding; Findings; Head; Imaging; Intracranial; Mitral regurgitation maximum velocity; MRI; Point in time; Radiology; Random; Skull	4180186
1989687	:::>::MR	4182948
1989693	XR Wrist-R Prone Oblique	4180186
1989693	1V; Arm; Carpal bone; Carpal bones; Carpal bones and joint; Document; EXT; Extr-R; Film; Finding; Findings; Imaging; MSK; Musculoskeletal; Obl; Ortho; Orthopedics; Plain Films; Point in time; Prone Oblique; R; Radiology; Random; RT; RUE; Single View; UE; UE-R; Up; Upper extremity joint; VW; Wrist-R; Xray; X-ray	4180186
1989693	  :::.>::X	4182948
1989694	Brain; CAT scan; CBCT; Computed tomography; Computerized tomography; Cone beam CT; Cranial; Cranium; CT scan; Dental scan; Dentascan; Document; Finding; Findings; Imaging; Intracranial; Point in time; Radiology; Random; Skull	4180186
1989694	CBCT Teeth	4180186
1989694	:::>::CT.	4182948
1989696	USE Brst	4180186
1989696	Brst; Document; Echography; Finding; Findings; Imaging; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; USE	4180186
1989696	:::::.	4182948
1989697	XR Hip-L Judet Ext Obl	4180186
1989697	1V; Document; EXT; Extr-L; Film; Finding; Findings; Hip-L; Imaging; Judet Ext Obl; L; LE; Leg; LE-L; LLE; Low; Lower extremity joint; LT; Obl; Plain Films; Point in time; Radiology; Random; Single View; VW; Xray; X-ray	4180186
1989697	 Judet :::.>::X	4182948
1989698	Abd; Abd+Pelvis; Abdo; Abdominal; CAT scan; Chest + Abd; Chest+Abd+Pelvis; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; Neck to Pelvis; Pelvic; Point in time; Radiology; Random; Thorax	4180186
1989698	CT Neck to Pelvis	4180186
1989698	:::+++::CT	4182948
1991070	Quality of life in last 2W	4180186
1991244	KOOS-PS	4180186
1991252	PROWL	4180186
1991268	I get upset when I can't do something because of my shortness of breath in past 7D	4180186
1991269	I worry about becoming short of breath in past 7D	4180186
1991273	I am embarrassed by using my oxygen in public in past 7D	4180186
1991293	Visual acuity.far^uncorrected	4180186
1991339	Surface.hand	4180186
1991342	Tibial nerve.right	4180186
1991344	Fibular nerve.left	4180186
1991345	Fibular nerve.right	4180186
1991349	Median nerve.right	4180186
1991352	Lateral antebrachial cutaneous nerve.left	4180186
1991354	Medial antebrachial cutaneous nerve.right	4180186
1991365	Intensity of shortness of breath in past 7D	4180186
1991387	Duration of shortness of breath in past 7D	4180186
1991409	Radial nerve.left	4180186
1991410	Radial nerve.right	4180186
1991417	Level of difficulty doing usual activities because of halos when wearing best corrective lenses in past 7D	4180186
1991419	How bothersome have halos been when wearing best corrective lenses in past 7D	4180186
1991420	Frequency of noticing glare when not wearing corrective lenses in past 7D	4180186
1991425	Level of difficulty doing usual activities because of starbursts when wearing best corrective lenses in past 7D	4180186
1991428	Horizontal prism.in far for Percival	4180186
1991429	Frequency of seeing starbursts when not wearing corrective lenses in past 7D	4180186
1991430	Horizontal prism.out far for Percival	4180186
1991431	Frequency of seeing starbursts when wearing best corrective lenses in past 7D	4180186
1991432	Horizontal prism.out far for Sheard	4180186
1991437	Horizontal prism.in near for Sheard	4180186
1991438	Horizontal prism.in for binocular accommodative lag	4180186
1991441	Horizontal prism.out for binocular accommodative lag	4180186
1991442	Horizontal prism.in for far fixation disparity	4180186
1991443	Seen starbursts in past 7D	4180186
1991444	Horizontal prism.out for far fixation disparity	4180186
1991446	Experienced blurry vision in past 7D	4180186
1991447	Horizontal prism.out for near fixation disparity	4180186
1991448	Horizontal prism.in for near fixation disparity	4180186
1991449	Horizontal prism.in for far phoria	4180186
1991450	Horizontal prism.out for far phoria	4180186
1991452	Horizontal prism.in for near phoria	4180186
1991465	Vertical prism.down for far fixation disparity	4180186
1991466	Vertical prism.down for near fixation disparity	4180186
1991470	Vertical prism.up for near phoria	4180186
1991472	Vertical prism.up for far phoria	4180186
1991557	Percent neutralization by SARS coronavirus 2 spike protein RBD Ab.neut	4180186
1991568	Missed taking medication in past Mo	4180186
1991569	Reason for missed medications in past Mo	4180186
1991590	H missed from work because of eye problems in past 7D	4180186
1991592	H worked in past 7D	4180186
1991594	Level that eye problems affected ability to do regular daily activities, other than work at a job in past 7D	4180186
1991599	Transforming growth factor beta.free	4180186
1991605	Leptospira weilii serovar Celledoni	4180186
1991608	Leptospira santarosai serovar Borincana	4180186
1991610	Leptospira interrogans serovar Wolffi	4180186
1991612	Leptospira borgpetersenii serovar Javanica	4180186
1991617	Bacterial trimethoprim resistance dfrA1 gene	4180186
1991619	Bacterial trimethoprim resistance dfrA12 gene	4180186
1991628	Views abduction + internal rotation	4180186
1991630	Extent that physical pain prevents activity in last 2W	4180186
1991631	Dependency on medical treatment to function in daily life in last 2W	4180186
1991633	Extent to which life is meaningful in last 2W	4180186
1991634	How safe do you feel in your daily life in last 2W	4180186
1991635	Healthiness of physical environment in last 2W	4180186
1991637	Able to accept body appearance in last 2W	4180186
1991639	Availability of information needed in daily life in last 2W	4180186
1991640	Extent of opportunity for leisure activities in last 2W	4180186
1991641	Ability to get around in last 2W	4180186
1991645	Satisfaction with self in last 2W	4180186
1991646	Satisfaction with personal relationships in last 2W	4180186
1991648	Satisfaction with support from friends in last 2W	4180186
1991650	Satisfaction with access to health services in last 2W	4180186
1991652	Frequency of negative feelings in last 2W	4180186
1991657	Difficulty level of paying expenses in past Mo	4180186
1991688	Ability to concentrate in last 2W	4180186
1991702	carBAMazepine & metabolites panel	4180186
1991711	SARS-CoV-2-related socioeconomic questionnaire for school-age children 12Mo follow-up	4180186
1991713	Were classes suspended in last 12Mo	4180186
1991715	Amount of school lost in last 12Mo	4180186
1991716	Reason for not participating in remote learning in last 12Mo	4180186
1991760	How bothersome has glare been in past 7D	4180186
1991764	How bothersome has glare been when not wearing corrective lenses in past 7D	4180186
1991765	How bothersome has glare been when wearing best corrective lenses in past 7D	4180186
1991771	Level of difficulty doing usual activities because of double images when wearing best corrective lenses in past 7D	4180186
1991776	Level of difficulty doing usual activities because of glare when wearing best corrective lenses in past 7D	4180186
1991779	HSVS	4180186
1991780	Behind on rent or mortgage in past 12Mo	4180186
1991781	Number of residential moves in past 12Mo	4180186
1991782	Homeless in past 12Mo	4180186
1991787	Polio virus Ab.Neut panel	4180186
1991788	Coxsackievirus B Ab.Neut panel	4180186
1991820	Olea europaea pollen Ab.IgG	4180186
1991935	Length.crown heel	4180186
1992140	SARS coronavirus 2 RdRp gene mutation	4180186
1992142	Gas & electrolytes panel	4180186
1992163	PNDS	4180186
1992202	Percent chance of contracting condition of interest in next 3Mo	4180186
1992219	No injury related to transfer &or transport during care	4180186
1992268	View Judet external oblique	4180186
1992269	View Judet internal oblique	4180186
1992274	CT.cone beam	4180186
1992275	MR.tractography	4180186
1992341	Pacemaker.permanent	4180186
1992345	Cell-free DNA.donor/Cell-free DNA.total^post cardiac transplant	4180186
1992346	Cell-free DNA.donor/Cell-free DNA.total^post kidney transplant	4180186
1992347	SARS coronavirus 2 spike protein	4180186
1992348	SARS coronavirus 2 nucleocapsid protein	4180186
1992396	Adalimumab & Adalimumab Ab panel	4180186
1992436	SARS coronavirus 2 spike & nucleocapsid protein stimulated gamma interferon panel	4180186
1992461	Frequency of demonstrating cognitive-communication skills to independently function safely without supervision &or assistance	4180186
1992483	ASHA NOMS	4180186
1992515	6-oxo-piperidine-2-carboxylate & 6(R+S)-oxo-propylpiperidine-2-carboxylate panel	4180186
1992519	Average frequency of primary pain in past 4W	4180186
1992521	Fluctuation of primary pain intensity in past 4W	4180186
1992524	Pain medication in the past 4W	4180186
1992566	Filaria Ab.IgG & IgM panel	4180186
1992644	Cervical &or Vaginal cytology study	4180186
1992674	Horse dander Ab.IgG	4180186
3000000	1 day; 24 hours; 24HR; Finding; Findings; Imm; Imun; Imune; nursing; Ordinal; QL; Qual; Qualitative; Screen; Sign and Symptom Check-List for Persons with HIV Disease; Survey; SURVEY.NURSING.HIV-SSC	4180186
3000002	Anserine Ur-sCnc	4180186
3000002	beta -alanyl-N-methylhistidine; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
3000002	::::	4182948
3000003	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Asparagus; Autoantibodies; Autoantibody; f261; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf261; Serum; SR	4180186
3000003	Asparagus IgE Qn	4180186
3000003	 .IgE::::	4182948
3000004	2D Echo est; Cardiac; Cardio; Cardiology; EF; estimation; Frac; Fract; Fractionation; Fractions; Heart Disease; Hemodynamics; HEMODYNAMICS.MOLEC; Hrt; Hrt ventr; Percent; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; RV; Ventricular; Volfr; Volume fraction	4180186
3000004	RV EF 2D Echo est	4180186
3000004	:::..::2D.	4182948
3000005	Insulin 8M p chal SerPl-mCnc	4180186
3000005	8M p chal; After; CHEMISTRY.CHALLENGE TESTING; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
3000005	^XXX8:::/:	4182948
3000009	#; ABS; absolute; absolutes; CC; Cnt; Coliform CC; Colonies; Count; Count/volume; CT; ID; Infectious Disease; InfectiousDisease; Microbiology; Mlk; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
3000009	Coliform CC # Mlk	4180186
3000009	::::	4182948
3000010	Exam; Examination; Finding; Findings; H+P; H+P.PX; Jnt; Nominal; P prime; Phys find; Point in time; Random	4180186
3000010	Phys find Joint	4180186
3000010	:::::	4182948
3000012	100 RBC; adj; Blood; Corrected reticulocyte count; Discocytes; Erthrocyte; Erythrocyte; Hct; Hct adj; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Number Fraction; PCV; Percent; Point in time; Polychromatophilic red cells; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Retic; Retics; Reticulocyte; Reticulocyte Index; Reticulocyte Production Index; RI; RPI; WB; Whole blood	4180186
3000012	/100 ^^::::	4182948
3000014	cAMP 24h Ur-sRate	4180186
3000014	1 day; 24 hours; 24HR; Adenosine 2'-Phosphate; Adenosine 3'-Phosphate; Adenosine 5'-Phosphate; Adenylic Acid; ADO; AMP; ANED; cAMP; Chemistry; CMP; Medication stress; Phosphaden; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
3000014	.::24::	4182948
3000015	Chemistry; E3; Estriol free; Gyn; Gynecology; MoM; Multiple of the median; OB; ObGyn; Obstetrics; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; u Estriol; uE3; Uncnj; Unconj; Unconjug; Unconjugat	4180186
3000015	u Estriol unadj MoM SerPl	4180186
3000015	.^^:::/:	4182948
3000016	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; T spiralis; Tric; Trich; Trichinellosis; Trichinosis	4180186
3000016	T spiralis Ab Ser Ql	4180186
3000016	 ::::	4182948
3000019	Agg; Agglut; Agglutination; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Nominal; Point in time; Random; S suis; Sertyp; Strep; Strept	4180186
3000019	S suis Sertyp Islt Aggl	4180186
3000019	 :::::	4182948
3000020	Arbitrary concentration; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000020	C1r2+C1s2 SerPl-aCnc	4180186
3000020	 C1r2+C1s2:::/:	4182948
3000021	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; EIV; EIV A1; Equin; Equine influenza; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary	4180186
3000021	EIV A1 Ab Ser Ql CF	4180186
3000021	 A1  :::::	4182948
3000023	Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST I-Amp 6ms L-V2; Voltage	4180186
3000023	ST I-Amp 6ms L-V2	4180186
3000023	ST  6 ms. V2:::::	4182948
3000027	c; Contr; Contra; Contrst; CorePlaybook; Document; EXT; Finding; Findings; Imaging; Kn; LE; Leg; Low; Lower extremity joint; Mitral regurgitation maximum velocity; MRI; MSK; Musculoskeletal; Ortho; Orthopedics; Playbook; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
3000027	MR Knee WO+W contr IV	4180186
3000027	^ & :::>::MR	4182948
3000029	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; Ecstasy; GCMS; Level; Mass concentration; MDMA; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
3000029	MDMA CtO Ur Cfm-mCnc	4180186
3000029	 :::::	4182948
3000030	Amikacin Rand EID SerPl-mCnc	4180186
3000030	After; Amikin; Aminoglycosides; DRUG/TOXICOLOGY; Drugs; EID; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Rand; Rand EID; Rando; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000030	^:::/:	4182948
3000032	Deprecated	4180186
3000032	ATTACH; ATTACH.REHAB; ATTACH.REHAB.NURS; Ident; Identifier; Intradermal; Nominal; Point in time; Random; Skilled nursing Tx; Skilled nursing Tx plan; Tx; Tx Plan	4180186
3000036	Discocytes; Ejaculate; Erthrocyte; Erythrocyte; FERTILITY TESTING; Genitourinary; GU; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Screen; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
3000036	RBC Smn Ql Micro	4180186
3000036	:::::.	4182948
3000037	Mescaline Ur Cfm-mCnc	4180186
3000037	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Peyote; Peyotl; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
3000037	:::::	4182948
3000040	L pneumo1 IgM Titr Ser IF	4180186
3000040	 1  .IgM:::::	4182948
3000040	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; i; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; L pneumo; L pneumo1; L pneumonphila; Legion; Legionela; Legionella pneumophila serogroup 1; Microbiology; Philadelphia 1; Pneu; pneum; Pneumophilia; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
3000042	Breathing; Clinical Care Classification; Finding; Findings; Lungs; nursing; Ordinal; Point in time; QL; Qual; Qualitative; Random; RS; Screen; Survey; SURVEY.NURSING.HHCC	4180186
3000043	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
3000043	HLA-DPw4 Ql	4180186
3000043	HLA-DPw4:::/:	4182948
3000044	Alfatil; ANTIBIOTIC SUSCEPTIBILITIES; AST; c7; Ceclor; Distaclor; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kefalor; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Panacef; Panoral; Point in time; QNT; Quan; Quant; Quantitative; Random; Rc7; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
3000044	Cefaclor Islt MLC	4180186
3000044	:::::	4182948
3000046	Meclizine SerPl Ql	4180186
3000046	Ancolan; Antivert; Bonamine; Bonine; Bonomine; C25H27ClN2; Calmonal; Diadril; Dramamine II; DRUG/TOXICOLOGY; Drugs; Histamethizine; Histametizine; Mazanor; Meclicot; Meclizine dihydrochloride monohydrate; Meclozine; Medivert; Navicalm; Neo-istafene; Ordinal; Peremesin; Pl; Plasma; Plsm; Point in time; Postafene; PR; QL; Qual; Qualitative; Random; Sabari; Screen; Sea-legs; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Verelan; Veritab	4180186
3000046	:::/:	4182948
3000048	Tarragon IgE Qn	4180186
3000048	A dracunculus; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Esdragol; f272; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf272; Serum; SR; Tarragon	4180186
3000048	 .IgE::::	4182948
3000055	Finding; Findings; Growth And Development Knowledge; NURSING; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NURSING.OMAHA	4180186
3000056	 .:::XXX::	4182948
3000056	WNV NAb Titr Spec Nt	4180186
3000056	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT; WNV	4180186
3000057	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; S pneum23; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; Streptococcus pneumoniae 23f	4180186
3000057	Deprecated S pneum23 Ab sp2 Ser-mCnc	4180186
3000058	p-nitrophenol/Creat Ur	4180186
3000058	4-nitrophenol; C6H5NO3; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Mixed isomers; Nitrophenols; p-nitrophenol; PNP; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
3000058	/::::	4182948
3000061	Acid elution; Blood; Fetal hemoglobin; Fetal maternal hemorrhage screen; Haemoglobin; Hb; HbF; HEMATOLOGY/CELL COUNTS; Hgb; Hgb F; KB; Kleih Betke; Kleihauer stain; Kleihauer test; Kleihauer-Betke stain; Kleihauer-Betke test; Kleihauer-Braun-Betke; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UniversalLabOrders; WB; Whole blood	4180186
3000061	Hgb F Bld Ql Kleih Betke	4180186
3000061	 F:::::Kleihauer-Betke 	4182948
3000062	Antigen; Antigens; H capsul; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; UniversalLabOrders	4180186
3000062	H capsul Ag Ser Ql	4180186
3000062	 ::::	4182948
3000064	Acyl carnitine; Acylcarni; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
3000064	Acylcarnitine Ur-sCnc	4180186
3000064	::::	4182948
3000065	EBV EA Ab Titr Ser	4180186
3000065	Epstein Barr  ::::	4182948
3000065	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EA; EBV; EBV EA; Epstn; HHV-4; human herpesvirus 4; ID; Infectious Disease; InfectiousDisease; Microbiology; Mono; Mononucleosis; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
3000067	Chemistry; Intact Parathormone; intact parathyroid hormone; iPTH; Level; Mass concentration; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; PTH-Intact; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders	4180186
3000067	PTH-Intact SerPl-mCnc	4180186
3000067	.:::/:	4182948
3000069	Dose med or substance; DRUG DOSES; Point in time; QNT; Quan; Quant; Quantitative; Random; Tarasan; Truxal; Truxaletten; Turactan	4180186
3000069	Chlorprothixene Dose	4180186
3000069	::::	4182948
3000070	20M p chal; After; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Level; Mammatropic hormone; Mammotropin; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000070	Prolactin 20M p chal SerPl-mCnc	4180186
3000070	^XXX20:::/:	4182948
3000071	DOC.MISC; Document; Finding; Findings; MISC	4180186
3000071	::-:^:	4182948
3000072	Abd; Abdo; Abdomen+; Abdominal; c; Contr; Contra; Contrst; CorePlaybook; Document; Finding; Findings; Imaging; L/sp; L-spine; Lumbar; Lumbo; Mitral regurgitation maximum velocity; MRI; Playbook; Point in time; Rad; Radiology; Random; Spinal; Spinal Cord; W contr IV; WC	4180186
3000072	MR L-spine W contr IV	4180186
3000072	^:::>.::MR	4182948
3000073	Hexosaminidase A Act Fib-Imp	4180186
3000073	B; Beta-hexosaminidase subunit alpha; B-NAH; Chemistry; Fib; Fibr; GM2 activator; GM2 Gangliosidoses; GM2-gangliosidosis; Hex A; Hex B; HEXA; Hexaminidase activator; Hexosaminidase; Hexosaminidase A; Hexosaminidase A Act; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Sandhoff disease; Tay Sachs Disease	4180186
3000073	Beta-N-.A.::::	4182948
3000074	Barbiturates Tested Ur Scn	4180186
3000074	Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Identity or presence; Nominal; Point in time; Random; Scn; Scr; Scrn; UA; UR; Urn	4180186
3000074	 :::::	4182948
3000075	Parakeet Serum Ab Ql ID	4180186
3000075	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e198; ID; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Ser; Serum; SR	4180186
3000075	 :::::	4182948
3000076	C16H19ClN2O; Clistin; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Palgic; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
3000076	Carbinoxamine Ur-mCnc	4180186
3000076	::::	4182948
3000077	#; ABS; absolute; absolutes; CD3 Cells; CD3+CD25+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; IL-2 receptor alpha chain; IL-2R; IL-2R Tac antigen; ILR2; Leu4; Leu-4; Misc; Miscellaneous; Number concentration; Number Concentration (count/vol); Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; T3; Tac antigen; To be specified in another part of the message; Unspecified	4180186
3000077	CD3+CD25+ Cells # Spec	4180186
3000077	.CD3+CD25+:::XXX:	4182948
3000079	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e74; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; Protein; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
3000079	 .IgE.RAST ::::	4182948
3000079	Deprecated Rat Urine Prot IgE RAST Ql	4180186
3000083	Deprecated NEFA SerPl-sCnc	4180186
3000083	Acd; Acid; Aliphatic carboxylate C10-C26; Chemistry; Fatty acid; FFA; Free Fatty Acids; Level; Lipid; NEFA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
3000085	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Fl; Fld; FLU; Fluid; Frac; Fract; Fraction; Fractionated; Fractionation; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; M-spikes; Narrative; Point in time; PR; Prot; Random; Report	4180186
3000085	Oligoclonal Bands Fld Elph-Imp	4180186
3000085	.:::::	4182948
3000088	C&S; Cerebral spinal fluid; Cerebrospinal Fl; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Neuro; Neurology; Nominal; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
3000088	Virus CSF Cult	4180186
3000088	 :::::	4182948
3000089	Antihemophilic factor C; Arbitrary concentration; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Fact XI; Fact XI Inhib; Factor 11; FXI; Hematology; Heme; Inhib; Inhibit; Plas; Plasma thromboplastin antecedent; Platelet poor plasma; Point in time; PTA; QNT; Quan; Quant; Quantitative; Random; Tilt tube	4180186
3000089	Fact XI Inhib PPP-aCnc	4180186
3000089	 XI :::::	4182948
3000091	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
3000091	B burgdor IgA CSF Ql IA	4180186
3000091	 .IgA:::::	4182948
3000092	Amm; Ammon; Amon; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Hepatology; Kidney; Level; Liver; Nephrology; NH3; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Substance Concentration	4180186
3000092	Ammonia Fld-sCnc	4180186
3000092	::::	4182948
3000093	Blood; HEMATOLOGY/CELL COUNTS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; WB; Whole blood	4180186
3000093	Morphology Bld-Imp	4180186
3000093	::::	4182948
3000095	by KM; Corneal; EYE; EYE.REFRACTION; L; L cornea; LT; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
3000095	L cornea Axis by KM	4180186
3000095	:::.::	4182948
3000096	US Guided Extr-Bl Drain+cath place	4180186
3000096	Bil; Bilat; Both; Cath; Document; Drain; Drain+cath place; Echography; EXT; Extr-Bl; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Radiology; Random; Removal of fluid; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
3000096	+:::.::	4182948
3000097	ATTACH; ATTACH.REHAB; ATTACH.REHAB.PT; Dx; Dx.addressed by plan; Ident; Identifier; Nominal; Physical Therapy; Physical therapy Tx; Point in time; PT; Random; Tx	4180186
3000097	Deprecated	4180186
3000098	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; CMV; Cytomegalo virus; Cytomgal; DFA; FA; Fluorescent antibody; Fluoresent; HHV-5; Human Herpesvirus-5; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF	4180186
3000098	CMV Ag SerPl Ql IF	4180186
3000098	 :::/::	4182948
3000099	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; UniversalLabOrders	4180186
3000099	ANA Ser IA-aCnc	4180186
3000099	 :::::	4182948
3000104	BLOOD BANK; F8; Fac; Fact; Fact VIII; Factor 8; FVIII; Gvn; Point in time; QNT; Quan; Quant; Quantitative; Random; Volume	4180186
3000104	Fact VIII Gvn Vol	4180186
3000104	 VIII :::^:	4182948
3000107	After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; sp5; sp5 p chal; Spec; SR; STH	4180186
3000107	GH sp5 p chal SerPl-mCnc	4180186
3000107	^XXX5:::/:	4182948
3000109	CD16 Cells; Cell; CELL MARKERS; Cellularity; FCGR3A; Gated cells; Leu11; Leu-11; Leu11b; Leu-11B; Misc; Miscellaneous; Number fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
3000109	CD16 Cells NFr Spec	4180186
3000109	.CD16/100 :::XXX:	4182948
3000114	Mesoridazine SerPl-mCnc	4180186
3000114	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Mesoridazine besylate; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serentil; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000114	:::/:	4182948
3000115	Antigen; Antigens; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Erythrocytes; Hematology; Heme; K (little p) (little a); Kell Blood Group System; Kp sup(a); Kp^a; Ordinal; p; P prime; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
3000115	Kp sup(a) Ag RBC BPU Ql	4180186
3000115	Kp^a :::^:	4182948
3000118	Antigen; Antigens; Canine distemper; CDV; Conjunct; Conjunctiva; Conjunctival; Dog; ID; Infectious Disease; InfectiousDisease; Microbiology; Morbillivirus; Ordinal; Palpebral sac; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Vet; Veterinary	4180186
3000118	CDV Ag Conjunct Ql	4180186
3000118	 ::::	4182948
3000119	Echography; Fet pres; Gyn; Gynecology; Narrative; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Pelvic; Point in time; Random; Report; Sonogram; Sonograph; Sonography; Typ; ULS; Ultrasound	4180186
3000119	Fet pres US	4180186
3000119	:::::	4182948
3000120	17OHCS 24h Ur-mRate	4180186
3000120	1 day; 17-CS; 17-hydroxy corticosteroids; 17OHCS; 17-OHCS; 24 hours; 24HR; Chemistry; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
3000120	17-::24::	4182948
3000123	GABA Amn-sCnc	4180186
3000123	4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; AF; Aminobutric; Aminobutyric; Amino-n-butyrate; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; GABA; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Level; Piperidic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
3000123	Gamma ::::	4182948
3000124	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept	4180186
3000124	S pneum Ab Ser-mCnc	4180186
3000124	 ::::	4182948
3000126	S Paraty A Ab Titr Ser	4180186
3000126	 A  ::::	4182948
3000126	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Paratyph; Paratyphoid; Point in time; Random; S paraty; S Paraty A; S paratyph; S paratyphi; Sal; Sal paratyph; Sal paratyphi; Salmonel; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
3000127	Achromycin V; ANTIBIOTIC SUSCEPTIBILITIES; AST; C18; c211; C75; Chemiciclina; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Panmycin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tetrabioptal	4180186
3000127	Tetracycline Islt MIC	4180186
3000127	:::::	4182948
3000128	^7th spec pst XXX chal; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal; sp7; sp7 p chal; Spec	4180186
3000128	Renin sp7 p chal Plas-cCnc	4180186
3000128	^XXX7::::	4182948
3000131	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Canine; Dog hair; e005; e5; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
3000131	 .IgE.RAST ::::	4182948
3000131	Deprecated Dog Dander IgE RAST Ql	4180186
3000132	TCTFE Bld-mCnc	4180186
3000132	1,1,2-trichloro-1,2,2-trifluoroethane; Blood; CFC-113; DRUG/TOXICOLOGY; Drugs; FC 133; Freon 113; Freon TF; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TCTFE; Trichloro 1,2,2-trifluoroethane; Trichlorotrifluoromethane; WB; Whole blood	4180186
3000132	::::	4182948
3000135	Deprecated Phytanate SerPl-mCnc	4180186
3000135	2,6,10,14-tetramethylpentadecanoate; C16:0(CH3)4; Chemistry; Level; Mass concentration; Phytanic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000139	Myelin IgM Titr Ser	4180186
3000139	 .IgM::::	4182948
3000139	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Immune globulin M; Immunoglobulin M; Point in time; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
3000141	Beryllium Tiss-mCnt	4180186
3000141	Be; Berylliosis; DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
3000141	::::	4182948
3000142	CV B4 Ab sp1 Titr Ser CF	4180186
3000142	 B4  ^1:::::	4182948
3000142	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; CF; Comp fixation; Compfix; Complement fixation; Coxsackie; Coxsackie virus; CV; CV B4; Dilution factor; Dilution Factor (Titer); First; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Pre immunization; Random; Serum; SmQn; sp1; Spec; SR; Titer; Titered; Titre; Ttr	4180186
3000144	Addiction; Amph; Amphet; Amphetam; Amphetamines; Ampht; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Speed; UA; UniversalLabOrders; UR; Urn	4180186
3000144	Amphet Ur Ql Scn	4180186
3000144	:::::	4182948
3000145	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin E; Immunoglobulin E; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; T gondii; Toxo; Toxoplasmosis	4180186
3000145	T gondii IgE Ser Ql	4180186
3000145	 .IgE::::	4182948
3000146	Clot; Clottable; Coag; Coagulation assay; Contrl; Control; Fac; Fact; Hematology; Heme; imm NP; Immediatedly after 1:1 addition of; Mixing studies; Normal; Plas; Platelet poor plasma; Point in time; Pro time; Prothrombin time; Protime; PT; PT correction study; PT immediate mix; PT incubated mix; QNT; Quan; Quant; Quantitative; Random; Tilt tube	4180186
3000146	PT imm NP Cont PPP	4180186
3000146	.^:::^::	4182948
3000148	Hgb Yakima Bld Ql	4180186
3000148	Blood; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Yakima; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
3000148	 Yakima::::	4182948
3000149	After; CHEMISTRY.CHALLENGE TESTING; Level; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Total gastrins; Zollinger-Ellison syndrome	4180186
3000149	Gastrin p meal SerPl-sCnc	4180186
3000149	^:::/:	4182948
3000150	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Clam; f207; Immune globulin E; Immunoglobulin E; Mollusc; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders	4180186
3000150	Clam IgE Qn	4180186
3000150	 .IgE::::	4182948
3000151	FLUoxetine SerPl-sCnc	4180186
3000151	DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; Prozac; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
3000151	:::/:	4182948
3000153	ATTACH; ATTACH.REHAB; ATTACH.REHAB.RT; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Lung; Narrative; notes; Point in time; Prog note; Pulmonary; Pulmonology; Random; Report; Respiratory; Respiratory therapy Tx; subsequent evaluation; subsequent visit evaluation; Tx; Visit note	4180186
3000153	Deprecated	4180186
3000156	Triazolam CtO Ur Scn-mCnc	4180186
3000156	APO-TRIAZO; CtO; DRUG/TOXICOLOGY; Drugs; Halcion; Level; Mass concentration; Novo-triolam; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn	4180186
3000156	 :::::	4182948
3000157	DRUG/TOXICOLOGY; Drugs; Inderal; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
3000157	Propranolol SerPl-sCnc	4180186
3000157	:::/:	4182948
3000162	BS; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Level; Mammatropic hormone; Mammotropin; Mass concentration; Pl; Plasma; Plsm; Point in time; PRL; Prol; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000162	Prolactin BS SerPl-mCnc	4180186
3000162	^:::/:	4182948
3000163	CDT; CDT Asialo; Chemistry; Glycosylated transferrin; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Siderophilin; SR; Tf; Tot; Totl; Trf; TRFRN	4180186
3000163	CDT Asialo/Tf MFr SerPl	4180186
3000163	../.:::/:	4182948
3000164	2D US; CARD.US; Cardiac; Cardio; Cardiology; Echography; Epi; Heart Disease; Hrt; Hrt ventr; L; Levels; Levl; LT; LV; LV.epi; LVAS; LVIDS; LVL; PAP; Point in time; QNT; Quan; Quant; Quantitative; Random; SAX; SAX PM sys; Sonogram; Sonograph; Sonography; Sys; Syst; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular	4180186
3000164	LV.epi SAX PM sys Area 2D US	4180186
3000164	..:::...::.2D	4182948
3000165	Amiopep; Catalytic Concentration; Chemistry; Cytosol AP; Leucine amino peptidase; Leucine aminopeptidase; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
3000165	Cytosol AP Ur-cCnc	4180186
3000165	::::	4182948
3000168	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bluetongue; BTV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Orbivirus; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Reovirus; Screen; Serum; SR; SUDS; Vet; Veterinary	4180186
3000168	BTV Ab Ser Ql IA	4180186
3000168	 :::::	4182948
3000169	DOPamine sp4 p chal Ur-mCnc	4180186
3000169	After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp4; sp4 p chal; Spec; UA; UR; Urn	4180186
3000169	^XXX4::::	4182948
3000170	ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; HIV type 1; HIV type I; HIV1; HIV1 gp120; HIV1 gp120+gp160; Human immunodeficiency virus; i; ID; IMMUNE BLOT; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot	4180186
3000170	HIV1 gp120+gp160 Ab Ser Ql IB	4180186
3000170	HIV 1  gp120+gp160 :::::	4182948
3000173	1/3 day; 8 hours; 8HR; ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; FO2Hb; Fractional hemoglobin; Haemoglobin; Haemoglobin oxygenated; Hb; HbO2; Hemoglobin oxygenated; Hgb; Lung; Mass Fraction; Minimal; minimum; O2 saturation; O2Hb; Oxygen saturation; Oxygenated haemoglobin; Oxygenated hemoglobin; Oxyhaemoglobin; OxyHgb; OxyHgb %; Percent; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; SaO2; SO2; Tot; Totl	4180186
3000173	OxyHgb 8h Min % BldA	4180186
3000173	/.::8^::	4182948
3000176	ATTACH; ATTACH.MEDS; Disch; Identity or presence; Med; MEDS; Nominal; Point in time; Random	4180186
3000176	:::.:	4182948
3000177	L mexicana IgG Titr Ser	4180186
3000177	 .IgG::::	4182948
3000177	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; L mexicana; Leishmaniasis; Leishmaniosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
3000178	CA; Misc; Miscellaneous; Nominal; Oncology; Other; Point in time; Random; Spec; Surg; To be specified in another part of the message; TUMOR REGISTRY(NAACCR); Typ; Unspecified	4180186
3000178	-:::.XXX:	4182948
3000180	1 day; 24 hours; 24HR; Chemistry; Mass Rate; mRate; PG; PGD2; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
3000180	Prostaglandin D2 24h Ur-mRate	4180186
3000180	 D2::24::	4182948
3000182	1 day; 24 hours; 24HR; Finding; Findings; nursing; Ordinal; QL; Qual; Qualitative; Screen; Sign and Symptom Check-List for Persons with HIV Disease; Survey; SURVEY.NURSING.HIV-SSC	4180186
3000185	Chemistry; Fe; FE/TIBC; Iron Satn; Iron/Iron binding capacity.total; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SAT; Satn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Transferrin saturation	4180186
3000185	Iron Satn MFr SerPl	4180186
3000185	:::/:	4182948
3000188	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Calcutta lucern; Clusterbean; Cyamopsis tetragonolobus; f246; Guar; Guar gum; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rf246; Screen; Serum; SR	4180186
3000188	 .IgE.RAST ::::	4182948
3000188	Deprecated Guar gum IgE RAST Ql	4180186
3000191	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Trecator	4180186
3000191	Ethionamide Susc Islt	4180186
3000191	::::	4182948
3000193	Antigen; Antigens; Avian chlamydiosis; C psittaci; Chlamydia; Chlamydia psittaci; Chlamydial abortion; CPS; Enzootic abortion of ewes; Gen; Genital tract; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Ornithosis; Ovine chlamydiosis; Point in time; PR; Psittacosis; QL; Qual; Qualitative; Random; Screen; Urogenit; Urogenital	4180186
3000193	C psittaci Ag Genital Ql	4180186
3000193	 ::::	4182948
3000196	R prowazek IgG Titr Ser	4180186
3000196	 .IgG::::	4182948
3000196	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Brill-zinsser disease; Dilution factor; Dilution Factor (Titer); Epidemic typhus; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R prowazek; R prowazekii; Random; Recrudescent typhus; Ricket; Rickettsial; Serum; SmQn; Sporadic typhus; SR; Titer; Titered; Titre; Ttr; Typhus	4180186
3000197	ANTIBIOTIC SUSCEPTIBILITIES; AST; B; Betalactamase; B-Lactamase; B-Lactamase Usual; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Nitrocefin; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
3000197	B-Lactamase Usual Susc Islt	4180186
3000197	Beta .::::	4182948
3000200	Cardiac; Cardio; Cardiology; EF; EF geometry formula; Frac; Fract; Fractionation; Fractions; Heart Disease; Hemodynamics; HEMODYNAMICS.MOLEC; Hrt; Hrt ventr; Nominal; Point in time; Random; Typ; Ventricular	4180186
3000200	Hrt ventr EF geometry formula	4180186
3000200	:::.::*	4182948
3000205	DIA; Diam; Echography; Fetal; Gyn; Gynecology; Kidney; Length; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Pelvic; Point in time; QNT; Quan; Quant; Quantitative; R; Random; Renal pelvis-R; RT; Sonogram; Sonograph; Sonography; ULS; Ultrasound; US+Meas	4180186
3000205	Fet Renal pelvis-R Diam US.meas	4180186
3000205	:::.^::.	4182948
3000206	Amperage; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST Slope L-AVL; Voltage rate	4180186
3000206	ST Slope L-AVL	4180186
3000206	ST . AVL:::::	4182948
3000213	1 day; 24 hours; 24HR; Chemistry; Normeta; Normetaneph; Normetanephrn; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
3000213	Normetanephrine 24h Ur-sRate	4180186
3000213	::24::	4182948
3000214	Silver Birch (rBet v) 2 IgE Qn	4180186
3000214	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Common silver birch; IFR; II; Immune globulin E; Immunoglobulin E; Isoflavone reductase; Point in time; QNT; Quan; Quant; Quantitative; Random; Rt216; Serum; Silver Birch; Silver Birch (rBet v) 2; SR; t216; t3	4180186
3000214	  (rBet v) 2 .IgE::::	4182948
3000215	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EHV; EHV4; Equin; Equine rhinopneumonitis; Herpes virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification; Vet; Veterinary	4180186
3000215	EHV4 DNA Tiss Ql NAA+probe	4180186
3000215	 4  DNA:::::..	4182948
3000217	Antigen; Antigens; CT; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Thyrocalcitonin; Tissue; Tissue, unspecified; Tumor marker	4180186
3000217	Calcit Ag Tiss Ql ImStn	4180186
3000217	 :::::	4182948
3000218	CD14 Abn Bld Cells NFr	4180186
3000218	abn; abnorm; Blood; CD14 Abn Bld Cells; CD14 Cells; Cell; CELL MARKERS; Cellularity; LeuM3; Leu-M3; LPS receptor; LPS-R; Mo2; Mo-2; My4; My-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
3000218	.CD14/.::::	4182948
3000219	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; HUM; Humulin; IH7; Insul; Lente; NPH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Semilente; Serology; Serum; Sliding; SR; Ultralente	4180186
3000219	Insulin Recep Ab Ser Ql	4180186
3000219	 ::::	4182948
3000220	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Arth; Autoantibodies; Autoantibody; CAE; CAEV; Caprine arthritis; Enc; Enceph; Encephalomyelitis; ID; Infectious Disease; InfectiousDisease; Lentivirus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary	4180186
3000220	CAEV Ab Ser Ql Aggl	4180186
3000220	 :::::	4182948
3000221	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
3000221	Theobromine Ur Ql	4180186
3000221	::::	4182948
3000222	2D US; Bdy surface; bod; Bodies; BSA; Calc; Calculation; CARD.US; Cardiac; Cardiac output/Heart beat; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt ventr; L; LT; LV; Method of discs; Method of disks; MOD-BP; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Surf; SV; ULS; Ultrasound; Ultrasound - 2-dimensional; US.2D.MOD-BP; US.2D.MOD-BP-EL; Ventricular; Vol; Volume/area	4180186
3000222	LV SVI US.2D.MOD-BP-EL	4180186
3000222	/:/::..::.2D...	4182948
3000223	Arg528His; Blood; CACH1; CACN1; CACNA1S p.R528h; CACNL1A3; calcium channel, voltage-dependent, L type, alpha 1S subunit; Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit; Cav1.1; CCHL1A3; DHP receptor; Genetics; Heredity; Heritable; HOKPP; HOKPP1; Hypokalemic periodic paralysis; HypoPP; Inherited; Malignant hyperthermia susceptibility 5; MHS5; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; P prime; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; TTPP1; WB; Whole blood; Whole blood or Tissue	4180186
3000223	CACNA1S p.R528h Bld/T Ql	4180186
3000223	CACA1S .p.R528H:::/::	4182948
3000224	5MTHF-Hcys-MT Ser-cCnc	4180186
3000224	5Me-tetrahydrofolate; 5MTHF; 5MTHF-Hcys-MT; Catalytic Concentration; Chemistry; HCY; Hcys; Hcyst; Homocyst(e)ine; Methyl transferase; MTR; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
3000224	5-::::	4182948
3000226	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
3000226	HLA-Cw6 Ql	4180186
3000226	HLA-Cw6:::/:	4182948
3000227	Chemistry; DCA; Deoxycholic acid; DO-cholate; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
3000227	DO-cholate Ser-mCnc	4180186
3000227	::::	4182948
3000231	Tricyclics SerPl-mCnc	4180186
3000231	Antidepres; Antidepressant; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCA; Tricyclics	4180186
3000231	:::/:	4182948
3000232	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; R rickettsi; R rickettsii; Random; Ricket; Rickettsial; RMSF; Rocky mountain spotted fever; Screen; Serum; Spotted fever; SR; Time Resolved Fluorescence; TRF	4180186
3000232	R rickettsi Ab Ser Ql IF	4180186
3000232	 :::::	4182948
3000233	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Enc; Enceph; Encephalomyelitis; Flavivirus; Hemagglutination inhibition; HI; ID; Infectious Disease; InfectiousDisease; Japanese B encephalitis; Japanese encephalitis; JBE; JE virus; JEV; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
3000233	JEV Ab Ser HAI-aCnc	4180186
3000233	 :::::	4182948
3000236	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Nalidix; Nalidixic acid; NEG; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
3000236	Nalidixate Islt MIC	4180186
3000236	:::::	4182948
3000237	AFB; Ansamycin; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Mycobutin; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
3000237	Rifabutin Islt SlowMyco	4180186
3000237	:::::	4182948
3000239	CV A9 Ab Titr CSF CF	4180186
3000239	 A9  :::::	4182948
3000239	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Cerebral spinal fluid; Cerebrospinal Fl; CF; Comp fixation; Compfix; Complement fixation; Coxsackie; Coxsackie virus; CV; CV A9; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr	4180186
3000242	Alzheimer disease; Alzheimer's disease; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Mass concentration; Neuro; Neurology; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
3000242	Tau Prot CSF-mCnc	4180186
3000242	Tau ::::	4182948
3000244	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zoloft	4180186
3000244	Sertraline SerPl-mCnc	4180186
3000244	:::/:	4182948
3000246	Acd; Acid fast Kiny Stn; Acid fast Mod Kiny Stn; Acid fast Stn; Acids; AFB stain; I belli; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; St; Stains; Stn; To be specified in another part of the message; UniversalLabOrders; Unspecified	4180186
3000246	I belli Spec Ql Acid fast Mod Kiny Stn	4180186
3000246	:::XXX::.Kinyoun 	4182948
3000249	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Mulberry; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t070; t70; White mulberry	4180186
3000249	Deprecated White mulberry IgE Qn	4180186
3000250	S paraty B H Ab Titr Ser	4180186
3000250	 B  H ::::	4182948
3000250	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bombay AB; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Paratyph; Paratyphoid; Point in time; Random; S paraty; S Paraty B; S paraty B H; S paratyph; S paratyphi; Sal; Sal paratyph; Sal paratyphi; Salmonel; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
3000251	Antigen; Antigens; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Throat; Upper respiratory	4180186
3000251	FLUBV Ag Throat Ql	4180186
3000251	 B  ::::	4182948
3000252	DRUG/TOXICOLOGY; Drugs; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000252	levoFLOXacin Trough SerPl-mCnc	4180186
3000252	^:::/:	4182948
3000254	LH 40M p chal SerPl-sCnc	4180186
3000254	40M p chal; After; CHEMISTRY.CHALLENGE TESTING; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; Level; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
3000254	^XXX40:::/:	4182948
3000255	Arsenic Gast-mCnc	4180186
3000255	AS; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
3000255	::::	4182948
3000259	ID; Infectious Disease; InfectiousDisease; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
3000259	Yeast UrnS Ql Micro	4180186
3000259	:::::.	4182948
3000261	LDL SerPl-mCnc	4180186
3000261	B; Chemistry; LDL; Level; Lip; Lipoprot; Lipoproteins; Low density lipoproteins; LP; Mass Concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000261	.Beta:::/:	4182948
3000262	EYE; EYE.GLASSES; Glasses Rx; Length; Ophthalmology; Ophtho; Ophthy; PD; PD monoc; Point in time; QNT; Quan; Quant; Quantitative; R; R glasses Rx; Random; RT; Rx	4180186
3000262	R glasses Rx PD monoc	4180186
3000262	:::..:	4182948
3000268	Sulfalazine IgE Qn	4180186
3000268	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
3000268	 .IgE::::	4182948
3000273	Butacote; Butadion; Butadione; Butazolidin; Butazone; Butrex; c231; C57; Carudol; Cotylbutazone; Dose med or substance; DRUG DOSES; Exiheudon N; Inflazone; Intrabutazone; Kadol; Novobutazone; Point in time; QNT; Quan; Quant; Quantitative; Random; Spondyril; Ticinil	4180186
3000273	Phenylbutazone Dose	4180186
3000273	::::	4182948
3000274	C rumin; C ruminantium; Cowdriosis; DNA NUCLEIC ACID PROBE; DNA probe; Heartwater; Hidrocarditis infecciosa; ID; Idropericardite dei ruminati; Infectious Disease; InfectiousDisease; Malkopsiekte; Microbiology; Misc; Miscellaneous; Ordinal; Other; Pericardite exsudative infectieuse; Point in time; PR; QL; Qual; Qualitative; Random; ribosomal RNA; Screen; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
3000274	C rumin rRNA Spec Ql Probe	4180186
3000274	 rRNA:::XXX::DNA	4182948
3000276	Art; Cardio; Cardiology; Count/time; DOP; DUPLEX; Echography; Heart beat; Heart Disease; HEART RATE.MOLEC; nRate; Number rate; Number Rate = Count/Time; Periph; Periph a; Point in time; Pulse; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
3000276	Heart rate Periph a DOP	4180186
3000276	:::::.	4182948
3000280	HYDROmorphone CtO Ur Scn-mCnc	4180186
3000280	CtO; Dihydromorphinone; Dilaudid; DRUG/TOXICOLOGY; Drugs; Hydromorphinone; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn	4180186
3000280	 :::::	4182948
3000281	Abd; Abdo; Abdomen+; Abdominal; Bx; c; Contr; Contra; Contrst; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Hepar; Hepatic; Imaging; Point in time; Rad; RADIOLOGY; Random; Transjugular Bx; W contr IV; WC	4180186
3000281	RF Guided Liver TJ Bx--W contr IV	4180186
3000281	^:::>::	4182948
3000283	Alc; alcoholic; Alcohol-substance abuse rehabilitation Tx; ATTACH; ATTACH.REHAB; ATTACH.REHAB.ABUSE; Complex; Medication.administered; Point in time; Random; Rehabilitation Tx; Subs; Tx	4180186
3000283	:::-:	4182948
3000284	Distal metatarsals; Document; EXT; Extr-R; Films; Finding; Findings; Imaging; Interphalangeal joints; LE; Leg; LE-R; Low; Metatarsophalangeal Joints; Phalanges; Plain Films; Point in time; R; Rad; RADIOLOGY; Random; RLE; RT; Toe; Toes-R; View; VWS; Xray; X-ray	4180186
3000284	XR Toes-R Views	4180186
3000284	:::.>::X	4182948
3000285	Blood; Chemistry; Level; Na; Na+; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UniversalLabOrders; WB; Whole blood	4180186
3000285	Sodium Bld-sCnc	4180186
3000285	::::	4182948
3000286	3h p L-D PO; After; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Left; Level; Levo; Mammatropic hormone; Mammotropin; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000286	Prolactin 3h p L-D PO SerPl-mCnc	4180186
3000286	^3:::/:	4182948
3000289	3,4-Dihydroxyphenylalanine; 3-Hydroxy-L-tyrosine; Dihydroxyphenylalanine; DRUG/TOXICOLOGY; Drugs; L-dopa; Level; Levo-dopa; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinemet; SR	4180186
3000289	L-Dopa SerPl-mCnc	4180186
3000289	:::/:	4182948
3000290	ABS; Aby; American plague; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; yellow jack; YFV	4180186
3000290	YFV IgG Ser-aCnc	4180186
3000290	 .IgG::::	4182948
3000291	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cysticercosis; Cysticercus; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; T sol; T sol lar; T solium; Tapeworm	4180186
3000291	T sol lar IgM Ser-aCnc	4180186
3000291	 .IgM::::	4182948
3000293	Atrial; Cardiac; Cardio; Cardiology; Echography; Fetal; Finding; Findings; Gyn; Gynecology; Heart Disease; Hrt; Hrt.atria; Hrt.atria^Fetus; Narrative; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; Random; Report; Sonogram; Sonograph; Sonography; Study report; ULS; Ultrasound	4180186
3000293	US Hrt.atria Fetus Study	4180186
3000293	:::.^::	4182948
3000295	Airway resist; Average; Avg; Breathing; Calc; Calculation; Fluid resistance; Lung; Lungs; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; RAW; Resist; Resistanc; Resistant; Resistent; Respiratory; RS; Studies; Study; Sutdies	4180186
3000295	Airway resist Mean Calc	4180186
3000295	.::^:.::	4182948
3000297	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum19; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; Streptococcus pneumoniae 19f; SUDS	4180186
3000297	Deprecated S pneum19 IgG Ser IA-aCnc	4180186
3000298	#; ABS; absolute; absolutes; Blood; CD4 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Helper T cells; Inducer T cells; L3T4; Leu3; Leu-3; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T4; T-4; W3/25; WB; Whole blood	4180186
3000298	Deprecated CD4 Cells # Bld	4180186
3000299	Angplsty; Art; Arteriogram; BrachCeph a; Brachiocephalic; c; Cardio; Cardiology; Contr; Contra; Contrst; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Heart Disease; Imaging; Innominate artery; Point in time; Rad; RADIOLOGY; Random; RFA; Thorax; W contr IA; WC	4180186
3000299	RFA Guided BrachCeph a Angio--W contr IA	4180186
3000299	^:::>::.	4182948
3000300	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Contagious agalactia; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; M agalactiae; MEIA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Vet; Veterinary	4180186
3000300	M agalactiae Ab Ser Ql IA	4180186
3000300	 :::::	4182948
3000301	Heavy Metals 24h Ur Ql	4180186
3000301	1 day; 24 hours; 24HR; DRUG/TOXICOLOGY; Drugs; Heavy met; Metal; Ordinal; PR; QL; Qual; Qualitative; Screen; UA; UR; Urn	4180186
3000301	::24::	4182948
3000303	Abd; Abdo; Abdomen; AC; der US; Echography; Fetal; Girth; Gyn; Gynecology; Kidney; Len; Length Ratio; Nephric; Nephrology; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
3000303	Fet Kidney len/AC der US	4180186
3000303	/:::^::.	4182948
3000304	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Beaver fever; Bowel movement; DFA; FA; Faecal; Faeces; Fecal; Feces; Fluorescent antibody; Fluoresent; G duodenalis; G intestinalis; G lamblia; Giardiasis; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Lamblia intestinalis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal; Time Resolved Fluorescence; TRF	4180186
3000304	G lamblia Ag Stl Ql IF	4180186
3000304	 :::::	4182948
3000305	Antigen; Antigens; CF; Comp fixation; Compfix; Complement fixation; Enc; Enceph; Encephalomyelitis; Equin; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Togavirus; Unspecified; VEE virus; VEEV	4180186
3000305	VEEV Ag Spec Ql CF	4180186
3000305	 :::XXX::	4182948
3000306	CV A9 Ab Titr CSF	4180186
3000306	 A9  ::::	4182948
3000306	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Cerebral spinal fluid; Cerebrospinal Fl; Coxsackie; Coxsackie virus; CV; CV A9; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr	4180186
3000307	ENA PM/SCL Ab Ser-aCnc	4180186
3000307	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ENA; ENA PM/SCL; Evening; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Scleroderma; Scleroderma ab; Serology; Serum; SR	4180186
3000307	PM-SCL  ::::	4182948
3000308	Wheal 2D p .1mL Trichophyt Diam	4180186
3000308	2D p .1mL Trichophyt; After; Dermatologic; Diameter; Epidermis; Identifier; Integument; Intradermal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; React; Rx wheal; Rxn; Skin test; SKIN TESTS; Skn	4180186
3000308	^0.1 mL2::::	4182948
3000310	Clozapine metabolite; Clozaril; Desmethylclozapine; DRUG/TOXICOLOGY; Drugs; FazaClo; Leponex; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000310	cloZAPine+Nor SerPl-mCnc	4180186
3000310	+:::/:	4182948
3000311	Enolase RBC-cCnc	4180186
3000311	Catalytic Concentration; Chemistry; Erythrocytes; Phosphopyruvate dehydratase; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
3000311	::::	4182948
3000312	EFA Bld-mCnc	4180186
3000312	Acd; Acid; Blood; Chemistry; EFA; Esterif; Fatty acid; Level; Lipid; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
3000312	.::::	4182948
3000316	C psittaci Ab Titr Ser IF	4180186
3000316	 :::::	4182948
3000316	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Avian chlamydiosis; C psittaci; Chlamydia; Chlamydia psittaci; Chlamydial abortion; CPS; Dilution factor; Dilution Factor (Titer); Enzootic abortion of ewes; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ornithosis; Ovine chlamydiosis; Point in time; Psittacosis; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
3000317	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f012; f12; Green pea; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Pea; peas; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
3000317	 .IgE.RAST ::::	4182948
3000317	Deprecated Pea IgE RAST Ql	4180186
3000318	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; e198; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Ser; Serum; SR	4180186
3000318	 .IgE.RAST ::::	4182948
3000318	Deprecated Parakeet Serum IgE RAST Ql	4180186
3000319	Alodorm; APODORM; AREM; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dormigen; Dormo-puren; DRUG/TOXICOLOGY; Drugs; Eatan N; GCMS; Imeson; Insoma; Ipersed; Level; Mass concentration; Mitidin; Mogadan; Mogadon; Nitrados; Nitrazepan; Novanox; Ormodon; Paxadorm; Pelson; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Remnos; Serenade; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somnibel n; Somniper; Somnite; SR; Surem	4180186
3000319	Nitrazepam SerPl Cfm-mCnc	4180186
3000319	:::/::	4182948
3000320	ATTACH; ATTACH.ED; Complex; DEEDS; ED consult pract; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Point in time; Random	4180186
3000320	::::	4182948
3000321	:::/:	4182948
3000321	Cr SerPl-sCnc	4180186
3000321	c609; Chrome; CR; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
3000325	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; IgE RAST; Immune globulin E; Immunoglobulin E; m10; Ordinal; Pleospora tarda; Point in time; PR; QL; Qual; Qualitative; Random; S botryosum; Screen; Serum; SR	4180186
3000325	 .IgE.RAST ::::	4182948
3000325	Deprecated S botryosum IgE RAST Ql	4180186
3000326	Arylsulfatase B Ser-cCnc	4180186
3000326	Aryl sulfatase B; Arylsulfatase B; Catalytic Concentration; Chemistry; GalNAc6S sulfatase; Maroteaux-Lamy disease; MPS VI; Point in time; QNT; Quan; Quant; Quantitative; Random; rh4S; rhASB; Serum; SR	4180186
3000326	N--4-::::	4182948
3000327	AcCoA:Glucosamine AT WBC-cCnt	4180186
3000327	AcCoA:Glucosamine AT; Acetyl-CoA:alpha glucosaminide n-acetyl transferase; Catalytic Content; Chemistry; Leukocytes; MPS III C; Point in time; QNT; Quan; Quant; Quantitative; Random; Sanfilippo disease, type C; WBCs; White blood cells	4180186
3000327	-CoA:::::	4182948
3000328	Abd; Abdo; Abdomen+; Abdominal; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; FNA; Guid; Guide; Guided; Imaging; NDL; Pancr; Pancreatc; Pancreatic; Perc; Point in time; Rad; Radiology; Random	4180186
3000328	CT Guided Pancreas FNA	4180186
3000328	:::>::CT	4182948
3000330	Sp Gr Ur Strip	4180186
3000330	:::::	4182948
3000330	Conc; Concentration; Den; Density; Dip stick; Dipstick; Grav; Point in time; Random; Relative density; SG; SmQn; Sp G; Sp Gr; Sp Grav; Spec; Spec grav; UA; UniversalLabOrders; UR; URINALYSIS; Urn	4180186
3000332	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Associated; Autoantibodies; Autoantibody; Baso; BasoBnd Ab; Basophil release; Basophils; Basos; Blood; bnd; Bph; Crab; f023; f23; Leukocyte histamine reaction; Leukocyte histamine release; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC release; Whole blood	4180186
3000332	Crab BasoBnd Ab Qn	4180186
3000332	 :::::	4182948
3000333	::::	4182948
3000333	Average; Avg; Blood pressure mean; BLOOD PRESSURE MEASUREMENTS.VENOUS.MOLEC; BP; BP mean; Cardio; Cardiology; Heart Disease; Intravenous; IV; MBP; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Venous	4180186
3000333	CVP mean	4180186
3000335	Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; First; Follicle stimulating hormone; FSH; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p chal; Spec; SR	4180186
3000335	FSH sp1 p chal SerPl-mCnc	4180186
3000335	^XXX1:::/:	4182948
3000336	Ribosomal Ab Ser Ql IA	4180186
3000336	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; SUDS	4180186
3000336	 :::::	4182948
3000339	Benzodiaz Vitf Ql	4180186
3000339	Benz; Benzodiaz; Benzodiazepine; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; VitF; Vitreous Fluid; Vitreous humor; Vitreous humour	4180186
3000339	::::	4182948
3000341	12 hours; 12HR; Fld; Flow; Fluid intake G-tube; G tube; IO_INTAKE; IO_INTAKE.TIMED.MOLEC; QNT; Quan; Quant; Quantitative; UGI; Up; Upr GI Tract; Volume Rate; vRate	4180186
3000341	Fluid intake G-tube 12h	4180186
3000341	.::12::	4182948
3000343	Energy; Eye; EYE.RETINAL_RX; Eyeball; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; RT; Treatment; Vision; Visual; YAG intensity	4180186
3000343	R eye YAG intensity	4180186
3000343	YAG :::.:	4182948
3000347	Antigen; Antigens; BLOOD BANK; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
3000347	Cellano Ag RBC Ql	4180186
3000347	Cellano ::::	4182948
3000348	Dip stick; Dipstick; Leuc; Leuk; Leukocytes; Lkcs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; URINALYSIS; Urn; WBC; WBCs; White blood cell; White blood cells	4180186
3000348	Leukocyte esterase Ur Ql Strip	4180186
3000348	:::::	4182948
3000349	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EBO; EBOV; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
3000349	EBOV Ab Ser-aCnc	4180186
3000349	 ::::	4182948
3000350	DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Ludiomil; Mass concentration; Novartis; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
3000350	Maprotiline Gast-mCnc	4180186
3000350	::::	4182948
3000351	BSA Measured	4180186
3000351	Bdy surface; bod; Bodies; BODY SURFACE AREA.ATOM; BSA; Point in time; QNT; Quan; Quant; Quantitative; Random; Surf	4180186
3000351	:::^::	4182948
3000354	Chemistry; HS; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf	4180186
3000354	Heparan sulfate SerPl Ql	4180186
3000354	:::/:	4182948
3000360	Blood; BRCA; BRCA1 c.5382insC; BRCAI; BRCC1; Breast cancer 1, early onset; BROVCA1; FANCS; Genetics; Heredity; Heritable; Inherited; IRIS; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Oncology; Ordinal; Papillary serous carcinoma of the peritoneum; PCR; PNCA4; Point in time; PPP1R53; PR; PSCP; QL; Qual; Qualitative; Random; RNF53; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
3000360	BRCA1 c.5382insC Bld/T Ql	4180186
3000360	BRCA1 .c.5382insC:::/::	4182948
3000361	Glucose 24h Ur-sRate	4180186
3000361	1 day; 24 hours; 24HR; Chemistry; Glu; Gluc; Glucoseur; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
3000361	::24::	4182948
3000362	2D US; Bdy surface; bod; Bodies; BSA; Calc; Calculation; CARD.US; Cardiac; Cardiac output/Heart beat; Cardio; Cardiology; Echography; Heart Disease; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Surf; SV; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume/area	4180186
3000362	LV SVI US.2D+Calc	4180186
3000362	/:/::..::.2D+	4182948
3000364	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
3000364	HLA-Cw3 Ql	4180186
3000364	HLA-Cw3:::/:	4182948
3000366	Breathing; Dynamic; Exp; FEF 25-75%; Flow; Forced expiratory flow rate; Gases; Lung; Lungs; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Volume rate; vRate	4180186
3000366	Gas flow FEV 25-75% airway	4180186
3000366	 25-75% :::.:	4182948
3000367	ATTACH; ATTACH.MEDS; Med; MEDS; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
3000367	 XXX:::.:	4182948
3000369	CD5+CD20+ Cells # WBC	4180186
3000369	#; ABS; absolute; absolutes; B1; B-1; Bp35; CD5 Cells; CD5+CD20+ Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Leu1; Leu-1; Leu16; Leu-16; Leukocytes; Ly-1; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; T1; Tp67; WBCs; White blood cells	4180186
3000369	.CD5+CD20+::::	4182948
3000372	C&S; Cult; Cultures; Fung; Fungal; Fungi; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Microbiology; Nominal; Point in time; Random; Thrush; UniversalLabOrders	4180186
3000372	Fungus Islt Cult	4180186
3000372	 :::::	4182948
3000373	CD42 Cells; Cell; CELL MARKERS; Cellularity; Gated cells; Misc; Miscellaneous; Number fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
3000373	CD42 Cells NFr Spec	4180186
3000373	.CD42/100 :::XXX:	4182948
3000374	Elastase Panc Ser-mCnc	4180186
3000374	Chemistry; ELA; Elastase Panc; Level; Mass concentration; Pancr; Pancreatc; Pancreatic elastase 1; Pancreatic elastase I; Pancreatopeptidase E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
3000374	.::::	4182948
3000378	Addiction; c260; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Morphine sulfate; MS; MSO4; OMPH; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000378	Morphine SerPl Ql	4180186
3000378	:::/:	4182948
3000380	ANTIBIOTIC SUSCEPTIBILITIES; AST; Dynapen; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Pathocil; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Veracillin; Veracilline	4180186
3000380	Dicloxacillin Susc Islt	4180186
3000380	::::	4182948
3000381	HSV2 IgM Titr Ser IF	4180186
3000381	 2  .IgM:::::	4182948
3000381	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; IFA; II; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; UniversalLabOrders	4180186
3000385	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum5; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept	4180186
3000385	Deprecated S pneum5 IgG Ser-mCnc	4180186
3000386	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Avian influenza; Bird flu; FLUA; FLUAV; FLUAV Vic; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
3000386	FLUAV Vic Ab Ser-aCnc	4180186
3000386	 A  Victoria  ::::	4182948
3000391	C1INH Functional SerPl Ql	4180186
3000391	C1 inactivator; C1 inhibiting factor; C1INA; C1INH; C1-INH; C1INH Functional; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Inhib; Inhibit; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000391	 C1 .:::/:	4182948
3000393	Moxalactam Titr SBT	4180186
3000393	:::+::	4182948
3000393	ANTIBIOTIC SUSCEPTIBILITIES; Baxal; Betalactam; Dilution factor; Dilution Factor (Titer); Festamoxin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Latamoxef; Latoxacef; Mactam; Moxacef; Moxalctam; Moxatres; Oxacef; Point in time; Polimoxal; Priolatt; Random; Sectam; Sequence based typing; Serum; SERUM BACTERICIDAL TITER; Serum killing test; Shiomarin; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
3000394	Fet pres; Gyn; Gynecology; Nominal; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Pelvic; Point in time; Random; Typ	4180186
3000394	Fet pres Palpation	4180186
3000394	:::::	4182948
3000396	Deprecated Periph ves DOP Periph plane	4180186
3000396	Document; DOP; DUPLEX; Echography; Finding; Findings; Imaging; Periph; Periph plane; Periph ves; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vesl	4180186
3000399	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Gastro; Gastroenterology; GI; Hematology; Heme; Immune globulin G; Immunoglobulin G; Ordinal; PCA; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
3000399	PCA IgG Ser Ql	4180186
3000399	 .IgG::::	4182948
3000400	Leucine Amn-sCnc	4180186
3000400	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Leu; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
3000400	::::	4182948
3000402	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cod worm; Immune globulin E; Immunoglobulin E; p4; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
3000402	Anisakis IgE Qn	4180186
3000402	 .IgE::::	4182948
3000405	Amphetamine; Benzedrine; DRUG/TOXICOLOGY; Drugs; Ephedrine; Identity or presence; Mescaline; Nominal; Point in time; Random; UA; UR; Urn	4180186
3000405	Sympathomimetics Ur	4180186
3000405	::::	4182948
3000406	5OH-Hexanoate/Creat Ur	4180186
3000406	5-Hydroxy hexanoate; 5-Hydroxycaproate; 5-Hydroxycaproic acid; 5-hydroxyhexanoic acid; 5-hydroxy-hexanoic acid; 5-OH-caproate; 5OH-Hexanoate; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
3000406	5-/::::	4182948
3000408	Churukian-Schenk Stn; Identity or presence; Nominal; Pathology; Point in time; Random; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
3000408	Churukian-Schenk Stn Tiss	4180186
3000408	:::::Churukian-Schenk 	4182948
3000410	Chlorothiazide SerPl Ql	4180186
3000410	Diuril; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000410	:::/:	4182948
3000411	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Trecator	4180186
3000411	Deprecated Ethionamide Islt SlowMyco	4180186
3000414	ENA SM+RNP Ab Ser Ql	4180186
3000414	ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; ENA; ENA RNP; ENA SM; ENA SM+RNP; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Ribonuclear protein; RNP; Ro; Screen; Serology; Serum; SM; SR	4180186
3000414	Smith + ::::	4182948
3000415	DRUG/TOXICOLOGY; Drugs; Haldol; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serenace; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000415	Haloperidol SerPl-mCnc	4180186
3000415	:::/:	4182948
3000417	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Epithelia; Feline; Felis domesticus; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
3000417	Deprecated Cat Hair+Epith IgE Qn	4180186
3000420	5-fluorocytosine Dose	4180186
3000420	Alcobon; Ancobon; Ancotil; Dose med or substance; DRUG DOSES; Flucytosine; Fluorocytosin; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
3000420	5-::::	4182948
3000422	OF .60% NaCl 24h Inc NFr RBC	4180186
3000422	.60% NaCl; .60% NaCl 24h Inc; @37c; Cl; Cl-; degree; Erythrocytes; Frag; Fragil; HEMATOLOGY/CELL COUNTS; Na; Na Cl; Na+; NaCl; Number Fraction; OF; Osmo; Osmo Frag; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
3000422	^0.60%  37 24::::	4182948
3000423	ACIF; ACNA; ACPA; ANCA; Anticomplement Immunofluorescence; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; Granulocyte ab; Granulocyte nucleus ab; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neut; Neutr; Neutrophils; NSNA; Ordinal; pANCA; p-ANCA; Perinuclear ANCA; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF; Vasculitis	4180186
3000423	p-ANCA Ser Ql IF	4180186
3000423	.:::::	4182948
3000424	1st; ATTACH; ATTACH.ED; DEEDS; Emergency Department; EMERGENCY DEPARTMENT (DEEDS); Encounter; Nominal; Resp rate; Resp rate special circumstances; Typ	4180186
3000424	 ::^:^:	4182948
3000425	Antigen; Antigens; HPIV; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Para; Parainflu; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
3000425	HPIV Ag Spec Ql	4180186
3000425	 :::XXX:	4182948
3000427	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue Cheese; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
3000427	 .IgE.RAST ::::	4182948
3000427	Deprecated Blue Cheese IgE RAST Ql	4180186
3000428	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; L monocytog; L monocytogenes; Listeriosis; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
3000428	L monocytog IgG Ser-aCnc	4180186
3000428	 .IgG::::	4182948
3000430	Pyrophos Cry Snv Ql Micro	4180186
3000430	Crys; Cryst; Crystal; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; Pyrophos Cry; Ql; Qual; Qualitative; Random; Screen; SF; SNV; Syn; Syn fl; Synov; Synovial fluid	4180186
3000430	:::::.	4182948
3000432	Art; Average; Avg; Blood pressure mean; BLOOD PRESSURE MEASUREMENTS.VENOUS.MOLEC; BP; BP mean; Cardio; Cardiology; H AWP; Heart Disease; Hep a; Hep a.wedge; Hepar; Hepatic capillary wedge pressure; Intravenous; IV; Liver; Liver artery; MBP; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Venous	4180186
3000432	Hep a.wedge BP mean	4180186
3000432	:::.:	4182948
3000433	Cont lens; Deutsch Optiker Zeitung; EYE; EYE.CONTACT_LENS; L; L cont lens; Length; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
3000433	L cont lens DOZ.inside	4180186
3000433	DOZ.:::.:	4182948
3000434	Argon LT; Argon LT effects; Cnt; Count; Eye; EYE.RETINAL_RX; Eyeball; L; L eye; LT; Number; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Treatment; Vision; Visual	4180186
3000434	L eye Argon LT effects	4180186
3000434	:()::.:	4182948
3000435	Abd; Abdo; Abdomen+; Abdominal; Document; Finding; Findings; Imaging; Plain Films; Point in time; Rad; Radiology; Random; XR tomo; Xray; X-ray	4180186
3000435	XR tomo Abd	4180186
3000435	:::::X.	4182948
3000436	Potassium intake 12h	4180186
3000436	12 hours; 12HR; IO_INTAKE_SALTS+CALORIES; k; K+; Potass; QNT; Quan; Quant; Quantitative; sRate; Substance Rate	4180186
3000436	::12:^:	4182948
3000447	Addiction; Amobarb; Amylobarbitone; Amytal; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
3000447	Amobarbital Ur Ql Cfm	4180186
3000447	:::::	4182948
3000448	Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; ID; Identity or presence; II; Infectious Disease; InfectiousDisease; Isolated; Lower respiratory; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spt; Sputum	4180186
3000448	Bacteria Spt Aerobe Cult org #2	4180186
3000448	 ^^^2:::::	4182948
3000449	Chemistry; CTG; Dextro; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction	4180186
3000449	Cathepsin D SFr SerPl	4180186
3000449	 D:::/:	4182948
3000452	BM IgG Ser Ql	4180186
3000452	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Basem; Basemt; BM; Immune globulin G; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
3000452	 .IgG::::	4182948
3000455	Anaero; Anaerobe; Anaerobe Cult; Bact; Bowel movement; C&S; Cult; Cultures; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Stl; Stool = Fecal	4180186
3000455	Bacteria Stl Anaerobe Cult	4180186
3000455	 :::::	4182948
3000459	AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Formiminoglutamic Acidemia; His; Histidinemia; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
3000459	Histidine Amn-mCnc	4180186
3000459	::::	4182948
3000460	3rd; Brain; Cranial; Cranium; Echoencephalogram; Echoencephalography; Echography; Fetal; Finding; Findings; Gyn; Gynecology; Head.3rd Vent; Head.3rd ventricle^Fetus; Intracranial; Narrative; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; Random; Report; Skull; Sonogram; Sonograph; Sonography; Study report; ULS; Ultrasound; US+Meas	4180186
3000460	US.meas Head.3rd Vent Fetus Study	4180186
3000460	:::.^::.	4182948
3000464	Clinical Care Classification; Finding; Findings; GU; NURSING; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NURSING.HHCC; Tot; Totl	4180186
3000465	 .:::::	4182948
3000465	JCV NAb Titr Ser Nt	4180186
3000465	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; JCV; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Point in time; Random; Serum; Serum virus neutralization; SmQn; SR; SVN; Titer; Titered; Titre; Ttr; Virus neutralization test; VNT	4180186
3000467	ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Lervipan; Point in time; Pondocil; Pondocillin; Proampi; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
3000467	Pivampicillin Islt KB	4180186
3000467	:::::	4182948
3000472	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
3000472	levoFLOXacin Islt Grad strip	4180186
3000472	:::::	4182948
3000475	#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBCs; White blood cell; White blood cells	4180186
3000475	WBC # Snv	4180186
3000475	::::	4182948
3000479	Finding; Findings; Interpersonal Relationship Status; NURSING; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NURSING.OMAHA	4180186
3000481	Antigen; Antigens; ERA+PGRA; Est; Estr; Estroge; Estrogens; Estrone+estradiol; Estrone+estradiol+estriol; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Oncology; Ordinal; P4; Pathology; PGRA; Point in time; PR; PRA; Prog; Proges; Progest; Progestin; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
3000481	ERA+PGRA Ag Tiss Ql ImStn	4180186
3000481	+ :::::	4182948
3000482	CD; Cerebral spinal fluid; Cerebrospinal Fl; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
3000482	Cadmium CSF-mCnc	4180186
3000482	::::	4182948
3000484	Manganese/Creat 24h Ur	4180186
3000484	1 day; 24 hours; 24HR; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; MN; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn	4180186
3000484	/::24::	4182948
3000486	Antiglob; Arbitrary concentration; BLOOD BANK; DAGT; DAT; DCT; Dir; Direct Coomb; Direct coombs test; Erythrocytes; Ordinal; Point in time; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen; Spec	4180186
3000486	Deprecated DAT Poly-Sp Reag RBC Ql	4180186
3000488	Disch; Exam; Examination; Finding; Findings; H+P; H+P.HX; Hosp; Nominal; P prime; Phys find; Point in time; Random	4180186
3000488	:::^:	4182948
3000493	Elliptocytes Bld Ql Smear	4180186
3000493	Blood; Elliptocyte; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
3000493	:::::.	4182948
3000501	Calc; Calculi; Chemistry; Crys; Cryst; Crystal; Gastro; Gastroenterology; GI; Infared spectoscopy; IR; Kidney; Magnesium hydrogen phosphate trihydrate; MgHPO4-3H2O; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; Stn; Stone; Stones	4180186
3000501	Newberyite Cry Stone Ql IR	4180186
3000501	:::::	4182948
3000505	Urea nit sp8 DiafP-mCnc	4180186
3000505	Blood urea nitrogen; Chemistry; Diaf; DiafP; Dialysate; Dialysis fluid; Level; Mass concentration; N; N2; Nit; Peritoneal Dialysis fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; sp8; Spec; UN	4180186
3000505	^8::::	4182948
3000508	Blood flow.diastolic.early wave.max; Cardio; Cardiology; DOP; DUPLEX; Early wave; Echography; E-wave; Fetal; Gyn; Gynecology; Heart Disease; Largest; Max V; Maximal; Maximum; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Peak; Peak E-wave; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; TV; ULS; Ultrasound; V max; Velocity; Vmax	4180186
3000508	Fet TV Peak E-wave DOP	4180186
3000508	E .:::^::.	4182948
3000513	c232; c251; CLID; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Xylocaine	4180186
3000513	Lidocain SerPl-sCnc	4180186
3000513	:::/:	4182948
3000516	Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; GLB; Glob; Glob%; Globul; Globulins; Joint aspirate; Joint fld; Joint flu; Joint fluid; Level; Mass concentration; Point in time; Protein gamma globulin; QNT; Quan; Quant; Quantitative; Random; Rheum; Rheumatology; SF; SNV; Syn; Syn fl; Synov; Synovial fluid	4180186
3000516	Gamma glob Snv Elph-mCnc	4180186
3000516	Gamma :::::	4182948
3000518	100WBC; abn; abnorm; Atypical; Blood; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lymp; Lymph; Lymph Abn; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
3000518	Lymph Abn/leuk NFr Bld Manual	4180186
3000518	./100 :::::	4182948
3000523	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; Coccidioides esteriformis; Coccidiomycosis; Coccio; EIA; ELFA; ELISA; Enzyme immunoassay; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; Pseudococcidioides mazzai; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; Serum; SR; SUDS; T proteolyticum; Trichosporon proteolyticum; Valley fever	4180186
3000523	C immitis IgA Ser IA-aCnc	4180186
3000523	 .IgA:::::	4182948
3000526	2D US; CARD.US; Cardiac; Cardio; Cardiology; DIA; Diam; diam S; Diam sys, short; Echography; Heart Disease; Hrt; Hrt ventr; L; Length; LT; LV; LVIDS; Minor axis systole; Point in time; QNT; Quan; Quant; Quantitative; Random; SAX; short axis; Sonogram; Sonograph; Sonography; Sys; Syst; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular	4180186
3000526	LV Diam sys, short 2D US	4180186
3000526	..:::..::.2D	4182948
3000527	# spec obtained; Cnt; Count; Endoscopy; Esophagogastro duodenoscopy; Esophagogastroduodenoscopy; Gastro; Gastroenterology; GI; GI.ENDOSCOPY; No; Num; Number; QNT; Quan; Quant; Quantitative; Studies; Study; Sutdies; UGI; Up	4180186
3000527	# spec obtained UGI EGD	4180186
3000527	:()::.::	4182948
3000528	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dis; Diseases; Dz; ID; Infectious Disease; InfectiousDisease; Kisanyi goat disease; Microbiology; Nairobi sheep disease; Nairovirus; NSDV; Ordinal; Ovine; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary	4180186
3000528	NSDV Ab Ser Ql	4180186
3000528	 ::::	4182948
3000536	A artemisiifolia; A elatior; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Ambrosia artemisiifolia; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Common ragweed; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Short ragweed; SR; w001; w1	4180186
3000536	Deprecated Common Ragweed IgE Qn	4180186
3000537	3; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; P prime; P wave; P' wave Amp L-III; P wave Amp L-III; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage	4180186
3000537	P' wave Amp L-III	4180186
3000537	P' . III:::::	4182948
3000538	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; E nigrum; E purpurascens; Epicoccum nigrans; Epicoccum nigrum; Epicoccus purpurascens; IgE RAST; Immune globulin E; Immunoglobulin E; m14; m73; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
3000538	 .IgE.RAST ::::	4182948
3000538	Deprecated E purpurascens IgE RAST Ql	4180186
3000541	Mononuc Cells # Snv	4180186
3000541	#; ABS; absolute; absolutes; Cell; Cellularity; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Mononuc; Mononuc Cells; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid	4180186
3000541	::::	4182948
3000544	#/area; Benzyl alcohol metabolite; Crys; Cryst; Crystal; Hipp; Hippramine; Hippuran; Hippuric acid; Hiprex; HIP-REX; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Toluene metabolite; UA; UR; Urex; URINALYSIS; Urine sediment; Urn; UrnS; Urotractan	4180186
3000544	Hippurate Cry #/area UrnS HPF	4180186
3000544	:::::..	4182948
3000545	2.5h p 50 g Lac PO; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; Mass concentration; p 50 g Lact PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
3000545	Glucose 2.5h p 50 g Lac PO SerPl-mCnc	4180186
3000545	^50 g2.5:::/:	4182948
3000550	Chemistry; HGA; Homogen; Homogentisic acid; Homogentistic acid; Level; Mass concentration; Melanate; Melanic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
3000550	Homogentisate Ur-mCnc	4180186
3000550	::::	4182948
3000552	Mesterolone 24h Ur-mRate	4180186
3000552	1 day; 24 hours; 24HR; DRUG/TOXICOLOGY; Drugs; Mass rate; Mestoranum; mRate; Proviron; Pro-viron; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
3000552	::24::	4182948
3000556	Aspirate; Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn	4180186
3000556	Gram Stn Aspirate	4180186
3000556	:::::	4182948
3000559	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Enc; Enceph; Encephalomyelitis; Flavivirus; ID; Infectious Disease; InfectiousDisease; Japanese B encephalitis; Japanese encephalitis; JBE; JE virus; JEV; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
3000559	JEV Ab CSF Ql	4180186
3000559	 ::::	4182948
3000562	18OH-Cortis 24h Ur-mCnc	4180186
3000562	1 day; 18OH-Cortis; 24 hours; 24HR; Chemistry; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
3000562	18-::24::	4182948
3000564	L pneumo Ab sp2 Titr Ser IF	4180186
3000564	 ^2:::::	4182948
3000564	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Convalescent; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; L pneumo; L pneumonphila; Legion; Legionela; Microbiology; Pneu; pneum; Pneumophilia; Point in time; Post immunization; Random; Second; Serum; SmQn; sp2; Spec; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
3000565	Dose med or substance; DRUG DOSES; Point in time; QNT; Quan; Quant; Quantitative; Random; Tambocor	4180186
3000565	Flecainide Dose	4180186
3000565	::::	4182948
3000566	AS; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
3000566	Arsenic Ur-mCnc	4180186
3000566	::::	4182948
3000567	Chemistry; Eye; Level; Na; Na+; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Vitf; Vitreous fluid; Vitreous humor; Vitreous humour	4180186
3000567	Sodium Vitf-sCnc	4180186
3000567	::::	4182948
